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ABSTRACT 
More than 650,000 people per year in the United States are affected by End Stage Renal 
Disease (ESRD) (US Renal Data System, 2013).  This diagnosis affects many areas of the 
patient’s life and patients have limited options for treatment. Kidney transplantation for patients 
with ESRD continues to be noted as the most optimal treatment (Rubin & Weir, 2015; Maggiore, 
et al., 2014; Patzer, Platinga, Krisher, & Pastan, 2014).  However, despite this information, 
utilization of transplantation remains inconsistent and variable in the population.   
There are many areas of disparities regarding the kidney transplant waitlist including wait 
times, gaining access to the wait list, and being changed to inactive status.  This paper will 
discuss the reasons identified in the literature for these inequalities and will also explore the 
impact that the demographics of the patient play a role in their ability attempt to better to be 
waitlisted.   Transplant recipients will be surveyed and also interviewed to gather more 
information on the transplant wait list process and possible reasons for the inequalities.     
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CHAPTER ONE: INTRODUCTION 
 More than 650,000 people per year in the United States are affected by End Stage Renal 
Disease (ESRD) (US Renal Data System, 2013).  Patients with this diagnosis have limited 
options for treatment. Some patients may choose to delay treatment, not pursue treatment at all 
or choose between either dialysis or kidney transplantation.  Kidney transplantation for patients 
with ESRD continues to be noted as the most optimal treatment (Rubin & Weir, 2015; Maggiore, 
et al., 2014; Patzer, Platinga, Krisher, & Pastan, 2014).  Compared to dialysis, transplantation 
offers patients increased quality of life and decreased mortality (Davis, et al., 2014).  However 
despite this information, utilization of transplantation remains inconsistent and variable in the 
population.   
Article 25 of the Universal Declaration of Human Rights states that “everyone has the 
right to a standard of living adequate for the health and well-being of himself and of his family, 
including food, clothing, housing and medical care and necessary social services, and the right to 
security in the event of unemployment, sickness, disability, widowhood, old age or other lack of 
livelihood in circumstances beyond his control” (United Nations, 1948).  In the U.S. there is 
evidence that many disparities persist in regard to access to needed health care.  These disparities 
are also evident in the area of kidney transplantation and access to kidney transplantation 
waitlists.   
Research has shown that organ transplantation access is problematic for many people in 
the United States.  As of January 2016, “there are currently 121,678 people waiting for lifesaving 
organ transplants in the U.S.  Of these, 100,791 await kidney transplants” (National Kidney 
Foundation, 2016, para 1). Many attempts have been made to improve the organ transplantation 
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process.  This research will focus specifically on one of these methods, the kidney transplant 
waitlist, and specifically sources of variability in access to the waitlist. 
 The organization of this thesis starts with an explanation of kidney disease including the 
criteria required for diagnosis at each stage of the disease.  The treatment options for each stage 
will also be discussed along with the steps in the transplant process, including access to 
transplant waitlists.  Evidence of disparities in all areas of the transplantation process will be 
identified and discussed in order to inform the central research question and to identify the 
reasons for disparities in access to transplant waitlists.  Fundamental cause theory will be 
discussed as it relates to kidney transplant waitlist variability and will guide the construct of the 
research questions.  The focus of this study is specifically on what factors contribute to race and 
ethnic differences in the transplant list, which ultimately affects the likelihood of receiving a 
transplant (Eggar, 2009). 
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CHAPTER TWO: LITERATURE REVIEW 
Kidney Disease 
When discussing the transplant waitlist, it is important to first give an overview of kidney 
disease, symptoms, possible interventions and explain how a person may find themselves in need 
of a transplant.  Chronic kidney disease is a public health problem with an estimated 26 million 
people diagnosed in the United States (National Kidney Foundation, 2016; Levey, et al., 2005).  
Unfortunately, most people who have this disease may not even know they have it because, 
many times, it goes undetected (National Kidney Foundation, 2016). This may be due to not 
receiving regular, routine health checkups.  It may also be due to lack of health insurance, lack of 
transportation, lack of health literacy, income, or lack of resources to afford necessary medical 
procedures (National Coalition for the Homeless, 2009).  Kidney disease that goes undetected 
can cause many other medical issues such as heart disease and can result in permanent kidney 
failure and ESRD (National Kidney Foundation, 2015).   
Symptoms of kidney disease differ at each stage of the diagnosis and symptoms may 
present differently in different patients (American Kidney Fund, 2016).  In the early stages of 
kidney disease, some of the symptoms may include itching, difficulty catching your breath,, 
swelling, loss of appetite, high blood pressure, changes in urine function, difficulty sleeping, 
nausea and vomiting and muscle cramps (American Kidney Fund, 2016; Mayo Clinic, 2016; 
National Kidney Foundation, 2016).         
Acute Kidney Injury (AKI) is defined as “a syndrome that results in a sudden decrease in 
kidney function or kidney damage within a few hours or few days” (National Kidney 
Foundation, 2016a, para 1).  This diagnosis tends to be more common for patients already in the 
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hospital setting and consists of waste buildup in the blood resulting in difficulties for the kidneys 
ability to control fluid in the body (National Kidney Foundation, 2016a).  AKI can lead to 
Chronic Kidney Disease (CKD) or even End Stage Renal Disease (ESRD). 
Chronic Kidney Disease has been classified into five stages by the National Kidney 
Foundation (2016b); these stages are utilized to best identify the patient’s diagnosis in order to 
provide the best plan of care.  In order to test a person’s kidney function and to calculate their 
stage of illness, the Glomerular Filtration Rate (GFR) is calculated (Davita, 2016).  The “GFR 
number tells how much kidney function you have” (National Kidney Foundation, 2016c, para 2).  
This test consists of a mathematical formula that is utilized with information including the 
person’s age, body size, race, gender and their level of serum creatinine (Davita, 2016; National 
Kidney Foundation, 2016c).  Creatinine is defined as “a waste product in your blood that comes 
from muscle activity…when kidney function slows down, the creatinine level rises” (National 
Kidney Foundation, 2016b, para 2).   
Healthy kidneys are able to remove creatinine from the blood; failing kidneys are less 
able to remove creatinine and the GFR goes down as kidney disease progresses.  Kidney damage 
is identified by a certain protein called albumin in the patient’s urine (National Kidney 
Foundation, 2016c).  Having albumin in the urine can be an early sign of kidney disease and 
patients with a large amount of this protein “are at an increased risk of having chronic kidney 
disease progress to kidney failure” (National Kidney Foundation, 2016c, para 5).   The figure 
below displays the amount of risk for the patient in each stage of CKD with the albumin level 
categories.           
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 Albuminuria categories 
A1 A2 A3 
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Severely 
increased 
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G1 Normal or high > 90 * ** *** 
G2 Mildly decreased 60-90 * ** *** 
G3a Mildly to moderately 
decreased 
45-59 ** *** + 
G3b Moderately to severely 
decreased 
30-44 *** + + 
G4 Severely decreased 15-29 + + ++ 
G5 Kidney Failure <15 ++ ++ ++ 
*Low Risk                                       +Very High Risk 
**Moderately Increased Risk          ++ Highest Risk  
*** High Risk 
Figure 1:Albumin Levels. 
Stages of CKD 
Stage 1 of CKD includes patients with a normal GFR or high level greater than 90 
ml/min (Davita, 2016; Cash & Glass, 2010).  Stage 2 of CKD includes patients with a GFR 
between 60 and 89 ml/min (Davita, 2016; Cash & Glass, 2010).  Patients typically do not even 
realize there has been a loss in kidney function in either of these two stages and there may not be 
any symptoms of kidney damage at this stage.  Hypertension, however, is usually present in early 
stages of kidney disease (Cash & Glass, 2010).  Davita (2016) states that patients in these stages 
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may only be diagnosed when getting testing done for other illnesses including diabetes and high 
blood pressure.  These two conditions have been noted to be the two leading causes of kidney 
disease (Davita, 2016; American Kidney Fund, 2016; Mayo Clinic, 2016; National Kidney 
Foundation, 2016).   
 A person with Stage 3 of CKD would be considered to have moderate kidney damage 
(Davita, 2016; The Renal Association, 2013; Mayo Clinic, 2016).  Stage 3 has been split into two 
separate categories; Stage 3A and Stage 3B.  Stage 3A consists of patients with GFR between 
45-59 mL/min and Stage 3B consists of patients with GFR between 30-44 mL/min (Davita, 
2016; The Renal Association, 2013).  The reason that this stage is divided into two categories is 
due to the increased risk of cardiovascular disease and CKD progression with the lower GFRs 
(Henry Ford Health System, 2011).  As stated previously, as the kidney function declines, the 
waste products continue to build up in the blood (Cash & Glass, 2010).    
 A person with Stage 4 CKD would be considered to have advanced kidney damage 
(Davita, 2016; The Renal Association, 2013).  In this stage, the GFR falls to a more severe level 
between 15-30 ml/min.  This is the stage where options such as dialysis, or future transplant 
discussions become necessary (Davita, 2016; Mayo Clinic, 2016 American Kidney Fund, 2016; 
National Kidney Foundation, 2016).  Many other symptoms and conditions become evident in 
this stage due to the increased waste buildup in the blood.  Davita (2016) notes some of these 
conditions to be heart and cardiovascular diseases, high blood pressure, bone disease and anemia.   
 The last stage of CKD is Stage 5.  When a person finds themselves at this stage, they are 
identified as having End Stage Renal Disease (ESRD).  This is when the GFR falls at or below 
15 ml/min (Davita, 2016; The Renal Association, 2013).  The kidneys have now been severely 
affected and can no longer function effectively.  They lose the ability to filter out the waste in the 
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bloodstream which then begins to build up.  They also begin to lose the ability to regulate blood 
pressure.  The person will begin feeling ill with symptoms such as nausea, vomiting, less urine 
production or no urine production, muscle cramps, etc. (Davita, 2016; Mayo Clinic, 2016 
American Kidney Fund, 2016; National Kidney Foundation, 2016).  Below is a table 
summarizing the stages of CKD and the GFR levels associated with each stage.  
  Table 1. Stages if CKD and GFR Levels 
 
CKD Stages Description GFR Levels 
At increased risk Risk factors for kidney disease* More than 90 
1 Kidney damage with normal kidney function 90 or above 
2 Kidney damage with mild loss of kidney function 89 to 60 
3a Mild to moderate loss of kidney function 59 to 44 
3b Moderate to severe loss of kidney function 44 to 30 
4 Severe loss of kidney function 29 to 15 
5 Kidney failure Less than 15 
*(e.g., diabetes, high blood pressure, family history, older age, ethnic group) 
                      
It is important to note the population differences in the diagnosis of ESRD.  In January 
2016, there were about 660,000 people documented as having ESRD (National Kidney 
Foundation, 2016).  Of these patients about 57% (378,185) were male and about 43% (281,604) 
were female (National Kidney Foundation, 2016).   ESRD occurs disproportionately in African 
Americans, with 30.68% of patients diagnosed with ESRD as black/African American, 61.73% 
of these patients identified as white, 16.91 % Hispanic, 5.58% Asian, and 1.09% American 
Indians (National Kidney Foundation, 2016).  Patients with family history of kidney failure or 
comorbidities such as diabetes or heart disease are more at risk of developing ESRD (National 
Kidney Foundation, 2016). 
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Treatment Options 
 In stages 1 and 2 of CKD, the treatment options usually include emphasis on a healthy 
diet plan.  This diet consists of foods high in protein, low in sodium and saturated fats, and 
includes fruits, vegetables and grains.  Davita (2016) also notes the importance of keeping blood 
pressure at healthy levels in these stages.  When diagnosed with Stage 3 CKD, treatment options 
also include discussion of diet but this stage also includes working with a dietitian as well as a 
nephrologist.  The nephrologist can order lab tests to monitor the patient and the dietitian can 
utilize the results of this lab work to assist with developing an appropriate diet plan to extend the 
life of the kidney (Davita, 2016).   
 When diagnosed with either Stage 4 or 5 of CKD, more intense treatment options are 
necessary.  The discussion of dialysis (described in detail below) as a treatment option begins 
when a patient is diagnosed with Stage 4 CKD (Davita, 2016).  Following up with a nephrologist 
and having routine lab tests are imperative.  Patients with Stage 5 CKD or ESRD, will need to 
begin dialysis and discussion of eligibility for transplant options and waitlisting should occur as 
well (Davita, 2016 American Kidney Fund, 2016; Mayo Clinic, 2016; National Kidney 
Foundation, 2016).      
 
Dialysis 
Dialysis is the medical procedure necessary for patients with kidney failure.  Dialysis is 
the artificial system for cleaning the patient’s blood (Emory Healthcare, 2016).  Some patients 
with acute kidney injury (AKI) may only need dialysis for a short period of time and then their 
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kidneys return to normal functioning (Levy, Brown, & Lawrence, 2015).  For others, when 
kidney failure is chronic (ESRD), the kidneys will never return back to normal functioning 
(Davita, 2016).  These patients will either be on dialysis for the remainder of their lives or they 
will be on dialysis until they are able to obtain a kidney transplant.  
 The unfortunate thing about dialysis is that it is not a long term, lifesaving intervention.  
The average life expectancy while on dialysis some say is 3 to 5 years, therefore transplantation 
is necessary for survival (Stokes, 2011).  Figure 1 displays the differences among treatment 
modality in ESRD patients (National Institute of Diabetes and Digestive and Kidney Diseases, 
NIDDK, 2012).  
  
Figure 2: Number of ESRD Patients by Treatment Modality.  
There are two different dialysis modalities, hemodialysis (In-center or at home) and 
peritoneal dialysis (continuous cycler-assisted or continuous ambulatory).     
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Hemodialysis  
Hemodialysis is the treatment modality consisting of a dialysis filtering system which 
removes small quantities of the patient’s blood in order to filter out the toxins and then the 
filtered blood is returned to the patient’s body (Davita, 2016).  Hemodialysis requires the patient 
have an access point where two needles connected to tubing are inserted.  One needle takes the 
blood from the patient and the other needle returns it (Emory Healthcare, 2016; Davita, 2016).   
This type of dialysis requires patients to have these treatments three times per week for 
anywhere from two and a half hours to four hours per treatment (Emory Healthcare, 2016).  
Typically this treatment is done in a dialysis center but patients also have the option of having 
the treatments at home which provides the patient with the opportunity to adjust treatment to 
their schedule. For in home hemodialysis, the patient and a caretaker are properly trained on 
treatment requirements (Emory Healthcare, 2016).   
Peritoneal Dialysis 
Peritoneal Dialysis is similar to hemodialysis in that the blood is cleansed however, with 
this treatment, a tube in placed in the abdomen (specifically in the peritoneal cavity) and a 
special solution is added in (Emory Healthcare, 2016).  The solution absorbs the waste product 
and is then drained from the body after a prescribed amount of time (Mayo Clinic, 2016).  This 
treatment is needed four to five times per day (Emory Healthcare, 2016).  This type of treatment 
may not be appropriate for all patients as the patient would need to be able to take care of 
themselves or would need the assistance of a reliable caregiver if they were unable to do so 
themselves (Mayo Clinic, 2016).  
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Prevalence of Dialysis Modalities by Population Subgroups 
 Out of all dialysis modalities 57% were male patients and 43% were females in 2015 
(USRDS, 2015).  In terms of race, out of all dialysis modalities, 57% of the patients were white, 
35% were black, 18% identified as Hispanic, 1% identified at Native American, 6% were Asian, 
and about .5% were labeled as other/unknown (USRDS, 2015).   
 In the table below, the differences amongst dialysis modalities by race and gender are 
depicted (USRDS, 2015). There is only small variability in dialysis type by gender, race and 
ethnicity. 
Table 2: Dialysis Treatment Modalities 
Type of Dialysis Male Female White Black Native Asian Hispanic 
Peritoneal 10% 10% 11% 7% 8% 13% 9% 
Hemodialyis 90% 89.4% 88% 93% 92% 87% 91% 
All Dialysis 57% 43% 57% 35% 1% 6% 18% 
 
Burdens of Dialysis 
Patients on any dialysis modality face many difficult challenges that can cause burden on 
the patient as well as their caregiver.  These challenges may differ by patient, caregiver, as well 
as the dialysis treatment modality.  The burden of dialysis can range from health, financial, 
employment, social supports, as well as overall quality of life (Browne, 2006).       
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Financial and Employment Burdens 
 One of the challenges noted in the literature is the ability to hold employment and 
preserve their socioeconomic status (Nakayama, et al., 2015).  The type of dialysis was identified 
as a factor in maintaining employment.  “The odds of unemployment after dialysis inception 
were 5.02 fold higher in those on in center hemodialysis compared to those on peritoneal 
dialysis, after adjusting for covariates” (Nakayama, et al., 2015, p. 523).  Patients on peritoneal 
dialysis were also shown to have a greater ability to maintain employment and also tend to have 
a greater income than those patients on in-home dialysis (Nakayama, et al., 2015).   
 A study by Walker, et al. (2016) uncovered themes related to the economic 
considerations when discussing patients on dialysis.  The three themes they identified were: 
productivity losses due to changes in employment, the need for subsidization of home dialysis 
expenses and the role of economic disadvantage as a barrier to home dialysis (Walker, et al., 
2016).  Home dialysis, while convenient, can also be costly to patients due to insurance coverage 
limits leaving out of pocket costs for the patient and patient’s family (Johnson, 2014).     The 
main advantage of a patient choosing home dialysis is that of flexibility.  This flexibility offered 
time for the patient to continue to work due to the convenience of being able to receive their 
treatments at home (Walker, et al., 2016).  In center dialysis can make it difficult to commit to a 
sufficient work schedule.   
Life Changes 
Those who choose in-center dialysis are required to go to a dialysis center typically three 
times per week for hours at a time (Davita, 2015).  Cantekin, Kavurmaci, and Tan (2016) found 
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that patients who are dependent on having to be at the hospitals or facilities on specific days for 
an allotted amount of time may begin to feel the burden with the changes it makes to their lives.  
These patients may see a decrease in physical activities, decrease in work labor, as well as 
financial loss due to the strain of the treatment (Cantekin, Kavurmaci, & Tan, 2016).  The long-
term effects may involve divorce or difficulty in relationships, difficulties with family members 
and many other psychosocial problems related to the treatment including less participation in 
social activities (Cantekin, Kavurmaci, & Tan, 2016).   
Physical Issues 
 ESRD and the treatment options all involve physical changes to the patient’s body 
(Muringai, Noble, McGowan, & Chamney, 2008).  As stated previously, peritoneal dialysis 
requires the insertion of a catheter and with hemodialysis access is normally created with a 
fistula or catheter in the arm, neck, leg or other femoral area (Muringai, Noble, McGowan, & 
Chamney, 2008).  These changes can cause the patient to have difficulty with their body image.  
This is also true post-transplant as transplantation leaves a scar.  Partridge and Robertson (2011) 
express the need for patient education regarding body image changes that will occur with 
different treatment modalities.   
 Besides body image, Öyekçin, Gülpek, Sahin, & Mete (2012) discovered that patients on 
dialysis also had difficulty with depression, anxiety and sexual ability.  They noted that “in 
hemodialysis group, as depression and anxiety levels increased, body image was disturbed. In 
both groups, long-term dialysis disturbed body image” (Öyekçin, Gülpek, Sahin, & Mete, 2012, 
p. 235).  In peritoneal dialysis group, as depression and anxiety levels increased, body image 
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changed and sexual satisfaction decreased” (Öyekçin, Gülpek, Sahin, & Mete, 2012).  Murtagh, 
Addington-Hall and Higginson (2004) found that 1 in 2 dialysis patients reported feelings of 
fatigue, constipation, pain and extreme itching.  They also noted sleep disturbance, depression, 
anxiety and difficulty breathing (Murtagh, Addington-Hall & Higginson, 2004).   
Sleep Disorders 
Sleep disorders are common in dialysis, with insomnia being reported by 19-71% of 
those dialysed and 30-80% are affected by sleep apnea (Merlino Gigli & Valente, 2008; Hanly, 
Pierratos, Mucsi, & Novak, 2016).  Some risk factors for insomnia include patients in the older 
age group, restless legs syndrome, sleep apnea and other common sleep disorders (Merlino Gigli 
& Valente,2008; Hanly, Pierratos, Mucsi, & Novak, 2016). Patients on dialysis also report 
excessive sleepiness during the daytime (Merlino, Gigli, & Valente, 2008).   
Hanly, Pierratos, Mucsi, and Novak (2016) found that the type of dialysis was not a 
factor in sleep disorder as patients reported insomnia on either hemodialysis or peritoneal 
dialysis. Insomnia has been linked with increased mortality amongst patients with ESRD (Hanly, 
Pierratos, Mucsi, & Novak, 2016).  Agarwal and Light (2011) found that patients on 
hemodialysis had more severe sleep disruption and patients with CKD who were not on dialysis 
also reported more sleep disruption than people without kidney disease.  They also found that 
patients who are non-compliant with dialysis treatments, either missing treatments or shortening 
the length of their assigned treatments, reported greater burden of sleep disturbance (Agarwal & 
Light, 2011).   
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Merlino, Gigli, and Valente (2008) explain that several sleep disturbances such as restless 
leg syndrome, sleep apnea syndrome, excessive daytime sleepiness, may be treated and if they 
are left untreated, it is possible that they may impair health status and increase the risk of 
mortality.  Risk of obstructive and central respiratory events are increased by renal failure and 
dialysis therapy (Merlino, Gigli, & Valente, 2008).  Many studies suggest that the concern of 
sleep disorders in this population are often not discussed (Merlino, Gigli, & Valente, 2008; 
Agarwal & Light, 2011; Hanly, Pierratos, Mucsi, & Novak, 2016).       
Fertility and Sexual Function  
 Eid, et al. (2013) studied female patients with kidney disease and found that as the 
duration of dialysis increased, the patient’s rating of their sexual function decreased.  When 
discussing sexual function, many areas were examined such as sexual desire, arousal, lubrication, 
and orgasm (Eid, et al., 2013).  Holley, and Schmidt (2003) explained that ESRD results in low 
rates of pregnancy in women and Eckersten, Giwercman, and Christensson (2015) reported 
impaired male reproductive function with ESRD.  While infertility has been noted in patients 
with kidney disease, fertility has been noted to be restored when the patient receives a successful 
kidney transplant (Holley, & Schmidt, 2013).  
Social Supports 
 Caregivers and social supports are integral for patients with ESRD in many stages of the 
disease.  Patients on dialysis and awaiting a transplant need a good support network to assist 
them with navigating the transplant system, caring for themselves and their daily living needs, 
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medication management as well as coping support (Ghai, et al., 2014).  Support can be divided 
into two categories: perceived and received support (Cangro, 2014).   Perceived social support 
refers to the perception that the person is cared for, is valued, and is part of a group (Uchino, 
2009).  Received support is described as a situational response to a difficult or stressful situation 
(Ochino, 2009).  Overall, perceived social support has been shown to predict positive health 
outcomes better than received social support (Uchino, 2009).  Both types of support 
demonstrated benefits when it comes to chronic illnesses such as CKD (Cangro, 2014).    
When interviewing caregivers, Ghai, et al. (2014) discovered that caregivers identified as 
feeling as though they are suffering a financial as well as a psychological burden.  They noted 
participating less in social activities as well as disruption in their family and work lives 
(Cantekin, Kavurmaci, & Tan, 2016).  Some risk factors for caregiver burden were 
unemployment, having to be a caregiver for more than 12 months, low income, being the female 
spouse, and the patient waiting longer than 12 months on the transplant waitlist (Ghai, et al., 
2014).  Families of ESRD patients are insufficiently knowledgeable of the disease, medical 
complications, treatment options and how the disease may impact the patient and family 
(Browne, 2006).        
Perceived support from the transplant team can lessen stress, anxiety and depression.  
Received support leads to graft survival and treatment compliance (Cangro, 2014).  Supports 
should be readdressed during treatment and progression of the disease as support systems may 
change throughout the progression of the disease (Cangro, 2014; Urchino, 2009).   
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Quality of Life 
  “Ill health can adversely affect an individual's quality of life, particularly if caused by 
long-term (chronic) conditions, such as chronic kidney disease—in the United States alone, 23 
million people have chronic kidney disease, of whom 570,000 are treated with dialysis or kidney 
transplantation” (Wyld, et al, 2012, p. 12).  Quality of life, in particular health related quality of 
life is defined as the subjective assessment of the impact of disease and its treatment across all  
domains of functioning and well-being (Pagels, et al., 2012).  Quality of life in patients with 
various stages of renal disease has been shown to have significant effects on the clinical 
outcomes of these patients (Stratta, & Coppo, 2008).   
Health related quality of life (HR-QOL) within dialysis patients has been shown to be 
poor on average (Chiu, et al., 2009).   While quality of life appears to improve with 
transplantation, it still remains lower for these patients than people without this diagnosis 
(Stratta, & Coppo, 2008).  Some reasons for this were identified the patient’s quality of life still 
being shown to be “affected by uncertainty about the final result, fear of having to go back on 
dialysis, or anger about unexpected complications” (Stratta, & Coppo, 2009, p. 48).  Poor quality 
of life “in ESRD is significantly linked to patient outcomes: decreased functional status, 
decreased well-being, increased hospitalizations, increased morbidity and higher mortality 
(Browne, 2006).  
Transplantation Process  
“For the >600, 000 patients in the United States with end stage renal disease (ESRD) 
kidney transplantation represents the optimal treatment for most patients, providing longer 
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survival, better quality of life, lower hospitalization rates and substantial cost savings compared 
with dialysis” (Patzer, Plantinga, Krisher, & Pastan, 2014, p. 1562).  There are two options for 
transplantation; live kidney donation or deceased kidney donation (Rudow, et al., 2015).  Rudow 
et al. (2015) states that live kidney transplantation is ideal in that it improves quality of life, 
patient survival, graft survival and are more cost effective overall.   
Despite all the positive outcomes of transplantation, many patients have difficulty in 
completing the pre-transplant evaluation, or may find themselves lost in the follow up procedures 
necessary for wait listing (Kazley, et al., 2014).  In order to receive a kidney transplant, one must 
first be placed on a kidney transplant waitlist which is not an easy task (see Figure 3 below).   
  
Figure 3: Flowchart of Transplant Process. 
 
To get onto the national waitlist, the first step is for the patient to be referred by their 
physician or nephrologist (UNOS, 2016). It is then the patient’s responsibility to contact a 
transplant hospital of their choice to learn more about them to determine if their program fits 
their specific needs, especially in areas such as location, finances, acceptable insurance (UNOS, 
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2016; National Kidney Foundation, 2016).  The patient must then schedule an appointment for 
evaluation at the transplant center which includes an in-person interview, medical testing, lab 
work, psychosocial evaluation, working with the multidisciplinary team and gaining financial 
clearance through insurance (Tampa General Hospital, 2017; Gill, Hendren, Dong, Johnston, & 
Gill, 2014).   
Calestani, et al.(2014) explains that it is difficult for medical personnel to agree on which 
patients are best for wait listing.  Due to this, the waitlist criteria and how the criteria is utilized 
varies greatly (Calestani, et al., 2014; Tong et al., 2014).  In the UK, even though national 
guidelines are present and describe which patients would be suitable for transplant the variation 
of who is waitlisted is also present (Calestani, et al., 2014).  The testing required in the clinical 
evaluation also varies amongst the centers (UNOS, 2016; Tampa General Hospital, 2016).     
Clinical Evaluation 
Testing, lab work and assessments are necessary in the evaluation process for 
transplantation (Gill, Hendren, Dong, Johnston, & Gill, 2014).  A psychosocial assessment to 
evaluate the psychosocial factors that have been identified as risk factors for transplantation is a 
requirement for all potential transplant patients (Cangro, 2014).  “Risk for nonadherence, the 
need for social support, and a realistic assessment of the cost of renal transplantation should be 
the cornerstone of the pre-transplant psychosocial evaluation” (Cangro, 2014, p. 173).  Behaviors 
identified as risk factors such as smoking, alcohol use, drug use, obesity, noncompliance with 
dialysis and noncompliance with follow up appointments become evident in these assessments 
(Cangro, 2014).   
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Some transplant centers provide information on the specific medical testing factored into 
their evaluation process and not all centers require the same types of testing (UNOS, 2016; 
Cangro, 2014).  For example, Tampa General Hospital (2017) requires tests such as kidney 
ultrasound, cardiac stress test, and a colonoscopy. UCDAVIS (2016) for instance, requires 
pulmonary function tests to check the function of your lungs, colonoscopy, cardiac testing, a 
dental exam as well as a test called a VCUG to test to see if the patient’s urinary tract is 
functioning normally. Beth Israel Deaconess Medical Center (2017) requires blood tests, chest x-
rays, cardiac testing, vascular studies, and cardiac catheterization if the patient has coronary 
artery disease.  They also require colonoscopies but only for men over 50 and they discuss 
mammograms and pap smears for women (Beth Israel Deaconess Medical Center, 2017). 
Testing for preexisting conditions is part of the overall pre-transplant evaluation.  Patients 
are tested for diabetes, cardiac concerns, disease, respiratory, and ability to survive the surgery 
(Cangro, 2014).  Patients with diagnoses such as cancer or cardiac disease may be asked to 
follow up with an outside specialist for evaluation and then return to the transplant center for 
reevaluation (Hricik, 2008).  Some centers may require a patient with a cancer diagnosis to be 
cancer free for 2-5 years before being considered for the transplant waitlist (Hricik, 2008).   
Tampa General Hospital (2016) lists what they call “absolute contradictions” meaning 
reasons that the patient would not be considered for transplant.  Some of this “contradictions” 
include patients over the age of 80, patients with active cancer, HIV positive patients, active 
substance abuse, BMI greater than 40, active mental health disorders, to name a few (Tampa 
General Hospital, 2016).  UCSF Medical Center (2016) lists some restrictions as patients who 
have recently had a heart attack, cancer, substance abuse or active infection.  They also discuss 
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that patients over 60 will be considered on a case to case basis (UCSF Medical Center, 2016).  
Transplant center policies such as these may make it more difficult for patients with a co-existing 
condition to be able to navigate their way to completion of the evaluation process.    
During the patient’s evaluation, it is important for the patient to ask questions to better 
educate them about the process at each center.  Not only does each center differ in the testing 
required during the evaluation stage, but each center also differs in the waitlist criteria utilized to 
determine if the patient will be accepted (UNOS, 2016; National Kidney Foundation, 2016).      
The determination of which patients are eligible for transplantation is a complex and 
varies across transplant centers (Patzer, et al., 2015).  Each transplant center may have different 
wait list criteria (Patzer, et al., 2015; UNOS, 2015; National Kidney Foundation, 2016).  Patients 
should have an understanding of these differences in order to better determine which transplant 
center to wait list with (National Kidney Foundation, 2016).  Some transplant centers such as 
Tampa General Transplant Center will accept patients that may be considered more high risk 
whereas other centers may be stricter with their criteria (Tampa General Hospital, 2016).   
Many factors come into play when it comes to identifying potential renal transplant 
recipients however there does not appear to be any one federal or standardized process for 
choosing the appropriate transplant candidates (UNOS, 2016; National Kidney Foundation, 
2015).  The medical decisions regarding wait listing are made based upon a patient’s chances of 
surviving the surgery and not being adversely effected by lifelong immunosuppressive therapy 
(Cangro, 2014).  “Clinical practice guidelines on wait listing for kidney transplantation are based 
on comorbidities, psychosocial and lifestyle factors vary in their recommendations, scope and 
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how criteria are defined” (Batabyal, et al., 2012, p.).  Some centers may also have restrictions 
based on age, lack of proper insurance coverage, lack of social supports and medical compliance 
issues (National Kidney Foundation, 2016; Tampa General Hospital, 2016; UCSF, 2016).   
It is also important that the patients are aware they are able to wait list at multiple centers 
if they so choose (UNOS, 2016; Tampa General Hospital, 2016).  Multiple listing is defined as a 
patient being placed on the transplant waitlist at more than one hospital simultaneously (UNOS, 
2016).  Some studies suggest that patients who list at multiple hospitals will have a shorter wait 
time for transplant, however there is no guarantee (UNOS, 2016; University of Wisconsin, 
2017).  It is also important to note that in order to be listed at multiple centers, the patient must 
complete the specific evaluation and testing required by each specific center (UNOS, 2016).   
Also some centers may not be willing to accept patients who are listed at multiple centers 
and they may set specific criteria for these patients or may refuse to accept these patients at all 
(UNOS, 2016; Tampa General Hospital, 2016; University of Wisconsin, 2017).  Medical 
insurance restrictions may also limit the number of centers the patient is allowed to be waitlisted 
with (National Kidney Foundation, 2016).  Madhavan, et al. (2014) identify the option of 
developing some uniform selection criteria within each transplant center in order to allow a fairer 
evaluation of the patient.  With some uniform selection criteria, it may lessen the opportunity for 
provider bias and may lessen the inequalities in accessibility overall (Madhavan, et al., 2014). 
As demonstrated above, gaining access to the kidney transplant list and staying on are not 
easy tasks.  Some patients may receive assistance from the interdisciplinary health care team 
while others who are in need of a transplant may never even make it onto the list (Grams, 
Massie, Schold, Chen, & Segev, 2013).  A policy change in 2003 allows for what is known as an 
inactive status on the transplant waitlist (Grams, et al, 2013).  A patient may be labeled as 
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inactive status for various reasons and is “sometimes used as a placeholder for reasons other than 
a candidate's medical fitness—until completion of the transplant work-up, for example, or 
achievement of a threshold body mass index (BMI) for surgery” (Grams, et al., 2013, p. 1012).   
Patients labeled as inactive are still able to accrue waiting time but will not be offered a 
kidney transplant once their number comes up (Gram, et al, 2013).  Patients can be initially 
placed on the waitlist as inactive and these patients are known as continuously inactive patients.  
Gram, et al. (2013) identified disparities in this continuously inactive group.  They noted that 
patients in this group were more likely to be African American, female, have diabetes, higher 
BMI, comorbidities and poor status (Gram, et al., 2013).   These patients have higher mortality 
rate and lower rate of getting to active status on the list. It was also noted that the continuously 
active (never placed as inactive status) group was younger and generally had less comorbidity 
(Gram, et al., 2013).  
Patient Education 
Education for patients regarding transplantation has been identified as an area in need of 
reform and may account for some of the disparities identified in the transplant evaluation (Patzer, 
et al., 2012).  Patients have reported the lack of information regarding transplantation in every 
stage of the process (Calestani, et al., 2014).  Some of these areas include patients being unaware 
of pre-emptive transplantation options, the listing process, patients not knowing they had been 
removed from the waitlist, and not knowing why they had been excluded from the list from the 
start (Calestani, et al., 2014).       
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Proper education can increase a patient’s health literacy which allows the patient and 
their caregivers to be able to better understand the information in order to make informed 
decisions regarding their care (Kazley, et al., 2014).  Increased literacy may offer patients the 
ability to feel they are able to navigate the transplant process and are more likely to actually 
complete the process and receive a transplant (Kazley, et al., 2014). The patients in one study 
were more likely to complete the transplant evaluation when an education program was 
implemented (Patzer, et al., 2012).  Kutner, et al. (2012) identified an association between early 
transplant education and earlier wait listing for patients.   
Tong et al. (2014) discusses that nephrologists believe that transplant education should be 
more than 20 minutes in length.  With that said, they found that only 43% of nephrologists 
reported actually enforcing this in their practice (Tong, et al., 2014).  Balhara et al. (2012) noted 
that for profit centers were less likely to spend more than 20 minutes on patient education and 
were less likely to include the patient’s family in the education process.   
Patient education should also occur early on in the diagnosis in order to allow the patient 
to feel informed before even beginning with dialysis (Madhavan, et al., 2014).  “Ongoing support 
and education about kidney transplantation for patients after dialysis start could help to build on 
early education and foster greater quality improvement in patient outcomes” (Kutner, et al., 
2012, p. 1017).   
The education should occur across the interdisciplinary team and Madhavan, et al. (2014) 
suggests also involving primary care providers in the education process.  Rudow, et al. (2015) 
also explains that in order to improve disparities, education should be available in the patient’s 
primary language and the staff should be required to engage in cultural competence trainings.  
Other reasons patients received less transplant education were identified as patients being 
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uninsured or having Medicaid, being in a for-profit center, patient refusal, or other medical 
issues such as obesity (Kurcika, et al., 2012).  This entire transplant process, as stated above, is 
quite lengthy and disparities (discussed below) are evident at every stage, beginning with 
referral.   
Source of Racial and Ethnic Disparities in the Transplantation Process 
Disparities are relevant in many areas leading up to transplant and these disparities have 
been recognized in many different populations which will be discussed below.  Some of the 
factors associated with transplant disparities include: education, race, socioeconomic status, 
gender, and health literacy (Batterham, Hawkins, Collins, Buchbinder, & Osborne, 2016; Tong, 
et al., 2012).  The literature has also noted some organizational factors for transplant disparities 
such as transplant waitlist criteria as well as university based centers vs. private centers (Ramos, 
et al., 1995). 
Race and Ethnic Disparities 
Despite similar prevalence rates for early stages of CKD, racial/ethnic minorities have 
poorer outcomes such as the diagnosis progressing to ESRD (Garcia-Garcia, & Jha, 2015). 
According to National Center for Chronic Disease Prevention (2014), Blacks and Hispanics are 
more likely to develop ESRD relative to Whites. Consequently, racial/ethnic minorities have 
experienced higher incidences of ESRD compared to Whites (Garcia-Garcia, & Jha, 2015). 
These statistics may be in part due to the fact that minority groups tend to experience a delay in 
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referral to the nephrologist which is an important factor to prevent the progression of the disease 
(Patzer & McClellan, 2014).  
This delay in referral can also increase morbidity, mortality, and cost due to the 
progression to ESRD (Patzer & McClellan, 2014).  CKD within minority populations also often 
goes unnoticed and undiagnosed until symptoms present themselves (Garcia-Garcia, & Jha, 
2015).   “Worse dialysis outcomes and reduced access to transplantation have also been 
associated with neighborhood factors such as poverty, urbanicity, and the proportion of African-
Americans residing in the neighborhood” (Saunders, et al., 2014, p. 291).    
The Black population has a higher incidence of comorbity with diagnoses such as 
diabetes, high blood pressure and hypertension (Wachetman, et al., 2015).   Patients who identify 
as Black who have diabetes are 3.5 times more likely than white patients to get kidney disease 
(American Kidney Fund, 2016).  Hypertension and diabetes have been identified as accounting 
for over 60% of ESRD diagnosis (Patzer & McClellan, 2014).  These diagnoses are more evident 
in minority populations (Patzer & McClellan, 2014).    
It has been noted that Black patients are less likely to receive dialysis at a high-quality 
facility due to the evidence of ongoing residential segregation (Saunders, et al., 2014).  This is 
due to the fact that there may not be high quality dialysis centers located in the neighborhoods 
they reside (Saunders, et al., 2014).  The literature has shown that there are differences between 
for profit and nonprofit dialysis centers such as referral rates, hospitaladmissions, successfully 
transplanted patients, and mortality rates (Lee, Chertow, & Zenios, 2010).  Prakashet, et al. 
(2010) also indicated that when the percentage of black individuals increases within a 
neighborhood, the likelihood of individuals in this neighborhood to gain access to nephrology 
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care decreased. Transplant recipients residing in Black communities are noted to have inferior 
outcomes post-transplant than any other race or ethnicity (Gordon, Ladner, Caicedo, & Franklin, 
2010).      
Sources of Racial and Ethnic Disparities in Transplant Waitlists 
The focus of this current study is specifically on what factors contribute to race and 
ethnic differences in the transplant list, which ultimately affects the likelihood of receiving a 
transplant (Egger, 2009).  In the initial steps of wait listing, minority patients tend to have a 
lower rate of referral to a transplant center despite their desire for transplant (Higgins & 
Fishman, 2006).  Black, Hispanic and Native American patients continue to be underrepresented 
on kidney waiting lists (Higgins & Fishman, 2006).  Black and Hispanic patients had 
significantly longer times from starting dialysis to wait listing, which may be related to their 
lower socioeconomic status and less preemptive wait listing (Shivam, et al., 2013).   
During 2014, 11,570 patients who received a deceased donor transplant, 42% were white 
compared to the 31% that were black (National Kidney Foundation, 2016).  This gap increases 
among patients who received a transplant from a live donor, with 67% of White patients 
receiving a transplant relative to 12% of black patients (National Kidney Foundation, 2016).  
Other factors come into play when discussing the racial disparities at each level of the 
transplantation process: lower socioeconomic status, less access to follow up care, lack of 
resources, higher levels of discrimination by healthcare professionals, and lack of proper health 
insurance (Schold, et al., 2011).   
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Patient-Level Variables in Wait Listing 
Education  
 Literature to date on the barriers for minorities at the individual level are attributed to 
health literacy (discussed previously), attitudes about transplant, concerns regarding risks, and 
concerns about cost (Purnell, Hall, & Bourware, 2013).  Purnell, Hall and Bourware (2013) 
identify that African Americans and Hispanic patients in particular, have been shown to have 
poor understanding and education about the risks and benefits of kidney transplant.  This lack of 
education may deter the patient from ever completing the evaluation process.   
Socioeconomic Factors  
When discussing socioeconomic status (SES), it is important to understand that poverty 
can affect the patient’s accessibility to proper medical care including transplant wait listing 
(Srinivas, 2014).  When discussing a patient’s accessibility to proper medical care, it is important 
to discuss insurance issues.  According to the Kidney Foundation (2017), patients with ESRD are 
automatically eligible for Medicare.  With that said, the patient must be knowledgeable of this 
information and also must complete the application process.  If the patient does in fact apply and 
get approved for Medicare, this insurance covers only 80% of costs for dialysis treatment and 
only 80% of the cost of immunosuppressant medications needed after transplant which leaves the 
patient responsible for any amount remaining (Kidney Foundation, 2017).  The patient could also 
apply for Medicaid to cover the excess costs, but again, the patient must be knowledgeable of 
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this process, complete the online application, turn in all necessary paperwork and be approved 
based upon their situation (Kidney Foundation, 2017).   
Low SES as noted to be a barrier to the transplantation list (Tong, et al., 2014).  “Low 
SES is associated with increased incidence of chronic kidney disease, progression to end-stage 
renal disease, inadequate dialysis treatment, reduced access to kidney transplantation, and poor 
health outcomes” (Patzer & McClellan, 2012, p. 1).  This could be due to many reasons such as 
lower education, inadequate or no insurance which leads to a lack of preventative care and early 
detection (Patzer & McClellan, 2012). 
In a study by Patzer, et al. (2012) one third of the racial differences between black 
patients and Caucasian patients in transplant rates could be explained by SES.  Lower SES 
patients and minority groups also experience a delay in referral to the nephrologist in the early 
stages of diagnosis which lead to worse outcomes (Patzer & McClellan, 2014).   Shivam, et al. 
(2013) discussed how patients living in a zip code associated with an impoverished 
neighborhood along with other variables such as insurance type, being a non-US citizen, and race 
(specifically black) were associated with longer average times from starting dialysis to 
waitlisting.  They also found an association between these variables and less preemptive 
waitlisting for patients in this population (Shivam, et al., 2013).   Similar to Patzer, et al. (2012), 
Shivam, et al. (2013) also found that the effects for patients identifying as black were mostly 
associated with their lower socioeconomic status.  It was also noted that poorer outcomes for 
Hispanics versus Caucasian were also associated with lower socioeconomic status and non-US 
citizenship (Shivam, et al., 2013).  
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Insurance Type 
 There have been many changes at the policy level when it comes to Medicare’s ESRD 
program and in 2010 when the ESRD Quality Incentive Program was created, Medicare changed 
to “pay-for-performance” (Lee, & Zenios, 2012).  This new program was developed with the 
hopes of implementing more standardized care focusing on best practices (Lee, & Zenios, 2012).  
However, lack of appropriate insurance continues to be identified in the literature as an area 
where inequality is evident. 
 Patients with CKD who require either dialysis or transplantation are considered disabled 
and are automatically eligible for Medicare (Rettig, 2011).  In order to be able to receive the 
insurance coverage, the patient would have had to have paid into the system for a long enough 
amount of time (Rettig, 2011).  It is important to note that there are initial waiting periods for the 
coverage and once a transplant is received, the insurance ends after three months (Rettig, 2011).   
When Johansen, et al. (2012) adjusted for race and ethnicity, insurance status was 
identified as a reason in which a patient would not be assessed for possible transplant.  Patients 
without insurance at all were the most disadvantaged followed by patients with Medicare, 
Medicaid or other insurance (Johansen, et al., 2012).  “Patients with Medicaid or without 
insurance were 11 to 14% more likely to be unassessed, respectively” (Kuricka, et al., 2012, p. 
351).   Non-private insurance along with the patient identifying as black lowered their chances of 
being waitlisted within the first 2 years of referral (Johansen, et al., 2012).  “Insurance status was 
strongly associated with transplant assessment, with privately insured patients substantially less 
likely to be not assessed” (Johansen, et al., 2012, p. 1495).  Once waitlisted, patients who did not 
have private insurance were more likely to be removed from the waitlist (Schold, et al., 2016).     
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Another area where insurance and socioeconomic status come into play occurs during 
post-transplant when the patient is required to remain on many immunosuppressive medications 
that can be costly for the patient.  Patients typically only receive coverage for these medications 
for a short time even though the medications will need to be taken for the remainder of the 
patient’s life (Gill & Tonelli, 2012).  Medicare currently covers the medications for only 3 years 
post-transplant unless the patient has a work-related disability or is 65 years old or older (Gill & 
Tonellie, 2012; Rettig, 2011).   
“Ensuring lifetime access to these medications for all Americans with kidney transplants 
would save lives as well as reduce the cost of treating patients with ESRD” (Gill & Tonelli, 
2012, p. 587).  In a survey in 2010, it was noted that more than 70% of kidney-transplant 
programs identified their patients having an extremely difficult time paying for the medications 
and 68% reported patient deaths and transplant failure due to non-adherence to medication 
attributed to costs (Gill & Tonelli, 2012).   
Age 
Wong et al. (2012) stated that “if there were an unlimited supply of organs and no 
waiting time, transplanting the younger, and healthier individuals saves the most number of life 
years and is cost-saving, whereas transplanting the middle-age to older patients still achieves 
substantial incremental gains in life expectancy compared to being on dialysis” (p. 1).  In older 
patients, non-assessment for transplant was noted to occur due to either being labeled medically 
unfit or unsuitable for transplant due to age (Johansen, et al., 2012).  Younger patients were also 
more likely to receive care from a nephrologist before ever beginning the dialysis treatments 
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(Johansen, et al., 2012).  Mackelaite, et al. (2014) noted that even patients who are 70 years of 
age or older can still benefit from transplantation.   
Bayat et al. (2015) discussed that in France they show similar issues with the association 
of age and waitlist status as in the U.S.  Patients ages 70 and older were 97.5% less likely to be 
waitlisted in France than patients between the ages of 18 and 39 (Bayat, et al., 2015).  Kurika et 
al. (2012) found older patients were less likely to be educated about transplant.   
Much like younger patients, elderly patients also experience improved quality of life with 
transplant versus dialysis (Tso, 2014).  Tso (2014) discussed the clinical guidelines set by the 
American Society of Transplantation in 2001 which states that “there shall be no absolute upper 
limit for excluding patients whose overall health and life situation suggest that transplantation 
will be beneficial” (p. 10).  
Physicians’ Evaluation of Patient 
 Health care providers’ perceptions of the patient is an important factor in the probability 
of a patient getting on a waitlist (Purnell, Hall, & Bourware, 2013).  The idea of how the health 
care provider perceives the patient as motivated for transplant is an important part of the clinical 
decision making for determining a patient’s appropriateness for transplant.  African Americans 
have a lower transplant rate than whites and this difference has been attributed to misconceptions 
by health care providers that African Americans are not interested in transplantation 
(Wachterman, McCarthy, Marcantonio, & Ersek, 2015).   Minority patients were less likely to be 
recommended for the waitlist as they were seen as being more at risk (Tong, et al., 2014).  
Patzer, et al. (2009) noted that “patient ethnicity may influence physician’s beliefs about a 
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patient’s risky behaviors and likelihood of treatment adherence” (p. 1337).  This, along with the 
lack of formal wait list evaluation standards, could lead to physician referral bias.   
 Wachetman, et al. (2015) discovered, however, that providers’ beliefs about patient 
motivation were not the relevant factor, but instead found that lack of communication between 
the patient and the health care provider was the most relevant factor in lower transplantation 
rates among African Americans in this study.  Nephrologists were less likely to refer black 
patients as they felt survival rate would be better in white patients (Tong, et al., 2012). 
 Another reason for racial disparities in referral was identified as physician’s views of 
perceived patient preference (Ayanian, et al., 2004). As far as patient’s attitude about transplant, 
Patzer, et al. (2009) noted studies have suggested that black patients were less likely to desire a 
transplant.  Ayanian, et al. (2004) discussed that physicians viewed black patients as less likely 
to prefer to pursue transplantation and would therefore not refer them.  Minority patients 
continue to experience low referral rates even when they have expressed interest in 
transplantation (Higgins & Fishman, 2006).   
Donor Service Area Location 
 OPTN (2016) demonstrates how the United States is divided into 11 UNOS transplant 
regions consisting of 58 donor service areas (DSA).  “Kidney allocation policy currently 
allocates a donated kidney first to patients in the same DSA of procurement (local allocation), 
then if necessary to patients in the same UNOS region of procurement (regional allocation) and 
ultimately nationally (national allocation)” (OPTN, 2010 as cited in Davis et al., 2014, p.1).  
With this allocation system in mind, with local allocation being the first disbursement of donor 
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organs, patients who are more financially stable may actually relocate in order to have an 
increased opportunity for a shorter wait time (Davis, et al., 2014).   
According to Davis, et al. (2014b), each DSA has their own waitlist.  Patients are able to 
list on DSAs not in their home area which can cause variations in wait times and the differences 
in wait times amongst some DSAs has increased to 4.72 years (Davis, et al., 2014a).  The figure 
below provides a depiction of the length of waiting times, the prevalence of waitlisting in those 
areas, prevalence of ESRD and the prevalence of deceased donor kidney transplant (Davis, et al., 
2014a).       
 
       Figure 4: Waitlist Wait times and Prevalence. 
The Southeast United States (identified as Region #3) has been identified as the 
geographic area with the lowest rates of patients on the transplant waitlist (Kazley, et al., 2014).  
Patzer, et al. (2012) discuss that race and the patient’s SES play roles in this as they found that 
patients who were black and who resided in lower income neighborhoods were noted to be 67% 
less likely to be placed on the deceased donor transplant wait list when compared to whites in 
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lower income neighborhoods.  Georgia in particular has the lowest referral rate in this region 
with only about 28% being referred for transplant after a year of dialysis (Patzer, et al. 2015).    
 
Figure 5: Transplant Regional Map. 
The Final Rule is a mandate created by the US Department of Health and Human 
Services in 1998 specifying that kidney allocations within the United States must prove to be 
equal geographically and it consists of many elements (Davis, et al., 2014).  It states that “organ 
allocation shall be based on many variables including (1) sound medical judgement; (2) the best 
use of donated organs; (3) [to be] specific for each organ type or combination of organs to be 
transplanted into a specific candidate; (4) [to be] designed to avoid wasting organs, to avoid 
futile transplants, to promote patient access to transplantation, and to promote efficient 
management of organ placement; and (5) shall not be based on the candidate’s place of residence 
or place of listing, except to the extent required by items previously listed” (Reed, et al., 2015).  
The Final Rule was implemented in attempts to eliminate geographic inequalities in organ 
allocation for transplantation (Davis, et al., 2014).   
Davis, et al. (2014) argue that the variation in wait times (in some cases, 4-year variation) 
for transplantation across the United States, violates this mandate.  Supply and demand in each 
DSA can vary greatly causing variations in wait times as well (Lewis, Sankar & Pittman, 2014).  
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A good example was provided by Lewis, Sankar & Pittman (2014) which showed that patients 
listing in Alabama waiting on average greater than 72 months for transplant and during that same 
5-year time frame from 2004-2009 patients in Oregon waited on average only about 19 months 
(SRTR, 2010).  
Dialysis Centers 
Patzer and Pastan (2014) discuss how the type of dialysis center can also play an 
important role in the transplantation process.  Some reasons for the variability among the dialysis 
centers could be that the patients receiving treatment at the specific center are not eligible but 
also patients may not be referred to the transplant centers, or that patients that are referred may 
not complete the evaluation process (Patzer, & Pastan, 2014).  Some interesting findings were 
that as the number of staff in the center increased the patient’s access to transplantation also 
increased (Patzer & Pastan, 2014).  It was also noted that the decrease in staffing will increase 
patient caseloads across the multidisciplinary team which may result in decreased quality of 
education for the patients (Patzer & Pastan, 2014).   
Disparities were also noted in the literature between for-profit and not for profit centers 
where for profit centers have lower transplant rates (Patzer & Pastan, 2014; Bayat, et al., 2015).  
In the United States, about 85% of the dialysis centers are identified as for-profit and these 
centers tend to employ less staff members (Palomino, 2015).  These for-profit centers also tend 
to have fewer resources to offer the patients and have higher mortality rates overall than non-
profit centers (Palomino, 2015).   
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Zhang et al. (2014) explained that 85% of for profit dialysis centers are affiliated with a 
chain organization or multicenter enterprise and 33% of non-profits are affiliated with a chain 
organization as well.  The change from independent dialysis centers into big corporation raises 
concerns for quality of care (Zhang, et al, 2014).  Patients from the for-profit chain centers were 
13% less likely to be waitlisted (Zhang, et al., 2014).    
 It may also be that dialysis center staff members need more training on which patients 
should receive referrals for transplant (Patzer, et al., 2015).  However, the national guidelines of 
the Organ Procurement Transplantation Network (OPTN, 2014) explain that if the healthcare 
team has any questions about whether a patient should be referred or not, the patient should 
actually be referred anyway.  This way the patient has the opportunity to complete all the pre-
transplant evaluation to determine if they are eligible for wait listing (OPTN, 2014).   
Patient Preferences 
Patient preferences in their health care can also play a role in the transplant waitlist 
process. Some studies suggest that "African American dialysis patients are less likely than whites 
to desire transplant" (Wachterman, et al., 2015, p.240). Wachterman, et al. (2015) found that it 
was not that they did not desire transplant but rather that they had many concerns and 
misunderstandings regarding transplant. Some of their concerns were centered around trust in 
many areas such as trust in physicians, donors, and in the equality of the waitlist process itself.  
Salter, et al. (2016) found that Black patients raised concerns about the increased burden 
of the medication regimen, fears in regard to risks of surgery and possible organ rejection when 
discussion transplantation. These patients also expressed feelings of being treated poorly by the 
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medical professional and also not receiving proper education about ESRD and the treatment 
options available to them. Salter, et al. (2016) also found that Black patients reported receiving 
inadequate information from their doctor and the expressed their lack of trust with medical 
decisions that were made. The Black patients in this study did show reluctance to pursue 
transplant but the researchers attributed this to their satisfactions with their level of activity while 
on dialysis.  
Robinson, et al. (2015), when researching kidney donations, found that "(1) Lack of 
knowledge and awareness of the topic of donation and transplantation; (2) Religious myths, 
misperceptions and superstitions; (3) Fear of premature death; (4) Concerns about 
racism/classism and transplant system inequities; and (5) lack of trust in healthcare systems" 
were all identified with Black patients (p.42).  
Patient Referral 
 Many areas of the transplant process have been studied in detail but literature regarding 
areas of pre-wait listing such as patient referral is scarce.  It is important to note that “dialysis 
facilities function as gatekeepers between kidney patients and new organs” (Palomino, 2015, 
p.2).  “Unfortunately, there are no standard measures for kidney transplant eligibility or kidney 
transplant referral processes in dialysis centers” (Browne, et al., 2016).  It is important for 
patients with CKD to be referred to a nephrologist early to a nephrologist before the disease 
progresses to ESRD (Cass, Cunningham, Snelling, & Ayanian, 2003).  Later referrals are 
associated with decreased survival rates and morbidity (Cass, Cunningham, Snelling, & Ayanian, 
2003). 
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 Patzer, et al. (2015) looked into the patient referral rates within dialysis centers in 
Georgia which has been labeled the state with the lowest transplant rates.  Out of the 308 dialysis 
facilities, they identified there were 15 facilities that did not refer any of the patients within their 
first year of dialysis treatment while some facilities that had a 75% referral rate (Patzer, et al., 
2015).  Rubin and Weir (2015) found that patients were more likely to be referred for transplant 
if the dialysis staff members had positive attitudes about transplant.  The authors explored factors 
associated with referral rates and found that the lower referring facilities were “more likely to be 
non-profit, to be hospital-based, to have more patients, to treat patients living in high poverty 
neighborhoods, and to have a high patient to social worker ratio compared with facilities with the 
highest referral” (Patzer, et al., 2015, p. 587).  Palomino (2015) found that when looking into the 
dialysis centers in Georgia, 9 out of 10 facilities were performing below the national average for 
referral between 2007-2010.      
“Interestingly, socioeconomic factors seemed to be significant modifiers of the 
differences between African Americans and Caucasians for the propensity to be placed on the 
waiting list in our population” (Schold, et al., 2011, p. 1763).  It is important to note the in a 
study by Patzer, et al. (2012) when they adjusted for SES, black patients still had a 59% lower 
rate of transplantation than whites.  Higgins and Fishman (2006) noted that referral rates are 
lower for minorities both at initial evaluation of transplantation as well as at placement on 
transplant list.  The lack of communication identified from physicians raised concerns amongst 
this population creating misconceptions about risk/benefit of transplantation and mistrust about 
equitable allocation of organs (Wachetman, et al., 2015).     
Patzer, et al. (2009) “found that black patients were less likely than whites to be placed 
on the kidney transplant waiting list, and this disparity was not associated with the distance to the 
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nearest transplant center. Furthermore, we observed that neighborhood poverty was associated 
with waitlist placement and we report for the first time that racial disparities differ as 
neighborhood poverty increases” (p. 1334).  Once on the wait list, the Hispanic population was 
shown to be removed from the wait list at a disproportionally higher rate (Schold, et al., 2016). 
Interdisciplinary Team Processes and the Transplant Waitlist 
 The importance of interdisciplinary teams in health care outcomes has been an area 
mentioned often in the literature.  The process of transplantation from original diagnosis to actual 
transplant includes many different actors.  Many different disciplines must work effectively 
together in order to achieve improved outcomes in the transplant realm.  An effective, patient-
focused team can assist in improving the patient’s quality of life (Nissenson, 2013).  “Medicare’s 
Final Rule of the Conditions for Coverage (April 2008) define the medical director of the 
dialysis center as the leader of the interdisciplinary team and the person ultimately accountable 
for quality, safety and care provided in the center” (Schiller, 2015, p. 493).  These directors are 
part of the collaborative team consisting of physicians, nephrologists, social workers, nurses and 
dietitians (Schiller, 2015).   
 As part of the interdisciplinary team, nephrology social workers also play a role 
throughout the transplant process.  The Centers for Medicare and Medicaid Services (CMS) 
require qualified, master’s level nephrology social workers to be part of the interdisciplinary 
team in both transplant centers as well as within dialysis centers (Avery, 2014; Nephrology 
News and Issues, 2014; Browne, 2006).  “This is very unique to the nephrology field only, and is 
the sole Medicare provision of its kind that recognizes that an illness like CKD carries with it 
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such psychosocial issues that only a master’s-level social worker an competently address with 
patients and their families (Browne, 2006, p. 11).  Quality Assessment and Performance 
Improvement (QAPI) Committees are required to continuously monitor and evaluate the 
transplant programs (Nephrology News and Issues, 2015).  The committee meets on a regular 
basis and is comprised of members of the interdisciplinary team (Nephrology News & Issues, 
2015).     
The role of the social worker in dialysis centers is to serve as a support system for the 
patient and patient’s families at the times of diagnosis, adjusting to the diagnosis and 
understanding the disease (Avery, 2014).  The social worker also serves as an advocate and 
assists in bridging the communication gap between the interdisciplinary team and the patient.   
Some areas of this assessment include: financial and insurance information, medical history, 
preference in treatment modality, family and support systems, mental health or substance abuse 
concerns (Avery, 2014).  
 Social workers are also responsible for collecting information on the patient’s quality of 
life based via an annual survey they must administer to patients (Avery, 2014).  This information 
can assess areas in which the patient needs more support and to also identify how the patient 
views his/her situation.  Some of the responsibilities of the social worker that are relevant to the 
transplant wait list process include: providing education and referrals to appropriate resources, 
assisting with obtaining and keeping insurance coverage, educated patients on the importance of 
their participation in their own care, and assisting patients with their rights and responsibilities 
(Avery, 2014).  
The nephrology social workers are responsible for completing psychosocial evaluations 
for the patient to assist in determining if they meet the transplant center’s psychosocial criteria 
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(Nephrology News & Issues, 2014; Miller, 2016; Browne, 2006).  The psychosocial assessment 
includes areas such as: cultural and language factors, plans for post-transplant medication 
adherence, ensuring the patient understands the risks and benefits of transplant, mental health 
and substance abuse history, and the ability to commit to a treatment regiment, just to name a 
few (Nephrology News & Issues, 2014; Miller, 2016; Browne, 2006).        
“The psychosocial patient selection criteria and psychosocial evaluation address 
psychosocial issues that affect patient and graft survival outcomes, similar to the medical patient 
selection criteria emphasis on the medical issues and how they affect patient and graft survival 
and outcomes” (Nephrology News & Issues, 2014, para 4).  There are many areas of 
psychosocial issues, discussed previously, that are specific to patients with ESRD (Browne, 
2006).  The information based on these assessments is presented to the interdisciplinary team to 
assist with determining if the patient is suitable for transplant and transplant wait listing.   
Synthesis of the Literature 
 The literature overwhelmingly identifies the benefits of transplantation such as cost, life 
expectancy and quality of life (Bayat, et al., 2015).  However, even with transplant as the best 
option for patient with ESRD, inequalities exist within access to the kidney transplant waitlist 
(Srinivas, 2014; Kutner, et al., 2012; Kucirka, et al., 2012; Garcia, Harden, & Chapman, 2012; 
Mackelaite, Gaweda, Muhs, & Ouseph, 2014; Bayat, et al., 2015).  The inequalities are evident 
within each area of the process from early access to healthcare, treatment options such as 
dialysis, referral for transplant, as well as achieving waitlist status (Kucirka, et al., 2012; Garcia, 
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Harden, & Chapman, 2012; Mackelaite, Gaweda, Muhs, & Ouseph, 2014; Bayat, et al., 2015; 
Patzer, Plantinga, Krisher, Pastan, 2014).   
With a diagnosis such as ESRD, early education about the disease and treatment options 
was shown to be an area of importance (Kutner, et al., 2012).  According to Kutner, et al. (2012) 
early education can increase the number of waitlisted patients.  The literature also discusses the 
concern that some patients do not receive any education at all regarding transplant as an option 
(Kucirka, et al., 2012; Mackelaite, Gaweda, Muhs, & Ouseph, 2014; Calestani, et al., 2014). 
Racial differences were also evident when discussing early education where whites were 
identified as receiving early education more often (Kutner, et al., 2012).        
Additionally, the evidence supports that the areas of inequalities present include the 
patient’s age, gender, ethnicity, geographic location, SES, lack of proper insurance and education 
level (Srinivas, 2014; Pussell, Bendorf, & Kerridge, 2012; Kutner, et al., 2012; Kucirka, et al., 
2012; Mackelaite, Gaweda, Muhs, & Ouseph, 2014; Bayat, et al., 2015; Patzer, Plantinga, 
Krisher, Pastan, 2014; Davis, et al., 2014; Axelrod, et al., 2014).  Calestani, et al. (2014) found 
that patients disclosed the distress they felt due to being excluded from the kidney transplant list 
because of their age and comorbidity and patients also discussed feelings of inequity regarding 
the waitlist process.  Patzer, et al. (2014) found that centers with lower transplant rates had a 
greater number of black patients, patients without proper medical insurance, and patients with 
diabetes.   
Davis, et al. (2014) found that longer wait times were in areas where more patients were 
black, had lower education and were less likely to waitlist outside of their area.  Mackelaite, 
Gaweda, Muhs, and Ouseph (2014) discussed how younger, healthier and wealthier patients have 
a better opportunity of getting on the transplant wait list.  They also found that female patients, 
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older adults, non-Caucasian patients and those with lower SES are less likely to obtain a kidney 
transplant (Mackelaite, Gaweda, Muhs, & Ouseph, 2014). Kucirka, et al. (2012) discovered that 
patients who were older, obese, uninsured or patients with Medicaid as well as patients at for-
profit centers were more likely to remain unassessed for transplant.        
Reasons noted as possible reasons for the inequalities were the physician’s or patient’s 
preference (Tong, et al., 2014; Watcherman, McCarthy, Marcantonio, & Ersek, 2015).  
Stereotypes exist amongst minority populations, one of which includes the stereotype which 
suggests that African American patients are less likely to desire transplantation (Watcherman, 
McCarthy, Marcantonio, & Ersek, 2015).  When discussing physician’s preference, Tong, et al. 
(2014) stated that nephrologists were less likely to recommend a patient for the waitlist who has 
comorbidities, was nonadherent, older adults, minority patients, lower SES, patients with 
diabetes, obese patients, patients with cardiovascular disease or those patients who smoke or 
have abused alcohol.  These preferences are thought to be accounted for due to the physician 
wanting to ensure the maximum efficiency of the transplant process (Tong, et al., 2014).     
The literature also discusses the process for transplant centers when evaluating patients 
who are possible candidates for transplant (Tampa General Hospital, 2017; Gill, Hendren, Dong, 
Johnston, & Gill, 2014).  There does not appear to be any one federal or standardized process for 
choosing the appropriate transplant candidates which leaves these decisions up to the transplant 
centers (UNOS, 2016; National Kidney Foundation, 2015; Bayat, et al., 2015).  The testing and 
lab work required in the clinical evaluation also varies amongst the centers (UNOS, 2016; 
Tampa General Hospital, 2016; Gill, Hendren, Dong, Johnston, & Gill, 2014).  The psychosocial 
evaluation is also part of the transplant candidate evaluation and the literature emphasizes the 
importance of including psychosocial factors in the evaluation (Cangro, 2014).  These factors, 
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including social support, coping skills and access to resources can help to determine the patient’s 
transplant success (Cangro, 2014).      
Thus, although the literature provides ample evidence that racial and ethnic disparities 
exist in the process of ESRD patients getting on transplant waitlists, this evidence begs the 
question of why these process differences occur.  To date, the literature does not include research 
that adequately answers this important question.  It is clearly difficult to answer this question 
through existing data which only allows for the analysis of associations between patient 
race/ethnicity and waitlists.  The process preceding the placement of a patient on a transplant 
waitlist has not been adequately detailed, and it may be quite variable from dialysis center to 
dialysis center.  
Theoretical Framework 
 Equal access to resources and healthcare has been a topic of discussion for quite some 
time.  Many definitions of what equality and equal access means are discussed in the literature.  
For the purposes of this paper, we will utilize the definition by Gutman (1983) which states that 
“a principle of equal access to health care demands that every person who shares the same type 
and degree of health need be given an equally effective chance of receiving appropriate treatment 
of equal quality so long as that treatment is available to anyone” (p. 44).  Yet disparities, as 
previously discussed, continue to exist in access to healthcare therefore first understanding the 
possible cause of these disparities becomes important.   
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Theory of Fundamental Causes 
 The Theory of Fundamental Causes attempts to account for the reasons socioeconomic 
and racial disparities persist in specific causes of mortality in spite of a variety of efforts to 
eliminate them and despite multiple risk pathways in the course of disease that change over time 
(Phelan, & Link, 2005). Phelan and Link (2005) identify that while there have been many 
advances in medicine, and improvements have been made in population health, certain 
populations continue to benefit more than others, and this is due to “key resources” that can be 
deployed by certain populations thereby influencing disease outcomes.  “The fundamental cause 
explanation focuses attention on flexible resources of knowledge, money, power, prestige, and 
beneficial social connections that can be used to harness advantages and avoid disadvantages in 
changing circumstances” (Phelan, & Link, 2005, p. S33).   
Link and Phelan (1995) also discuss that the patient’s flexible resources operate at not 
only the individual level but the contextual level as well.  At the individual level, the resources 
shape the patient’s access to finances and social support for accessing the best treatment (Link & 
Phelan, 1995).  At the contextual level of flexible resources lies the idea that patients with 
flexible resources obtain the advantage of health enhancing circumstances such as better 
neighborhoods and quality health care resources (Link & Phelan, 1995).   
 In the area of access to the kidney transplant list, disparities as previously stated can be 
identified despite advances in the treatment of the disease.  While transplant is identified as the 
ideal treatment for ESRD both medically as well as financially, access to transplant continues to 
be associated with inequalities.  Kidney transplant is acknowledged as a major advance in the 
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medical field as it improves the longevity and quality of life for patients diagnosed with ESRD 
(Garcia, Harden, & Chapman, 2012).   
The overall cost of transplantation has also been noted to be less than annual dialysis 
treatment costs.  Hemodialysis can have an annual average cost of $72, 000 per patient in the 
United States (U.S. Renal Data System, 2014).  Peritoneal dialysis can have an average annual 
cost of $53, 000 per patient (U.S. Renal Data System, 2014).  While the average cost of a kidney 
transplant is about $32, 000 for the actual transplant surgery and then an annual post-surgery cost 
of $25, 000 (U.S. Renal Data System, 2014). 
 Link and Phelan (1995) suggest that a fundamental social cause of health inequalities has 
four essential features.  These features are: 1) The cause influences various diseases, 2) it affects 
the outcome of the disease with multiple risk factors, 3) it affects access to resources that can be 
used to either avoid risk or lessen consequences of the disease, and 4) the association between a 
fundamental cause and health is reproduced over time via the replacement of intervening 
mechanisms.  
The first feature of fundamental cause theory is that these causes, such as low SES and 
lack of education, can be utilized when discussing different diseases such as cardiac disease, 
communicable diseases and chronic diseases (Phelan, Link, & Theranifar, 2010).  Rubin, Colen, 
& Link (2010) used this theory to identify inequalities evident in mortality of HIV/AIDS 
patients.  They found that the introduction of a life-extending treatment actually increased the 
inequalities evident in areas of SES and race (Rubin, Colen, & Link, 2010).   
Polonijo and Carpiano (2012) discussed fundamental cause theory as it relates to 
inequalities associated with the Human Papilloma Virus (HPV) vaccine.  They discovered that 
patients with minority parents or low SES were less likely to be knowledgeable about the 
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vaccine’s benefits and were less likely to have received a physician referral for the vaccine 
(Polonijo& Carpiano, 2012).  Phelan, Link, & Tehranifar (2010) referred to this theory when 
looking at two separate diabetes clinics and they found that the clinic treating higher SES 
patients provided better continuity of care and the patients were noted to be more knowledgeable 
about their treatment.  For the purposes of this paper, we will be using fundamental cause theory 
to frame disparities in treatment in ESRD. 
The second feature of this theory is that socioeconomic status can affect the outcome of 
the disease with multiple risk factors.  This feature is evident within ESRD and access to 
treatment options such as access to the transplant list (Axelrod, et al., 2010; Srinivas, 2014; 
Patzer, et al. 2012).  Srinivas (2014) states that the southeast United States has the lowest health 
status attainment than any other area.  This region also has poor access to health care and some 
of the lowest transplant rates.  Socioeconomic status accounts for the high rate of poverty in this 
area and may also account for the high prevalence of ESRD, poor access to healthcare and lower 
transplant rates (Srinivas, 2014).   
 Axelrod, et al. (2010) found that patients with higher SES had better access to receiving a 
transplant and noted that they were 76% more likely to receive an organ from a live donor.  
Patients in the lower SES had higher incidence of death while on the waitlist as well as mortality 
post-transplant (Axelrod, et al., 2010).  As discussed earlier, patients have the option of wait 
listing at multiple centers which may be more feasible for patients in the higher SES and these 
patients have the ability to travel across donor service areas to increase their access to donor 
organs (Axelrod, et al., 2010).  Discussion of clinical advantages related higher SES leads 
directly into the discussion of the next feature of this theory which is access to resources.  
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  The third feature involves access to resources that can be utilized to either avoid risk or 
to less the consequences of the disease (Phelan, Link, & Theranifar, 2010).  The key resources 
are identified as knowledge, money, power, prestige, and beneficial social connections (Phelan, 
Link, & Theranifar, 2010).  Jain and Green (2016) discuss the importance of knowledge, 
identified as health literacy at every stage of chronic kidney disease from diagnosis to dialysis to 
transplant.  Education on the transplant practices, policies, referral and evaluation are all 
important pieces of knowledge that would enhance a patient’s ability to lessen the consequence 
of the disease (Davis, et al., 2014).  Health literacy is also important when discussing dialysis 
(Green, et al., 2013).  Green, et al. (2013) identified that limited health literacy regarding dialysis 
was associated with increased non-compliance and an increase in missed treatment 
appointments.  This also led to more hospitalizations and more emergency room visits for these 
patients (Green, et al., 2013).  Without transplantation, as discussed previously, the patient would 
have to remain on dialysis and their life expectancy shortens greatly.   
The areas of money, power and prestige all seem to relate to one another and can be 
identified by differences in SES and minority status.  Those patients with lower socioeconomic 
status, as discussed previously tend to have less power and prestige and tend to have a more 
difficult time navigating through the transplant system (Axelrod, et al., 2010; Srivinas, 2012).  
The race/ethnicity of the patient also plays a role here in that patients who identified as black 
were 28% more likely to have limited health literacy whereas 5% of patients who identified as 
white were said to have limited health literacy regarding chronic kidney disease (Jain & Green, 
2016).  This is increasingly important as the American Kidney Fund (2015) explains that there 
are certain racial and ethnic groups who are more at risk for having kidney failure.  When it 
comes to diagnosis of kidney failure, “compared to whites, the risk for African Americans is 
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almost 4 times high, Native Americans is 1.5 times higher, Asians is 1.4 times higher” 
(American Kidney Fund, 2015, p.1).   
Phelan, Link and Theranifar (2010) define what they refer to as flexible resources as 
resources that can be utilized in different ways as needed in different situations.  These resources 
are noted as operating at either the individual and contextual levels (Phelan, Link, & Theranifar, 
2010).  Flexible resources for certain individuals accumulate because of the context they live in 
(Phelan, Link, & Theranifar, 2010).  Persons with higher SES live in neighborhoods with better 
quality health care, for example and the geographic differences in wait listing may be accounted 
to some degree by this factor.  Early detection of kidney failure can be effective in ensuring the 
patient receives proper treatments to prevent the disease from worsening (Phelan, Link, & 
Theranifar, 2010).  It is important for the patient to have the resources to be able to obtain these 
early screenings.  If resources are available, this flexibility of resources provides the patient with 
options at each stage of their disease.    
For instance, in the early stages of kidney disease, resources may be utilized to avoid risk 
of the disease progressing into ESRD.  Some of the emphasis for treatment options in the early 
stages of the disease are healthy diet, and lower blood pressure which are more accessible to 
those individuals by virtue of SES levels (Davita, 2016; Mayo Clinic, 2016 American Kidney 
Fund, 2016; National Kidney Foundation, 2016).  Similarly, when the disease progresses to 
Stage 3 CKD, the patient would need to have resources such as health insurance, access to 
transportation, access to a nephrologist as well as a dietitian as these are all recommended to 
lessen the risk of progression at this stage (Davita, 2016; Mayo Clinic, 2016 American Kidney 
Fund, 2016; National Kidney Foundation, 2016).       
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  As far as social connections in the patient population, a strong social support network is 
of great importance.  As discussed previously, during the evaluation process for the transplant 
list, the patient meets with the transplant social worker to uncover any biopsychosocial concerns 
(Nephrology News & Issues, 2014; Miller, 2016; Browne, 2006).  Social supports are identified 
as protective factors and the patient has lower risk factors such as medication adherence when 
there is evidence of a support system (Danovich, 2009).  Patel, Peterson, and Kimmel (2005) 
discuss the importance of social support with chronic diagnoses such as CKD.  They found that 
social supports can be beneficial in many areas such as treatment and medication compliance, 
increased access to health care, enhanced psychosocial and nutritional status and immune 
function, and having support has been shown to decrease stress levels (Patel, Peterson, & 
Kimmel, 2005).   
The last feature of the Fundamental Cause theory is the association between a 
fundamental cause and health outcomes over time (Link & Phelan, 1995).  In other words, a way 
to prove a particular fundamental cause exists is if this cause continues to be a powerful predictor 
of poor outcomes through time.  This is evident in the racial and socioeconomic disparities 
identified in obtaining a transplant (Patzer, et al., 2015).  The literature has shown that disparities 
due to the patient’s socioeconomic status and the patient’s race have existed for a long time.  For 
instance, in a study by Gaylin, et al. (1993) found that previous reports of lower transplant rates 
for lower income, nonwhite patients were confirmed in their study.  Held, et al. (1988) looked at 
a random sample of new dialysis patients from each year between 1981 and 1985 and the 
fundamental causes were evident then as well.  They found that young, male white patients 
within the high-income bracket were more likely to receive a transplant (Held, et al., 1988).  
Socioeconomic status and the race and ethnicity of the patient have been powerful predictors of 
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poorer transplant outcomes over time (Patzer, et al., 2015; Gaylin, et al., 1993; Held, et al., 
1988).     
 If the fundamental causes are the persistent reasons for inequality, it appears that 
identifying ways to lessen these causes may provide a better chance to ensure equal opportunity 
for wait listing.  A discussion of Rawls Theory of Social Justice along with Daniels’ Theory of 
Health Care Justice is below.  The Theory of Health Care Justice discusses health and healthcare 
as being thought of as a basic need and therefore the access to treatment should organizationally 
be more equal.   
Rawls and Daniel’s Theory of Justice  
It would appear that a theory focused on social justice would be suitable when discussing 
the disparities of the kidney transplant list.  Rawls Theory of Social Justice has many features 
that are pertinent to this topic.  Rawls discussed the two principles of justice: 1) justice requires a 
liberal democratic political position to make sure that the citizens’ basic need for goods are met; 
2) justice includes regulation on institutions to assure that the -  First, Rawls (2009) explains that 
per the "equal opportunity principle," inequalities are acceptable if every person in society has a 
reasonable chance of obtaining the positions that lead to the inequalities.  According to Rawls’ 
theory, there is inevitably going to be disparities and he identifies the need for what is known as 
the difference principle to address these disparities (Rawls, 2009).   
The difference principle infers that “social and economic equalities…. are to be to the 
greatest benefit of the least advantaged members of society” (Rhodes, Battin & Silver, 2013, 
p.3).  This accounts for the policies that are unequal in the distribute goods and services as long 
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as the end result is the benefit of the least well off in the population (Rhodes, Battin, & Silver, 
2013).  Rawls did not apply his theory specifically to healthcare and this is where Daniel’s 
Theory of Healthcare Justice (2001) comes into play.         
Daniel’s (2001) interpretation of Rawls’ theory as it applies to healthcare can be a good 
fit when discussing the transplant waitlist process.   Daniel’s (2001) explained that a theory of 
justice for healthcare should be designed to answer three important questions. The first of these 
questions is “Is healthcare special?” which was addressed by Daniels (2001) when he argued that 
healthcare should be considered a basic need since healthcare works to maintain a person’s 
normal functioning.  When relating this to ESRD, dialysis and transplantation can be seen as 
working to bring a patient’s health back to normal functioning.   
With the second question, “When are health inequalities considered unjust?”, it takes into 
account social standing and the underlying inequalities already embedded in society (Daniels, 
2001).  This is particularly important in the discussion of access to the transplant list as the 
inequalities are not just evident in the availability of healthcare but also within the social 
inequalities such as poverty and racism that have been identified in this population.  Lastly, with 
the question, “How can the competing healthcare needs be met under resource constraints?”  
Daniels (2001) identifies the difficulty working with limited resources.  This is relatable to the 
kidney transplant wait list as the demands for kidney transplants far outweigh the supply of 
donations (The Kidney Fund, 2015).  This is where the allocation of organs is important to 
ensure that the available organs are provided in a fair and equitable manner.  The difficulty is 
that there is no true agreement on what distributive justice with healthcare should look like 
(Daniels, 2001). The same can be said about the allocation of organs as changes have been made 
over the years in hopes of improving the distribution but yet disparities still exist.      
54 
 
 “From Daniels point of view…the allocation of healthcare resources should be aimed at 
equalizing social opportunity” (Rhodes, Battin, & Silver, 2013, p. 61).  According to Rhodes, 
Battin and Silver (2013) Daniel’s argument extends further using Rawls’ difference principle 
idea to state that due to social inequalities, health care should then be provided to those who are 
the most disadvantaged in terms of their health, which in the case of patients with chronic 
disease such as ESRD, this may be applied.  Daniels would argue that this population would not 
have what he calls “normal species function” until transplant is complete due to the limitations 
the disease places on the individual (Rhodes, Battin, & Silver, 2013).   
The differences in the wait list criteria amongst the transplant centers may be an area in 
need of review as there are currently no set mandates on this criterion.  This allows the transplant 
centers to be able to choose which patients they feel are appropriate for the wait list at their 
center (UNOS, 2016; National Kidney Foundation, 2015).  Each transplant center has their own 
multidisciplinary transplant committee who meet regularly to discuss each patient and ultimately 
decide if the patient meets their criteria (UNOS, 2016; National Kidney Foundation, 2015; 
Tampa General Hospital, 2016).  
Critical Race Theory 
Due to the variations in waitlist criteria and disparities noted in the literature in regard to 
the waitlist process, Critical Race Theory (CRT) can be useful as a theoretical framework and 
will be integrated into the Anderson model for the purposes of this study. Ford, Collins, and 
Airhihenbuwa (2010) explain that the Anderson model discusses race in terms of being a 
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characteristic that can innately cause inequalities but states that when combined with CRT, the 
socially constructed component of race is also addressed.  
According to Stovall (2005), CRT examines racism at all levels including the individual 
and group levels. It also attempts to identify any institutional or systematic reasons that promote 
the function of racism (Stovall, 2005). Another important component of CRT is that it 
"recognizes the complex relationships and intersections that reside within race, class, gender and 
sexuality differences and feature prominently in the social world of ethnic minorities" (Graham, 
et al., 2011, p. 82).  
Ford, Collins, and Airhihenbuwa (2010) discuss the four features of CRT they have 
identified, which include: race consciousness, contemporary orientation, centering the margins 
rather than in the mainstream and praxis. Race consciousness is identified as the person's 
awareness and understanding of the presence of racism in their personal life and how it affects 
them (Ford, Collins, & Airhihenbuwa, 2010). For example, in terms of kidney transplant 
patients, Cuevas and O'Brien (2017) identified that the patient's racial identity was an important 
component of the patient's experience in terms of receiving equitable health care.  
The second feature of CRT, contemporary orientation has to do with understanding race 
at the system level. This feature explains racism as an ordinary component of society (Ford, 
Collins, & Airhihenbuwa, 2010). This concept provides an explanation for why some people 
may begin to either ignore racism or become hypervigilant as it has become a regular component 
of their everyday life. When discussing the kidney transplant waitlist and patient's behaviors in 
the early steps of the process, this ordinariness may have some influence as to whether a patient 
pursues transplant. Cuevas, O'Brien, and Saha (2017) explained that "although African 
Americans perceive discrimination in health care settings, experience higher levels of medical 
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mistrust compared with European Americans, and experience poorer communication with health 
care providers" (p. 987).  
The third feature of centering the margins has to do with lessening some of the innate 
biases between the researcher and the minority group (Ford, Collins, & Airhihenbuwa, 2010). 
The "outsiders within" approach has been noted to be a valuable component of this feature as the 
minority's perspective of their experiences are taken into account which allows for greater 
understanding. This approach will also be valuable in the kidney transplant arena as patients 
have expressed discrimination in health care providers and in their communication with minority 
patients (Hausmann, et al., 2011).  
The last feature of CRT that will be discussed is known as praxis. Praxis can guide the 
research by focusing on the information provided by those within the marginalized communities 
(Ford, Collins, & Airhihenbuwa, 2010). The kidney transplant patients themselves will be 
surveyed in this study to provide more meaningful data about their personal experiences 
navigating through the transplant waitlist system and this will provide insight into how race may 
play a role in this process.  
Anderson’s Behavioral Health Model of Health Services Use 
 The Behavioral Model of Health Services Use was originally created to help develop an 
understanding of why families utilize health services, to determine a way to define and measure 
access to healthcare, and to assist in policy development to promote equitable access (Anderson, 
1995).  The reason the family was the original focus was because Anderson (1995) identified that 
the social and economic characteristics of a family can indicate the type of medical care the 
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patient receives.  This model was since changed to focus more on the individual patient which is 
the model that will be utilized for the purposes of this paper.   
The Anderson Model was used to organize the examination of factors that impact the 
likelihood of a patient moving onto a transplant waitlist.  This model coincides with fundamental 
cause theory regarding resources operating at the individual and organizational levels that result 
in variance in health care utilization, in this case in inclusion on the transplant waitlist. The 
Anderson Model posits predisposing characteristics (or causes) including demographics, social 
structure and health beliefs play a role in the patient’s use and access to healthcare.  The model 
also includes enabling resources, which much like the flexible resources in Phelan and Link’s 
(1995) theory are identified as being necessary and these resources must be present for the 
patient to be able to access healthcare services (Anderson, 1995).  This model also takes into 
account the patient’s need for medical services which Anderson (1995) divides amongst 
perceived health need versus evaluated needs for health services.  The patient’s predisposing 
characteristics as well as their enabling resources can play an integral part in identifying the 
patient’s need as well as their ability to access proper healthcare.    
The figure below depicts the behavioral model as it relates to patients with ESRD and 
these areas will also be addressed in the survey measurement tool.  Starting with the predisposing 
characteristics of the patient, this is broken down into: demographics, social structure and health 
beliefs (Anderson, 1995).  In terms of demographics, the focus is on the patient’s age and gender 
which have been shown in the literature to play a role in the patient’s access to the kidney 
transplant wait list (Patzer, et al., 2014).  When discussing social structure, it is composed of the 
patient’s ethnicity, education, and employment.  As discussed previously, all of these 
components play a role in the patient’s ability to gain access to the transplant wait list as well as 
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the inequalities evident in the process. Finally, in the area of health beliefs, the patient’s 
knowledge about kidney disease, attitudes about transplantation as well as health literacy are 
taken into account.  
 
Predisposing   Enabling    Need   Use of Health  
Characteristics   Resources     
 Resources 
 
             
 
Age    Social Support  Patient’s View of Health 
Gender   Insurance Type  Patient’s Perception of Condition 
Race    Socioeconomic Status 
    Perceived barrier to care 
      
 
Ethnicity          Geographic Residence            Physician’s Evaluation of Patient 
Education  Region    Physician Perception of Patient  
Employment  Transplant Center Location Transplant Center Evaluation of pt. 
  Transplant Center Type 
   
 
Knowledge about kidney disease 
Attitudes about transplantation 
Health Literacy 
 
Figure 6: The Anderson Behavioral Health Model of Patients with ESRD. 
Application of Theories 
 The literature discussed previously provides evidence of the disparities that exist in 
kidney transplant wait listing (CITE).  The theories identified above can be utilized to identify 
and explain the areas of inequalities.  These theories will also be utilized to explore associations 
Demographics Personal/Family Resources Perceived Health 
Social 
Structure 
Community Resources Evaluated Health
  
  
 
  
  
 
 
 
Health Beliefs 
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between the region the transplant center is located, the differences amongst transplant center wait 
list criteria and the patient access inequalities that exist in these centers.  Fundamental causes of 
these inequalities will also become evident with the use of the theory.  
Daniels’ Theory of Justice focuses on patient’s equal access to healthcare.  This theory 
provides a perspective that can be used when looking at the lack of standardization for transplant 
wait list criteria.  Daniels (2001), much like Rawls discusses the difference principle which 
accounts for any unequal distribution so long as it benefits the least advantaged members of 
society.  However, the literature has shown that this is not necessarily true when discussing the 
transplant wait as there are many disadvantaged patients who have difficulty accessing the 
transplant list.  Daniels believes that the citizens have equal opportunity to the goods and 
services (Rhodes, Battin, & Silvers, 2013).  While it is known that inequalities exist when 
discussing the transplant list, however it is not clear as to whether the wait list criteria designated 
at each transplant center may be a systematic reason for the inequalities.  This study will be using 
this theory when looking into the differences amongst transplant wait list criteria.   
 Fundamental Cause Theory provides a framework for identifying the reasons why 
inequalities exist and also demonstrates that these causes have been evident for years.  Link and 
Phelan (1995)’s notion that flexible resources influence racial disparities in health care outcomes 
and can operate at the individual level and the contextual level.  At the individual level, the 
resources shape the patient’s access to finances and social support for accessing the best 
treatment (Link & Phelan, 1995).  At the contextual level of flexible resources Link & Phelan 
posit that the opportunity for equitable health outcomes is dependent on the resources existing in 
the external context, including primarily the level of neighborhood socioeconomic development 
vs. level of poverty.  Furthermore, it is reasonable to assume that neighborhood socioeconomic 
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status acts as a proxy for the flexibility of resources in the macro-context, including the quality 
of health care resources, rates of insured vs. uninsured, and the density of minorities.  The 
fundamental causes that will be addressed in this study are socioeconomic status of the county 
within which the respondents’ dialysis centers reside.   
 Link and Phelan (1995) explain that patients with flexible resources available to them, 
may be better able to gain access to quality healthcare, have the financial and social support 
necessary for accessing the best treatment option and may reside in more advantageous 
neighborhoods. These resources are necessary for patients to be able to navigate through the 
transplant evaluation process and to successfully complete the transplant process.  This study 
will assess how the patient’s flexible resources may play a role in their ability to access the wait 
list.   
Anderson’s Behavioral Health Model will be utilized to classify the potential sources of 
variation in kidney transplant wait listing (predisposing, enabling, etc.).  The predisposing factors 
that will be included in the model specific to transplant wait listing include the patient’s age, 
gender, ethnicity, education level, employment status, as well as the patient’s health literacy.  
The enabling resources that will be addressed in this study include social support, insurance type, 
SES, geographic location including the patient’s geographic region, as well as the availability of 
resources.  The last component of the model includes the patient’s perceived health and 
evaluated health which includes areas such as the transplant center’s evaluation of the patient 
including waitlist criteria, the physician’s perception of the patient as well as the patient’s view 
in these areas.      
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Research Questions and Hypotheses 
Due to the differences in patients who gain access to the kidney transplant waitlist as well 
as differences in transplant center criteria regarding wait list practices, this study focuses on 
gaining a better understanding of the factors that may play a role in variations in patients’ 
experiences in accessing the transplant list. Ideally, in order to understand what affects racial 
disparities in transplant waitlists one would attempt to specify a model wherein the outcome 
variable measured the likelihood of Black ESRD patients getting on a waitlist and then regressed 
the variables from the Anderson Model on that outcome. However, numbers and racial 
characteristics of patients ending up on waitlists versus those who do not end up on a waitlist are 
difficult to obtain. For this reason, we must look to find informants who have been through the 
process, who can help to indicate which factors from the theoretical model they see as influential 
in the waitlist decision making process in their center. Patients who have received a transplant 
will serve as expert informants to the factors affecting the process of wait-listing, since these 
individuals have been involved in the wait listing process through completing all necessary 
evaluations and by navigating through the transplant process.  
We surveyed kidney transplant recipients to find out their level of endorsement of the 
importance of the predisposing, enabling and need variables from the Anderson model in the 
transplant waitlist process. We then looked at whether the factors endorsed by the transplant 
recipients as important in wait listing vary by contextual factors including organizational factors 
of the waitlist sites (type of transplant center, rural or urban location, or university vs. hospital-
based center).  We also asked transplant recipients to estimate the time from learning that they 
needed a transplant until the time they were put on a waitlist, and then the time from first being 
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put on a waitlist until they received the transplant. These time factors will also be explored as a 
function of the recipients’ characteristics and their responses to the two discrimination indexes in 
the survey.  Lastly, in depth interviews were conducted with some respondents to explore 
nuances present in the wait list process and to gain a better understanding from the patient’s 
perspective.   
Research Questions 
The research questions in this section were explored through a survey of transplant 
recipients. Anderson’s Model of Health Behavior and CRT served as the framework for 
specification of the first three research questions in this analysis.  This data was collected via a 
cross-sectional survey of members of kidney transplant support groups (see below for details of 
survey recruitment). The survey included Likert-scaled questions to measure the recipients’ 
perceptions of the impact of each of the variables from the Anderson Model on the process of 
getting on transplant waitlists. This data offered a descriptive analysis of transplant recipients’ 
perceptions of the factors that affect the process of getting on transplant waitlist (see RQ1 and 
RQ2).  
R1 – To what degree do transplant recipients perceive the role of their predisposing 
characteristics (race/ethnicity, age, gender, education level) as important in the process of 
getting on the kidney transplant waitlist?  
H1a-Respondents will report that they perceive their race/ethnicity as important in  
the process of getting waitlisted.  
H1b- Respondents will report that they perceive their age as important in the  
process of getting waitlisted.  
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H1c- Respondents will report that they perceive their sex as important in the  
process of getting waitlisted.  
H1d- Respondents will report that they perceive their education level as important  
in the process of getting waitlisted.  
 
R2- To what degree do transplant recipients and perceive the role of their enabling 
resources (patients’ SES, health insurance type, support system, transplant center type and 
location) as important in the process of getting on the kidney transplant waitlist?  
H2a- Respondents will report that they perceive their income level as important in      
the process of getting waitlisted.  
H2b- Respondents will report that they perceive their health insurance type as  
important in the process of getting waitlisted.  
H2c- Respondents will report that they perceive their support system as important  
in the process of getting waitlisted.  
 
The literature review also indicates that there are potential external influences on the 
process of wait listing, including characteristics of the Donor Service Area (DSA) region the 
transplant center is located in (length of waiting times, the prevalence of wait listing in those 
areas, prevalence of ESRD and the prevalence of deceased donor kidney transplant), 
organizational differences in transplant centers (type of transplant center and transplant center 
location type).  Data for these external factors was sourced in several ways. First, the transplant 
recipients were asked questions about the location of the transplant center and organizational 
characteristics of their center.  Data from the cross-sectional surveys was stratified by these 
organizational variables in order to explore differences in survey responses across organizational 
strata.   
64 
 
R3. To what degree do transplant recipients’ perceived discrimination differ amongst their 
predisposing characteristics (age, race, sex, educational achievement) and enabling 
resources (insurance type, transplant center type and income level)?  
H3a-Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents in the older age groups  
H3b- Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents in non-white racial groups  
H3c- Higher mean scores on the Discrimination in Medical Settings will be found  
in female respondents   
H3d- Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents with lower educational achievement  
H3e- Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents in the lower income groups. 
  H3f-Higher mean scores on the Discrimination in Medical Settings will be found   
    in respondents with non-private insurance.  
H3g- Higher mean scores on the Discrimination in Medical Settings will be found  
            in respondents in rural transplant centers.  
R4. To what degree do transplant recipients’ perceived trust of the interdisciplinary team 
differ amongst their predisposing characteristics (age, race, sex, educational achievement) 
and enabling resources (insurance type, transplant center type and income level)?  
H4a-Higher mean scores on the Medical Mistrust Scale will be found in   
         respondents in the older age groups  
H4b- Higher mean scores on the Medical Mistrust Scale will be found in   
         respondents in non-white racial groups  
H4c- Higher mean scores on the Medical Mistrust Scale will be found in   
         female respondents   
H4d- Higher mean scores on the Medical Mistrust Scale will be found in   
         respondents with lower educational achievement  
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H4e- Higher mean scores on the Medical Mistrust Scale will be found in   
         respondents in the lower income groups.  
H4f-Higher mean scores on the Medical Mistrust Scale will be found in    
         respondents with non-private insurance.   
  H4g-Higher mean scores on the Medical Mistrust Scale will be found in  
respondents in rural transplant centers.  
Respondents were asked to identify characteristics related to the sites they received their 
transplants, including proprietary status and location in order to explore associations between 
treatment context and respondents’ perceptions of the waitlist process. Trends in transplant 
recipients’ responses to the Anderson model categories were further explored by examining 
correlations and interactions with organizational characteristics of the transplant center type and 
location type.  
R5. Are reported kidney transplant wait times (pre and post) associated with the 
recipients’ predisposing characteristics (age, race, sex, educational achievement), enabling 
resources (insurance type, transplant center type and income level) or with their perceived 
discrimination or mistrust?  
H5a-Longer reported wait times will be found in respondents in the older age          
        groups  
H5b- Longer reported wait times will be found in respondents in non-white racial  
        groups  
H5c- Longer reported wait times will be found in female respondents   
H5d- Longer reported wait times will be found in respondents with lower  
         educational achievement  
H5e- Longer reported wait times will be found in respondents in the lower income  
            groups.  
  H5f-Longer reported wait times will be found in respondents in rural transplant  
                                  centers.  
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H5g- Longer reported wait times will be found in respondents with higher scores  
          on the MMS scale. 
H5h- Longer reported wait times will be found in respondents with higher scores  
          on the DMS scale. 
Detailed descriptions of these survey items and measures are described in Chapter 3 in 
the Measurement Section. Demographic information was also collected on respondents to 
explore trends in process factors and perceived discrimination by age, gender, SES, race and 
ethnicity.  The survey also included some open-ended questions to allow respondents the 
opportunity to provide more detail and anecdotal information on their own experience in the 
waitlist process.   
Finally, in order to more deeply explore possible sources of racial and ethnic based 
differences in the process of wait listing for kidney transplants and in order to triangulate the data 
in the analysis, there was a qualitative arm of the study. Specifically, in-depth interviews were 
conducted with ten transplant recipients who completed the survey and agreed to provide contact 
information for a follow-up interview. Ideally, this process will yield a sufficiently diverse set of 
interviewees in order to more fully compare the waitlisting experience across race and ethnicity. 
A more in-depth description of the interview process is provided later. 
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CHAPTER THREE: RESEARCH METHODOLOGY 
Sample Recruitment 
 Originally, the intended recruitment plan for the sample was to attempt to survey kidney 
transplant recipients from kidney transplant support groups solely in the state of Florida. When 
researching the kidney transplant support groups, an online search was started via Google with 
the keywords “transplant support groups” which brought up a broad range of groups which 
included many different types of organ transplants such as: kidney, heart, lung and liver. 
Through this search, it was noted that UNOS Transplant Living (2018) provided a list of 348 
support groups across the United States, 19 of which were listed as being located in Florida and 
only five of these groups in Florida focused on kidney transplantation.   
In order to identify more groups for survey recruitment, the search was modified via 
Google by entering the key words “kidney transplant support groups in Florida” into the search 
engine.  With this search in addition to the five groups from the previous search, the total number 
of kidney transplant support groups identified in Florida was now 19 groups.  
The group leader listed for each group was contacted via email and a brief description of 
the study purpose was provided.  Group leaders’ email responses provided information about 
their group and information on which groups were willing to allow participants to participate in 
the survey.  The responses from group leaders varied and are listed below.   
• Some group leaders had stated that their groups no longer meet face to face due to 
lack of attendance (n=2).   
• Some leaders stated that the group no longer exists (n=3). 
• Some group leaders did not respond at all (n=5).   
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• Some of the contact information for the group had numbers or emails that were no 
longer valid (n= 5). 
Due to the small number of kidney transplant support groups in the state of Florida that 
meet face to face (n=4), a new IRB addendum was submitted to open the sample to online kidney 
transplant support groups as well.  The IRB addendum was approved on September 26, 2018.  
Once approved by IRB, the statement “online kidney transplant support groups” was 
entered into the Google search engine.  From this, eleven online forums and support groups were 
identified.  The group leader listed for each of these groups was contacted via email and a brief 
description of the study purpose was provided and is shown below.   
Hello Everyone, 
I am the wife of a kidney transplant recipient and I am also working on my PhD at University of 
Central Florida where my focus is on the Disparities in Kidney Transplant Waitlisting and I would 
love to hear about your experience. 
· Are you over 21 years old? 
· Have you received a kidney transplant within the last 10 years? 
If you answered YES to these questions then we would love for you to share your kidney transplant 
waitlist experiences with us.  
The purpose of this research study is to explore transplant patients’ experiences with getting on the 
kidney transplant waitlist, and will also examine how patients’ characteristics are associated with 
these experiences and attitudes related to the process of getting on a transplant waitlist. 
All you have to do is complete a survey online which should take approximately 30 minutes of your 
time. You will also have the option to volunteer to participate in a phone survey at a later date if you 
so choose. 
Once a response from the group leader was received, the plan for how to properly 
disperse the surveys to the group was identified.  If the group leader felt the survey was best 
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completed in electronic format, then that was available to them and a paper form was also 
available for groups that felt this was a better option.  The eligibility criteria were only that the 
participant has to be an adult kidney transplant recipient (age 21 or older) who received a 
transplant within the last 10 years.  Patients who are still on the waitlist or on dialysis awaiting a 
transplant were not included in the study.  Finally, for the support groups that met face to face, 
their leaders were given the option for the researcher to come to the support group and distribute 
surveys in person to the members. 
Out of the four face to face groups, the group leaders offered to disperse the surveys 
either via email to their participants or in person when they attended group.  The group leaders 
had stated that they are not always sure how many participants will show up to the groups each 
time they meet.  One group leader even offered to post the information about the study in their 
weekly newsletter.   
Online groups leaders’ responses were quite similar to each other.  Many group leaders 
offered for the researcher to post the description of the study (same as described previously) 
along with a link for the survey for their members to access easily.    
If the group leader’s plan was to have the survey dispersed via email or by posting online, 
the following process took place to ensure a good response rate.  In order to gain a better 
response rate, Schaefer and Dillman (1998) recommend personalizing the email if the survey is 
sent via email.  The transplant recipients may receive many emails and online posts in a single 
day so research has shown that sending a mass email or post without any personalized 
information may result in decreased response rates (Schaefer & Dillman, 1998).  With this in 
mind, each email survey was sent with a personalized message in attempts to increase the 
response rate.  This was also true for posts in online groups or forums.    
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According to Schaefer and Dillman (1998), another way to increase response rates of 
emailed surveys, multiple contacts must be made.  Therefore, two weeks after the surveys had 
been sent out, a reminder email/post was sent to those participants who had not yet responded.  
Two weeks following the reminder email/post another reminder was sent, and another two weeks 
later, one final reminder email/post was sent in hopes of increasing the response rate.  Schaefer 
and Dillman (1998) mentioned that the response rate with only one contact is about 28% and 
increases to 41% with two contacts and then increases even more to 57% for three or more 
contacts which is why more than three contact attempts were made.   
Since the recruitment letter was posted on each forum or support group site, along with 
link for the survey, it was decided that it may be beneficial to be able to determine which groups 
the responses were coming from.  Specific links for each recruitment group were created through 
Qualtrics in order to determine which group the respondents belonged to.  The survey was 
identical on all links but were labeled with a letter to be able to distinguish which group the 
answers were coming from.  For example, Survey form A, B, C etc.    
Once the responses began coming in, it was noted that many of the responses were 
coming in from the online support groups and forums (n=129).  It was also noted that from these 
responses, many of the participants completing the survey did not receive their transplant in 
Florida (n=120).  This may be due to the availability of online support groups to reach many 
people all over the world, however it is unclear as to exactly why this may have occurred.  In 
order to increase the number of survey responses to be included in the data analysis an addendum 
to the IRB approval was submitted and approved which authorized the use of the data from any 
of the responses nationally, not limiting them to just the state of Florida.  An application for IRB 
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approval was submitted and approved as Exempt Human Research after all addendums on 
December 4, 2018.  
To ensure that the final sample used in the analysis was large enough for results to have 
external validity, a power analysis was conducted to determine minimum necessary sample size. 
As a function of effect size, alpha and statistical power, a power analysis indicates that with a 5% 
margin of error and a 95% confidence level, and α=.0.05, the target sample size required 
approximately 150 kidney transplant recipients to create an acceptable sample size for the study 
(Calculator, 2015).  
Measurement 
The survey consists of a total of 60 questions which are either likert-scale, open ended or 
multiple-choice questions.  Within the survey are two scales, The Discrimination in Medical 
Settings Scale and the Medical Mistrust Scale.  There is also a qualitative component to the data 
collection which consisted of phone interviews.  The survey and qualitative interviews are 
described in detail below.  
Survey  
The first item on the survey ensured that all participants in the study were kidney 
transplant recipients by simply asking, “Are you a kidney transplant recipient?”.  Items 2-6 
covered individual predisposing characteristics (demographics) by asking the participants to 
indicate their age, sex, describe their race, income level, and educational level.  Items 7-10 
included information relating to enabling resources, in particular, geographic location and region 
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of the transplant center and patient’s residence.  Items 11-18 provided information on the 
patient’s experience on the kidney transplant waitlist including: 
What age were you first told you needed a transplant? 
What year did you receive your transplant? 
What was the approximate time from knowing and getting on the list? 
What was the approximate time from waitlisted to getting transplant? 
Were you ever removed or labeled inactive status on the list? 
If so, how many times were you removed and why? 
What year did you receive your transplant?   
Questions 19-22 included questions about support the patient may have including 
questions about if a social worker assisted them in the waitlist process, how important was the 
social worker, what did they do to support them, and what types of support or assistance do they 
wish they had throughout the process.  The next ten questions (22-33) were Likert scaled 
questions (strongly agree (5), agree (4), neutral (3), disagree (2) and strongly disagree (1)) to 
look into the patient’s feelings about each of the predisposing characteristics, enabling resources 
and perceived need.  Out of these, questions 23-27 included the questions about: age, ethnicity, 
race and gender and were worded as: I feel that my ___________ had a negative effect on my 
waitlist experience. Questions 28-33 were worded a bit differently.  For example: I feel that if I 
had better (health insurance, paying job, support system, education, information) the wait list 
process would have been easier. 
Hausmann, et al. (2008) focused on race-based discrimination in health care settings and 
they explained that “there is strong evidence suggesting that people who perceive more 
discrimination directed at themselves or other members of their group are at greater risk for 
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reduced mental and physical health status” (p.905).  Peek, et al. (2011) also discussed perceived 
racial discrimination in health care as it was associated with lower patient satisfaction, less 
adherence to treatment, poor communication between patient and provider, as well as less use of 
preventative services.   
Table 3. Study Variables 
Study Variables Variable Survey Question RQ Hypo 
Outcome Variables Pre Wait-Times 14 R5 H5a-H5h 
Post-Wait Times 15 R5 H5a-H5h 
Medical Mistrust Scale 34-40 R4 H4a-H4g 
Discrimination in Medical Settings Scale 41-57 R3 H3a-H3g 
Level One:  
Predisposing  
Characteristics 
Age 2 R1 H1b 
Sex 3 R1 H1c 
Race 4 R1 H1a 
Income 5 R2 H2a 
Education 6 R1 H1d 
Level Two: 
Enabling 
Resources 
 
Social Supports 30 R2 H2c 
Insurance Type 13 R2 H2b 
Socioeconomic Status 5 R2 H2a 
Geographic Residence 7 ------ ------- 
Region of Residence 7 ------- ------- 
Level Three: Need Patient’s Perception MMI, DMS & 
23-33 
R3 & R4 H3a-H3g 
H4a-H4g 
 Perceived Discrimination  DMS R3 H3a-H3g 
 Perceived Mistrust MMI R4 H4a-H4g 
External Variables Center Location (rural, suburban, etc) 9 R5 H5f 
 Center Type (hospital or university based) 8 ------- -------- 
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Because much of the data collection includes Likert-scale data, nominal data and interval 
level data, care must be taken to utilize analytic techniques appropriate to each measurement 
type. Analysis of Likert-scale data has been said to be problematic for several reasons and these 
issues will be considered here.  First there is the problem of data distortion.  First depending on 
the nature of the question sets and to some degree the subjective lens of the respondents, there 
may be low likelihood of utilizing the extreme ends of the Likert scale (i.e., 1 or 5) which is 
referred to as “central tendency bias, acquiescence bias and/ or social desirability bias.    
To minimize these sources of potential bias, the survey instrument was designed to 
balance the Likert scale items with negative and positive statements, which is the best solution 
for acquiescence bias.  In order to reduce the risk of central tendency bias, the survey directions 
urged the respondents to utilize the full scale in their responses.  And to minimize social 
desirability bias respondents were urged to understand the critical nature of the problem the 
survey is investigating and how important it is to provide the most accurate responses possible in 
order to achieve the most accurate results. 
As stated previously, two scales were included in the survey, The Discrimination in 
Medical Settings Scale and the Medical Mistrust Index 2.1, to provide more information in these 
areas.  Below is a description of the scales utilized in this study.   
 Discrimination in Medical Settings Scale  
The Discrimination in Medical Settings Scale was utilized to provide information on the 
patient’s experiences of mistreatment in healthcare (in this case during the transplant process) 
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due to the patient’s race.  This is a 7-item (items 34-40 in the survey) scale used by Bird, et al. 
(2001) that had been modified from the original Everyday Discrimination Scale (EDS) which 
had “high levels of internal consistency, convergent validity and divergent validity among 
African American men and women” (Peek, et al., 2011, p.3).  This scale has been utilized in 
many other studies with different populations with different medical diagnoses.   
For instance, this scale was used by Cloyes, and Rivera (2015) with LGBT older adults to 
look into their perceptions of discrimination in the medical setting as there were LGBT older 
adults who reported fearing discrimination by health care providers.  The scale was used to 
determine if their sexual orientation predicted their score on this scale as this is important to 
know as this may prevent members of this population from getting the medical care they need.  
Bisexuals in this study reportedly had significantly lower scores (Cloyes & Rivera, 2015) which 
is also important to know so that further studies can be conducted to look into why this 
population tends to have lower scores which in turn means, less perceived discrimination.    
Lopez-Cervallos and Harvey (2016) used the Discrimination in Medical Settings Scale 
with a group of young adult Latinos.  They discussed how health care discrimination is causing 
barriers to health care services in many minority groups including the Latino population.  The 
statement on the scale they mentioned with the lower score for this population was “A doctor or 
a nurse acts as if he or she is afraid of you” (Lopez-Cervallos & Henry, 2016) which is important 
to note as patients may be less likely to see medical care if they feel the health care provider is 
afraid of them.  Rivera, et al. (2016) used this scale in female to male transgender patients to 
evaluate times they perceived discrimination in the medical setting.  They found that participants 
scored higher 2.45 on the statement “I felt I was treated with less respect than other patients”.  
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Rivera, et al. (2016) noted that the majority of this population surveyed had reported that 
discrimination occurs sometimes.   
Lastly the study by Peek, et al. (2011) used the scale with African American patients and 
it was noted that the patients with diabetes who reported health care discrimination had more 
health complications and worse control of their control.  The scores in this study had an overall 
mean of 1.71 and the highest mean 1.91 was with the statement “you feel like a doctor or nurse is 
not listening to what you are saying” (Peek, et al., 2011).  The statement with the lowest mean 
1.33 was “A doctor or nurse acts as if he or she is afraid of you” (Peek, et al., 2011).  This 
finding was similar to Lopez-Cervallos, & Henry (2016).        
 The participant’s responses were assessed on a 5-point scale (1-never, 2-rarely, 3-
sometimes, 4-most of the time, 5-always) and the mean score on each statement was calculated. 
The higher the mean score, the more perceived discrimination.     
Medical Mistrust Scale 2.1   
 LaVeist, Nickerson, and Bowie (2000) found that African American patients were more 
likely to perceive racism and also more likely to report mistrust with the medical system.  They 
found that this perceived racism and mistrust played a role in patient satisfaction.  The Medical 
Mistrust Scale 2.1 was also utilized in the survey to provide more information about how patients 
feel about trust in the medical setting.  This scale consists of 17 items (statements 41-57 in the 
survey) and include statements such as “patients should always follow the advice given to them 
at healthcare organizations” and “healthcare organizations put the patient’s health first”.  
Participants are asked to rate these statements with either: 5-strongly agree, 4-agree, 3-neutral, 2-
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disagree or 1-strongly disagree.  As in previous studies, the mean score on each statement was 
calculated.  The higher the mean score, the more perceived medical mistrust.      
 LaVeist (n.d) discussed the importance of understanding the trust needed when 
navigating through a health care system.  He explains that trust is evident in many areas such as 
doctor/patient relationships, trust in the pharmaceutical companies, trust in competence of the 
health care team, and trust in the education received and appropriate decision making in regard to 
the diagnosis (LaVeist, n.d.).  This is true in the kidney transplant process as there are many 
steps to the waitlisting process and this begins with trusting that the patient will receive a referral 
to begin the process. 
Qualitative Interviews 
Survey respondents were also asked if they would volunteer to be contacted at a later date 
to participate in a phone interview.  They were told that this interview would allow for a more in 
depth look into the transplant recipients experience overall as it relates to the focus of this paper, 
that each interview would consist of eight open ended questions to allow the respondent to 
answer freely without being limited by multiple choice options or likert scale response options.  
The eight interview questions are listed below.  These questions were designed to allow the 
respondent to identify any areas of the waitlist process that were particularly difficult as well as 
areas they find to have been easy to navigate which will provide more information directly from 
the patients who have had to experience this process.    
Survey respondents who indicated they were willing to be recruited for an in-depth 
telephone interview provided their names and a contact email and telephone number on their 
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surveys.  Because a key research question is the role of patient race in waitlisting experiences, I 
attempted to recruit five African American respondents and Caucasian respondents for 
interviews.  I emailed ten potential interview recruits, reminded them of the purpose of the study 
and asked if they were still willing to be interviewed and open to having their interview 
audiotaped over the phone to please respond to my email and to provide potential days and times 
in the next month that they could be interviewed. 
These interviews were conducted by phone and were semi-structured with the intent of 
exploring further each respondents’ wait list experiences.  A list of the interview questions is 
provided below.  
• Please discuss the steps of the transplant waitlist process and approximately how long 
each step took for you.  
• Please describe some of the obstacles you experienced when trying to get wait listed.  
• Please describe any areas of the waitlist process that you found to be easy to navigate. 
• Please discuss any people in particular that were helpful during the transplant waitlist 
process.  
• Please discuss any times where you felt discriminated against for any reason during the 
waitlist process.  
• Describe anything about yourself or your personal situation that, if you had the ability to 
change it, would have made the transplant waitlist process easier.  
• Is there any advice you would give to other patients trying to get onto the transplant 
waitlist?  
• Please discuss any areas that you feel could have been improved in order to make wait 
listing easier for you.  
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CHAPTER FOUR: RESULTS 
             The survey was entered into Qualtrics to be able to provide a link for the online version 
of the survey for the support groups and forums that meet online and for the support group 
leaders who requested to disperse the survey via email.  The data was collected in Qualtrics, 
cleaned and stored in the password-protected database accessible by the researcher and then 
analyzed using the Statistical Product and Service Solutions (SPSS) software version 25 (IBM 
Corporation, 2012).  Once surveys were completed and the survey was closed, frequency 
distributions were run on all demographic data to better understand the sample of the population 
that completed the survey.  This data was analyzed and is described in detail in the subsequent 
section under sample. 
Data Analysis 
This chapter discusses the results of data analysis, including a descriptive outline of the 
respondents’ demographics including age, race, sex, educational level, income level and 
insurance type, relationship and prediction.  The dependent variables in the analysis are reported 
wait times, mean scores on the Medical Mistrust Scale, and mean scores on the Discrimination in 
Medical Settings Scale. Descriptive analysis includes examination of measures of central 
tendency and variability in all the independent and dependent variables. The survey items, 
previously described, include mainly Likert-scale questions and several nominal response items 
which were first examined with descriptive statistics.  Each Likert item was analyzed separately 
in univariate analysis including percentage distribution of responses in each of the five Likert 
response categories and measures of central tendency including the mean. 
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  As in previous studies, the mean scores from the Discrimination in Medical Settings 
Scale and the Medical Mistrust Index were also computed for each respondent.  Descriptive 
approaches were used to begin to explore the trends in mean scores across different moderator 
variables including: respondent gender, age-group, race/ethnicity; respondent’s organization 
characteristics including region, location of the center (rural or urban) and the type of center 
(university or hospital based). 
 Although there are some debates about the use of averages from Likert response data in 
parametric analyses, in this analysis of the two standardized scales, since groups of Likert 
response items were coded and mean scores were calculated, the mean scores can be defended as 
an approximation of interval data.  Thus, an analysis of variance was used as the primary 
methods for exploring the relationships between the study variables and the scale scores.  
Analysis of variance was also employed to explore how relationships of the three dimensions of 
the Anderson Model of Health Behavior (predisposing, enabling and need scores) and transplant 
center organization variables varied significantly across the reported waitimes. 
 With the Medical Mistrust Scale and Discrimination in Medical Settings Scale, the mean 
scores on the scale were compared by predisposing characteristics and enabling resources.  A 
one-way ANOVA was used for the medical mistrust scale (categorical independent variable, 
continuous dependent variable) and the Discrimination in Medical Settings Scale. An ANOVA 
was run for each demographic variable, the post-hoc (in the hopes of significant results) and 
graphs showing the mean plots for all variables. 
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Qualitative Analysis of Interviews 
 Ten in-depth interviews were conducted by phone with kidney transplant recipients.  
Interview data was audio recorded and transcribed verbatim.  A team of two doctoral students 
coded the data.  They employed an iterative coding process that applied techniques of grounded 
theory (Strauss & Corbin, 1998) and directed content analysis (Hsieh & Shannon, 2005). 
Specifically, to initiate team-based codebook development, coders independently reviewed the 
first two interview transcripts with the intention of coding descriptive labels for responses to 
each of the open-ended questions. 
Using the constant comparison method (Strauss & Corbin, 1998) coders grouped and 
named common concepts as a means to generate their version of a coding grid that included each 
concept’s name, working definition, coding criteria and notes, and illustrative examples 
(MacQueen, 1998).  The primary researcher (Bergeron) reviewed and compiled the two-coder’s 
initial coding grid into one team-based codebook in an Excel file (MacQueen, 1998).  The two 
coders then returned to the initial transcript and reach consensus on coding utilizing this coding 
grid, as well as make any agreed changes to the coding grid.   They then independently coded the 
remaining interview transcripts and met regularly to discuss emergent codebook and coding 
issues (e.g., unclear coding definitions, overlap among codes, challenging survey responses). 
Descriptive Analysis  
Survey Respondents. The survey respondents consisted of kidney transplant recipients 
from kidney transplant support groups.  As stated previously, in order to distinguish which group 
each survey response came from to be able to understand the types of groups were represented in 
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the data, identical forms of the survey were created and each was labeled with a different letter to 
distinguish which group the respondent was a member of.   Subsequently, in order to protect 
respondent identities, specific group names were removed from the data and only the group IDs 
were kept and referred to in the analysis.    
Five of the support groups the respondents were from were online support groups, one of 
the groups was an online forum and four groups were face to face support groups. The type of 
support group that yielded the most responses was the online support group.   
Table 4. Respondent Groups 
 
Frequency Percent Cumulative Percent 
 Online 115 83.4% 83.9% 
Forum  14 10.2% 94.2% 
Face to face 8 5.8% 100% 
Total 137 100.0  
 
Once all of the survey data was collected and the survey was closed, the data was 
reviewed and cleaned.  Upon reviewing the Qualtrics data set, it originally consisted of 163 
surveys.  Out of this total, it was noted that five surveys had no responses at all, therefore these 
five were removed from the analysis leaving 158 total surveys for analysis.  The focus of this 
study was on kidney transplant recipients and there were two subjects that did not meet this 
criteria and their responses were also removed from the final data set leaving 156 total responses.  
One of which answered “no” to the first question on the survey which asked if the participant 
was a kidney transplant recipient and the other also answered “no” to the first question but 
completed the survey stated they had received a liver not kidney transplant.   
83 
 
With the first question of the survey, there were also seven respondents who did not put a 
response for this question at all.  These participant’s responses for the rest of the survey were 
then reviewed.  Six of the seven surveys were left in the data set even though the first question’s 
response was blank because the respondent had answered all the other questions including year 
of the transplant and information about the transplant center they had received the transplant at.  
The one that was removed was because not only did the person leave the first question blank but 
they had also left the year they received their transplant blank bringing the total to 155 total.    
The last reason that data was removed was due to the respondent’s location.  This 
research is focused on patients in the United States therefore 18 responses were removed due to 
the patient residing and receiving their transplant outside of the United States.  Two of these 
respondents were from Australia, three were from South Africa, four from India, five from 
Canada, one from Norway, one from Qatar, one from DiDo (unknown origin) and one from 
Germany.  This left a total of 137 responses to be analyzed for this study.    
Table 5. Survey Deletions   
# Surveys Deleted Reason for Deletion 
5 No responses to any of the survey questions 
1 Answered “no” to being a transplant recipient 
1 Received a liver not kidney transplant 
1 Unable to identify if they are a kidney transplant pt. as they left question 1 blank  
18 Resided outside of the US and the study focus is US recipients 
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Dependent Variables 
Wait Times 
 As previously discussed, wait times can vary not only once a patient is on the transplant 
list but may also vary during the time the patient is waiting to get onto the list after they begin 
the process.  The frequency table below shows the length of time, in months, the survey 
respondents reported they had to wait to get onto the list once they were notified they needed a 
transplant.  
Table 6. Pre-Wait Times 
           Frequency Percent Valid Percent 
Cumulative 
Percent 
0 8 5.8 6.0 6.0 
1 8 5.8 6.0 11.9 
2 5 3.6 3.7 15.7 
3 19 13.9 14.2 29.9 
4 6 4.4 4.5 34.3 
5 6 4.4 4.5 38.8 
6 17 12.4 12.7 51.5 
7 3 2.2 2.2 53.7 
8 2 1.5 1.5 55.2 
9 2 1.5 1.5 56.7 
10 2 1.5 1.5 58.2 
11 5 3.6 3.7 61.9 
12 10 7.3 7.5 69.4 
13 1 .7 .7 70.1 
14 1 .7 .7 70.9 
15 2 1.5 1.5 72.4 
18 3 2.2 2.2 74.6 
20 1 .7 .7 75.4 
23 1 .7 .7 76.1 
24 10 7.3 7.5 83.6 
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Frequency Percent Valid Percent 
Cumulative 
Percent 
30 1 .7 .7 84.3 
36 6 4.4 4.5 88.8 
37 1 .7 .7 89.6 
40 1 .7 .7 90.3 
48 4 2.9 3.0 93.3 
50 1 .7 .7 94.0 
72 1 .7 .7 94.8 
78 1 .7 .7 95.5 
84 1 .7 .7 96.3 
93 1 .7 .7 97.0 
120 2 1.5 1.5 98.5 
168 1 .7 .7 99.3 
324 1 .7 .7 100.0 
Total 134 97.8 100.0  
Missing 3 2.2   
  
As you can see from the table above, 51.5% of the respondents reported waiting 6 months 
or less to get onto the waitlist.  69.4% of the respondents reported waiting a year or less whereas 
83.6% reported waiting 2 years or less to get onto the waitlist.  The least amount of time was 
reported by eight respondents who reported they were able to get onto the list in less than a 
month and the longest time reported was 324 months by one respondent.     
Post Wait Time 
            The frequency table below shows the length of time, in months, the survey respondents 
reported they had to wait for a transplant once they were on the wait list. 
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Table 7. Post-Wait Times 
                    Frequency Percent Valid Percent 
Cumulative 
Percent 
0 7 2.8 5.4 5.4 
1 6 2.4 4.6 10.0 
2 2 .8 1.5 11.5 
3 9 3.6 6.9 18.5 
4 4 1.6 3.1 21.5 
5 5 2.0 3.8 25.4 
6 9 3.6 6.9 32.3 
7 2 .8 1.5 33.8 
8 6 2.4 4.6 38.5 
9 2 .8 1.5 40.0 
10 3 1.2 2.3 42.3 
11 2 .8 1.5 43.8 
12 7 2.8 5.4 49.2 
13 4 1.6 3.1 52.3 
14 3 1.2 2.3 54.6 
17 1 .4 .8 55.4 
18 5 2.0 3.8 59.2 
19 2 .8 1.5 60.8 
21 1 .4 .8 61.5 
24 7 2.8 5.4 66.9 
26 2 .8 1.5 68.5 
28 1 .4 .8 69.2 
30 3 1.2 2.3 71.5 
32 1 .4 .8 72.3 
36 5 2.0 3.8 76.2 
37 1 .4 .8 76.9 
38 1 .4 .8 77.7 
40 1 .4 .8 78.5 
42 2 .8 1.5 80.0 
43 1 .4 .8 80.8 
45 1 .4 .8 81.5 
46 1 .4 .8 82.3 
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Frequency Percent Valid Percent 
Cumulative 
Percent 
48 1 .4 .8 83.1 
54 3 1.2 2.3 85.4 
57 1 .4 .8 86.2 
60 4 1.6 3.1 89.2 
72 3 1.2 2.3 91.5 
73 1 .4 .8 92.3 
78 1 .4 .8 93.1 
84 2 .8 1.5 94.6 
85 1 .4 .8 95.4 
100 1 .4 .8 96.2 
120 1 .4 .8 96.9 
144 1 .4 .8 97.7 
168 3 1.2 2.3 100.0 
Total 130 51.6 100.0  
System 122 48.4   
252 100.0   
 
As you can see from the table above, only about 32% of the respondents reported waiting 
6 months or less to get onto the waitlist.  49% of the respondents reported waiting a year or less 
whereas about 67% reported waiting 2 years or less to get onto the waitlist.  The least amount of 
time was reported by seven respondents who reported they were able to get onto the list in less 
than a month and the longest time reported was 168 months by three respondents. 
Discrimination in Medical Setting Scale 
Respondents with this scale were asked: During your kidney transplant experience, have 
you ever had any of the following things happen to you? (all statements are shown in the table 
below).  A large percentage of the respondents indicated that they have never: had a doctor or 
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nurse act as though they were afraid of them (86%), had a doctor or nurse act as though they 
thought they were not smart (66%), had a doctor or nurse act as if they were better than them 
(65%), feel they were treated with less courtesy than others (81%), received poorer services than 
others (82%), felt treated with less respect (83%) or felt like a doctor or nurse was not listening 
to what they were saying (55%).   
The Likert scaled items were assigned a numerical value and the mean score was derived 
from these values.  The response, “most of the time”(4), “sometimes” (3), “rarely” (2) and 
“never” (1).  The higher the average score for each statement, the higher the perceived 
discrimination.  All of the mean scores were below 2 so there was not much perceived 
discrimination in the medical setting in this sample.  The highest mean (1.85) was on the 
statement about not feeling like a doctor or nurse was listening to what they were saying and this 
mean was still in the “rarely/never” category.  The lowest mean (1.21) was on the statement, “I 
had a doctor or nurse act as though they were afraid of me”.   
With this said, the responses overall did not yield much evidence of perceived 
discrimination in this process.  The scores in our study were similar to those in the study by 
Peek, et al. (2011). They had an overall mean of 1.71 where our overall mean was 1.44.  The 
highest mean in their study was 1.91 with the statement “you feel like a doctor or nurse is not 
listening to what you are saying” (Peek, et al., 2011).  The statement with the lowest mean 1.33 
was “A doctor or nurse acts as if he or she is afraid of you” (Peek, et al., 2011).  This finding was 
also similar to Lopez-Cervallos, & Henry (2016).       
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Table 8. Discrimination in Medical Settings Scale  
 Most of the Time Sometimes Rarely  Never Mean 
I had a doctor or nurse act as though they were afraid of me 0 % 6.6% 7.3% 85.4% 1.21 
I had a doctor or nurse act as though they thought I was not smart  3.7% 14.6% 15.3% 65.7% 1.56 
I had a doctor or nurse act as if he or she was better than me  4.4% 17.5% 12.4% 65% 1.61 
I felt I was treated with less courtesy than other people  1.5% 5.8% 10.9% 79.6% 1.28 
I felt I received poorer services than other people 2.9% 4.4% 10.2% 81.8% 1.28 
I felt as though I was treated with less respect than other people 2.2% 5.1% 9.5% 82.5% 1.26 
I felt like a doctor or nurse was not listening to what I was saying 8.8% 22.6% 13.1% 54.7% 1.85 
 
Medical Mistrust Scale 
The survey then asked a few questions about how respondents feel about any healthcare 
organization where they received their healthcare throughout their ESRD treatments all the way 
through transplant.  These statements are shown in the table below.   
Similar to the previous scale, the Likert scaled items were assigned a numerical value and 
the mean score was derived from these values.  The response, “strongly agree”(5), “agree” (4), 
“neither” (3),“disagree” (2), and “strongly disagree” (1).  As stated previously, to minimize any 
sources of potential bias, the survey instrument was designed to balance the Likert scale items 
with negative and positive statements, which is the best solution for acquiescence bias.  This 
scale does just that and when looking at the table below, the first ten statements are negative 
statements and the last seven statements (shown highlighted darker in the table) are positive 
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statements.  Therefore, for the positive statements, the scoring scale was reversed where the 
responses were scored as“strongly agree”(5), “agree” (4), “neither” (3),“disagree” (2), and 
“strongly disagree” (1).   
For the negative statements, most were a mean of three or less, therefore there was not 
much evidence of perceived mistrust.  For the positive statements, the means were similar to the 
negative statements with means below 3.45.  The lowest mean overall was 2.35 which was on 
the statement “I trust that the healthcare organizations keep up with the latest medical 
information”.  The highest mean overall was 3.45 for the statement “I trust that healthcare 
organizations will tell me if mistake is made about my treatment”. Other than that, the means 
remained less than three which indicates that there is little evidence of perceived medical 
mistrust.   
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Table 9. Medical Mistrust Scale 
Statements Strongly 
Agree 
Agree Neither Disagree Strongly 
Disagree 
Mean 
You better be cautious when dealing with healthcare organizations 5.8% 23% 32% 19% 18.2% 2.79 
Patients have sometimes been deceived or mislead by healthcare organizations 6.6% 29% 27.7% 19.7% 16% 2.90 
I trust that healthcare organizations will tell me if a mistake is made about my 
treatment 
.7% 24% 24.8% 29% 20.4% 3.45 
Healthcare organizations often want to know more about your business than they 
need to know. 
15.3% 16% 41.6% 17.5% 5% 3.20 
When healthcare organizations make mistakes they usually cover it up 9.5% 25.5% 41.6% 17.5% 5% 3.17 
Healthcare organizations have sometimes done harmful experiments on patients 
without their knowledge 
5.8% 10.9% 40.9% 27.7% 13.9% 2.67 
The patient’s medical needs come before other considerations at healthcare 
organizations 
7.3% 36.5% 35.8% 16.8% 2.9% 2.76 
Healthcare organizations are more concerned about making money than taking care 
of people 
5% 25.5% 30.7% 27.7% 10.2% 3.06 
Healthcare organizations put the patient’s health first 9.5% 34.3% 32% 19.7% 3.6% 2.71 
Healthcare organizations don’t always keep your information totally private 11.7% 32% 32% 19% 2.9% 2.88 
Patients should always follow the advice given to them at healthcare organizations 6.6%  44.5% 35.8% 8.8%  2.2%  2.74 
I typically get a second opinion when I am told something about my health 3.6% 43.8% 40% 9.5% .7% 3.31 
I trust that healthcare organizations check their staff’s credentials to make sure they 
are hiring the best people 
5.8% 26.3% 36.5% 21.2% 8% 2.54 
They know what they are doing at healthcare organizations 5.8% 39.4% 35% 17.5% .7% 2.59 
Sometimes I wonder if healthcare organizations really know what they are doing 13% 52.6% 18.2% 12.4% 1.5% 3.04 
Mistakes are common in healthcare organization 7.3% 36.5% 35.8% 16.8% 2.9% 3.33 
I trust that healthcare organizations keep up with the latest medical information 5% 25.5% 30.7% 27.7% 10.2% 2.35 
 
There was a large percentage of respondents who chose the neither agree or disagree 
answer and remained neutral on these subjects.  Thirty-two respondents agreed that you need to 
be cautious when dealing with healthcare organizations whereas twenty-five respondents 
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strongly disagreed with this statement.  Forty respondents agreed that patients have sometimes 
been deceived or mislead by healthcare organizations and twenty-two respondents strongly 
disagreed with this statement.       
Table 10. Dependent Variable Descriptives  
DV Mean SD Range 
Pre-Wait Times 18.65 months 36.58 324 months 
Post Wait Times 26.8 months 34.18 168 months 
DMS 1.44 0.24 0.64 
MMS 2.91 0.31 1.10 
 
Independent Variables 
Predisposing Characteristics 
Age 
The largest age group was the 55-64 year old age group (28.5%).  The survey resulted in 
respondents from younger age groups younger than this group were the 21-35 year old group 
(24%), 35-44 year old group (19%) and 45-54 year old group (21.9%).  The largest respondent 
age group category was the 55-64 year old respondents (28.6%).  There were 17 respondents 
(12.4%) in the oldest group of 65 and older.     
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Table 11. Respondent’s Age 
 
 Frequency Percent Cumulative Percent 
 21-35 24 17.5 17.5 
35-44 27 19.7 37.2 
45-54 30 21.9 59.1 
55-64 39 28.5 87.6 
65 or older 17 12.4 100.0 
Total 137 100.0  
 
Respondent’s Gender 
 Out of the 137 respondents, 77.4% (106 respondents) identified themselves as female and 
22.6% (31 respondents) identified as male.  The distribution of the respondent’s gender is shown 
in the table below.  The reason for the large difference in respondent’s gender is difficult to 
determine but will be discussed later.  
 
Table 12. Respondent’s Sex 
 Frequency Percent Cumulative Percent 
 Female 106 77.4 77.4 
Male 31 22.6 100.0 
Total 137 100.0  
      
Respondent’s Race/Ethnicity 
 In terms of race, only one respondent did not disclose their race.  The rest of the 
respondents’ answers varied and their answers in their original form are depicted in the table 
below. 
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Table 13. Respondent’s Race/Ethnicity (Original Version) 
 Frequency Percent Cumulative Percent 
Missing 1 .7 .7 
Asian 2 1.5 2.2 
Asian, Native Hawaiian or 
Pacific Islander, Filipino 
1 .7 2.9 
Asian, Vietnamese, Other 1 .7 3.6 
Black, African American 14 10.2 13.9 
Chinese 1 .7 14.6 
Hispanic 4 2.9 17.5 
Korean 1 .7 18.2 
Mexican 1 .7 18.9 
Other 2 1.5 28.4 
White 105 76.6 97.1 
White, Asian 1 .7 97.8 
White, Cuban 1 .7 98.5 
White, Other 1 .7 99.3 
White, Puerto Rican, 
American Indian, or Alaskan 
Native 
1 .7 100 
Total 137 100 100 
This list was then recoded into the following 6 collapsed categories: missing, Asian, 
Black/African American, Hispanic, White or Other/Mixed.  The Asian category is comprised of 
respondents who identified themselves as: Asian, Asian Native Hawaiian or Pacific Islander, 
Asian Other, Asian Vietnamese, Chinese or Korean.  The Black/African American Category 
included respondents who identified as Black or African American. Unfortunately, only 10% of 
the respondents were in this category, which limits our ability to draw conclusions about race 
differences in transplant wait times.  The Hispanic category included Hispanic and respondents 
who identified as Mexican.  The White category was the largest ethnicity category (76.6%).  The 
last category, Other/Mixed included individuals who identified as other, or identified as more 
than one race such as White along with Puerto Rican, American Indian and Alaskan Native or 
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White other, White Asian or White Puerto.  These collapsed categories are shown in the table 
below.  
     Table 14. Respondent’s Race/Ethnicity (cleaned version)   
 Frequency Percent Cumulative Percent 
 
Missing 
1 .7% .7 
Asian 6 4.4% 5.1 
Black, African American 14 10% 15.1 
Hispanic 5 3.6% 18.7 
White 105 76.6% 95.3 
Other/Mixed  6 4.4% 100 
Total 137 100%  
 
Education 
One respondent reported having less than a high school diploma and 28 (20.4%) 
identified themselves as being a high school graduate.  Forty-one respondents (24.8%) reported 
having some college education and 74 respondents (29.9%) reported having a college degree or  
a graduate or professional degree (24.1%).    
Table 15. Respondent’s Education 
 Frequency Percent Cumulative Percent 
 
Less than high school diploma 1 .7 75.2 
High school graduate 28 20.4 74.5 
Some college 34 24.8 100.0 
College degree 41 29.9 29.9 
Graduate or professional degree 33 24.1 54.0 
Total 137 100.0 100.0 
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Enabling Resources 
Socioeconomic Status 
Respondents were also asked about their current household income and four respondents 
left this question blank and are labeled as missing on the table below.  There were 27 
respondents who reported a household income less than $24,999 and 14 of these respondents 
reported making less than $15,000 per year.  There were 33 respondents who reported making 
between $25,000 and $54,999.  There were another 38 respondents who reported making 
between $55,000 and $94,999.  The last group of 35 respondents reported a current annual 
household income of greater than $95,000.  The amount of people represented within the 
household for each respondent is unknown 
Table 16. Respondent’s Income 
 Frequency Percent Cumulative Percent 
 
Missing 
4 2.9 2.9 
Less than $15, 000 
14 10.2 13.1 
$15,000-$24,999 13 9.5 22.6 
$25,000-$34,999 12 8.8 31.4 
$35,000-$44,999 12 8.8 40.2 
$45,000-$54,999 9 6.6 46.8 
$55,000-$64,999 6 4.4 51.2 
$65,000-$74,999 14 10.2 61.4 
$75,000-$84,999 12 8.8 70.2 
$85,000-$94,999 6 4.4 74.6 
greater than $95,000 35 25.5 100 
Total 137 100.0 100.0 
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Health Insurance 
 Having proper medical insurance can be essential when needing a kidney transplant.  The 
survey asked respondents about the insurance they had and also left a text box in case someone 
had an insurance that was not on the list.  The original version of the insurances that recipients’ 
listed is shown below.  
Table 17. Respondent’s Insurance (original version) 
  Frequency Percentage Cumulative Percent 
 Medicaid 7 5.1 5.1 
Medicaid,Medicare 19 13.9 19.0 
Medicare 11 8 27.0 
Medicare,Other 12 8.8 35.8 
Other 6 4.4 40.1 
Private 40 29.2 69.3 
Private,Medicaid 1 .7 70.1 
Private,Medicaid,Medicare 3 2.2 72.3 
Private,Medicare 35 25.5 97.8 
Private,Medicare,Other 1 .7 98.5 
Private,Medicare,VA insurance 1 .7 99.3 
Private,Other 1 .7 100.0 
Total 137   
 
 This list of insurances was then cleaned into a more concise table which is shown below.  
The first category identified as Medicaid includes the 26 respondents who identified as having 
Medicaid or Medicaid and Medicare combined.  The next category was Medicare which included 
23 respondents who stated they had either “Medicare” or “Medicare Other”.  The category listed 
as Private includes 40 total respondents who answered as having “private” insurance.  The 
category listed as Private+ includes the respondents who identified as having private insurance 
along with another insurance which totaled 42 respondents.  This group includes “private 
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Medicaid”, “private Medicaid Medicare”, “Private Medicare”, “Private Medicare Other” “Private 
Other” and “Private Medicare VA insurance”.  The last category is named “Other” which 
included anyone who identified by checking the box for other.  This category included six 
respondents.    
         Table 18. Respondent’s Insurance (cleaned version) 
 
Percent 
Cumulative 
Percent 
 
Medicaid 26 
18.98 18.98 
Medicare 23 
16.77 35.75 
Other 6 
4.4 40.15 
Private 40 
29.20 69.35 
Private+ 42 
30.65 100.00 
 137 100.0 100 
 
Organizational Characteristics 
Transplant Centers 
 As stated previously, UNOS has divided the country into transplant regions and some 
regions have been shown to be more successful when it comes to kidney transplantation (OPTN, 
2016).  Patients are allowed to be waitlisted in multiple centers, multiple states and multiple 
transplant regions.  Respondents were asked about the state they reside as well as the state they 
received their transplant in.  These answers were in open text and then were recoded by region 
number which has been identified by UNOS (OPTN, 2016).   
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Region of Residence vs. Region of Transplant 
 The table below depicts the states included in each region.   
Table 19. States in each Transplant Region 
1 Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Eastern Vermont 
2 Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania, West Virginia, Northern Virginia 
3 Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, Puerto Rico 
4 Oklahoma, Texas 
5 Arizona, California, Nevada, New Mexico, Utah 
6 Alaska, Hawaii, Idaho, Montana, Oregon, Washington 
7 Illinois, Minnesota, North Dakota, South Dakota, Wisconsin 
8 Colorado, Iowa, Kansas, Missouri, Nebraska, Wyoming 
9 New York, Western Vermont 
10 Indiana, Michigan, Ohio 
11 Kentucky, North Carolina, South Carolina, Tennessee, Virginia 
 
There were two respondents which could not be coded as one was unidentifiable and one 
respondent only entered US for place of residence but did not indicate which state.  Out of the 
surveys that were recoded, the most responses were from Region 3 (29 responses or 21.2%) 
which includes Florida, Georgia, Alabama, Arkansas, Louisiana, Mississippi and Puerto Rico  
Region 2 which includes states in the Northeast was the next largest with a total of 19 responses 
(13.2%) and then Region 7, midwestern states, with 18 responses (13.1%).  The region with the 
least amount of responses was Region 9 (6 responses, or 4.4%). 
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Table 20. Respondents’ UNOS Regions 
Transplant Region Frequency Percent Cumulative Percent 
  6 3.7 3.7 
1 12 7.4 11.0 
2 19 11.7 33.1 
3 25 15.3 48.5 
4 9 5.5 54.0 
5 11 6.7 60.7 
6 9 5.5 66.3 
7 18 11.0 77.3 
8 10 6.1 83.4 
9 8 4.9 88.3 
10 10 6.1 17.2 
11 7 4.3 21.5 
       
 Similar to the information above, respondents were asked to identify where their 
transplant center was located.  This answer was also open text and the answers were recoded into 
the UNOS regions.  There were a total of twelve respondents (8.8%) who reported having their 
transplant in a different region than their residence.   
Survey respondents were then asked which type of area the center was located.  A large 
portion of the respondents (70.1%) stated that they received their transplant in a transplant center 
located in an urban area.  Twenty-five respondents (18.2%) stated their center was located in a 
suburban area and nine respondents (6.6%) stated their center was in a rural location.  The rest of 
the respondents either marked other (3.6%) or did not answer this question (1.5%).   
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        Table 21. Respondent’s Transplant Center Location 
 Frequency Percent 
Cumulative 
Percent 
 
Missing 
2 1.5 1.5 
Other 5 3.6 5.1 
Rural 9 6.6 11.7 
Suburban 25 18.2 29.9 
Urban 96 70.1 100.0 
Total 137 100.0  
     
In regard to the type of transplant center setting that patients received their transplant, 83 
respondents (60.6%) identified their center as a University or University Affiliated Center.  
Thirty-six respondents (26.3%) identified their center as a Private Hospital Transplant Center.  
Some respondents (6.6%) were unsure of the type of setting, eight respondents checked “other” 
and one respondent did not answer the question and was recoded as missing.   
Table 22. Transplant Center Type 
 Frequency Percent 
Cumulative 
Percent 
 
 
 Missing 1 .7 .7 
Other 8 5.8 6.6 
Private Hospital 36 26.3 32.8 
University or University Affiliated  83 60.6 93.4 
Unsure 9 6.6 100.0 
Total 137 100.0  
     
Inactively Waitlisted 
One of the difficult parts of the transplant waitlist is that there are sometimes when a 
patient may be on the waitlist but may then be labeled as inactive which means they still have a 
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placehold on the list but they are unable to receive a transplant even if it is their turn and a 
kidney is available.  The transplant recipients responded that 34 of them or 24.8% had been 
labeled as inactive at some point in their time on the waitlist.  Five respondents were unsure if 
they had ever been labeled as inactive.  Over 70% (98) of the respondents indicated that they had 
never been removed or labeled as inactive on the waitlist at any point.  
Table 23. Waitlist Inactivity 
 Frequency Percent 
Cumulative 
Percent 
Valid No 98 71.5 71.5 
Not Sure 5 3.6 75.2 
Yes 34 24.8 100.0 
Total 137 100.0  
  
When asked if the patient had been removed from the waitlist, there was also an open text 
box which allowed for those who had been removed to state what it was that made them inactive 
or removed from the list.  The qualitative responses were categorized by the reason for removal 
and they were entered into the table below.   
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Table 24. Inactivity Reasons 
Category Qualitative Response 
Number of removals Once (n=11) 
Twice (n=2) 
Received Transplant Son donated kidney 
Issues with Weight I was inactive until I met BMI requirement 
First time because I gained weight 
I was inactive accruing time due to weight issues 
Non-Compliance Non-compliance with medication and appointments 
Insurance Waiting on Medicaid and Medicare to go through 
Lab work/testing 
issues 
Creatinine went down temporarily 
Once, labs stable 
Once for high antibiotics 
Test results not received from another Dr. 
False pregnancy test 
Was told pap wasn’t current (it was), and irregular echo 
Organ issues Septic shock, lung surgery 
Once due to lung surgery 
Triple bypass 
Once.  I had a coronary stent placed in 2018 
I was having issues with diverticulitis and had a colon resection 
I was placed on hold for 2 months 
1 time for approximately 4 mths while they were looking at growths in my lungs 
2 times, second time because I was diagnosed with breast cancer 
Once, due to having developed Cardiomyopathy 
I was only removed when the first one failed and had to do the evaluation again after I 
recovered.  I have been active since 
Infection Once due to severe abdominal infection 
Inactive more times than I count from countless infections 
Was removed because of infections 
Improved function Inactive once because gfr went up 
Once, improved function and no need for dialysis for 7 years 
Moved Yes. Moved out of state 
 
Research Questions 
Research Question 1: To what degree do transplant recipients perceive the role of their 
predisposing characteristics (race/ethnicity, age, gender, education level) as important in the 
process of getting on the kidney transplant waitlist?  
 Frequency Distributions were run on the Likert scale responses to the questions 
regarding the respondents’ perception of the role their race, age, sex, or educational level had on 
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their transplant waitlist experience.  The Likert scale responses were coded: strongly agree (5), 
agree (4), neutral (3), disagree (2) and strongly disagree (1).  The tables below depicts the 
responses.  The participants were asked how much they agree that each of these predisposing 
characteristics played a negative role in their ability to get waitlisted.    
Respondents Beliefs About Impacts on Waitlisting 
 The survey respondents were asked how they felt their predisposing characteristics: race, 
ethnicity, education, employment, age, gender and health literacy impacted their waitlist 
experience.  They were also asked how they feel their enabling resources: insurance, social 
support, geographic location and socioeconomic status impacted their waitlist experience.  The 
responses to all of these questions are shown on the table below.   
All questions for the first four categories: age, ethnicity, race and gender were worded as: 
I feel that my ___________ had a negative effect on my waitlist experience.  The largest 
percentage of respondents indicated that they strongly disagreed that their race (62%), ethnicity 
(61.3%), age (56.2%) or gender (63.5%) had a negative effect on their waitlist experience.  No 
respondents reported that they felt their gender had a negative effect on their waitlist experience 
and only one respondent strongly agreed that their race and ethnicity had a negative effect on 
their waitlist experience. Two respondents strongly agreed that age had a negative effect as well.   
The questions for the next four categories were worded a bit differently.  For example: I 
feel that if I had better (health insurance, paying job, support system, education) the wait list 
process would have been easier. The survey showed that 71 respondents (51.8%) strongly 
disagreed that if they had better health insurance, the waitlist process would have been easier for 
them.  Similar results were found in terms of having a better paying job (48.2%), better social 
supports (45.3%) and better education (51.8%) as these respondents also strongly disagreed that 
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the waitlist process would have been easier.  There were, however, three respondents (2.2%) that 
strongly agreed that better insurance would have made the process easier.  Six respondents 
(4.4%) strongly agreed that having a better paying job would have helped, five respondents 
(3.6%) felt that having a better support system would have helped and one respondent (.7%) 
strongly agreed that the waitlist process would have been easier had they had a better education.   
The last two categories referred to the information communicated to the patient.  The 
statements on the survey for these categories were: I feel that I was not provided enough 
information about the waitlist process and I feel I was not provided enough information about 
my kidney disease which made it more difficult to pursue transplant.  In terms of information 
provided on the waitlist process, 50 (36.5%) of respondents strongly disagreed that they were not 
provided enough information and only 5 respondents (3.6%) strongly agreed with this statement.  
In terms of information provided on kidney disease itself, 72 respondents (52.6%) strongly 
disagreed with this statement while four respondents (2.9%) strongly agreed.      
Table 25. Factors Perceived As Impacting Waitlisting         
 Strongly Agree Agree Neutral  Disagree Strongly Disagree Mean 
Race 1 (.7%) 5 (3.6%) 19 (13.9%) 27 (19.7%) 86(62%) 1.61 
Ethnicity 1 (.7%) 4 (2.9%) 18 (13.1%) 29 (21.2%) 84 (61.3%) 2.02 
Age 2 (1.5%) 6 (4.4%) 20 (14.6%) 31 (22.6%) 77 (56.2%) 1.71 
Gender 0 0 19 (13.9%) 30 (21.9%) 87 (63.5%) 1.5 
Insurance 3 (2.2%) 6 (4.4%) 23 (16.8%) 34 (24.8%) 71 (51.8%) 1.8 
Job/$ 6 (4.4%) 7 (5.1%) 23 (16.8%) 34 (24.8%) 66 (48.2%) 1.64 
Support 5 (3.6%) 13 (9.5%) 20 (14.6%) 36 (26.3%) 62 (45.3%) 1.99 
Education 1 (.7%) 5 (3.6%) 22 (16.1%) 37 (27%) 71 (51.8%) 1.74 
Waitlist Info 5 (3.6%) 21 (15.3%) 18 (13.1%) 43 (29.2%) 50 (36.5%) 2.18 
CKD Info 4 (2.9%) 5 (3.6%) 17 (12.4%) 38 (27.7%) 72 (52.6%) 1.76 
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In terms of race, participants were provided with the statement: I feel that my race had a 
negative effect on my waitlist experience and were asked to rate their responses on a 5 point 
Likert Scale ranging from Strongly Agree to Strongly Disagree.  Table 26 below provides the 
information from the frequency distribution for the characteristic of race.  86 respondents 
(62.8%) stated that they strongly disagree that their race had a negative effect on their waitlist 
experience.  Whereas one person reported that they strongly agreed with this statement (.7%) and 
five reported they agreed (3.6%).   
Table 26. Perceived Impact of Race on Waitlist Experience 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
 Strongly Disagree 86 62.8 62.8 62.8 
Disagree 27 19.7 19.7 82.5 
Neutral 18 13.1 13.1 95.6 
Agree 5 3.6 3.6 99.3 
Strongly Agree 1 .7 .7 100.0 
Total 137 100.0 100.0  
 
In terms of ethnicity, participants were provided with the statement: I feel that my 
ethnicity had a negative effect on my waitlist experience and were asked to rate their responses 
on a 5 point Likert Scale ranging from Strongly Agree to Strongly Disagree.  The table below 
provides the information from the frequency distribution for the characteristic of ethnicity.  
Similar findings were identified such as 85 respondents (62%) stated that they strongly disagree 
that their ethnicity had a negative effect on their waitlist experience.  Whereas one person 
reported that they strongly agreed with this statement (.7%) and four reported they agreed 
(2.9%).   
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Table 27. Perceived Impact of Ethnicity on Waitlist Experience 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
 Strongly Disagree 85 62.0 62.5 62.5 
Disagree 29 21.2 21.3 83.8 
Neutral 17 12.4 12.5 96.3 
Agree 4 2.9 2.9 99.3 
Strongly Agree 1 .7 .7 100.0 
Total 136 99.3 100.0  
 Missing 1 .7   
Total 137 100.0   
 
In terms of age participants were provided with the statement: I feel that my age had a 
negative effect on my waitlist experience and were asked to rate their responses on a 5 point 
Likert Scale ranging from Strongly Agree to Strongly Disagree.  The table below provides the 
information from the frequency distribution for the characteristic of age.  78 respondents (56.9%) 
stated that they strongly disagree that their age had a negative effect on their waitlist experience.  
Whereas two people reported that they strongly agreed (1.5%) with this statement and six 
reported they agreed (4.4%).  
Table 28. Perceived Impact of Age on Waitlist Experience 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 Strongly Disagree 78 56.9 56.9 56.9 
Disagree 32 23.4 23.4 80.3 
Neutral 19 13.9 13.9 94.2 
Agree 6 4.4 4.4 98.5 
Strongly Agree 2 1.5 1.5 100.0 
 
Total 137 100.0 100.0  
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In terms of their sex, participants were provided with the statement: I feel that my sex had 
a negative effect on my waitlist experience and were asked to rate their responses on a 5 point 
Likert Scale ranging from Strongly Agree to Strongly Disagree.  The table below provides the 
information from the frequency distribution for the characteristic of sex.  Similar to race and 
ethnicity, 85 respondents (62%) stated that they strongly disagree that their age had a negative 
effect on their waitlist experience.  Whereas two people reported they agreed (1.5%) and no one 
reported strongly disagreeing with this statement.    
Table 29. Perceived Impact of Sex on Waitlist Experience 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
 Strongly Disagree 85 62.0 62.0 62.0 
Disagree 32 23.4 23.4 85.4 
Neutral 18 13.1 13.1 98.5 
Agree 2 1.5 1.5 100.0 
Strongly Agree 0 0 0 100.0 
Total 137 100.0 100.0  
 
In terms of educational level, participants were provided with the statement: I feel that if I 
had a better education, the waitlist process would have been easier and were asked to rate their 
responses on a 5 point Likert Scale ranging from Strongly Agree to Strongly Disagree.  The table 
below provides the information from the frequency distribution for the characteristic of age.  72 
respondents (52.6%) stated that they strongly disagree that their educational level needed to be 
better to make the waitlist experience easier.  Whereas, similar to race and ethnicity, one person 
reported that they strongly agreed (.7%) with this statement and six reported they agreed (4.4%). 
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Table 30. Perceived Impact of Education Level on Waitlist Experience  
 Frequency Percent Valid Percent 
Cumulative 
Percent 
 Strongly Disagree 72 52.6 52.6 52.6 
Disagree 36 26.3 26.3 78.8 
Neutral 22 16.1 16.1 94.9 
Agree 6 4.4 4.4 99.3 
Strongly Agree 1 .7 .7 100.0 
Total 137 100.0 100.0  
 
Research Question 2- To what degree do transplant recipients and perceive the role of their 
enabling resources (patients’ SES, health insurance type, support system) as important in the 
process of getting on the kidney transplant waitlist?  
 Frequency Distributions were run on the Likert scale responses to the questions 
regarding the respondents’ perception of the role their SES (measured in income level), health 
insurance and support system had on their transplant waitlist experience.  The Likert scale 
responses were coded: strongly agree (5), agree (4), neutral (3), disagree (2) and strongly 
disagree (1).  The tables below depicts the responses.  The participants were asked how much 
they agree that each of these predisposing characteristics played a negative role in their ability to 
get waitlisted.    
  In terms of income, participants were provided with the statement: I feel that if I had a 
better paying job making more money, the waitlist process would have been easier and were 
asked to rate their responses on a 5 point Likert Scale ranging from Strongly Agree to Strongly 
Disagree.  The table below provides the information from the frequency distribution for the 
characteristic of income.  67 respondents (48.9%) stated that they strongly disagree that with a 
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better paying job the waitlist experience would have been easier.  Whereas six people reported 
that they strongly agreed with this statement (4.4%) and seven reported they agreed (5.1%).   
Table 31. Perceived Impact of Income on Waitlist Experience 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
 Strongly Disagree 67 48.9 48.9 48.9 
Disagree 35 25.5 25.5 74.5 
Neutral 22 16.1 16.1 90.5 
Agree 7 5.1 5.1 95.6 
Strongly Agree 6 4.4 4.4 100.0 
Total 137 100.0 100.0  
 
In terms of health insurance, participants were provided with the statement: I feel that if I 
had a better health insurance, the waitlist process would have been easier and were asked to rate 
their responses on a 5 point Likert Scale ranging from Strongly Agree to Strongly Disagree.  The 
table below provides the information from the frequency distribution for the characteristic of 
health insurance.  71 respondents (51.8 %) stated that they strongly disagree that with a better 
insurance the waitlist experience would have been easier.  Whereas three people reported that 
they strongly agreed with this statement (2.2%) and six reported they agreed (4.4%).   
Table 32. Perceived Impact of Health Insurance on Waitlist Experience 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
 Strongly Disagree 71 51.8 51.8 51.8 
Disagree 35 25.5 25.5 77.4 
Neutral 22 16.1 16.1 93.4 
Agree 6 4.4 4.4 97.8 
Strongly Agree 3 2.2 2.2 100.0 
Total 137 100.0 100.0  
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In terms of support systems, participants were provided with the statement: I feel that if I 
had a better support system, the waitlist process would have been easier and were asked to rate 
their responses on a 5 point Likert Scale ranging from Strongly Agree to Strongly Disagree.  The 
table below provides the information from the frequency distribution for the characteristic of 
support system.  61 respondents (44.5%) stated that they strongly disagree that with a better 
support system the waitlist experience would have been easier.  Whereas five people reported 
that they strongly agreed with this statement (3.6%) and thirteen reported they agreed (9.5%).  
Table 33. Perceived Impact of Support System on Waitlist Experience 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
 Strongly Disagree 61 44.5 44.5 44.5 
Disagree 38 27.7 27.7 72.3 
Neutral 20 14.6 14.6 86.9 
Agree 13 9.5 9.5 96.4 
Strongly Agree 5 3.6 3.6 100.0 
Total 137 100.0 100.0  
 
Research Question 3. To what degree do transplant recipients’ perceived discrimination 
differ amongst their predisposing characteristics (age, race, sex, educational achievement) 
and enabling resources (insurance type, transplant center type and income level)?  
ANOVA-Comparing Mean Scores on the Discrimination in Medical Settings Scale 
and respondents predisposing characteristics/enabling resources.  
Assumption #1 
 The one way ANOVA assumes that the dependent variable is either interval or ratio level 
data. This assumption has been met as the survey asks the participants to rate their responses on a 
5-point Likert Scale where the mean scores were computed. This assumption was met. 
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Assumption #2 
  The independent variable must consist of two or more categorical, independent groups.  
In the case of this study, the independent variables are the predisposing characteristics and 
enabling resources.  These include age, race, sex, educational level, and income level.  The 
organizational characteristics also meet the assumption requirements as they are rural, urban, 
hospital or university-based transplant centers.  This assumption was met. 
Assumption #3 
 This assumption states that there must be independence of observations, meaning there is 
no relationship between each group.  The participants in this study identified the group they fit in 
based on the demographic information they provided therefore no respondent was in more than 
one group.  This assumption was met.  
Assumption #4 
 This assumption states that there should be no significant outliers.  To test this, box plots 
were run to identify any outliers and to determine if these outliers are effecting the data set.  The 
box plots for each category for each question are shown below.   
 When evaluating the box plots for each question within each category, there was one 
question that had no outliers (question 7 in the categories of age and sex).  This was assessed by 
inspection of the boxplot for values greater than 1.5 box-lengths from the edge of the box (Laerd 
Statistics, 2019).  The questions showing the most outliers were in questions 1, 4, 5 and 6.  The 
data was reviewed to ensure it was entered properly and it was noted that the answers to these 
questions due vary quite a bit amongst respondents but the data was entered correctly.  It was 
decided that the outliers will remain in the data set and the ANOVA will be run with and without 
them to determine if they effect the analysis significantly or not.  
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Assumption #5 
 This assumption is regarding the dependent variable being approximately normally 
distributed (Laerd Statistics, 2019).  To test for the normal distribution, the Shapiro-Wilk test of 
normality was completed.  The results of this test for each variable is displayed below.   
 As you can see in the table in the Appendix, there are some questions where the scores 
were normally distributed (they are highlighted in gray as p>.05).  The other areas do not 
indicate normal distribution, however the data will be run due to the “robust” nature of an 
ANOVA.  “In conclusion, non-normality does not affect Type I error rate substantially and the 
one-way ANOVA can be considered robust to non-normality” (Laerd Statistics, 2019, p.10) 
Assumption #6  
The one way ANOVA assumes homogeneity of variances and this assumption was tested 
using Levene’s test of equality of variances to see if the variances between the groups for the 
dependent variable are equal (Laerd Statistics, 2019).  The table below shows the results of this 
test.  There was homogeneity of variances, as assessed by Levene’s test for equality of variances 
(p>.05) for all of the questions for this scale when compared with respondent’s age.  
ANOVA 
Now that all of the assumptions have been addressed, the ANOVA was run to look at 
differences in total mean scores of the Discrimination in Medical Settings Scale across each 
variable, beginning with the respondent’s age.  Then the ANOVA was run to look at differences 
in mean scores of each individual question across each variable.   The results are shown in the 
table and graphs below. 
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   Table 34. ANOVA-Age and DMS Score 
 Sum of Squares df Mean Square F Sig. 
Between Groups .761 4 .190 .484 .747 
Within Groups 51.458 131 .393   
Total 52.219 135    
 
Table 35. ANOVA Descriptives by Age 
 N Mean SD Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
21-35 25 1.5772 .67032 .13406 1.3005 1.8539 1.00 3.43 
35-44 27 1.4659 .57055 .10980 1.2402 1.6916 1.00 3.14 
45-54 30 1.3913 .67156 .12261 1.1406 1.6421 1.00 3.57 
55-64 38 1.3979 .58814 .09541 1.2046 1.5912 1.00 3.14 
65 + 16 1.3481 .64976 .16244 1.0019 1.6944 1.00 3.14 
Total 136 1.4371 .62194 .05333 1.3316 1.5425 1.00 3.57 
 
In terms of the respondent’s age, there was no statistically significant difference in the 
total mean score on the Discrimination in Medical Settings Scale between the different age 
groups.   
Total Mean Score F(4, 131)=.484, p=.747 
 
Next the ANOVA was run to look at differences in mean scores on each question on the 
Discrimination in Medical Settings Scale across the respondent’s age groups. 
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Table 36. ANOVA-Individual DMS Question Means by Age  
 Sum of Squares df Mean Square F Sig. 
Q_1 Between Groups .515 4 .129 .425 .790 
Within Groups 39.720 131 .303   
Total 40.235 135    
Q_2 Between Groups 1.038 4 .259 .332 .856 
Within Groups 102.492 131 .782   
Total 103.529 135    
Q_3 Between Groups 3.188 4 .797 .923 .453 
Within Groups 113.157 131 .864   
Total 116.346 135    
Q_4 Between Groups 1.160 4 .290 .698 .595 
Within Groups 53.623 129 .416   
Total 54.784 133    
Q_5 Between Groups .865 4 .216 .450 .772 
Within Groups 62.951 131 .481   
Total 63.816 135    
Q_6 Between Groups .274 4 .068 .153 .961 
Within Groups 58.660 131 .448   
Total 58.934 135    
Q_7 Between Groups 3.978 4 .995 .886 .474 
Within Groups 147.080 131 1.123   
Total 151.059 135    
 
In terms of the respondent’s age, there were no statistically significant differences in 
mean scores on each question of the Discrimination in Medical Settings Scale between the 
different age groups.   
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Sex 
Next the ANOVA was run to look at difference in total mean scores on the 
Discrimination in Medical Settings Scale across the respondent’s sex groups and the results are 
displayed in the table below. 
 
Table 37. ANOVA-Sex and DMS Score. 
 
 
 
 
 
 In terms of the respondent’s sex, there was no statistically significant difference in total 
mean score on the Discrimination in Medical Settings Scale between the different sex groups.   
     Table 38. Mean DMS Score by Sex. 
Total Mean Score F(1, 134)=2.238, p=.137 
 The ANOVA was then run to look at differences in mean scores on each question on the 
Discrimination in Medical Settings Scale across the respondent’s sex groups. 
 
 
 
 
 
 
 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups .858 1 .858 2.238 .137 
Within Groups 51.361 134 .383   
Total 52.219 135    
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Table 39. ANOVA- Individual DMS Question Means by Sex. 
 
 
In terms of the respondent’s sex, there were no statistically significant differences in 
mean scores on each question of the Discrimination in Medical Settings Scale between the male 
or female respondents. 
 
 
 
 
 
Sum of 
Squares Df Mean Square F  Sig. 
Q_1 Between Groups .142 1 .142 .475 .492 
Within Groups 40.093 134 .299   
Total 40.235 135    
Q_2 Between Groups 1.172 1 1.172 1.535 .218 
Within Groups 102.357 134 .764   
Total 103.529 135    
Q_3 Between Groups 1.385 1 1.385 1.615 .206 
Within Groups 114.960 134 .858   
Total 116.346 135    
Q_4 Between Groups .317 1 .317 .768 .382 
Within Groups 54.467 132 .413   
Total 54.784 133    
Q_5 Between Groups 1.246 1 1.246 2.668 .105 
Within Groups 62.570 134 .467   
Total 63.816 135    
Q_6 Between Groups 1.001 1 1.001 2.316 .130 
Within Groups 57.933 134 .432   
Total 58.934 135    
Q_7 Between Groups 1.253 1 1.253 1.120 .292 
Within Groups 149.806 134 1.118   
Total 151.059 135    
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Table 40. Results of DMS Question Means by Sex 
Question 1 F(1,134)=.475, p=.492 
Question 2 F(1, 134)=1.535, p=.218 
Question 3 F(1, 134)=1.615, p=.206 
Question 4 F(1, 132)=.768, p=.382 
Question 5 F(1, 134)=.2.668, p=.105 
Question 6 F(1, 134)=2.316, p=.130 
Question 7 F(1, 134)=1.120, p=.292 
Race 
Next the ANOVA was run to look at differences in total mean scores on the 
Discrimination in Medical Settings Scale across the respondent’s race groups. 
Table 41.  Descriptives-Race and DMS Scores 
 N Mean Std. Deviation Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
Asian 6 1.1917 .23353 .09534 .9466 1.4367 1.00 1.57 
Black 14 1.7043 .84641 .22621 1.2156 2.1930 1.00 3.57 
Hispanic 5 1.6000 .81841 .36601 .5838 2.6162 1.00 2.86 
Mixed 6 1.5000 .33604 .13719 1.1474 1.8526 1.00 1.86 
White 104 1.4080 .60413 .05924 1.2905 1.5255 1.00 3.43 
Total 135 1.4403 .62310 .05363 1.3342 1.5464 1.00 3.57 
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Table 42. ANOVA-Race and DMS Scores 
 Sum of Squares df Mean Square F Sig. 
Between Groups 1.604 4 .401 1.034 .392 
Within Groups 50.422 130 .388   
Total 52.026 134    
 
In terms of the respondent’s race, there was no statistically significant difference in the 
total mean score on the Discrimination in Medical Settings Scale between the different race 
groups.   
    Table 43. Mean DMS and Race. 
Total Mean Score F(4, 130)=1.034, p=.392 
 
Next the ANOVA was run to look at differences in mean scores on each question on the 
Discrimination in Medical Settings Scale across the respondent’s race groups. 
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Table 44. ANOVA-Individual DMS Question Mean Scores by Race. 
 
 Sum of Squares df Mean Square F Sig. 
Q_1 Between Groups 1.019 4 .255 .845 .499 
Within Groups 39.174 130 .301   
Total 40.193 134    
Q_2 Between Groups 2.367 4 .592 .763 .551 
Within Groups 100.848 130 .776   
Total 103.215 134    
Q_3 Between Groups 4.220 4 1.055 1.227 .302 
Within Groups 111.750 130 .860   
Total 115.970 134    
Q_4 Between Groups 3.301 4 .825 2.055 .091 
Within Groups 51.406 128 .402   
Total 54.707 132    
Q_5 Between Groups 3.514 4 .879 1.897 .115 
Within Groups 60.219 130 .463   
Total 63.733 134    
Q_6 Between Groups 3.702 4 .926 2.181 .075 
Within Groups 55.157 130 .424   
Total 58.859 134    
Q_7 Between Groups 3.321 4 .830 .734 .570 
Within Groups 147.005 130 1.131   
Total 150.326 134    
 
In terms of the respondent’s race, there were no statistically significant differences in 
mean scores on the Discrimination in Medical Settings Scale due to respondent’s race.  
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Table 45. Results of DMS Question Means by Race.  
Question 1 F(4,130)=.845, p=.499 
Question 2 F(4, 130)=.763, p=.551 
Question 3 F(4, 130)=1.227, p=.302 
Question 4 F(4, 128)=2.055, p=.091 
Question 5 F(4, 130)=1.897, p=.115 
Question 6 F(4, 130)=2.181, p=.075 
Question 7 F(4, 130)=.734, p=.570 
Income 
The ANOVA was then run to look at differences in total mean scores on the 
Discrimination in Medical Settings Scale across the respondent’s income groups. 
Table 46. ANOVA-Descriptives by Income Level.  
 N Mean SD Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
less than $15,000 11 1.3782 .46729 .14089 1.0643 1.6921 1.00 2.29 
$15,000-$24,999 12 1.5708 .68078 .19652 1.1383 2.0034 1.00 3.14 
$25,000-$34,999 12 1.1317 .15620 .04509 1.0324 1.2309 1.00 1.43 
$35,000-$44,999 10 1.8140 .90138 .28504 1.1692 2.4588 1.00 3.43 
$45,000-$54,999 6 1.3083 .34161 .13946 .9498 1.6668 1.00 1.71 
$55,000-$64,999 14 1.8071 .85127 .22751 1.3156 2.2987 1.00 3.57 
$65,000-$74,999 12 1.3917 .54881 .15843 1.0430 1.7404 1.00 2.57 
$75,000-$84,999 6 1.2850 .31220 .12746 .9574 1.6126 1.00 1.57 
$85,000-$94,999 35 1.3637 .63635 .10756 1.1451 1.5823 1.00 3.14 
greater than $95,000 14 1.3464 .54849 .14659 1.0297 1.6631 1.00 2.57 
Total 132 1.4384 .62775 .05464 1.3303 1.5465 1.00 3.57 
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Table 47. ANOVA-Income Level and DMS Score. 
 Sum of Squares df Mean Square F Sig. 
Between Groups 5.276 9 .586 1.543 .140 
Within Groups 46.346 122 .380   
Total 51.622 131    
 
In terms of the respondent’s income, there was no statistically significant difference in 
the total mean score on the Discrimination in Medical Settings Scale between the different 
income levels.   
     Table 48. Mean DMS and Income 
Total Mean Score F(9, 122)=1.543, p=.140 
 
Next the ANOVA was run to look at differences in mean scores on each question on the 
Discrimination in Medical Settings Scale across the respondent’s income groups. 
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Table 49. ANOVA-Individual DMS Question Mean Scores by Income Level.  
 Sum of Squares df Mean Square F Sig. 
Q_1 Between Groups 3.032 9 .337 1.110 .361 
Within Groups 37.028 122 .304   
Total 40.061 131    
Q_2 Between Groups 11.470 9 1.274 1.708 .094 
Within Groups 91.045 122 .746   
Total 102.515 131    
Q_3 Between Groups 7.976 9 .886 1.027 .423 
Within Groups 105.319 122 .863   
Total 113.295 131    
Q_4 Between Groups 6.059 9 .673 1.684 .100 
Within Groups 47.972 120 .400   
Total 54.031 129    
Q_5 Between Groups 6.228 9 .692 1.485 .161 
Within Groups 56.833 122 .466   
Total 63.061 131    
Q_6 Between Groups 4.878 9 .542 1.230 .283 
Within Groups 53.751 122 .441   
Total 58.629 131    
Q_7 Between Groups 9.187 9 1.021 .899 .528 
Within Groups 138.472 122 1.135   
Total 147.659 131    
 
In terms of the respondent’s income level, there were no statistically significant 
differences in mean scores on the Discrimination in Medical Settings Scale questions due to 
respondent’s income level.  
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Table 50. Results of DMS Question Means by Income Level. 
Question 1 F(9,122)=1.110, p=.361 
Question 2 F(9,122)=1.708, p=.094 
Question 3 F(9,122)=.1.027, p=.423 
Question 4 F(9,122)=1.684, p=.100 
Question 5 F(9,122)=.1.485, p=.161 
Question 6 F(9,122)=1.230, p=.283 
Question 7 F(9,122)=.899, p=.528 
 
Education 
The ANOVA was then run to look at differences in total mean scores on the 
Discrimination in Medical Settings Scale across the respondent’s education groups. 
Table 51. ANOVA-Descriptives by Education Level.  
 N Mean SD 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
High School 42 1.6157 .68159 .10517 1.4033 1.8281 1.00 3.43 
Some College 33 1.5115 .65684 .11434 1.2786 1.7444 1.00 3.14 
College 27 1.0848 .20359 .03918 1.0043 1.1654 1.00 1.86 
Graduate or 
Professional degree 
33 1.4367 .64282 .11190 1.2087 1.6646 1.00 3.57 
Total 135 1.4403 .62310 .05363 1.3342 1.5464 1.00 3.57 
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Table 52. ANOVA-Education Level and DMS Score. 
 Sum of Squares df Mean Square F Sig. 
Between Groups 4.872 3 1.624 4.512 .005 
Within Groups 47.154 131 .360   
Total 52.026 134    
 
In terms of the respondent’s education, there was a statistically significant difference in 
the total mean score on the Discrimination in Medical Settings Scale between the different 
education groups.  Participants who had a high school educational level reported having the 
highest average score (1.62) on the Discrimination in Medical Settings Scale.  The participants 
who identified as having a college education reported the lowest average score (1.08).    
    
  Table 53. Mean DMS and Education 
Total Mean Score F(3, 131)=4.512, p=.005 
 
Next the ANOVA was run to look at differences in mean scores on each question on the 
Discrimination in Medical Settings Scale across the respondent’s education groups. 
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Table 54. ANOVA-Descriptives Individual DMS Mean Scores by Education Level 
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Table 55. ANOVA-Individual DMS Question Mean Scores by Education Level 
 Sum of Squares df Mean Square F Sig. 
Q_1 Between Groups 3.015 3 1.005 3.541 .017 
Within Groups 37.177 131 .284   
Total 40.193 134    
Q_2 Between Groups 5.862 3 1.954 2.629 .053 
Within Groups 97.353 131 .743   
Total 103.215 134    
Q_3 Between Groups 8.888 3 2.963 3.624 .015 
Within Groups 107.082 131 .817   
Total 115.970 134    
Q_4 Between Groups 2.824 3 .941 2.340 .076 
Within Groups 51.883 129 .402   
Total 54.707 132    
Q_5 Between Groups 2.348 3 .783 1.670 .176 
Within Groups 61.385 131 .469   
Total 63.733 134    
Q_6 Between Groups 2.113 3 .704 1.626 .186 
Within Groups 56.747 131 .433   
Total 58.859 134    
Q_7 Between Groups 17.071 3 5.690 5.594 .001 
Within Groups 133.255 131 1.017   
Total 150.326 134    
 
In terms of the respondent’s education level, there were three questions that showed 
statistically significant differences in mean scores (Q1, 3, and 7) on the Discrimination in 
Medical Settings Scale. One statement showing a significant difference in mean score amongst 
respondents’ education level was: I had a doctor or nurse act as though they were afraid of me.  
Respondents with a college education had the highest mean (1.38) and those with a high school 
diploma had the lowest mean (1.00).  For question 3:  I had a doctor or nurse act as if he or she 
was better than me, respondents with a college education again had the highest mean (1.81) and 
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those with a high school diploma again had the lowest mean (1.12).  Question 7: I felt like a 
doctor or nurse was not listening to what I was saying had similar results as the respondents with 
a college education had the highest mean (2.24) and those with a high school diploma had the 
lowest mean (1.23).        
Table 56. Results of DMS Question Means by Education Level. 
Question 1 F(3, 131)=3.541, p=.017 
Question 2 F(3, 131)=2.629, p=.053 
Question 3 F(3, 131)=3.624, p=.015 
Question 4 F(3, 129)=2.340, p=.076 
Question 5 F(3, 131)=1.670, p=.176 
Question 6 F(3, 131)=1.626, p=.186 
Question 7 F(3, 131)=5.594, p=.001 
 
Insurance Type 
Next the ANOVA was run to look at differences in total mean scores on the 
Discrimination in Medical Settings Scale across the respondent’s insurance type. 
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     Table 57. ANOVA-Descriptives by Insurance Type. 
 N Mean SD Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
Medicaid 25 1.3084 .60027 .12005 1.0606 1.5562 1.00 3.43 
Medicare 22 1.5132 .53125 .11326 1.2776 1.7487 1.00 2.86 
Other 7 1.6114 .85167 .32190 .8238 2.3991 1.00 3.14 
Private 41 1.2898 .46565 .07272 1.1428 1.4367 1.00 3.14 
Private+ 41 1.5922 .74143 .11579 1.3582 1.8262 1.00 3.57 
Total 136 1.4371 .62194 .05333 1.3316 1.5425 1.00 3.57 
 
Table 58. Insurance Type and DMS Score. 
 Sum of Squares df Mean Square F Sig. 
Between Groups 2.631 4 .658 1.737 .146 
Within Groups 49.588 131 .379   
Total 52.219 135    
 
In terms of the respondent’s insurance type, there was no statistically significant 
difference in the total mean score on the Discrimination in Medical Settings Scale between the 
different insurance groups.   
      Table 59. DMS and Insurance Type 
Total Mean Score F(4, 131)=1.737, p=.146 
. 
The ANOVA was then run to look at differences in mean scores on each question on the 
Discrimination in Medical Settings Scale across the respondent’s insurance groups. 
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Table 60. ANOVA-Descriptives Individual DMS
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Table 61. ANOVA-Individual DMS Question Mean Scores by Insurance Type. 
 Sum of Squares df Mean Square F Sig. 
Q_1 Between Groups 3.200 4 .800 2.830 .027 
Within Groups 37.035 131 .283   
Total 40.235 135    
Q_2 Between Groups 5.328 4 1.332 1.777 .137 
Within Groups 98.201 131 .750   
Total 103.529 135    
Q_3 Between Groups 7.932 4 1.983 2.396 .054 
Within Groups 108.414 131 .828   
Total 116.346 135    
Q_4 Between Groups 4.016 4 1.004 2.551 .042 
Within Groups 50.768 129 .394   
Total 54.784 133    
Q_5 Between Groups 1.702 4 .425 .897 .468 
Within Groups 62.115 131 .474   
Total 63.816 135    
Q_6 Between Groups .781 4 .195 .440 .779 
Within Groups 58.153 131 .444   
Total 58.934 135    
Q_7 Between Groups 2.436 4 .609 .537 .709 
Within Groups 148.623 131 1.135   
Total 151.059 135    
 
In terms of the respondent’s insurance type, there were three questions that showed 
statistically significant differences in mean scores (Q1, Q3 and Q4) on the Discrimination in 
Medical Settings Scale due to respondent’s insurance type.  The first statement that showed 
statistically significance was: I had a doctor or nurse act as though they were afraid of me.  
Respondents who marked other as their insurance type had the highest mean (1.57) and those 
with private insurance had the lowest mean (1.05).  For statement 3: I had a doctor or nurse act 
as if they were better than me the respondents with Medicare had the highest mean (1.95) and 
those with Medicaid had the lowest mean (1.36).  For the last statement: I felt I was treated with 
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less courtesy than other people, respondents who marked Private + insurance had the highest 
mean score (1.51) and those with Private insurance had the lowest score (1.10).     
 
Research Question 4: To what degree do transplant recipients’ perceived trust of the 
interdisciplinary team differ amongst their predisposing characteristics (age, race, sex, 
educational achievement) and enabling resources (insurance type, transplant center type 
and income level)?  
The Medical Mistrust Index 2.1 
ANOVA-Comparing Mean Scores on the Medical Mistrust Scale and respondents 
predisposing characteristics/enabling resources. 
ANOVA 
All assumption testing was completed and once all of the assumptions were addressed, 
the ANOVA was run to look at differences in total mean scores of the Medical Mistrust Scale 
across each variable, beginning with the respondent’s age.  Then the ANOVA was run to look at 
differences in mean scores of each individual question across each variable.   The results are 
shown in the table and graphs below.  
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Age       
Table 62. ANOVA-Descriptives MMS by Age.  
 N Mean SD Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
21-35 25 2.8720 .23198 .04640 2.7762 2.9678 2.29 3.41 
35-44 27 2.7656 .22640 .04357 2.6760 2.8551 2.35 3.24 
45-54 29 2.8662 .24436 .04538 2.7733 2.9592 2.35 3.29 
55-64 38 2.7776 .32855 .05330 2.6696 2.8856 1.89 3.35 
65+ 17 2.7400 .29732 .07211 2.5871 2.8929 2.06 3.24 
Total 136 2.8068 .27308 .02342 2.7605 2.8531 1.89 3.41 
 
Table 63. ANOVA-MMS Score and Age.  
 Sum of Squares Df Mean Square F Sig. 
Between Groups .363 4 .091 1.224 .304 
Within Groups 9.704 131 .074   
Total 10.067 135    
 
In terms of the respondent’s age, there was no statistically significant difference in the 
total mean score on the Medical Mistrust Scale between the different age groups.   
     Table 64. Mean MMS and Age 
Total Mean Score F(4, 131)=1.224, p=.304 
 
The ANOVA was then run to look at differences in mean scores on each question on the 
Medical Mistrust Scale across the respondent’s age groups.   
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Table 375. ANOVA-Descriptives Individual MMS Mean Scores by Age 
 N Mean SD Std. Error 
 
Minimum Maximum Lower Bound Upper Bound 
Q_1_t41 21-35 25 3.08 1.038 .208 2.65 3.51 1 5 
35-44 26 2.54 1.174 .230 2.06 3.01 1 5 
45-54 30 2.67 1.124 .205 2.25 3.09 1 5 
55-64 38 2.95 1.184 .192 2.56 3.34 1 5 
65+ 17 2.47 1.375 .333 1.76 3.18 1 5 
Total 136 2.77 1.174 .101 2.57 2.97 1 5 
Q_2_t42 21-35 25 3.52 1.005 .201 3.11 3.93 1 5 
35-44 27 2.67 1.209 .233 2.19 3.14 1 5 
45-54 30 2.93 1.143 .209 2.51 3.36 1 5 
55-64 38 2.79 1.166 .189 2.41 3.17 1 5 
65+ 17 2.59 1.278 .310 1.93 3.25 1 5 
Total 137 2.91 1.181 .101 2.71 3.10 1 5 
Q_3_t43 21-35 25 2.88 1.092 .218 2.43 3.33 1 5 
35-44 27 2.52 1.189 .229 2.05 2.99 1 4 
45-54 30 2.50 1.137 .208 2.08 2.92 1 4 
55-64 38 2.45 1.005 .163 2.12 2.78 1 4 
65+ 17 2.71 1.263 .306 2.06 3.36 1 5 
Total 137 2.58 1.116 .095 2.40 2.77 1 5 
Q_4_t44 21-35 25 2.64 1.075 .215 2.20 3.08 1 5 
35-44 27 2.74 1.095 .211 2.31 3.17 1 5 
45-54 30 2.83 .986 .180 2.47 3.20 1 5 
55-64 38 2.50 1.109 .180 2.14 2.86 1 5 
65+ 17 2.41 .870 .211 1.96 2.86 1 4 
Total 137 2.64 1.042 .089 2.46 2.81 1 5 
Q_5_t45 21-35 25 3.24 .970 .194 2.84 3.64 1 5 
35-44 27 3.11 .934 .180 2.74 3.48 1 5 
45-54 30 3.27 1.048 .191 2.88 3.66 1 5 
55-64 38 2.97 1.026 .166 2.64 3.31 1 5 
65+ 17 3.24 1.091 .265 2.67 3.80 1 5 
Total 137 3.15 1.004 .086 2.98 3.32 1 5 
Q_6_t46 21-35 25 2.40 .957 .191 2.00 2.80 1 4 
35-44 27 2.85 .989 .190 2.46 3.24 1 5 
45-54 30 2.87 1.167 .213 2.43 3.30 1 5 
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 N Mean SD Std. Error Lower Bound  Upper Bound Minimum Maximum 
55-64 38 2.45 1.032 .167 2.11 2.79 1 5 
65+ 17 2.76 1.091 .265 2.20 3.33 1 5 
Total 137 2.65 1.054 .090 2.47 2.83 1 5 
Q_7_t47 21-35 25 3.36 .860 .172 3.00 3.72 2 5 
35-44 27 3.11 1.188 .229 2.64 3.58 1 5 
45-54 30 2.93 1.081 .197 2.53 3.34 1 5 
55-64 38 3.29 1.088 .177 2.93 3.65 1 5 
65+ 17 3.35 1.222 .296 2.72 3.98 1 5 
Total 137 3.20 1.084 .093 3.01 3.38 1 5 
Q_8_t48 21-35 25 3.16 1.068 .214 2.72 3.60 1 5 
35-44 27 3.22 1.013 .195 2.82 3.62 1 5 
45-54 29 3.10 1.113 .207 2.68 3.53 1 5 
55-64 38 2.82 1.182 .192 2.43 3.20 1 5 
65+ 17 2.88 1.111 .270 2.31 3.45 1 5 
Total 136 3.03 1.102 .094 2.84 3.22 1 5 
Q_9_t49 21-35 25 3.20 .707 .141 2.91 3.49 2 5 
35-44 27 3.11 1.013 .195 2.71 3.51 1 5 
45-54 30 3.27 .944 .172 2.91 3.62 2 5 
55-64 38 3.37 .942 .153 3.06 3.68 2 5 
65+ 17 3.71 1.105 .268 3.14 4.27 1 5 
Total 137 3.31 .944 .081 3.15 3.47 1 5 
Q_10_t50 21-35 25 3.00 1.041 .208 2.57 3.43 1 4 
35-44 27 2.63 1.006 .194 2.23 3.03 1 5 
45-54 30 3.07 1.143 .209 2.64 3.49 1 5 
55-64 38 2.71 1.037 .168 2.37 3.05 1 5 
65+ 17 2.88 1.111 .270 2.31 3.45 1 5 
Total 137 2.85 1.063 .091 2.67 3.03 1 5 
Q_11_t51 21-35 25 2.92 1.115 .223 2.46 3.38 1 5 
35-44 27 2.67 1.038 .200 2.26 3.08 1 5 
45-54 30 2.90 .923 .168 2.56 3.24 1 5 
55-64 38 2.92 1.024 .166 2.58 3.26 1 5 
65+ 17 2.47 1.125 .273 1.89 3.05 1 5 
Total 137 2.81 1.033 .088 2.64 2.98 1 5 
Q_12_t52 21-35 25 2.52 1.122 .224 2.06 2.98 1 5 
35-44 27 2.74 .859 .165 2.40 3.08 2 5 
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 N Mean SD Std. Error Lower Bound  Upper Bound Minimum Maximum 
45-54 29 2.69 .967 .180 2.32 3.06 1 4 
55-64 37 2.89 1.075 .177 2.53 3.25 1 5 
65+ 17 2.41 .939 .228 1.93 2.89 1 4 
Total 135 2.69 1.003 .086 2.52 2.86 1 5 
Q_13_t53 21-35 25 2.48 1.005 .201 2.07 2.89 1 5 
35-44 27 2.59 .844 .162 2.26 2.93 1 5 
45-54 29 2.69 .712 .132 2.42 2.96 2 4 
55-64 37 2.49 .932 .153 2.18 2.80 1 5 
65+ 17 2.41 .618 .150 2.09 2.73 1 3 
Total 135 2.54 .844 .073 2.40 2.68 1 5 
Q_14_t54 21-35 25 2.44 .768 .154 2.12 2.76 1 4 
35-44 27 2.56 .892 .172 2.20 2.91 1 5 
45-54 29 2.69 .660 .123 2.44 2.94 2 4 
55-64 37 2.59 .725 .119 2.35 2.84 1 4 
65+ 16 2.63 .719 .180 2.24 3.01 2 4 
Total 134 2.58 .749 .065 2.45 2.71 1 5 
Q_15_t55 21-35 25 3.04 1.136 .227 2.57 3.51 1 5 
35-44 27 2.96 .980 .189 2.58 3.35 2 5 
45-54 29 2.97 .906 .168 2.62 3.31 1 5 
55-64 38 3.08 1.050 .170 2.73 3.42 1 5 
65+ 16 2.94 1.124 .281 2.34 3.54 1 5 
Total 135 3.01 1.018 .088 2.83 3.18 1 5 
Q_16_t56 21-35 25 2.68 .852 .170 2.33 3.03 1 4 
35-44 27 2.67 .877 .169 2.32 3.01 1 5 
45-54 29 2.76 .872 .162 2.43 3.09 1 4 
55-64 38 2.68 .842 .137 2.41 2.96 1 4 
65+ 17 2.59 1.004 .243 2.07 3.10 1 4 
Total 136 2.68 .867 .074 2.54 2.83 1 5 
Q_17_t57 21-35 25 2.28 .936 .187 1.89 2.67 1 4 
35-44 27 2.33 .832 .160 2.00 2.66 1 5 
45-54 29 2.55 .827 .154 2.24 2.87 2 4 
55-64 37 2.22 1.031 .170 1.87 2.56 1 5 
65+ 17 2.35 .996 .242 1.84 2.87 1 4 
Total 135 2.34 .924 .079 2.18 2.50 1 5 
 
137 
 
Table 66. ANOVA-Individual MMS Question Mean Scores by Age. 
 Sum of Squares Df Mean Square F Sig. 
Q_1_t41 Between Groups 6.836 4 1.709 1.250 .293 
Within Groups 179.098 131 1.367   
Total 185.934 135    
Q_2_t42 Between Groups 13.226 4 3.307 2.472 .048 
Within Groups 176.540 132 1.337   
Total 189.766 136    
Q_3_t43 Between Groups 3.480 4 .870 .693 .598 
Within Groups 165.805 132 1.256   
Total 169.285 136    
Q_4_t44 Between Groups 3.022 4 .756 .689 .601 
Within Groups 144.729 132 1.096   
Total 147.752 136    
Q_5_t45 Between Groups 1.954 4 .489 .477 .752 
Within Groups 135.126 132 1.024   
Total 137.080 136    
Q_6_t46 Between Groups 5.855 4 1.464 1.329 .262 
Within Groups 145.328 132 1.101   
Total 151.182 136    
Q_7_t47 Between Groups 3.687 4 .922 .780 .540 
Within Groups 155.991 132 1.182   
Total 159.679 136    
Q_8_t48 Between Groups 3.691 4 .923 .755 .557 
Within Groups 160.192 131 1.223   
Total 163.882 135    
Q_9_t49 Between Groups 4.219 4 1.055 1.191 .318 
Within Groups 116.905 132 .886   
Total 121.124 136    
Q_10_t50 Between Groups 4.038 4 1.009 .890 .472 
Within Groups 149.743 132 1.134   
Total 153.781 136    
Q_11_t51 Between Groups 3.527 4 .882 .822 .513 
Within Groups 141.538 132 1.072   
Total 145.066 136    
Q_12_t52 Between Groups 3.616 4 .904 .895 .469 
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 Sum of Squares Df Mean Square F Sig. 
Within Groups 131.317 130 1.010   
Total 134.933 134    
Q_13_t53 Between Groups 1.200 4 .300 .413 .799 
Within Groups 94.326 130 .726   
Total 95.526 134    
Q_14_t54 Between Groups .895 4 .224 .391 .814 
Within Groups 73.702 129 .571   
Total 74.597 133    
Q_15_t55 Between Groups .403 4 .101 .095 .984 
Within Groups 138.589 130 1.066   
Total 138.993 134    
Q_16_t56 Between Groups .326 4 .081 .106 .980 
Within Groups 101.079 131 .772   
Total 101.404 135    
Q_17_t57 Between Groups 1.961 4 .490 .567 .687 
Within Groups 112.365 130 .864   
Total 114.326 134    
 
In terms of the respondent’s age, there was only one question (Q2) that was statistically 
significant in mean scores on the Medical Mistrust Scale between the different age groups.  The 
statement on the scale for this question was that: Patients have sometimes been deceived or 
mislead by healthcare organizations.  For this statement, the youngest respondent group (ages 
21-35) had the highest mean (3.52) whereas the oldest group (65+) had the lowest mean score 
(2.59).   
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Table 67. Results of MMS Question Means by Age. 
Question 1 F(4, 131)=1.250, p=.293 
Question 2 F(4, 132)=2.472, p=.048 
Question 3 F(4, 132)=.693, p=.598 
Question 4 F(4, 132)=.689, p=.601 
Question 5 F(4, 132)=.477, p=.752 
Question 6 F(4, 132)=1.329, p=.262 
Question 7 F(4, 132)=.780, p=.540 
Question 8 F(4, 131)=.755, p=.557 
Question 9 F(4, 132)=1.191, p=.318 
Question 10 F(4, 132)=.890,p=.472 
Question 11 F(4, 131)=.822, p=.513 
Question 12 F(4, 130)=.895, p=.469 
Question 13 F(4, 130)=.413,p=.799 
Question 14 F(4, 129)=.391, p=.894 
Question 15 F(4, 130)=.095, p=.984 
Question 16 F(4, 131)=.106, p=.980 
Question 17 F(4, 130)=.567, p=.687 
 
Sex 
 
Next the ANOVA was run to look at differences in total mean scores on the Medical 
Mistrust Scale across the respondent’s sex groups. 
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     Table 68. ANOVA-Descriptives MMS by Sex. 
 N Mean SD Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
Male 30 2.8357 .28574 .05217 2.7290 2.9424 2.24 3.29 
Female 106 2.7986 .27023 .02625 2.7465 2.8506 1.89 3.41 
Total 136 2.8068 .27308 .02342 2.7605 2.8531 1.89 3.41 
 
Table 69.  ANOVA-MMS Score and Respondent’s Sex. 
 Sum of Squares df Mean Square F Sig. 
Between Groups .032 1 .032 .429 .513 
Within Groups 10.035 134 .075   
Total 10.067 135    
 
In terms of the respondent’s sex, there was no statistically significant difference in the 
total mean score on the Medical Mistrust Scale between the different groups.   
Table 70. MMS and Patient’s Sex 
Total Mean Score F(1, 134)=.429, p=.513 
 
The ANOVA was then run to look at differences in mean scores on each question on the 
Medical Mistrust Scale across the respondent’s sex groups. 
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 Table 71. ANOVA-Descriptives Individual MMS Mean Scores by Sex 
 N Mean SD Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
Q_1_t41 Male 30 2.97 1.066 .195 2.57 3.36 1 5 
Female 106 2.72 1.201 .117 2.49 2.95 1 5 
Total 136 2.77 1.174 .101 2.57 2.97 1 5 
Q_2_t42 Male 30 2.77 1.251 .228 2.30 3.23 1 5 
Female 107 2.94 1.164 .113 2.72 3.17 1 5 
Total 137 2.91 1.181 .101 2.71 3.10 1 5 
Q_3_t43 Male 30 2.63 1.066 .195 2.24 3.03 1 4 
Female 107 2.57 1.134 .110 2.35 2.79 1 5 
Total 137 2.58 1.116 .095 2.40 2.77 1 5 
Q_4_t44 Male 30 2.63 1.033 .189 2.25 3.02 1 4 
Female 107 2.64 1.050 .101 2.43 2.84 1 5 
Total 137 2.64 1.042 .089 2.46 2.81 1 5 
Q_5_t45 Male 30 3.23 1.040 .190 2.84 3.62 1 5 
Female 107 3.12 .997 .096 2.93 3.31 1 5 
Total 137 3.15 1.004 .086 2.98 3.32 1 5 
Q_6_t46 Male 30 2.57 1.006 .184 2.19 2.94 1 5 
Female 107 2.67 1.071 .104 2.47 2.88 1 5 
Total 137 2.65 1.054 .090 2.47 2.83 1 5 
Q_7_t47 Male 30 3.37 .964 .176 3.01 3.73 1 5 
Female 107 3.15 1.114 .108 2.94 3.36 1 5 
Total 137 3.20 1.084 .093 3.01 3.38 1 5 
Q_8_t48 Male 30 3.07 1.048 .191 2.68 3.46 1 5 
Female 106 3.02 1.121 .109 2.80 3.23 1 5 
Total 136 3.03 1.102 .094 2.84 3.22 1 5 
Q_9_t49 Male 30 3.43 .728 .133 3.16 3.71 2 5 
Female 107 3.27 .996 .096 3.08 3.46 1 5 
Total 137 3.31 .944 .081 3.15 3.47 1 5 
Q_10_t50 Male 30 2.83 1.177 .215 2.39 3.27 1 5 
Female 107 2.85 1.035 .100 2.65 3.05 1 5 
Total 137 2.85 1.063 .091 2.67 3.03 1 5 
Q_11_t51 Male 30 2.60 1.003 .183 2.23 2.97 1 4 
Female 107 2.87 1.038 .100 2.67 3.07 1 5 
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 N Mean SD Std. Error Lower Bound  Upper Bound Minimum Maximum 
Total 137 2.81 1.033 .088 2.64 2.98 1 5 
Q_12_t52 Male 30 2.77 .858 .157 2.45 3.09 1 4 
Female 105 2.67 1.044 .102 2.46 2.87 1 5 
Total 135 2.69 1.003 .086 2.52 2.86 1 5 
Q_13_t53 Male 30 2.57 .728 .133 2.29 2.84 1 4 
Female 105 2.53 .878 .086 2.36 2.70 1 5 
Total 135 2.54 .844 .073 2.40 2.68 1 5 
Q_14_t54 Male 30 2.53 .681 .124 2.28 2.79 1 4 
Female 104 2.60 .770 .075 2.45 2.75 1 5 
Total 134 2.58 .749 .065 2.45 2.71 1 5 
Q_15_t55 Male 30 3.10 1.094 .200 2.69 3.51 1 5 
Female 105 2.98 1.000 .098 2.79 3.17 1 5 
Total 135 3.01 1.018 .088 2.83 3.18 1 5 
Q_16_t56 Male 30 2.70 .794 .145 2.40 3.00 1 4 
Female 106 2.68 .890 .086 2.51 2.85 1 5 
Total 136 2.68 .867 .074 2.54 2.83 1 5 
Q_17_t57 Male 30 2.43 1.073 .196 2.03 2.83 1 4 
Female 105 2.31 .880 .086 2.14 2.48 1 5 
Total 135 2.34 .924 .079 2.18 2.50 1 5 
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       Table 72. ANOVA-Individual MMS Question Mean Scores by Sex. 
 Sum of Squares Df Mean Square F Sig. 
Q_1_t41 Between Groups 1.458 1 1.458 1.059 .305 
Within Groups 184.476 134 1.377   
Total 185.934 135    
Q_2_t42 Between Groups .736 1 .736 .526 .470 
Within Groups 189.030 135 1.400   
Total 189.766 136    
Q_3_t43 Between Groups .094 1 .094 .075 .785 
Within Groups 169.191 135 1.253   
Total 169.285 136    
Q_4_t44 Between Groups .000 1 .000 .000 .992 
Within Groups 147.752 135 1.094   
Total 147.752 136    
Q_5_t45 Between Groups .293 1 .293 .289 .592 
Within Groups 136.787 135 1.013   
Total 137.080 136    
Q_6_t46 Between Groups .264 1 .264 .237 .628 
Within Groups 150.918 135 1.118   
Total 151.182 136    
Q_7_t47 Between Groups 1.105 1 1.105 .940 .334 
Within Groups 158.574 135 1.175   
Total 159.679 136    
Q_8_t48 Between Groups .053 1 .053 .044 .835 
Within Groups 163.829 134 1.223   
Total 163.882 135    
Q_9_t49 Between Groups .617 1 .617 .691 .407 
Within Groups 120.507 135 .893   
Total 121.124 136    
Q_10_t50 Between Groups .007 1 .007 .006 .938 
Within Groups 153.774 135 1.139   
Total 153.781 136    
Q_11_t51 Between Groups 1.697 1 1.697 1.598 .208 
Within Groups 143.368 135 1.062   
Total 145.066 136    
Q_12_t52 Between Groups .233 1 .233 .230 .632 
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 Sum of Squares Df Mean Square F Sig. 
Within Groups 134.700 133 1.013   
Total 134.933 134    
Q_13_t53 Between Groups .026 1 .026 .036 .850 
Within Groups 95.500 133 .718   
Total 95.526 134    
Q_14_t54 Between Groups .092 1 .092 .163 .687 
Within Groups 74.505 132 .564   
Total 74.597 133    
Q_15_t55 Between Groups .331 1 .331 .317 .574 
Within Groups 138.662 133 1.043   
Total 138.993 134    
Q_16_t56 Between Groups .010 1 .010 .013 .908 
Within Groups 101.394 134 .757   
Total 101.404 135    
Q_17_t57 Between Groups .331 1 .331 .386 .536 
Within Groups 113.995 133 .857   
Total 114.326 134    
 
In terms of the respondent’s sex, there was no statistical significance in mean scores on 
the Medical Mistrust Scale questions between the different sex groups. 
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 Table 73. Results of MMS Question Means by Sex. 
Question 1 F(1, 134)=1.059, p=.305 
Question 2 F(1, 135)=.526, p=.470 
Question 3 F(1, 135)=.075, p=.785 
Question 4 F(1, 135)=.000, p=.992 
Question 5 F(1, 135)=.289, p=.592 
Question 6 F(1, 135)=.237, p=.628 
Question 7 F(1, 135)=.940, p=.334 
Question 8 F(1, 134)=.044, p=.835 
Question 9 F(1, 135)=.691, p=.407 
Question 10 F(1, 135)=.006,p=.938 
Question 11 F(1, 133)=1.598, p=.208 
Question 12 F(1, 133)=.230, p=.632 
Question 13 F(1, 133)=.036,p=.850 
Question 14 F(1, 132)=.163, p=.687 
Question 15 F(1, 133)=.314, p=.574 
Question 16 F(1, 134)=.013, p=.908 
Question 17 F(1, 133)=.286, p=.536 
 
Race 
Next the ANOVA was run to look at differences in total mean scores on the Medical 
Mistrust Scale across the respondent’s race groups. 
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Table 74. ANOVA-Descriptives MMS by Respondent’s Race. 
 N Mean SD Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
Asian 6 2.8917 .18872 .07705 2.6936 3.0897 2.65 3.18 
Black 14 2.9814 .20983 .05608 2.8603 3.1026 2.59 3.29 
Hispanic 4 3.0725 .25656 .12828 2.6642 3.4808 2.82 3.41 
Mixed 6 2.7833 .10783 .04402 2.6702 2.8965 2.65 2.94 
White 105 2.7703 .28016 .02734 2.7161 2.8245 1.89 3.35 
Total 135 2.8071 .27407 .02359 2.7605 2.8538 1.89 3.41 
 
  Table 75. ANOVA-MMS Score and Respondent’s Race. 
 Sum of Squares df Mean Square F Sig. 
Between Groups .896 4 .224 3.175 .016 
Within Groups 9.169 130 .071   
Total 10.065 134    
 
In terms of the respondent’s race, there was a statistically significant difference in the 
total mean score on the Medical Mistrust Scale between the different race groups.  Participants 
who identified as White (2.77), had the lowest mean score on the Medical Mistrust Scale.  
Hispanic participants had the highest average score (3.07) with black participants having the 
second highest average score (2.98)   
 
      Table 76. MMS and Race 
Total Mean Score F(4, 130)=3.175, p=.016 
 
Then the ANOVA was run to look at differences in mean scores on each question on the 
Medical Mistrust Scale across the respondent’s race groups. 
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Table 77. ANOVA-Descriptives Individual MMS Mean Scores by Race 
 N Mean SD Std. Error 
 
Minimum Maximum Lower Bound Upper Bound 
Q_1_t41 Asian 6 2.83 .983 .401 1.80 3.87 2 4 
Black 14 2.64 1.151 .308 1.98 3.31 1 4 
Hispanic 5 3.60 1.342 .600 1.93 5.27 2 5 
Mixed 6 2.67 1.033 .422 1.58 3.75 1 4 
White 104 2.76 1.195 .117 2.53 2.99 1 5 
Total 135 2.78 1.176 .101 2.58 2.98 1 5 
Q_2_t42 Asian 6 3.17 .983 .401 2.13 4.20 2 4 
Black 14 3.29 1.204 .322 2.59 3.98 1 5 
Hispanic 5 3.80 1.304 .583 2.18 5.42 2 5 
Mixed 6 3.17 .983 .401 2.13 4.20 2 4 
White 105 2.78 1.185 .116 2.55 3.01 1 5 
Total 136 2.90 1.186 .102 2.70 3.11 1 5 
Q_3_t43 Asian 6 3.17 1.169 .477 1.94 4.39 1 4 
Black 14 2.29 1.139 .304 1.63 2.94 1 4 
Hispanic 5 2.00 1.000 .447 .76 3.24 1 3 
Mixed 6 3.50 1.225 .500 2.21 4.79 2 5 
White 105 2.57 1.091 .106 2.36 2.78 1 5 
Total 136 2.59 1.119 .096 2.40 2.78 1 5 
Q_4_t44 Asian 6 2.83 1.329 .543 1.44 4.23 1 5 
Black 14 3.14 .770 .206 2.70 3.59 2 4 
Hispanic 5 3.20 .837 .374 2.16 4.24 2 4 
Mixed 6 2.50 1.049 .428 1.40 3.60 1 4 
White 105 2.53 1.057 .103 2.33 2.74 1 5 
Total 136 2.63 1.046 .090 2.46 2.81 1 5 
Q_5_t45 Asian 6 3.50 .837 .342 2.62 4.38 3 5 
Black 14 3.71 .825 .221 3.24 4.19 2 5 
Hispanic 5 4.00 1.000 .447 2.76 5.24 3 5 
Mixed 6 2.83 1.329 .543 1.44 4.23 1 4 
White 105 3.02 .980 .096 2.83 3.21 1 5 
Total 136 3.14 1.005 .086 2.97 3.31 1 5 
Q_6_t46 Asian 6 3.50 1.049 .428 2.40 4.60 2 5 
Black 14 4.00 .784 .210 3.55 4.45 3 5 
Hispanic 5 3.00 1.225 .548 1.48 4.52 1 4 
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 N Mean SD Std. Error Lower Bound  Upper Bound Minimum Maximum 
Mixed 6 2.50 .548 .224 1.93 3.07 2 3 
White 105 2.41 .948 .092 2.23 2.59 1 5 
Total 136 2.65 1.058 .091 2.47 2.83 1 5 
Q_7_t47 Asian 6 3.17 .753 .307 2.38 3.96 2 4 
Black 14 3.14 1.292 .345 2.40 3.89 1 5 
Hispanic 5 2.80 1.095 .490 1.44 4.16 1 4 
Mixed 6 3.50 1.049 .428 2.40 4.60 2 5 
White 105 3.20 1.087 .106 2.99 3.41 1 5 
Total 136 3.19 1.085 .093 3.01 3.38 1 5 
Q_8_t48 Asian 6 3.67 .516 .211 3.12 4.21 3 4 
Black 13 3.31 .855 .237 2.79 3.82 2 5 
Hispanic 5 3.80 .837 .374 2.76 4.84 3 5 
Mixed 6 3.17 .753 .307 2.38 3.96 2 4 
White 105 2.91 1.161 .113 2.69 3.14 1 5 
Total 135 3.03 1.106 .095 2.84 3.22 1 5 
Q_9_t49 Asian 6 3.00 .000 .000 3.00 3.00 3 3 
Black 14 3.43 .756 .202 2.99 3.87 2 5 
Hispanic 5 3.00 .707 .316 2.12 3.88 2 4 
Mixed 6 3.67 .516 .211 3.12 4.21 3 4 
White 105 3.30 1.018 .099 3.10 3.49 1 5 
Total 136 3.30 .945 .081 3.14 3.46 1 5 
Q_10_t50 Asian 6 2.83 .983 .401 1.80 3.87 2 4 
Black 14 3.29 1.204 .322 2.59 3.98 1 5 
Hispanic 5 3.40 .548 .245 2.72 4.08 3 4 
Mixed 6 2.33 1.033 .422 1.25 3.42 1 4 
White 105 2.78 1.056 .103 2.58 2.99 1 5 
Total 136 2.84 1.063 .091 2.66 3.02 1 5 
Q_11_t51 Asian 6 2.83 1.329 .543 1.44 4.23 1 5 
Black 14 3.07 .917 .245 2.54 3.60 1 4 
Hispanic 5 3.00 .707 .316 2.12 3.88 2 4 
Mixed 6 2.83 1.169 .477 1.61 4.06 2 5 
White 105 2.75 1.045 .102 2.55 2.95 1 5 
Total 136 2.80 1.032 .088 2.63 2.98 1 5 
Q_12_t52 Asian 6 2.50 .837 .342 1.62 3.38 2 4 
Black 13 1.92 .641 .178 1.54 2.31 1 3 
149 
 
 N Mean SD Std. Error Lower Bound  Upper Bound Minimum Maximum 
Hispanic 4 2.00 .816 .408 .70 3.30 1 3 
Mixed 6 3.00 1.265 .516 1.67 4.33 1 4 
White 105 2.81 1.001 .098 2.62 3.00 1 5 
Total 134 2.69 1.005 .087 2.52 2.87 1 5 
Q_13_t53 Asian 6 2.50 .548 .224 1.93 3.07 2 3 
Black 13 2.85 .899 .249 2.30 3.39 1 4 
Hispanic 4 3.25 .957 .479 1.73 4.77 2 4 
Mixed 6 1.67 .516 .211 1.12 2.21 1 2 
White 105 2.53 .833 .081 2.37 2.69 1 5 
Total 134 2.54 .846 .073 2.40 2.69 1 5 
Q_14_t54 Asian 6 2.67 .516 .211 2.12 3.21 2 3 
Black 13 2.69 .630 .175 2.31 3.07 2 4 
Hispanic 4 3.00 .816 .408 1.70 4.30 2 4 
Mixed 6 1.83 .408 .167 1.40 2.26 1 2 
White 104 2.59 .771 .076 2.44 2.74 1 5 
Total 133 2.58 .751 .065 2.45 2.71 1 5 
Q_15_t55 Asian 6 2.50 .548 .224 1.93 3.07 2 3 
Black 14 2.64 .745 .199 2.21 3.07 2 4 
Hispanic 4 2.50 .577 .289 1.58 3.42 2 3 
Mixed 6 3.50 1.517 .619 1.91 5.09 1 5 
White 105 3.08 1.035 .101 2.88 3.28 1 5 
Total 135 3.01 1.018 .088 2.83 3.18 1 5 
Q_16_t56 Asian 6 2.50 .837 .342 1.62 3.38 2 4 
Black 14 2.14 .663 .177 1.76 2.53 1 3 
Hispanic 4 2.00 .816 .408 .70 3.30 1 3 
Mixed 6 2.83 .983 .401 1.80 3.87 2 4 
White 105 2.79 .863 .084 2.62 2.96 1 5 
Total 135 2.69 .868 .075 2.54 2.84 1 5 
Q_17_t57 Asian 6 2.00 1.095 .447 .85 3.15 1 4 
Black 13 3.00 .707 .196 2.57 3.43 2 4 
Hispanic 4 2.75 .957 .479 1.23 4.27 2 4 
Mixed 6 1.83 .408 .167 1.40 2.26 1 2 
White 105 2.30 .929 .091 2.12 2.48 1 5 
Total 134 2.34 .927 .080 2.18 2.50 1 5 
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    Table 78. ANOVA-Individual MMS Question Mean Scores by Race. 
 Sum of Squares Df Mean Square F Sig. 
Q_1_t41 Between Groups 3.762 4 .940 .673 .612 
Within Groups 181.571 130 1.397   
Total 185.333 134    
Q_2_t42 Between Groups 8.472 4 2.118 1.530 .197 
Within Groups 181.286 131 1.384   
Total 189.757 135    
Q_3_t43 Between Groups 10.036 4 2.509 2.068 .089 
Within Groups 158.905 131 1.213   
Total 168.941 135    
Q_4_t44 Between Groups 6.637 4 1.659 1.542 .194 
Within Groups 140.981 131 1.076   
Total 147.618 135    
Q_5_t45 Between Groups 11.193 4 2.798 2.929 .023 
Within Groups 125.152 131 .955   
Total 136.346 135    
Q_6_t46 Between Groups 36.668 4 9.167 10.498 .000 
Within Groups 114.390 131 .873   
Total 151.059 135    
Q_7_t47 Between Groups 1.382 4 .345 .287 .886 
Within Groups 157.648 131 1.203   
Total 159.029 135    
Q_8_t48 Between Groups 7.917 4 1.979 1.650 .166 
Within Groups 155.964 130 1.200   
Total 163.881 134    
Q_9_t49 Between Groups 2.030 4 .508 .561 .692 
Within Groups 118.610 131 .905   
Total 120.640 135    
Q_10_t50 Between Groups 6.255 4 1.564 1.401 .237 
Within Groups 146.186 131 1.116   
Total 152.441 135    
Q_11_t51 Between Groups 1.483 4 .371 .342 .849 
Within Groups 142.157 131 1.085   
Total 143.640 135    
Q_12_t52 Between Groups 11.842 4 2.960 3.115 .017 
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 Sum of Squares Df Mean Square F Sig. 
Within Groups 122.614 129 .950   
Total 134.455 133    
Q_13_t53 Between Groups 7.822 4 1.956 2.886 .025 
Within Groups 87.409 129 .678   
Total 95.231 133    
Q_14_t54 Between Groups 4.264 4 1.066 1.945 .107 
Within Groups 70.157 128 .548   
Total 74.421 132    
Q_15_t55 Between Groups 6.388 4 1.597 1.566 .187 
Within Groups 132.605 130 1.020   
Total 138.993 134    
Q_16_t56 Between Groups 7.495 4 1.874 2.607 .039 
Within Groups 93.438 130 .719   
Total 100.933 134    
Q_17_t57 Between Groups 8.778 4 2.195 2.685 .034 
Within Groups 105.431 129 .817   
Total 114.209 133    
 
In terms of the respondent’s race, there were six questions on the scale that statistically 
significant differences in mean scores on the Medical Mistrust Scale due to respondent’s race (Q 
5, 6, 12, 13, 16 and 17).  For question 5, the statement was: When healthcare organizations make 
mistakes they usually cover them up.  For the fifth question, the Hispanic respondents had the 
highest mean (4.00) whereas the respondents who identified as mixed (2.83).  For the sixth 
question, the statement: Healthcare organizations have done harmful experiments on patients 
without their knowledge, the black respondents had the highest mean (4.00).  The statement for 
question 12 is: I typically get a second opinion when I am told something about my health.  For 
this, the group with the highest mean was the mixed group (3.00) and the lowest group was the 
black respondents (1.92).  The statement: I trust that healthcare organizations check their staff’s 
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credentials to make sure they are hiring the best people showed Hispanics with the highest mean 
(3.25) and the respondents who identified as mixed had the lowest mean (1.67).   
The next statement that had a statistical significance was: mistakes are common in the 
healthcare organization, respondents who identified as mixed had the highest mean (2.83) and 
Hispanic respondents have the lowest mean (2.00).  Lastly, for the statement: I trust that 
healthcare organizations keep up with the latest medical information black respondents had the 
highest mean (3.00) and respondents who identified as mixed had the lowest mean (1.83).   
  Table 79. Results of MMS Question Means by Race.   
Question 1 F(4, 130)=.673, p=.612 
Question 2 F(4, 131)=1.530, p=.197 
Question 3 F(4, 131)=2.068, p=.089 
Question 4 F(4, 131)=1.542, p=.194 
Question 5 F(4, 131)=2.929, p=.023 
Question 6 F(4, 131)=10.498, p=.000 
Question 7 F(4, 131)=.287, p=.886 
Question 8 F(4, 130)=1.650, p=.166 
Question 9 F(4, 131)=.561, p=.692 
Question 10 F(4, 131)=1.401, p=.237 
Question 11 F(4, 131)=.342, p=.849 
Question 12 F(4, 129)=3.115, p=.017 
Question 13 F(4, 129)=2.886, p=.025 
Question 14 F(4, 128)=1.945, p=.107 
Question 15 F(4, 130)=1.566, p=.187 
Question 16 F(4, 130)=2.607, p=.039 
Question 17 F(4, 129)=2.685, p=.034 
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Income Level 
Next the ANOVA was run to look at differences in total mean scores on the Medical 
Mistrust Scale across the respondent’s income level groups. 
Table 80. ANOVA-Descriptives MMS by Income Level. 
 N Mean SD Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
Less than $15,000 14 2.9186 .22532 .06022 2.7885 3.0487 2.59 3.41 
$15,000-$24,999 11 2.8027 .31538 .09509 2.5909 3.0146 2.24 3.24 
$25,000-$34,999 12 2.8183 .24591 .07099 2.6621 2.9746 2.41 3.18 
$35,000-$44,999 12 2.8192 .28247 .08154 2.6397 2.9986 2.29 3.19 
$45,000-$54,999 10 2.6270 .29124 .09210 2.4187 2.8353 2.06 3.00 
$55,000-$64,999 7 2.6214 .38563 .14576 2.2648 2.9781 1.94 3.15 
$65,000-$74,999 14 2.9193 .26143 .06987 2.7683 3.0702 2.53 3.35 
$75,000-$84,999 12 2.8633 .36423 .10514 2.6319 3.0948 1.89 3.24 
$85,000-$94,999 6 2.7650 .23856 .09739 2.5146 3.0154 2.41 3.06 
> $95,000 34 2.7800 .20629 .03538 2.7080 2.8520 2.29 3.18 
Total 132 2.8053 .27466 .02391 2.7580 2.8526 1.89 3.41 
 
Table 81. ANOVA-MMS Score and Respondent’s Income Level. 
 Sum of Squares Df Mean Square F Sig. 
Between Groups .992 9 .110 1.513 .151 
Within Groups 8.890 122 .073   
Total 9.882 131    
 
In terms of the respondent’s income, there was no statistically significant difference in 
the total mean score on the Medical Mistrust Scale between the different income groups.   
   
  Table 82. MMS and Income 
Total Mean Score F(9, 122)=1.513, p=.151 
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The ANOVA was then run to look at differences in mean scores on each question on the 
Medical Mistrust Scale across the respondent’s income groups. 
Table 83. ANOVA-Descriptives Individual MMS Mean Scores by Income Level 
 N Mean SD Std. Error 
95% Confidence Interval for Mean Min Max 
Lower Bound Upper Bound   
Q_1_t4
1 
$15,000-$24,999 11 2.36 1.206 .364 1.55 3.17 1 5 
$25,000-$34,999 12 2.50 1.087 .314 1.81 3.19 1 4 
$35,000-$44,999 12 2.92 .900 .260 2.34 3.49 1 4 
$45,000-$54,999 10 2.50 1.509 .477 1.42 3.58 1 5 
$55,000-$64,999 7 2.00 1.155 .436 .93 3.07 1 4 
$65,000-$74,999 14 2.93 .997 .267 2.35 3.50 1 4 
$75,000-$84,999 12 3.33 1.073 .310 2.65 4.02 1 5 
$85,000-$94,999 6 3.33 1.033 .422 2.25 4.42 2 5 
Greater than $95,000 34 2.74 1.136 .195 2.34 3.13 1 5 
Less than $15,000 14 2.93 1.141 .305 2.27 3.59 1 5 
Total 132 2.77 1.138 .099 2.57 2.96 1 5 
Q_2_t4
2 
$15,000-$24,999 11 2.45 1.368 .413 1.54 3.37 1 4 
$25,000-$34,999 12 2.58 1.240 .358 1.80 3.37 1 4 
$35,000-$44,999 12 3.00 1.044 .302 2.34 3.66 1 4 
$45,000-$54,999 10 2.90 1.729 .547 1.66 4.14 1 5 
$55,000-$64,999 7 2.29 .951 .360 1.41 3.17 1 3 
$65,000-$74,999 14 3.07 .997 .267 2.50 3.65 2 5 
$75,000-$84,999 12 3.42 1.165 .336 2.68 4.16 1 5 
$85,000-$94,999 6 2.50 1.378 .563 1.05 3.95 1 4 
Greater than $95,000 35 2.80 1.132 .191 2.41 3.19 1 5 
Less than $15,000 14 3.50 .650 .174 3.12 3.88 3 5 
Total 133 2.89 1.176 .102 2.69 3.10 1 5 
Q_3_t4
3 
$15,000-$24,999 11 2.73 1.191 .359 1.93 3.53 1 4 
$25,000-$34,999 12 3.17 1.030 .297 2.51 3.82 2 5 
$35,000-$44,999 12 3.08 .900 .260 2.51 3.66 2 4 
$45,000-$54,999 10 2.20 1.398 .442 1.20 3.20 1 4 
$55,000-$64,999 7 3.29 1.254 .474 2.13 4.45 1 5 
$65,000-$74,999 14 2.64 1.082 .289 2.02 3.27 1 4 
$75,000-$84,999 12 2.08 1.165 .336 1.34 2.82 1 4 
$85,000-$94,999 6 2.50 1.049 .428 1.40 3.60 1 4 
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 N Mean SD Std. Error Lower Bound Upper Bound Min Max 
Greater than $95,000 35 2.23 1.031 .174 1.87 2.58 1 4 
Less than $15,000 14 2.79 .699 .187 2.38 3.19 2 4 
Total 133 2.59 1.102 .096 2.40 2.78 1 5 
Q_4_t4
4 
$15,000-$24,999 11 2.36 1.120 .338 1.61 3.12 1 4 
$25,000-$34,999 12 2.33 .985 .284 1.71 2.96 1 4 
$35,000-$44,999 12 2.50 .905 .261 1.93 3.07 1 4 
$45,000-$54,999 10 2.10 1.197 .379 1.24 2.96 1 5 
$55,000-$64,999 7 2.00 .816 .309 1.24 2.76 1 3 
$65,000-$74,999 14 3.07 .917 .245 2.54 3.60 2 4 
$75,000-$84,999 12 3.00 .953 .275 2.39 3.61 1 5 
$85,000-$94,999 6 2.67 1.033 .422 1.58 3.75 1 4 
Greater than $95,000 35 2.71 1.152 .195 2.32 3.11 1 5 
Less than $15,000 14 3.00 .877 .234 2.49 3.51 1 4 
Total 133 2.64 1.047 .091 2.46 2.82 1 5 
Q_5_t4
5 
$15,000-$24,999 11 2.82 1.401 .423 1.88 3.76 1 5 
$25,000-$34,999 12 2.67 .888 .256 2.10 3.23 1 4 
$35,000-$44,999 12 3.00 .739 .213 2.53 3.47 2 4 
$45,000-$54,999 10 2.40 1.075 .340 1.63 3.17 1 4 
$55,000-$64,999 7 3.14 1.069 .404 2.15 4.13 1 4 
$65,000-$74,999 14 3.21 .975 .261 2.65 3.78 2 5 
$75,000-$84,999 12 3.50 1.000 .289 2.86 4.14 2 5 
$85,000-$94,999 6 3.33 .816 .333 2.48 4.19 2 4 
Greater than $95,000 35 3.31 .963 .163 2.98 3.65 1 5 
Less than $15,000 14 3.57 .646 .173 3.20 3.94 2 4 
Total 133 3.14 .993 .086 2.97 3.31 1 5 
Q_6_t4
6 
$15,000-$24,999 11 2.55 1.368 .413 1.63 3.46 1 5 
$25,000-$34,999 12 2.33 .888 .256 1.77 2.90 1 4 
$35,000-$44,999 12 2.92 .900 .260 2.34 3.49 2 5 
$45,000-$54,999 10 2.10 1.101 .348 1.31 2.89 1 4 
$55,000-$64,999 7 2.71 1.380 .522 1.44 3.99 1 5 
$65,000-$74,999 14 2.79 .802 .214 2.32 3.25 1 4 
$75,000-$84,999 12 2.75 1.138 .329 2.03 3.47 1 5 
$85,000-$94,999 6 2.17 .983 .401 1.13 3.20 1 3 
Greater than $95,000 35 2.71 1.126 .190 2.33 3.10 1 5 
Less than $15,000 14 2.86 .949 .254 2.31 3.41 1 4 
Total 133 2.64 1.061 .092 2.46 2.82 1 5 
156 
 
  N Mean SD Std. Error Lower Bound Upper Bound Min Max 
Q_7_t4
7 
$15,000-$24,999 11 3.18 1.250 .377 2.34 4.02 1 5 
$25,000-$34,999 12 3.50 1.000 .289 2.86 4.14 1 5 
$35,000-$44,999 12 3.33 1.303 .376 2.51 4.16 1 5 
$45,000-$54,999 10 3.10 1.197 .379 2.24 3.96 1 5 
$55,000-$64,999 7 2.86 .900 .340 2.03 3.69 2 4 
$65,000-$74,999 14 3.43 .938 .251 2.89 3.97 1 4 
$75,000-$84,999 12 3.08 1.379 .398 2.21 3.96 1 5 
$85,000-$94,999 6 3.67 1.211 .494 2.40 4.94 2 5 
Greater than $95,000 35 3.06 1.083 .183 2.69 3.43 1 5 
Less than $15,000 14 3.29 .611 .163 2.93 3.64 2 4 
Total 133 3.22 1.075 .093 3.03 3.40 1 5 
Q_8_t4
8 
$15,000-$24,999 11 2.73 1.348 .407 1.82 3.63 1 5 
$25,000-$34,999 12 2.83 1.030 .297 2.18 3.49 1 4 
$35,000-$44,999 11 2.55 1.214 .366 1.73 3.36 1 4 
$45,000-$54,999 10 2.50 1.080 .342 1.73 3.27 1 4 
$55,000-$64,999 7 2.71 .951 .360 1.83 3.59 1 4 
$65,000-$74,999 14 3.21 1.051 .281 2.61 3.82 2 5 
$75,000-$84,999 12 3.42 1.379 .398 2.54 4.29 1 5 
$85,000-$94,999 6 3.17 1.472 .601 1.62 4.71 1 5 
Greater than $95,000 35 3.09 .951 .161 2.76 3.41 1 5 
Less than $15,000 14 3.50 .941 .251 2.96 4.04 2 5 
Total 132 3.02 1.112 .097 2.82 3.21 1 5 
Q_9_t4
9 
$15,000-$24,999 11 3.27 1.104 .333 2.53 4.01 1 5 
$25,000-$34,999 12 3.67 .778 .225 3.17 4.16 2 5 
$35,000-$44,999 12 3.50 .798 .230 2.99 4.01 2 4 
$45,000-$54,999 10 3.60 1.174 .371 2.76 4.44 2 5 
$55,000-$64,999 7 4.00 .577 .218 3.47 4.53 3 5 
$65,000-$74,999 14 3.07 .829 .221 2.59 3.55 2 4 
$75,000-$84,999 12 3.17 1.267 .366 2.36 3.97 1 5 
$85,000-$94,999 6 3.50 1.225 .500 2.21 4.79 2 5 
Greater than $95,000 35 3.20 .901 .152 2.89 3.51 1 5 
Less than $15,000 14 2.93 .616 .165 2.57 3.28 2 4 
Total 133 3.32 .940 .082 3.15 3.48 1 5 
Q_10_t
50 
$15,000-$24,999 11 2.45 1.440 .434 1.49 3.42 1 5 
$25,000-$34,999 12 2.58 .996 .288 1.95 3.22 1 4 
$35,000-$44,999 12 2.33 .888 .256 1.77 2.90 1 4 
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 N Mean SD Std. Error Lower Bound Upper Bound Min Max 
$45,000-$54,999 10 2.80 1.033 .327 2.06 3.54 1 5 
$55,000-$64,999 7 2.43 1.272 .481 1.25 3.61 1 5 
$65,000-$74,999 14 3.14 1.099 .294 2.51 3.78 1 5 
$75,000-$84,999 12 3.08 1.379 .398 2.21 3.96 1 5 
$85,000-$94,999 6 3.67 .816 .333 2.81 4.52 2 4 
Greater than $95,000 35 2.97 .891 .151 2.67 3.28 1 4 
Less than $15,000 14 2.79 .975 .261 2.22 3.35 1 4 
Total 133 2.83 1.074 .093 2.65 3.02 1 5 
Q_11_t
51 
$15,000-$24,999 11 2.73 1.104 .333 1.99 3.47 1 5 
$25,000-$34,999 12 2.75 1.138 .329 2.03 3.47 1 5 
$35,000-$44,999 12 2.58 .996 .288 1.95 3.22 1 4 
$45,000-$54,999 10 2.70 .949 .300 2.02 3.38 1 4 
$55,000-$64,999 7 2.57 1.397 .528 1.28 3.86 1 4 
$65,000-$74,999 14 2.86 .949 .254 2.31 3.41 1 4 
$75,000-$84,999 12 3.00 1.206 .348 2.23 3.77 1 5 
$85,000-$94,999 6 3.17 .753 .307 2.38 3.96 2 4 
Greater than $95,000 35 2.86 .974 .165 2.52 3.19 1 5 
Less than $15,000 14 2.79 1.188 .318 2.10 3.47 1 5 
Total 133 2.80 1.033 .090 2.63 2.98 1 5 
Q_12_t
52 
$15,000-$24,999 11 3.00 1.414 .426 2.05 3.95 1 5 
$25,000-$34,999 12 3.42 .793 .229 2.91 3.92 2 5 
$35,000-$44,999 12 2.67 .985 .284 2.04 3.29 2 4 
$45,000-$54,999 10 2.50 .707 .224 1.99 3.01 1 3 
$55,000-$64,999 6 2.50 .548 .224 1.93 3.07 2 3 
$65,000-$74,999 14 2.93 1.141 .305 2.27 3.59 1 4 
$75,000-$84,999 12 2.42 .900 .260 1.84 2.99 1 4 
$85,000-$94,999 6 1.83 .983 .401 .80 2.87 1 3 
Greater than $95,000 34 2.65 .981 .168 2.30 2.99 1 5 
Less than $15,000 14 2.43 .938 .251 1.89 2.97 1 4 
Total 131 2.68 1.010 .088 2.50 2.85 1 5 
Q_13_t
53 
$15,000-$24,999 11 2.64 1.120 .338 1.88 3.39 1 5 
$25,000-$34,999 12 2.42 .793 .229 1.91 2.92 1 3 
$35,000-$44,999 12 2.58 .996 .288 1.95 3.22 1 4 
$45,000-$54,999 10 2.60 .699 .221 2.10 3.10 2 4 
$55,000-$64,999 6 2.17 .753 .307 1.38 2.96 1 3 
$65,000-$74,999 14 2.64 1.082 .289 2.02 3.27 1 5 
158 
 
 N Mean SD Std. Error Lower Bound Upper Bound Min Max 
$75,000-$84,999 12 2.42 .669 .193 1.99 2.84 1 3 
$85,000-$94,999 6 2.33 1.033 .422 1.25 3.42 1 3 
Greater than $95,000 34 2.56 .660 .113 2.33 2.79 2 4 
Less than $15,000 14 2.71 .994 .266 2.14 3.29 1 5 
Total 131 2.54 .844 .074 2.40 2.69 1 5 
Q_14_t
54 
$15,000-$24,999 11 2.64 1.027 .310 1.95 3.33 1 5 
$25,000-$34,999 12 2.25 .866 .250 1.70 2.80 1 4 
$35,000-$44,999 12 2.25 .622 .179 1.86 2.64 2 4 
$45,000-$54,999 10 2.50 .972 .307 1.80 3.20 1 4 
$55,000-$64,999 5 2.40 .548 .245 1.72 3.08 2 3 
$65,000-$74,999 14 2.71 .825 .221 2.24 3.19 1 4 
$75,000-$84,999 12 2.67 .651 .188 2.25 3.08 2 4 
$85,000-$94,999 6 2.67 .516 .211 2.12 3.21 2 3 
Greater than $95,000 34 2.65 .597 .102 2.44 2.86 2 4 
Less than $15,000 14 2.71 .726 .194 2.29 3.13 2 4 
Total 130 2.57 .736 .065 2.44 2.70 1 5 
Q_15_t
55 
$15,000-$24,999 11 3.55 1.368 .413 2.63 4.46 1 5 
$25,000-$34,999 12 3.42 1.084 .313 2.73 4.11 2 5 
$35,000-$44,999 12 3.25 .866 .250 2.70 3.80 2 4 
$45,000-$54,999 10 3.30 1.252 .396 2.40 4.20 1 5 
$55,000-$64,999 7 2.71 .756 .286 2.02 3.41 2 4 
$65,000-$74,999 14 2.86 .949 .254 2.31 3.41 2 5 
$75,000-$84,999 11 2.91 .701 .211 2.44 3.38 2 4 
$85,000-$94,999 6 2.00 .894 .365 1.06 2.94 1 3 
Greater than $95,000 34 2.94 .983 .169 2.60 3.28 1 5 
Less than $15,000 14 2.93 .829 .221 2.45 3.41 2 4 
Total 131 3.02 1.011 .088 2.85 3.20 1 5 
Q_16_t
56 
$15,000-$24,999 11 3.55 .934 .282 2.92 4.17 2 5 
$25,000-$34,999 12 2.83 .835 .241 2.30 3.36 2 4 
$35,000-$44,999 12 3.00 .739 .213 2.53 3.47 2 4 
$45,000-$54,999 10 2.80 1.033 .327 2.06 3.54 1 4 
$55,000-$64,999 7 2.43 .976 .369 1.53 3.33 1 4 
$65,000-$74,999 14 2.79 .893 .239 2.27 3.30 1 4 
$75,000-$84,999 12 2.58 .669 .193 2.16 3.01 2 4 
$85,000-$94,999 6 2.17 .753 .307 1.38 2.96 1 3 
Greater than $95,000 34 2.50 .826 .142 2.21 2.79 1 4 
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 N Mean SD Std. Error Lower Bound Upper Bound Min Max 
Less than $15,000 14 2.43 .514 .137 2.13 2.73 2 3 
Total 132 2.70 .856 .074 2.55 2.84 1 5 
Q_17_t
57 
$15,000-$24,999 11 2.64 1.286 .388 1.77 3.50 1 5 
$25,000-$34,999 12 2.67 .985 .284 2.04 3.29 1 4 
$35,000-$44,999 12 2.42 .900 .260 1.84 2.99 2 5 
$45,000-$54,999 10 2.10 .876 .277 1.47 2.73 1 4 
$55,000-$64,999 6 1.83 .753 .307 1.04 2.62 1 3 
$65,000-$74,999 14 2.29 .914 .244 1.76 2.81 1 4 
$75,000-$84,999 12 2.08 .900 .260 1.51 2.66 1 4 
$85,000-$94,999 6 2.33 1.366 .558 .90 3.77 1 4 
Greater than $95,000 34 2.29 .719 .123 2.04 2.54 1 4 
Less than $15,000 14 2.50 1.019 .272 1.91 3.09 1 4 
Total 131 2.34 .925 .081 2.18 2.50 1 5 
 
       Table 84. ANOVA-Individual MMS Question Mean Scores by Income Level.  
 Sum of Squares Df Mean Square F Sig. 
Q_1_t41 Between Groups 14.283 9 1.587 1.246 .274 
Within Groups 155.437 122 1.274   
Total 169.720 131    
Q_2_t42 Between Groups 16.109 9 1.790 1.323 .232 
Within Groups 166.418 123 1.353   
Total 182.526 132    
Q_3_t43 Between Groups 20.302 9 2.256 1.983 .047 
Within Groups 139.953 123 1.138   
Total 160.256 132    
Q_4_t44 Between Groups 14.160 9 1.573 1.483 .162 
Within Groups 130.517 123 1.061   
Total 144.677 132    
Q_5_t45 Between Groups 15.064 9 1.674 1.787 .077 
Within Groups 115.222 123 .937   
Total 130.286 132    
Q_6_t46 Between Groups 7.740 9 .860 .751 .662 
Within Groups 140.937 123 1.146   
Total 148.677 132    
Q_7_t47 Between Groups 5.195 9 .577 .481 .885 
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 Sum of Squares Df Mean Square F Sig. 
Within Groups 147.482 123 1.199   
Total 152.677 132    
Q_8_t48 Between Groups 13.115 9 1.457 1.194 .305 
Within Groups 148.854 122 1.220   
Total 161.970 131    
Q_9_t49 Between Groups 9.865 9 1.096 1.261 .265 
Within Groups 106.872 123 .869   
Total 116.737 132    
Q_10_t50 Between Groups 13.443 9 1.494 1.323 .232 
Within Groups 138.918 123 1.129   
Total 152.361 132    
Q_11_t51 Between Groups 2.564 9 .285 .253 .985 
Within Groups 138.353 123 1.125   
Total 140.917 132    
Q_12_t52 Between Groups 15.079 9 1.675 1.726 .090 
Within Groups 117.455 121 .971   
Total 132.534 130    
Q_13_t53 Between Groups 2.203 9 .245 .328 .964 
Within Groups 90.316 121 .746   
Total 92.519 130    
Q_14_t54 Between Groups 3.652 9 .406 .735 .676 
Within Groups 66.224 120 .552   
Total 69.877 129    
Q_15_t55 Between Groups 14.074 9 1.564 1.592 .125 
Within Groups 118.857 121 .982   
Total 132.931 130    
Q_16_t56 Between Groups 14.135 9 1.571 2.344 .018 
Within Groups 81.744 122 .670   
Total 95.879 131    
Q_17_t57 Between Groups 5.693 9 .633 .725 .685 
Within Groups 105.528 121 .872   
Total 111.221 130    
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In terms of the respondent’s income level, there were statistically significant differences 
in mean scores on question 3: I trust that health care organizations will tell me if a mistake is 
made about my treatment.  For this question, the respondents with the highest mean (3.29) were 
in the $55,000 to $64,999 category.  There was also statistical significance for question 16: 
Mistakes are common in healthcare organization on the Medical Mistrust Scale due to 
respondent’s income.  For this question, the lowest income level $15,000 to $24,999 had the 
highest mean (3.55) and the second highest income level $85,000 to $94,999 had the lowest 
mean (2.17).   
Table 85.   Results of MMS Question Means by Income Level. 
Question 1 F (9, 122)=1.246, p=.274 
Question 2 F (9, 123)=1.323, p=.232 
Question 3 F (9, 123)=1.983, p=.047 
Question 4 F (9, 123)=1.483, p=.162 
Question 5 F (9, 123)=1.787, p=.077 
Question 6 F (9, 123)=.751, p=.662 
Question 7 F (9, 123)=.481, p=.885 
Question 8 F (9, 122)=1.194, p=.305 
Question 9 F (9, 123)=1.261, p=.265 
Question 10 F (9, 123)=1.323, p=.232 
Question 11 F (9, 123)=.253, p=.985 
Question 12 F (9, 121)=1.726, p=.090 
Question 13 F (9, 121)=.328, p=.964 
Question 14 F (9, 120)=.735, p=.676 
Question 15 F (9, 121)=1.592, p=.125 
Question 16 F (9, 122)=2.344, p=.018 
Question 17 F (9, 121)=.725, p=.685 
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Education 
Next the ANOVA was run to look at differences in total mean scores on the Medical 
Mistrust Scale across the respondent’s education level. 
Table 86. ANOVA-Descriptives MMS by Education Level.  
 N Mean SD Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
High School 42 2.8231 .26770 .04131 2.7397 2.9065 1.89 3.35 
Some College 34 2.8144 .23833 .04087 2.7313 2.8976 2.35 3.24 
College 27 2.7381 .33842 .06513 2.6043 2.8720 1.94 3.41 
graduate or  
professional degree 
32 2.8456 .25239 .04462 2.7546 2.9366 2.29 3.29 
Total 135 2.8093 .27254 .02346 2.7629 2.8557 1.89 3.41 
 
Table 87. ANOVA-MMS Score and Respondent’s Education Level.  
 Sum of Squares df Mean Square F Sig. 
Between Groups .188 3 .063 .840 .474 
Within Groups 9.765 131 .075   
Total 9.953 134    
 
In terms of the respondent’s education, there was no statistically significant difference in 
the total mean score on the Medical Mistrust Scale between the different education levels.   
     Table 88. MMS and Education Level 
Total Mean Score F(3, 131)=.840, p=.474 
 
Next the ANOVA was run to look at differences in mean scores on each question on the 
Medical Mistrust Scale across the respondent’s education level. 
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Table 89. ANOVA-Descriptives MMS Questions by Education Level.  
 N Mean SD SE 
 
Min Max Lower Bound Upper Bound 
Q_1_t41 College 42 2.90 1.055 .163 2.58 3.23 1 5 
Grad/profess. degree 34 3.09 1.240 .213 2.66 3.52 1 5 
high school 27 2.22 1.155 .222 1.77 2.68 1 5 
some college 32 2.78 1.128 .199 2.37 3.19 1 5 
Total 135 2.79 1.168 .101 2.59 2.98 1 5 
Q_2_t42 College 42 2.93 1.197 .185 2.56 3.30 1 5 
Grad/profess. degree 34 3.03 1.114 .191 2.64 3.42 1 5 
high school 27 2.52 1.252 .241 2.02 3.01 1 5 
some college 33 3.12 1.111 .193 2.73 3.52 1 5 
Total 136 2.92 1.174 .101 2.72 3.12 1 5 
Q_3_t43 College 42 2.69 1.093 .169 2.35 3.03 1 4 
Grad/profess. degree 34 2.32 1.121 .192 1.93 2.71 1 5 
high school 27 2.63 1.149 .221 2.18 3.08 1 4 
some college 33 2.64 1.113 .194 2.24 3.03 1 5 
Total 136 2.57 1.113 .095 2.38 2.76 1 5 
Q_4_t44 College 42 2.69 .975 .150 2.39 2.99 1 5 
Grad/profess. degree 34 2.74 .931 .160 2.41 3.06 1 5 
high school 27 2.52 1.189 .229 2.05 2.99 1 5 
some college 33 2.61 1.116 .194 2.21 3.00 1 5 
Total 136 2.65 1.037 .089 2.47 2.82 1 5 
Q_5_t45 College 42 3.10 1.100 .170 2.75 3.44 1 5 
Grad/profess. degree 34 3.32 1.007 .173 2.97 3.67 1 5 
high school 27 2.81 1.001 .193 2.42 3.21 1 5 
some college 33 3.33 .816 .142 3.04 3.62 2 5 
Total 136 3.15 1.003 .086 2.98 3.32 1 5 
Q_6_t46 College 42 2.74 1.106 .171 2.39 3.08 1 5 
Grad/profess. degree 34 2.71 1.219 .209 2.28 3.13 1 5 
high school 27 2.59 .931 .179 2.22 2.96 1 4 
some college 33 2.58 .902 .157 2.26 2.90 1 4 
Total 136 2.66 1.049 .090 2.48 2.84 1 5 
Q_7_t47 College 42 3.33 1.074 .166 3.00 3.67 1 5 
Grad/profess. degree 34 2.76 1.130 .194 2.37 3.16 1 5 
high school 27 3.56 .974 .187 3.17 3.94 1 5 
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 N Mean SD SE Lower Bound Upper Bound Min Max 
some college 33 3.15 1.034 .180 2.78 3.52 1 5 
Total 136 3.19 1.085 .093 3.01 3.38 1 5 
Q_8_t48 College 41 3.02 1.107 .173 2.68 3.37 1 5 
Grad/profess. degree 34 3.12 1.094 .188 2.74 3.50 1 5 
high school 27 2.81 1.178 .227 2.35 3.28 1 5 
some college 33 3.15 1.064 .185 2.77 3.53 1 5 
Total 135 3.04 1.102 .095 2.85 3.22 1 5 
Q_9_t49 College 42 3.29 .944 .146 2.99 3.58 1 5 
Grad/profess. degree 34 3.29 .906 .155 2.98 3.61 1 5 
high school 27 3.56 .934 .180 3.19 3.92 1 5 
some college 33 3.12 .992 .173 2.77 3.47 1 5 
Total 136 3.30 .945 .081 3.14 3.46 1 5 
Q_10_t50 College 42 2.95 1.058 .163 2.62 3.28 1 5 
Grad/profess. degree 34 2.97 1.087 .186 2.59 3.35 1 5 
high school 27 2.56 1.050 .202 2.14 2.97 1 4 
some college 33 2.85 1.064 .185 2.47 3.23 1 5 
Total 136 2.85 1.065 .091 2.67 3.03 1 5 
Q_11_t51 College 42 2.88 .968 .149 2.58 3.18 1 5 
Grad/profess. degree 34 3.06 1.043 .179 2.69 3.42 1 5 
high school 27 2.48 1.014 .195 2.08 2.88 1 5 
some college 33 2.76 1.091 .190 2.37 3.14 1 5 
Total 136 2.82 1.034 .089 2.64 2.99 1 5 
Q_12_t52 College 42 2.86 1.002 .155 2.54 3.17 1 4 
Grad/profess. degree 33 2.30 .847 .147 2.00 2.60 1 4 
high school 27 2.78 1.050 .202 2.36 3.19 1 5 
some college 32 2.75 1.047 .185 2.37 3.13 1 5 
Total 134 2.68 1.001 .086 2.51 2.85 1 5 
Q_13_t53 College 42 2.33 .816 .126 2.08 2.59 1 5 
Grad/profess. degree 33 2.67 .736 .128 2.41 2.93 1 4 
high school 27 2.63 .884 .170 2.28 2.98 1 5 
some college 32 2.63 .942 .166 2.29 2.96 1 5 
Total 134 2.54 .846 .073 2.40 2.69 1 5 
Q_14_t54 College 42 2.48 .707 .109 2.26 2.70 1 4 
Grad/profess. degree 32 2.78 .659 .117 2.54 3.02 2 4 
high school 27 2.59 .844 .162 2.26 2.93 1 5 
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 N Mean SD SE Lower Bound Upper Bound Min Max 
some college 32 2.53 .803 .142 2.24 2.82 1 4 
Total 133 2.59 .750 .065 2.46 2.72 1 5 
Q_15_t55 College 42 2.98 .897 .138 2.70 3.26 1 5 
Grad/profess. degree 33 2.88 1.023 .178 2.52 3.24 1 5 
high school 27 3.04 1.091 .210 2.61 3.47 1 5 
some college 32 3.13 1.129 .200 2.72 3.53 1 5 
Total 134 3.00 1.019 .088 2.83 3.17 1 5 
Q_16_t56 College 42 2.69 .680 .105 2.48 2.90 2 4 
Grad/profess. degree 34 2.38 .985 .169 2.04 2.73 1 4 
high school 27 2.78 .934 .180 2.41 3.15 1 5 
some college 32 2.88 .833 .147 2.57 3.18 1 4 
Total 135 2.67 .862 .074 2.53 2.82 1 5 
Q_17_t57 College 42 2.14 .872 .134 1.87 2.41 1 4 
Grad/profess. degree 33 2.45 .905 .157 2.13 2.78 1 4 
high school 27 2.48 1.014 .195 2.08 2.88 1 5 
some college 32 2.38 .942 .166 2.04 2.71 1 5 
Total 134 2.34 .927 .080 2.18 2.50 1 5 
 
Table 90. ANOVA-Individual MMS Question Mean Scores by Education Level. 
 
Q_1_t41 Between Groups 15.444 4 3.861 2.967 .022 
Within Groups 170.490 131 1.301   
Total 185.934 135    
Q_2_t42 Between Groups 9.754 4 2.439 1.788 .135 
Within Groups 180.012 132 1.364   
Total 189.766 136    
Q_3_t43 Between Groups 4.935 4 1.234 .991 .415 
Within Groups 164.350 132 1.245   
Total 169.285 136    
Q_4_t44 Between Groups 3.538 4 .885 .810 .521 
Within Groups 144.213 132 1.093   
Total 147.752 136    
Q_5_t45 Between Groups 6.613 4 1.653 1.673 .160 
Within Groups 130.468 132 .988   
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Total 137.080 136    
Q_6_t46 Between Groups 3.425 4 .856 .765 .550 
Within Groups 147.757 132 1.119   
Total 151.182 136    
Q_7_t47 Between Groups 11.319 4 2.830 2.518 .044 
Within Groups 148.360 132 1.124   
Total 159.679 136    
Q_8_t48 Between Groups 3.061 4 .765 .623 .647 
Within Groups 160.822 131 1.228   
Total 163.882 135    
Q_9_t49 Between Groups 3.312 4 .828 .928 .450 
Within Groups 117.812 132 .893   
Total 121.124 136    
Q_10_t50 Between Groups 3.997 4 .999 .881 .478 
Within Groups 149.784 132 1.135   
Total 153.781 136    
Q_11_t51 Between Groups 5.977 4 1.494 1.418 .231 
Within Groups 139.088 132 1.054   
Total 145.066 136    
Q_12_t52 Between Groups 8.154 4 2.039 2.090 .086 
Within Groups 126.779 130 .975   
Total 134.933 134    
Q_13_t53 Between Groups 3.063 4 .766 1.077 .371 
Within Groups 92.463 130 .711   
Total 95.526 134    
Q_14_t54 Between Groups 2.165 4 .541 .964 .430 
Within Groups 72.432 129 .561   
Total 74.597 133    
Q_15_t55 Between Groups 2.038 4 .510 .484 .748 
Within Groups 136.954 130 1.053   
Total 138.993 134    
Q_16_t56 Between Groups 6.232 4 1.558 2.145 .079 
Within Groups 95.172 131 .727   
Total 101.404 135    
Q_17_t57 Between Groups 2.761 4 .690 .804 .525 
Within Groups 111.565 130 .858   
Total 114.326 134    
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In terms of the respondent’s education, there were statistically significant differences in 
mean scores on questions 1 (you better be cautious when dealing with healthcare organizations) 
and 7 (The patient’s medical needs come before other considerations at healthcare 
organizations) of the Medical Mistrust Scale due to respondent’s education.  For question 1, 
respondents with a graduate/professional degree had the highest mean (3.09) and repondents 
with a high school diploma had the lowest mean (2.22).  Interestingly enough, it was the opposite 
results for question 7.  The respondents with the graduate/professional degree had the lowest 
mean (2.76) whereas respondents with a high school diploma had the highest mean (3.56).   
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Table 91. Results of MMS Question Means by Education Level. 
Question 1 F (4, 131)=2.967, p=.022 
Question 2 F (4, 132)=1.788, p=.135 
Question 3 F (4, 132)=.991, p=.415 
Question 4 F (4, 132)=.810, p=.521 
Question 5 F (4, 132)=1.673, p=.160 
Question 6 F (4, 132)=.765, p=.550 
Question 7 F (4, 132)=2.518, p=.044 
Question 8 F (4, 131)=.623, p=.647 
Question 9 F (4, 132)=.928, p=.450 
Question 10 F (4, 132)=.881, p=.478 
Question 11 F (4, 132)=1.418 p=.231 
Question 12 F (4, 130)=2.090, p=.086 
Question 13 F (4, 130)=1.077, p=.371 
Question 14 F (4, 129)=.964, p=.430 
Question 15 F (4, 130)=.484, p=.748 
Question 16 F (4, 131)=2.145, p=.079 
Question 17 F (4, 130)=.804, p=.525 
 
Research Question 5: Are reported kidney transplant wait times (pre and post) associated with 
the recipients’ predisposing characteristics (age, race, sex, educational achievement), enabling 
resources (insurance type, transplant center type, transplant center location and income level) or 
with their perceived discrimination or mistrust?  
ANOVA-Comparing age and reported wait times both pre listing (time from 
diagnosis to getting waitlisted) and post listing (time from getting wait listed to receiving 
transplant) 
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  Table 92. ANOVA-Descriptives Wait times by Age. 
 N Mean SD Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
Pretime 21-35 24 10.25 24.168 4.933 .04 20.46 0 120 
35-44 27 16.26 17.995 3.463 9.14 23.38 0 72 
45-54 29 20.79 29.190 5.420 9.69 31.90 0 120 
55-64 37 22.43 53.794 8.844 4.50 40.37 0 324 
65 or ol 17 22.41 39.770 9.646 1.96 42.86 0 168 
Total 134 18.65 36.578 3.160 12.40 24.90 0 324 
Posttime 21-35 24 28.92 28.556 5.829 16.86 40.97 0 100 
35-44 27 23.52 29.977 5.769 11.66 35.38 0 144 
45-54 29 28.86 43.966 8.164 12.14 45.59 0 168 
55-64 36 24.22 27.786 4.631 14.82 33.62 0 120 
65 or ol 14 32.00 45.037 12.037 6.00 58.00 0 168 
Total 130 26.82 34.188 2.998 20.88 32.75 0 168 
 
       Table 93. ANOVA-Wait times by Age. 
 Sum of Squares df Mean Square F Sig. 
Pretime Between Groups 2750.872 4 687.718 .506 .731 
Within Groups 175193.643 129 1358.090   
Total 177944.515 133    
Posttime Between Groups 1139.325 4 284.831 .238 .916 
Within Groups 149634.245 125 1197.074   
Total 150773.569 129    
 
In terms of the respondent’s age, there were no statistically significant differences noted 
in pre or post-wait times. However, as you can see from Table 75, even though the participant’s 
age group did not seem to have a significant effect on pre-wait times, the mean wait time does 
increase over the age groups.  For instance, participants in the youngest age group reported 
waiting less on average than any other group.  The youngest age group (21-34) reported waiting 
6 months less than the next age group (35-44), 10 months less than the 45 to 54-year-old group 
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and 12 months less than the 55 to 64-year-old group.  The data showed a positive relationship 
between pre-wait times and the participants’ age group.  Important to note is that in the post-wait 
time category did not show this wait time increase over age groups.  In fact, the group with the 
shortest reported wait time was the oldest age group of participants 65 years or older.     
ANOVA-Comparing race and reported wait times both pre listing (time from 
diagnosis to getting waitlisted) and post listing (time from getting wait listed to receiving 
transplant) 
Table 94. ANOVA-Descriptives Wait times by Race. 
        
 N Mean SD Std. Error Lower Bound Upper Bound Minimum Maximum 
Pretime Asian 6 15.83 17.577 7.176 -2.61 34.28 3 50 
Black 14 34.21 45.831 12.249 7.75 60.68 1 168 
Hispanic 5 15.00 15.000 6.708 -3.62 33.62 0 36 
Mixed 6 10.83 10.998 4.490 -.71 22.38 0 24 
White 102 17.38 37.694 3.732 9.98 24.79 0 324 
Total 133 18.70 36.711 3.183 12.40 25.00 0 324 
Posttime Asian 6 30.50 17.615 7.191 12.01 48.99 5 48 
Black 13 37.31 59.027 16.371 1.64 72.98 1 168 
Hispanic 5 26.60 19.995 8.942 1.77 51.43 12 60 
Mixed 6 14.83 12.336 5.036 1.89 27.78 0 28 
White 99 26.18 32.280 3.244 19.74 32.62 0 168 
Total 129 26.99 34.261 3.017 21.02 32.96 0 168 
 
        Table 95. ANOVA-Wait times by Race. 
 Sum of Squares df Mean Square F Sig. 
Pretime Between Groups 4035.858 4 1008.964 .743 .565 
Within Groups 173864.112 128 1358.313   
Total 177899.970 132    
Posttime Between Groups 2409.962 4 602.491 .505 .732 
Within Groups 147839.030 124 1192.250   
Total 150248.992 128    
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In terms of the respondent’s race, there were no statistically significant differences in pre 
or post-wait times.  However, of note, during both the pre-wait time and the post-wait times, 
black patients reported waiting longer in both time frames.  During the pre-wait times, black 
patients reported waiting an average of 16.8 months longer than white patients and close to 2 
years longer than patients that identified as mixed race.  During post-wait times, black patients 
reported waiting an average of 11.13 months longer than white patients.     
ANOVA-Comparing respondent’s sex and reported wait times both pre listing (time 
from diagnosis to getting waitlisted) and post listing (time from getting wait listed to 
receiving transplant) 
Table 96. ANOVA-Descriptives Wait times by Sex. 
 N Mean SD Std. Error 
95% Confidence Interval for 
Mean 
Minimum Maximum Lower Bound Upper Bound 
Pretime Male 30 16.27 18.903 3.451 9.21 23.32 0 93 
Female 104 19.34 40.310 3.953 11.50 27.18 0 324 
Total 134 18.65 36.578 3.160 12.40 24.90 0 324 
Posttime Male 30 19.20 21.246 3.879 11.27 27.13 0 72 
Female 100 29.10 36.985 3.698 21.76 36.44 0 168 
Total 130 26.82 34.188 2.998 20.88 32.75 0 168 
 
       Table 97. ANOVA-Wait times by Sex. 
 Sum of Squares df Mean Square F Sig. 
Pretime Between Groups 219.427 1 219.427 .163 .687 
Within Groups 177725.088 132 1346.402   
Total 177944.515 133    
Posttime Between Groups 2261.769 1 2261.769 1.949 .165 
Within Groups 148511.800 128 1160.248   
Total 150773.569 129    
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In terms of the respondent’s sex, there were no statistically significant differences in pre 
or post-wait times. However, of note, during the pre-wait time women reported waiting an 
average of 3 months longer than men.  This gap becomes even larger during the post-wait time 
where women reported waiting an average of almost 10 months longer than men.   
ANOVA-Comparing respondent’s education level and reported wait times both pre 
listing (time from diagnosis to getting waitlisted) and post listing (time from getting wait 
listed to receiving transplant) 
Table 98. ANOVA-Descriptives Wait times by Education Level.  
 N Mean SD 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Pretime High School 42 13.43 17.801 2.747 7.88 18.98 0 78 
Some College 33 17.61 30.508 5.311 6.79 28.42 0 168 
College 27 26.41 64.380 12.390 .94 51.88 0 324 
Grad/profess. degree 31 20.29 28.560 5.130 9.81 30.77 0 120 
Total 133 18.70 36.711 3.183 12.40 25.00 0 324 
Posttime High School 42 18.76 21.769 3.359 11.98 25.55 0 84 
Some College 31 33.52 44.997 8.082 17.01 50.02 1 168 
College 25 33.32 42.998 8.600 15.57 51.07 0 168 
Grad/profess. degree 31 26.52 26.162 4.699 16.92 36.11 0 100 
Total 129 26.99 34.261 3.017 21.02 32.96 0 168 
 
      Table 99. ANOVA-Wait times by Education Level. 
 Sum of Squares df Mean Square F Sig. 
Pretime Between Groups 2888.900 3 962.967 .710 .548 
Within Groups 175011.070 129 1356.675   
Total 177899.970 132    
Posttime Between Groups 5172.449 3 1724.150 1.486 .222 
Within Groups 145076.543 125 1160.612   
Total 150248.992 128    
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In terms of the respondent’s educational level, there were no statistically significant 
differences in pre or post-wait times.  Interestingly enough, it was identified in both the pre and 
post-wait times that patients with a college degree reported longer average wait times.  During 
the pre-wait times, patients with a college degree reported waiting about a year longer than 
patients with a high school diploma.  During post-wait times, patients with a college degree 
reported waiting, on average, about 15 months longer than those with a high school diploma.     
ANOVA-Comparing respondent’s income level and reported wait times both pre 
listing (time from diagnosis to getting waitlisted) and post listing (time from getting wait 
listed to receiving transplant). 
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Table 100. ANOVA-Descriptives Wait times by Income Level. 
 N Mean SD 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Pretime < $15,000 10 13.40 10.157 3.212 6.13 20.67 3 36 
$15,000-$24,999 12 26.00 46.093 13.306 -3.29 55.29 0 168 
$25,000-$34,999 12 18.08 32.670 9.431 -2.67 38.84 3 120 
$35,000-$44,999 10 14.00 14.832 4.690 3.39 24.61 1 36 
$45,000-$54,999 7 56.86 118.921 44.948 -53.13 166.84 0 324 
$55,000-$64,999 14 26.71 31.099 8.312 8.76 44.67 0 93 
$65,000-$74,999 12 18.67 19.764 5.705 6.11 31.22 1 72 
$75,000-$84,999 6 28.50 31.760 12.966 -4.83 61.83 0 78 
$85,000-$94,999 35 5.97 5.623 .950 4.04 7.90 0 24 
> $95,000 13 21.38 32.528 9.022 1.73 41.04 3 120 
Total 131 18.76 36.913 3.225 12.38 25.14 0 324 
Posttime <$15,000 11 47.73 57.226 17.254 9.28 86.17 1 168 
$15,000-$24,999 12 28.75 47.826 13.806 -1.64 59.14 0 168 
$25,000-$34,999 12 32.08 49.074 14.166 .90 63.26 0 168 
$35,000-$44,999 8 17.00 16.767 5.928 2.98 31.02 2 54 
$45,000-$54,999 4 14.50 16.683 8.342 -12.05 41.05 0 38 
$55,000-$64,999 14 20.86 25.237 6.745 6.29 35.43 0 78 
$65,000-$74,999 12 14.17 17.246 4.978 3.21 25.12 1 54 
$75,000-$84,999 6 26.50 15.424 6.297 10.31 42.69 12 45 
$85,000-$94,999 34 23.29 30.440 5.220 12.67 33.92 0 120 
> $95,000 13 38.92 27.140 7.527 22.52 55.32 1 100 
Total 126 26.73 34.718 3.093 20.61 32.85 0 168 
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       Table 101. ANOVA-Wait times by Income Level.   
 Sum of Squares df Mean Square F Sig. 
Pretime Between Groups 18576.937 9 2064.104 1.575 .130 
Within Groups 158557.246 121 1310.390   
Total 177134.183 130    
Posttime Between Groups 11309.614 9 1256.624 1.046 .408 
Within Groups 139359.211 116 1201.373   
Total 150668.825 125    
In terms of the respondent’s income level, there were no statistically significant 
differences in pre or post-wait times.  
ANOVA-Comparing Transplant Center Locations and reported wait times both pre 
listing (time from diagnosis to getting waitlisted) and post listing (time from getting wait 
listed to receiving transplant) 
All assumption testing was completed and once all of the assumptions were addressed, 
the ANOVA was run for each location category.  The responses for each location category were 
run by the respondent’s reported pre and post-wait times and the results are shown in the table 
and graphs below.   
     Table 102. ANOVA-Descriptives Wait times by Transplant Center Location 
 N Mean SD SE 
 
Min Max Lower Bound Upper Bound 
Pretime Rural 9 15.89 22.217 7.406 -1.19 32.97 0 72 
Urban 93 19.22 28.619 2.968 13.32 25.11 0 168 
Suburban 25 21.28 63.584 12.717 -4.97 47.53 0 324 
Other 5 6.00 4.583 2.049 .31 11.69 1 13 
Total 132 18.88 36.808 3.204 12.54 25.22 0 324 
Posttime Rural 8 21.38 18.392 6.503 6.00 36.75 1 54 
Urban 92 29.96 38.029 3.965 22.08 37.83 0 168 
Suburban 23 15.39 18.923 3.946 7.21 23.57 0 60 
Other 5 34.80 31.862 14.249 -4.76 74.36 0 72 
Total 128 26.99 34.409 3.041 20.97 33.01 0 168 
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             Table 103. ANOVA-Wait times by Transplant Center Location. 
 Sum of Squares df Mean Square F Sig. 
Pretime Between Groups 1064.433 3 354.811 .257 .856 
Within Groups 176413.628 128 1378.231   
Total 177478.061 131    
Posttime Between Groups 4461.013 3 1487.004 1.264 .290 
Within Groups 145907.979 124 1176.677   
Total 150368.992 127    
 
In terms of the transplant center location type, there were no statistically significant 
differences in pre or post-wait times.  
ANOVA-Comparing Transplant Center Type and reported wait times both pre 
listing (time from diagnosis to getting waitlisted) and post listing (time from getting wait 
listed to receiving transplant) 
 All assumption testing was completed and once all of the assumptions had been 
addressed, the ANOVA was run for each transplant center category.  The responses on the type 
of transplant center were run by the pre and post-wait times and the results are shown in the table 
and graphs below. 
              Table 104. ANOVA-Wait times by Transplant Center Type.  
 Sum of Squares df Mean Square F Sig. 
Pretime Between Groups 6223.702 3 2074.567 1.561 .202 
Within Groups 171474.072 129 1329.256   
Total 177697.774 132    
Posttime Between Groups 200.127 3 66.709 .056 .983 
Within Groups 150136.803 125 1201.094   
Total 150336.930 128    
In terms of the type of transplant center, there were no statistically significant differences 
in pre and post wait times between the transplant center types. 
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T-Tests with the Medical Mistrust Scale 
In order to run t-tests on the pre and post wait times reported by the respondents, the wait 
times were broken up into two categories: more than two years and two years or less.  The first 
three assumptions of the t-test: continuous variable, independent variable is categorical with two 
groups and there is independence of observations have already been discussed and met.  
 Assumption #4 
This assumption states that there should be no significant outliers.  To test this, box plots 
were run to identify any outliers and to determine if these outliers are affecting the data set.  The 
box plots for each category for each question are located in the Appendix. 
The data was reviewed to ensure it was entered properly and it was noted that the answers 
to these questions due vary quite a bit amongst respondents, but the data was entered correctly.  
It was decided that the outliers will remain in the data set and the t-tests will be run with and 
without them to determine if they effect the analysis significantly or not.  
Assumption #5 
 This assumption is regarding the dependent variable being approximately normally 
distributed (Laerd Statistics, 2019).  To test for the normal distribution, the Shapiro-Wilk test of 
normality was completed.  The results of this test for each variable is displayed in the Appendix.   
 There are some questions where the scores were normally distributed.  The other areas do 
not indicate normal distribution, however the data will be run due to the “robust” nature of a t-
test.  “The assumption of normality is necessary for statistical significance testing using an 
independent-samples t-test. However, the independent-samples t-test is considered "robust" to 
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violations of normality. This means that some violation of this assumption can be tolerated and 
the test will still provide valid results” (Laerd Statistics, 2019, p.7) 
Assumption #6  
The t-test assumes homogeneity of variances and this assumption was tested using 
Levene’s test of equality of variances to see if the variances between the groups for the 
dependent variable are equal (Laerd Statistics, 2019).  The tables below show the results of this 
test.  
Pre-wait times 
There was homogeneity of variances, as assessed by Levene’s test for equality of 
variances (p>.05) for all the questions on the scale as shown in the table below except for 
questions 3 (p=.011) and question 7 (p=.045).    
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Table 105. Pre-wait Time Levene’s Test. 
 F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
 
Lower Upper 
Q_1 Equal variances assumed .134 .715 .266 131 .790 .034 .129 -.221 .290 
Equal variances not assumed   .253 28.622 .802 .034 .136 -.243 .312 
Q_2 Equal variances assumed .450 .504 -1.758 131 .081 -.359 .204 -.763 .045 
Equal variances not assumed   -1.658 28.419 .108 -.359 .217 -.803 .084 
Q_3 Equal variances assumed 6.656 .011 -1.455 131 .148 -.314 .216 -.741 .113 
Equal variances not assumed   -1.236 26.345 .227 -.314 .254 -.836 .208 
Q_4 Equal variances assumed .318 .574 -.392 129 .696 -.061 .155 -.367 .246 
Equal variances not assumed   -.356 26.071 .725 -.061 .170 -.411 .290 
Q_5 Equal variances assumed .703 .403 .487 131 .627 .079 .162 -.242 .400 
Equal variances not assumed   .493 30.277 .626 .079 .160 -.248 .407 
Q_6 Equal variances assumed .375 .541 -.433 131 .666 -.066 .152 -.367 .235 
Equal variances not assumed   -.401 28.019 .691 -.066 .164 -.402 .271 
Q_7 Equal variances assumed 4.104 .045 -1.261 131 .209 -.307 .244 -.789 .175 
Equal variances not assumed   -1.100 26.810 .281 -.307 .279 -.880 .266 
 
T-test Results for Pre-Wait Times 
The table below shows the results of the pre-wait time t-test.  The results are displayed 
for each question on The Discrimination in Medical Settings Scale.  
 
 
 
 
 
180 
 
Table 106. Pre-Wait Time T-Test Results by Question on the DMS. 
Question 1 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the pre-wait time groups, with the shorter wait time groups scoring higher than the longer 
wait time groups M = .034, SE = 0.129, t(131) = .266, p = .790 
Question 2 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the pre-wait time groups, with the longer wait time groups scoring higher than the shorter 
wait time groups M = -.359, SE = 0.204, t(131) = -1.758, p = .081 
Question 3 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the pre-wait time groups, with the longer wait time groups scoring higher than the shorter 
wait time groups M = -.314, SE = 0.216, t(131) = -1.455, p = .148 
Question 4 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the pre-wait time groups, with the longer wait time groups scoring higher than the shorter 
wait time groups M = -.061, SE = .155, t(129) = -.392, p = .696 
Question 5 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the pre-wait time groups, with the shorter wait time groups scoring higher than the longer 
wait time groups M = .079, SE = 0.162, t(131) = .487, p = .627 
Question 6 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the pre-wait time groups, with the longer wait time groups scoring higher than the shorter 
wait time groups M = -.066, SE = 0.152, t(131) = -.433, p = .666 
Question 7 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the pre-wait time groups, with the longer wait time groups scoring higher than the shorter 
wait time groups M = -.307, SE = 0.244, t(131) = -1.261, p = .209 
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Post Wait Times 
There was homogeneity of variances, as assessed by Levene’s test for equality of 
variances (p>.05) for all the questions on the scale as shown in the table below except for 
questions 1 (p=.042), question 2 (p=.015) and question 5 (p=.015).  
Table 107. Post-wait Time Levene’s Test. 
 F Sig. T df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
 
Lower Upper 
Q_1 Equal variances assumed 4.239 .042 1.024 128 .308 .104 .102 -.097 .305 
Equal variances not assumed   1.099 116.015 .274 .104 .095 -.083 .292 
Q_2 Equal variances assumed 6.022 .015 1.754 128 .082 .280 .159 -.036 .595 
Equal variances not assumed   1.848 110.961 .067 .280 .151 -.020 .580 
Q_3 Equal variances assumed 1.312 .254 .829 128 .409 .143 .172 -.198 .484 
Equal variances not assumed   .844 100.743 .401 .143 .169 -.193 .478 
Q_4 Equal variances assumed 1.122 .291 .646 126 .520 .078 .121 -.161 .317 
Equal variances not assumed   .653 96.440 .515 .078 .119 -.159 .315 
Q_5 Equal variances assumed 6.101 .015 1.333 128 .185 .170 .127 -.082 .422 
Equal variances not assumed   1.437 117.217 .153 .170 .118 -.064 .404 
Q_6 Equal variances assumed 1.266 .263 .643 128 .521 .079 .123 -.165 .323 
Equal variances not assumed   .661 103.516 .510 .079 .120 -.159 .317 
Q_7 Equal variances assumed .009 .925 1.291 128 .199 .250 .193 -.133 .632 
Equal variances not assumed   1.259 88.547 .211 .250 .198 -.145 .644 
 
T-test Results for Post-Wait Times 
The table below shows the results of the post-wait time t-test.  The results are displayed 
for each question on The Discrimination in Medical Settings Scale.   
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Table 108. Post-Wait Time T-Test Results by Question on the DMS. 
Question 1 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the post-wait time groups, with the shorter wait time groups scoring higher than the 
longer wait time groups M = .104, SE = 0.102, t(128) = 1.024, p = .308 
Question 2 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the post-wait time groups, with the shorter wait time groups scoring higher than the 
longer wait time groups M = .280, SE = 0.159, t(128) = 1.754, p = .082 
Question 3 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the post-wait time groups, with the shorter wait time groups scoring higher than the 
longer wait time groups M = .143, SE = 0.172, t(128) = .829, p = .172 
Question 4 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the post-wait time groups, with the shorter wait time groups scoring higher than the 
longer wait time groups M = .078, SE = 0.121, t(126) = .646, p = .520 
Question 5 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the post-wait time groups, with the shorter wait time groups scoring higher than the 
longer wait time groups M = .170, SE = 0.127, t(128) = 1.333, p = .185 
Question 6 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the post-wait time groups, with the shorter wait time groups scoring higher than the 
longer wait time groups M = .079, SE = 0.123, t(128) = .643, p = .123 
Question 7 There was not a statistically significant difference in scores on the Discrimination in Medical Settings 
Scale between the post-wait time groups, with the shorter wait time groups scoring higher than the 
longer wait time groups M = .250, SE = 0.193, t(128) = 1.291, p = .199 
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T-Tests of Pre and Post Wait Times with Mean Scores on the Medical Mistrust Scale 
In order to run t-tests on the pre and post wait times reported by the respondents, the wait 
times were broken up into two categories: more than two years and two years or less.  The first 
three assumptions of the t-test: continuous variable, independent variable is categorical with two 
groups and there is independence of observations have already been discussed and met.  
 Assumption #4 
This assumption states that there should be no significant outliers.  To test this, box plots 
were run to identify any outliers and to determine if these outliers are effecting the data set.  The 
box plots for each category for each question are located in the Appendix. 
When analyzing the box plots, some outliers were noted for pre and post times on 
specific questions on the Medical Mistrust Scale.  The table below provides a list of the outliers 
for each wait time category.   
Table 109. Medical Mistrust Scale Outliers. 
 2 years or less More than 2 years 
Pre-time 4, 6, 9, 11, 13, 14, 16,17 7, 15 
Post-time 3, 6, 7, 9, 12, 13, 17 4, 5, 6, 9, 11, 13, 14, 16, 17  
 
This was assessed by inspection of the boxplot for values greater than 1.5 box-lengths 
from the edge of the box (Laerd Statistics, 2019).  The data was reviewed to ensure it was 
entered properly and it was noted that the answers to these questions due vary quite a bit 
amongst respondents but the data was entered correctly.  It was decided that the outliers will 
remain in the data set and the t-tests will be run with and without them to determine if they effect 
the analysis significantly or not.  
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Assumption #5 
 This assumption is regarding the dependent variable being approximately normally 
distributed (Laerd Statistics, 2019).  To test for the normal distribution, the Shapiro-Wilk test of 
normality was completed.  The results of this test for each variable is displayed in the Appendix.   
 There are some questions where the scores were normally distributed.  The other areas do 
not indicate normal distribution, however the data will be run due to the “robust” nature of a t-
test.  “The assumption of normality is necessary for statistical significance testing using an 
independent-samples t-test. However, the independent-samples t-test is considered "robust" to 
violations of normality. This means that some violation of this assumption can be tolerated and 
the test will still provide valid results” (Laerd Statistics, 2019, p.7) 
Assumption #6  
The t-test assumes homogeneity of variances and this assumption was tested using 
Levene’s test of equality of variances to see if the variances between the groups for the 
dependent variable are equal (Laerd Statistics, 2019).  The tables below show the results of this 
test.   
Pre-wait times 
There was homogeneity of variances, as assessed by Levene’s test for equality of 
variances (p>.05) for all the questions on the scale as shown in the table below.   
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Table 110. MMS Pre-wait Time Levene’s Test. 
 
 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
 
Lower Upper 
Q_1_t41 Equal variances 
assumed 
.145 .704 -.058 131 .954 -.016 .274 -.558 .526 
Equal variances 
not assumed 
  
-.059 30.345 .953 -.016 .270 -.567 .535 
Q_2_t42 Equal variances 
assumed 
2.913 .090 -.091 132 .928 -.025 .278 -.575 .524 
Equal variances 
not assumed 
  
-.080 27.082 .937 -.025 .313 -.668 .617 
Q_3_t43 Equal variances 
assumed 
.001 .982 -.388 132 .699 -.101 .262 -.619 .416 
Equal variances 
not assumed 
  
-.386 29.695 .702 -.101 .263 -.639 .436 
Q_4_t44 Equal variances 
assumed 
.207 .650 -.083 132 .934 -.020 .243 -.501 .461 
Equal variances 
not assumed 
  
-.090 32.055 .929 -.020 .227 -.482 .441 
Q_5_t45 Equal variances 
assumed 
.802 .372 -.788 132 .432 -.183 .233 -.644 .277 
Equal variances 
not assumed 
  
-.911 35.044 .368 -.183 .201 -.592 .225 
Q_6_t46 Equal variances 
assumed 
.973 .326 -1.077 132 .284 -.265 .247 -.753 .222 
Equal variances 
not assumed 
  
-1.134 31.411 .265 -.265 .234 -.743 .212 
Q_7_t47 Equal variances 
assumed 
.661 .418 -.086 132 .931 -.022 .254 -.524 .480 
Equal variances 
not assumed 
  
-.091 31.371 .928 -.022 .241 -.513 .470 
Q_8_t48 Equal variances 
assumed 
.010 .921 -.386 131 .700 -.100 .259 -.611 .412 
Equal variances 
not assumed   
-.386 29.908 .702 -.100 .259 -.628 .429 
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  F Sig. t df Sig. Mean Diff. SE Diff. Lower Upper 
Q_9_t49 Equal variances 
assumed 
.660 .418 -.651 132 .516 -.142 .218 -.574 .289 
Equal variances 
not assumed 
  
-.611 28.259 .546 -.142 .232 -.618 .334 
Q_10_t50 Equal variances 
assumed 
1.463 .229 -.350 132 .727 -.088 .250 -.583 .408 
Equal variances 
not assumed 
  
-.305 26.736 .763 -.088 .288 -.678 .503 
Q_11_t51 Equal variances 
assumed 
.575 .450 -1.381 132 .170 -.332 .240 -.808 .144 
Equal variances 
not assumed 
  
-1.448 31.260 .158 -.332 .229 -.800 .136 
Q_12_t52 Equal variances 
assumed 
2.080 .152 .756 130 .451 .179 .237 -.289 .647 
Equal variances 
not assumed 
  
.884 33.223 .383 .179 .202 -.233 .591 
Q_13_t53 Equal variances 
assumed 
.829 .364 -2.140 130 .034 -.427 .200 -.822 -.032 
Equal variances 
not assumed 
  
-2.296 30.068 .029 -.427 .186 -.807 -.047 
Q_14_t54 Equal variances 
assumed 
.801 .372 -1.003 129 .318 -.178 .177 -.529 .173 
Equal variances 
not assumed 
  
-.903 25.927 .375 -.178 .197 -.583 .227 
Q_15_t55 Equal variances 
assumed 
.024 .876 1.131 130 .260 .264 .233 -.198 .725 
Equal variances 
not assumed 
  
1.168 30.989 .252 .264 .226 -.197 .724 
Q_16_t56 Equal variances 
assumed 
.739 .391 1.130 131 .260 .230 .203 -.172 .632 
Equal variances 
not assumed 
  
1.040 27.888 .307 .230 .221 -.223 .682 
Q_17_t57 Equal variances 
assumed 
5.527 .020 -1.282 130 .202 -.283 .221 -.720 .154 
Equal variances 
not assumed 
  
-1.094 24.967 .284 -.283 .259 -.816 .250 
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T-test Results for Pre-Wait Times 
The table below shows the results of the pre-wait time t-test.  The results are displayed 
for each question on The Medical Mistrust Scale.   
Table 111. Pre-Wait Time T-Test Results by Question on the MMS. 
Question 1 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.016, SE = 
0.274, t(131) = -.058, p = .954 
Question 2 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.025, SE = 
0.278, t(132) = -.091, p = .928 
Question 3 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.101, SE = 
0.262, t(132) = -.0.388, p = .699 
Question 4 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.020, SE = 
0.243, t(132) = -.083, p = .934 
Question 5 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.183, SE = 
0.233, t(132) = -.788, p = .432 
Question 6 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.265, SE = 
0.247, t(132) = -1.077, p = .284 
Question 7 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.022, SE = 
0.254, t(132) = -.086, p = .931 
Question 8 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.100, SE = 
0.259, t(131) = -.386, p = .259 
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Question 9 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.142, SE = 
0.218, t(132) = -.651, p = .516 
Question 10 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.088, SE = 
0.250, t(132) = -.350, p = .727 
Question 11 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.332, SE = 
0.240, t(132) = -1.381, p = .170 
Question 12 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups M = -.179, SE = 
0.237, t(130) = .756, p = .451 
Question 13 There was a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.427, SE = 
0.200, t(130) = -2.140, p = .034 
Question 14 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.178, SE = 
0.177, t(129) = -1.003, p = .318 
Question 15 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups  M = .264, SE = 
0.233, t(130) = 1.131, p = .260 
Question 16 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups  M = .230, SE = 
0.203, t(131) = 1.130, p = .260 
Question 17 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the pre-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.283, SE = 
0.221, t(130) = -1.282, p = .202 
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Post-Wait Times 
There was homogeneity of variances, as assessed by Levene’s test for equality of 
variances (p>.05) for all the questions on the scale as shown in the table below 
Table 112. Post-Wait Time Levene Test for MMS. 
 
F Sig. T df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
 
Lower Upper 
Q_1 Equal variances assumed .091 .764 -.823 127 .412 -.178 .216 -.606 .250 
Equal variances not assumed   -.825 93.660 .411 -.178 .216 -.607 .250 
Q_2 Equal variances assumed .011 .917 -.359 128 .720 -.078 .217 -.507 .351 
Equal variances not assumed   -.361 96.637 .719 -.078 .216 -.507 .351 
Q_3 Equal variances assumed .058 .810 -1.03 128 .305 -.208 .202 -.608 .191 
Equal variances not assumed   -1.02 93.933 .308 -.208 .203 -.611 .195 
Q_4 Equal variances assumed .544 .462 1.541 128 .126 .291 .189 -.083 .664 
Equal variances not assumed   1.595 105.711 .114 .291 .182 -.071 .653 
Q_5 Equal variances assumed .112 .739 -1.18 128 .237 -.214 .180 -.569 .142 
Equal variances not assumed   -1.20 99.690 .231 -.214 .177 -.565 .138 
Q_6 Equal variances assumed 1.310 .254 -.220 128 .826 -.042 .192 -.422 .337 
Equal variances not assumed   -.227 104.163 .821 -.042 .186 -.412 .327 
Q_7 Equal variances assumed .203 .653 .513 128 .609 .101 .198 -.290 .492 
Equal variances not assumed   .506 91.848 .614 .101 .200 -.296 .499 
Q_8 Equal variances assumed .155 .695 -.461 127 .646 -.091 .198 -.482 .300 
Equal variances not assumed   -.458 94.128 .648 -.091 .199 -.486 .304 
Q_9 Equal variances assumed .307 .580 .073 128 .942 .013 .171 -.326 .351 
Equal variances not assumed   .074 97.224 .941 .013 .170 -.325 .350 
Q_10 Equal variances assumed .180 .672 1.482 128 .141 .286 .193 -.096 .667 
Equal variances not assumed   1.492 97.484 .139 .286 .192 -.094 .666 
Q_11 Equal variances assumed .725 .396 .250 128 .803 .047 .188 -.325 .419 
Equal variances not assumed   .239 83.463 .812 .047 .197 -.344 .438 
Q_12 Equal variances assumed .001 .981 -.764 126 .446 -.142 .186 -.509 .226 
Equal variances not assumed   -.757 93.548 .451 -.142 .187 -.514 .230 
Q_13 Equal variances assumed .120 .729 -.573 126 .568 -.090 .156 -.399 .220 
Equal variances not assumed   -.581 100.250 .563 -.090 .154 -.396 .216 
Q_14 Equal variances assumed 3.633 .059 .041 126 .967 .006 .140 -.271 .282 
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 F Sig. t df Sig. Mean Diff. SE Diff. Lower Upper 
Equal variances not assumed   .039 78.724 .969 .006 .149 -.291 .303 
Q_15 Equal variances assumed .028 .867 -.248 126 .805 -.046 .185 -.413 .321 
Equal variances not assumed   -.246 93.759 .806 -.046 .187 -.417 .325 
Q_16 Equal variances assumed .005 .944 -.467 127 .641 -.074 .158 -.387 .239 
Equal variances not assumed   -.460 91.543 .647 -.074 .161 -.393 .245 
Q_17 Equal variances assumed 2.368 .126 -.751 126 .454 -.126 .168 -.458 .206 
Equal variances not assumed   -.723 85.535 .472 -.126 .174 -.472 .220 
 
T-test Results for Post-Wait Times 
The table below shows the results of the post-wait time t-test.  The results are displayed 
for each question on The Medical Mistrust Scale.   
Table 113. Post-Wait Time T-Test Results by Question on the MMS. 
Question 1 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.178, SE = 0.216, t(127) 
= -.823, p = .412 
Question 2 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.078, SE = 0.217, t(128) 
= -.359, p = .720 
Question 3 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.208, SE = 0.202, t(128) 
= -1.031, p = .305 
Question 4 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups M = .291, SE = 0.189, t(128) 
= 1.541, p = .126 
Question 5 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.214, SE = 0.180, t(128) 
= -1.187, p = .237 
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Question 6 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -0.42, SE = 0.192, t(128) 
= -.220, p = .826 
Question 7 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups M = .101, SE = 0.198, t(128) 
= .513 p = .609 
Question 8 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.091, SE = 0.198, t(127) 
= -.461, p = .646 
Question 9 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups M = .013, SE = 0.171, t(128) 
= .073, p = .942. 
Question 10 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups M = -.286, SE = 0.193, t(128) 
= 1.482, p = .141 
Question 11 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups M = -.047, SE = 0.188, t(128) 
= -.250, p = .803 
Question 12 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.142, SE = 0.186, t(128) 
= .764, p = .446 
Question 13 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.090, SE = 0.156, t(126) 
= -.573, p = .568 
Question 14 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the shorter wait time groups scoring higher than the longer wait time groups M = .006, SE = 0.140, t(126) 
= .041, p = .967 
Question 15 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M =-.046, SE = 0.185, t(126) 
= -.248, p = .805 
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Question 16 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.074, SE = 0.158, t(127) 
= -.467, p = .641 
Question 17 There was not a statistically significant difference in scores on the Medical Mistrust Scale between the post-wait time 
groups, with the longer wait time groups scoring higher than the lower wait time groups M = -.126, SE = 0.168, t(126) 
= -.751, p = .454 
 
Qualitative Analysis 
 In order to get a more nuanced dive into the research questions, ten in-depth interviews 
were conducted by phone with kidney transplant recipients.  The researcher compiled a list of the 
respondents who provided their contact information and volunteered for an interview on the 
survey.  As previously discussed, the sample for this study consisted of primarily white 
participants (77%).  The original list of participants who agreed to be contacted for an interview 
consisted of 75 transplant recipients.  Two of these participants were excluded as they had not 
fully completed the survey.  Similar to the total sample, the interview sample was primarily 
white as well.  Out of the 73 interview respondents remaining, seven identified as Black (9.6%), 
one identified as Middle Eastern (1.4%), five were Asian (6.8%) and three were Hispanic (4.1%) 
and the remaining 57 (78%) identified as White.  
Based on the literature review and the theories chosen for this research, Fundamental 
Cause Theory and Critical Race Theory, the researcher attempted to contact all minority 
participants (16) who agreed to be called for an interview.  Unfortunately, there were some 
participants who also had to be excluded from the interviews due to the inability to get into 
contact with them.  One Black participant and one Hispanic participant did not provide a phone 
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number but rather only an email address which, when emailed came up as invalid therefore these 
participants could not be interviewed.  One participant who identified as southeast Asian only 
provided an email and did not respond to the email to set up an interview.  The last reason for 
exclusion was simply that multiple contact attempts were made and messages were left for the 
participants but no return phone call was received (one Asian participant and two black 
participants).             
Therefore, the ten interviews were conducted with one Middle Eastern participant, three 
Asian participants, two Hispanic participants and four Black participants.  As previously stated, 
these interviews were audio recorded, transcribed verbatim and coded by a team of two doctoral 
students.  The content analysis began using open coding.  Two coders began by independently 
reviewing the first two interview transcripts.  The two coders went through the two interviews 
thoroughly identifying and noting all categories that emerged from each interview question.  
Once both interviews were reviewed, the two coders met and compared categories.   
Any category that differed between the coders was discussed and a conclusion on which 
category to use was made.  Subcategories were also identified within some of the categories.  For 
example, under the category of discrimination, there were subcategories of no discrimination, 
subtle discrimination, ageism, and multifactorial discrimination.  During the open coding stage, 
coders used relevant quotations from the interviews to add evidence of the category assigned.  
The researcher worked through the interviews until saturation of the themes was reached (Strauss 
& Corbin, 1990).  As all of the interviews were being analyzed, fewer new categories emerged 
which indicated saturation.  Below is the codebook which provides all of the identified codes, 
definitions and direct quotes from the interviews to depict each code.  This information provides 
an in depth look into each interviewee’s experience. 
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Code Book 
Code Definition Evidence from the interviews 
Communication This includes any issues with 
regards to communication 
between the transplant center 
and patient. 
*I have not really gotten any update if I  
   am on the list or not but that is    
   something I am working on 
*It is still challenging because again I do  
   not know what is going on, they are not  
   really up to date with telling me    
   information about me being on the list 
*Sure um I was placed on the waiting list   
   and I waited 7 years, I never got a single   
   phone call, nothing 
*The lack of communication with the transplant  
   center, always getting mixed up about which  
   test I got, which test I need to get, which test I  
   don’t need to take and with the lack of  
   communication and getting everything mixed  
   up, the test I took expired so I had to go back  
   and retake some of the tests 
*probably knowing what is going on, you know  
  letting me know what is going on because I  
  would like to know you know 
*they do not tell me anything 
* I think at the transplant center um they really  
  rushed through the information like um when I  
  got there for my consult I feel like they rushed.     
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  I mean she explained how the waitlist worked   
  but you really have to kind of be proactive and  
  do your own research because I just feel like  
  they are so busy I feel like sometimes they rush  
  through it 
*Communication made it all difficult because  
  with the transplant center, you cannot just pop  
  up there without an appointment so of course I    
  was never going to drive an hour away to not be  
  seen because I didn’t have an appointment you  
  know.  So it was definitely hard with the lack of  
  communication and then you know I didn’t  
  know that anyone could apply at any transplant  
  center. 
*I still have no idea what I am doing, you know I  
  still need help asking how to do I get on the list  
  and how do I do this and how do I do that.  And  
  you know it is not new to me but it is  
  challenging 
Center Wait Times This includes any information 
respondents provided about wait 
times in the transplant center. 
*um I did Northwestern and their waittime  
   is 5 to 10 years 
*Wisconsin’s wait time is shorter and their  
   waittime is 3 to 5 years 
*so the waittimes in Chicago are insane they are  
  five to seven years I think. Um and then he said,  
   and what I heard from different centers in  
   Wisconsin I think on average is about two to  
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   three years but obviously it is just a different  
   population, being from Chicago or New York  
  or anything like that.  And similarly in Iowa the  
   waittimes were about 1 to 3 years.   
Previous transplant This includes information 
regarding participants who have 
received previous kidney 
transplants 
*I received my kidney back in 2014 and it  
   lasted me 4 ½ years 
*December will be 6 years, 2013 I got mine.  
   I had 2 kidney transplants 
* They wanted to make sure that I was  
  completely well, in the mental capacity to  
  have another transplant, so the second  
  transplant was in September 2017 so I was        
  on dialysis for like 13 months.   
Multi-listing This includes any information 
regarding participants who listed 
on more than one transplant list 
at a time. 
*I was on Madison’s Waiting List and  
   Freider’s Waiting List and over here in  
   Illinois I was on Northwestern’s waiting  
   List. I said I am going to list on all the  
   transplant lists.  I will go to Tampa General, I  
   went to Gainesville, and I went to Miami,  
   listed on all three 
*1st transplant I was on Michigan and Minnesota    
   because my main doctors were at the Mayo      
   Clinic in Minnesota and that is where I actually  
    ended up having my transplant.  2nd  
    transplant but I was waiting longer than that I  
   was listed in two states, I was listed in    
   Michigan and Ohio.  And I actually got the call  
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   in Ohio three times however I was the backup  
   each time so I never got, never got the  
  opportunity to get the kidney then. 
Personal wait times Information about how long 
each participant was either on 
the wait list for or how long it 
took to get on the waitlist 
*I was on the waiting list for about 3 ½  
   years and they actually added that time I  
   was on dialysis they added that to the  
  waiting points 
*I was placed on the waiting list and I  
   waited 7 years.  I was actually diagnosed  
   15 years before I received the transplant 
*I was part of the paired exchange so my  
   husband donated on my behalf and we did the     
  swap so I was on there maybe a year, maybe a  
  year and ten months, a year and nine months. 
*My whole process from when I was diagnosed,  
  I never even went on dialysis, but from the  
  time I was diagnosed to the time I received my  
  transplant was less than a year 
*I was on the list for 14 years 
  Were you on dialysis that whole time? 
  That whole time.   
*I was on dialysis for a little over a year. Just  
  listed at the one center 
*Oh my goodness, it took a good couple of  
  months, close to three months (to get on the  
  wait list) cuz where I live.  I had to travel an  
  hour away to get the tests done 
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*I was on dialysis for a little over 3 years, when I  
  found a donor, from the time I found the donor  
  to the time of the transplant it was about 5  
  months.   
*So the first one well I started, well mine is a  
  little bit different because I was not in America  
  when I was having kidney issues. So when I  
  came to America I was waiting for dialysis and      
  already I think after a couple of years I go on  
  the list and then I waited for about 4 to 5 years  
  before I got called for the transplant 
  You waited how long for the second one? 
  4 years because in 2007 I got the transplant        
*Yeah so the first one was 7 years ago in 2012                                                     
and I was on dialysis for 14 months and I was on 
the waiting list for shorter than that because I had 
gotten listed after I started dialysis  
*2nd time I knew prior to that that I was in kidney 
failure because I actually got listed, I got listed 
before I had dialysis this time around. So I was 
listed in February of 2016, I had a family friend 
had gotten tested and he was a match so we went 
ahead once we found out he was a match in I 
want to say July, we scheduled it for September  
Compliance Any information provided 
regarding compliance with 
medication, appointments, and 
medical regimen. 
*I was a terrible patient to be honest and the  
  reason I needed another transplant was  
  because I was not compliant.  With the  
  medications, with follow ups, with taking care  
  of it, with everything.  I drank, i was just stupid  
  then and this time. And actually while I was  
  waitlisted, I was put on hold due to non- 
  compliance as well 
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Paired Exchange Information participants’ 
provided on group studies and 
paired exchange programs. 
*I was the last person to receive a kidney out of 
the 4 families that were donating 
*okay so there are four families and the first 
family donates to the second family, um the 
second family has a family member that can 
donate to the third family member that is waiting 
and the third family member donates their kidney 
to me so that they can get bumped up the list 
faster to receive a kidney 
*Um I do not think (the experience was easy) 
because I was lucky actually because I waited 
only 3 ½ years and I actually received my kidney 
from a complete stranger through a group study 
* I had a couple of people who would donate but 
I would never have thought that their kidney 
would have to be some sort of swap system 
*They were like hey we are going to put you in a 
group study and you will get the call when we 
have a family that is going to donate a kidney to 
you. And that is when they called me and they 
were like, well fingers crossed you will get this 
kidney but if like the first, second or third family 
doesn’t want to donate, then you will not have a 
kidney.  Because if the first family member 
decided to not donate to the second family in 
need, then I wouldn’t receive one 
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Lack of Support This includes information 
regarding when support was not 
available to the participant. 
*when I first started on the list, yes I did (have 
support), now not so much, now it is just me 
dealing with it 
*I am dealing with it on my own, so I mean it is 
nothing new to me but it would be nice to have 
someone there you know 
*I thought maybe my family would be more 
involved, it was kind of, the family support was 
not what I thought it would be.  Because there 
were some people who were against my husband 
donating and all the drama of that you, some 
people on my side they were just apprehensive 
about the whole thing. 
*Yeah you know that’s true, that is true, this 
process opened my eyes to a lot.  The people I 
thought would come through were the ones who 
disappeared.   
Support System Support from family *my mom was by my side the first time I went 
through all of this, she was my rock and it was 
difficult for her, you know it was very emotional 
*My husband is always dependable but I was 
actually more worried about him donating um 
versus some of my other family members but it 
just worked out that he donated. 
*Family and friends 
*My family has been always around.  Like in 
Minnesota when we moved it was just me and my 
sister I, my parents used to come back and forth 
from Dubai to here.  You know because my dad 
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had a business in Dubai so I used to live with my 
cousins in Minnesota, I have a few cousins. 
*Family support has always been there for me so 
I have never any issues about that                   
*Family and friends                                             
*My wife would have to be the one I would say 
was my main support.         
Support from friends *I also had a friend, a friend of 30 years and 
mother or my godson who offered to donate and 
she flew all the way from Virginia to have her 
testing done.  but that didn’t work out.  But that 
was very heartwarming to have her do that 
*I have my best friend who would like to donate 
her kidney to me 
*Yeah so I have my best friend 
*Um honestly a lot of the people we were friends 
with came through, We have a lot of friends 
*A lot of friends and friends of friends helped us 
more than our own family 
 
Support from online support 
groups 
*the people in the support groups on Facebook, 
they been through it, they really helped too, they 
answered questions sometimes better than the 
doctors (laughter).  Yeah I think that was my best 
resource.   
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*Like you know my husband he donated and he 
had his own separate group and he was able to 
ask them a bunch of questions and you know that 
I couldn’t answer or that the doctor couldn’t 
answer really or like truthfully I would say 
*the people I least expected were so sweet to us, 
so loving to us and it was just amazing                                                          
Support from the healthcare 
team 
*I had a nurse who drove up all the way from 
Miami it was on a Saturday or whenever she 
could to come give me the IVIG medicaition 
*The nurses were actually very helpful.                
*I really um I really liked my pretransplant nurse 
coordinator um she just like every time she called 
me and told me about the possibility of the 
kidney maybe there being a kidney for me, it was 
like one of my family members was calling me.  
She was just as excited as my mom was.     * I 
really had some awesome people on my medical 
team that were just like super helpful and always 
there to answer questions and whatnot.                                                                  
*Yes definitely so I would say the nurse 
coordinator for sure           
*Also the transplant RN, Brittany, I remember 
her name because she went above and beyond 
and she did not need to.  Post transplant I was not 
feeling well and I could not keep any food down.  
She saw me in the office and gave me some of 
203 
 
her own soup that she was planning on having for 
lunch.  She waited with me to make sure I was 
able to keep the soup down before having me 
leave the office.                                    
Discrimination  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Responses that indicate no 
discrimination 
*there was no overt discrimination that I can 
think of 
*No, no not at all                                                          
*No only for being a bad patient but it was 
warranted (laughter) 
Responses that indicate little, 
very subtle discrimination 
Well I started the process when I was about 58 
and as I got closer and closer to 65, I kept making 
sure my team knew I was still working.  And I 
worked up until the day before my transplant and 
I had a sense, and they may be totally in my head, 
but I had a sense that since I was still contributing 
to society, I was working and paying taxes, and 
this may have given me a slight edge over 
somebody who didn’t do those things or who 
couldn’t work.  Well that could be all in my head  
*Um yes and no, I would say that a lot of times 
they dismiss your concerns and that just urks me, 
like if you have a concern, they just dismiss it or 
they compare you to the whole group.  
So that would be my only thing and I think 
sometimes too since I am a nurse, sometimes they 
I do not know, sometimes they get irritated if you 
have a lot of questions and I think this just gets 
passed over 
204 
 
Statements about being treated 
differently due to insurance or 
income 
*Right you could start that process (early).  The 
doctors are funny about who they tell, if you got 
good insurance, then they will let you know and 
if you have VA or if you are a veteran or if you 
are a business person, someone with a lot of 
money, they are going to let you know, you cant 
avoid a transplant and they start doing the tests.  
So as soon as you get close, you get on the list, 
you can get a transplant and avoid dialysis.   
*But there are people that they say oh well, you 
have to be on Medicaid or Medicare for at least a 
year or year and a half before you can do 
anything.  Well who is in charge and who is the 
one decided which people get on the list, not get 
on the list, you know insurance company, the 
doctors you know and it is not fair.   
*Now they are saying you got to have at least 
3,500 in the bank and you got to show it.  You 
gotta show it.  And that is crazy and you know 
the thing about it is they tell you that you gonna 
have to be able to afford these drugs, well you 
know some people are, some people don’t but 
you know it is just crazy.  For them to make you 
say you need to have this money in the back 
Ageism 
Statements where participants 
felt discriminated by age 
*Well no not really but I felt like because I was 
so young they just were like “oh you just got to 
make sure you take your meds” and they just kept 
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constantly repeating themselves, “take your 
meds”, take your meds”  
*I will remember this, you do not have to tell me 
everytime, all the time, you know so that I felt 
like because I was young they were like oh gotta 
do this, you gotta do that, and I was like okay I 
will.  You don’t have to worry I will take my 
meds on time you don’t have to remind me and I 
was doing good 
*Yeah, Yeah and I just feel like because I am 
young, they don’t want to tell me some things 
and I get upset so I start snapping on them and 
they get all upset  but I wouldn’t be snapping on 
them if they would just tell me what is going on 
Multifactorial discrimination 
Statements indicating 
discrimination across many 
factors 
*Those kidneys are going to waste and there are 
people who need um but you cant get um because 
your transplant center is already discriminating 
against you because maybe you are an African 
American, you have Medicare, you cant afford 
your 20% and plus you need to have your 3-5,000 
dollars in the bank.  Then you gotta go fundraise 
Changes to Make Waitlist 
Process Easier 
No changes *No no I personally did not run into any issues at 
all so no.   
Response regarding better 
education as a change to the 
waitlist process 
*With the waitlist I would say more research I 
guess because I realize now there are different 
regions um that have different wait times and 
maybe I could have went to a different state where 
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I have family, you know.  I think they just don’t 
really talk about that very much like if you live in 
a certain region.  Cause I guess on the East Coast 
the times might be long and maybe if you do have 
finances or family in another state, I think they 
should talk more to that and maybe you could go 
somewhere else and get listed faster  besides just 
going to another hospital in your region, you could 
go outside of your region 
Responses regarding changes 
needed when a patient gets a 
call for a transplant 
*I was offered a kidney three times, one was a 
cadaver um it wasn’t a complete match, um I 
went all the way up to Madison they took my 
blood, I spent the whole night there and the next 
morning they were like, I am sorry it is not a 
100% match, so I was crushed you know, 
heartbroken 
*the second time, a few months later, they called 
me up and was like um we have a kidney for you 
and at the time I had a common cold and I told 
them I was sick and they were like oh well then 
we cant give you this kidney if you are sick 
because we need you to be 100% healthy so I was 
kind of bummed out about that and then the third 
call was the group study call.   
Reponses related to financial 
issues in the process. 
Well like I said before, if I had the right 
insurance, we would not have had to raise any of 
the money.   
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Post-Transplant  Information regarding side 
effects post-transplant  
*Oh yeah because now I have diarrhea from one 
of the meds, I have lower back pain which is 
another side effect of one of the meds, and I am 
so tired, even more tired than I was before 
Information about feelings post-
transplant 
 
*Absolutely.  In fact, my health is worse than 
before transplant.   
* So yeah transplant did not improve my life, it 
worsened it. 
* what I have done is I have exchanged length of 
life for quality of life.   
*I didn’t feel badly.  The only symptom I had 
was that towards the end I was feeling more tired. 
*Transplant is not and easy thing you know 
because you have to take so many pills and stuff 
like that  
Obstacles  Information about obstacles 
endured in the waitlist process. 
Just the travel. You know people that live in rural 
areas like that could be an issue but for me, it was 
not since for both transplants I had them near my 
home, even Toledo was only about an hour away 
so had I got a call and had to be there in under 2 
hours, I could have done it.   
* when I got ready to get onto the transplant list, 
they said you know you gotta lose weight and all 
of that sort of thing and I said ok no problem 
*It was me and my medical issues that caused 
obstacles 
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*Well we were notified that I was placed as 
inactive on the list because with my insurance, 
there was concern that I could not afford the 
medications if I did get a transplant.  Well first of 
all, I had Medicare insurance and I thought I also 
had Medicaid but there was some kind of issue 
where the Medicaid was terminated. I called and 
spoke with many people at Medicaid but there 
was no quick fix for the problem so we had to 
fundraise and we were told we needed $5000 in 
the account to get back to active status 
Advice for New Patients Information respondents 
provided as advice for new 
kidney patients 
*Do it as soon as possible, because you never 
know if they get you on or not and then you are 
sitting there wasting your time doing treatment 
and that is just like am I on the list for a kidney 
because that would be great and if not what can 
we do 
*I would just recommend that people try one or 
more transplant centers because when I went to 
the second one, they were more thorough than the 
first place that I went to so I think that helped 
hearing the information again from a different 
transplant center. 
*Yeah, yeah I feel really bad about the people 
who cannot get on the list because I have heard a 
lot of people who say they financially they cannot 
do it or they do not feel they have the support to 
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do it. You know because they find dialysis is too 
hard 
*I would try to get on (the list) even if you have 
reservations with it, whether it be financial or 
support, because I know at the dialysis center 
there were a couple of people who choose not to 
get on the transplant list and from the ones that I 
do talk to they said it was because of their age, or 
maybe they did not have enough support or you 
need all this financial money to get on the list, um 
I think you should get on just in case and not be 
so reserved about it but I think that comes with 
education too 
*Oh yeah copies of everything.  And multiple 
lists. Yeah I am always telling people to get on 
many lists, I tell them about the new centers in 
Largo, there is one in Orlando, you got Shands, 
you got Tampa General and I think they just 
opened a new one in Ft. Myers.   
*Do your yearly tests, your heart stress tests, etc.  
The communication breaks down.  Are you doing 
your physicals, for a woman you have to do your 
breast tests, your pap smears, they don’t care if 
you have had a hysterectomy or not, they still 
want you to do it every year 
*Right and then another thing that people don’t 
know is that if you are at a 3.5 creatinine, or 
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predialysis, CKD, you should automatically start 
going onto the transplant list.   
*Definitely do your research and do not limit to 
just one hopefully you have a good support team 
but definitely do your research, there are a lot of 
things out there that they will not tell you.   
*Um yeah follow all the rules, do everything they 
tell you.  I mean it is a process, be patient.  There 
is a lot that they need but there is a reason for 
everything that the doctors and the medical staff 
need so I would just say be patient and do 
whatever you need to do to get onto that waitlist 
Information on the importance 
of maintaining a positive 
outlook. 
*there are a lot of people that are reading and 
they are so depressed about dialysis and stuff like 
that.  If they are going to be that way you know it 
is going to be hard for them so it is better to just 
be positive  
*from age 16 I was on dialysis and I been 
through all that so I mean people need to be 
positive, stop being depressed about it if you not 
getting a transplant you know, hopefully some 
day your day will come 
*It is just a state of your mind, you know, that is 
how I look at it you know ok I have many other 
medical conditions, you know, but things could 
be worse you know 
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Ways to Improve the 
Waitlist Process 
Wait times  
Statements identifying shorter 
wait times as the way to 
improve the process 
*Um yeah wishing the waiting time is less 
instead of years because there is a lot of people 
who need organs, you know, there are people 
dying every day waiting 
*Finding a way to shorten waittimes would 
obviously be ideal.  This would help in so many 
ways. 
  
Quality of Life  
Statements identifying ways to 
improve quality of life as a way 
to make wait listing more 
bearable. 
*being on the machine 3 days out the week for 3 
½ hours it is tough, its draining, it is exhausting 
and you know people just want to live their life as 
normal as they can but we cant because we are on 
a machine 
*I can tell a difference, my heart was so weak 
before the transplant, I mean like even now, I still 
get short of breath but it is so much better than 
when I was in dialysis and before it was hard to 
even walk a little bit. 
*Right, it gives you back some quality of life 
It is a different way, definitely not the same life, 
there are side effects which I feel they do not 
discuss that either I think of transplant.  You 
might think it is a cure all but it is definitely a 
new life, you will not go exactly back to your old 
life but I think they not prepare me for that, just 
knowing that your life is still changing, you will 
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not be completely back to where you were, but 
just know it is going to be a new life.  
*Yeah, I think this was kind of heart breaking for 
me in the beginning, I was like oh, this was not 
what I expected.  I wanted to be back to my old 
self.      
Communication/Education 
Statements identifying ways to 
improve communication and 
education as a way to improve 
the wait list process 
*Communication most definitely and a more fair 
and equal system.  Also more education like I try 
my best to educate in my group and in the 
community but many people do not know what is 
out there.  
*They just need to be better with the 
communication because I probably would have 
been on the waitlist a lot sooner if the 
communication was there to where the tests 
didn’t expire  
*I did not even know that some of my tests had 
expired until my kidney transplant date was set so 
basically like 4 days before my transplant I am 
running around and trying to get my tests done 
rather than just waiting for my transplant.   
* Also education and information could be 
improved. The communication could be 
improved as well 
Outlook  *So so I mean it is emotional and it is tiring but I 
take it day by day and I have to be positive 
through life  
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Statements identifying ways to 
improve patient’s outlook as a 
way to improve wait listing. 
*So I mean, I do not take life for granted so I 
have to live life positive and just gotta believe 
that there is going to be good out there 
eventually, hopefully 
*Yeah and then when I go to dialysis I see the 
grumpy old people and they are like “I need this” 
“I need that” and I am just like why cant you just 
be thankful that you are still here 
*And they both told me, you just wait, the minute 
you wake up from your transplant you are going 
to feel 100% better, it is such a wonderful feeling, 
all of a sudden you feel healthy again  
 
 
 The categories for the codebook were originally organized by the interview question they 
coincided with but once the categories were reviewed, it was noted that there were categories 
that overlapped.  The categories were reorganized and categories that were the same were 
combined together.  For example, a common theme amongst the interview questions was issues 
with communication.  Many interviewees mentioned how difficult the lack of communication 
was for their waitlist process across many of the questions asked. The categories are discussed in 
detail below. 
Communication 
Many interviewees expressed how they would not even know what tests they needed, if 
they needed to complete anything else, and some even stated that they were not sure if they were 
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on the list at all.  One participant stated “It is still challenging because again I do not know what 
is going on, they are not really up to date with telling me information about me being on the list”, 
while another stated “I have not really gotten any update if I am on the list or not but that is 
something I am working on”.  Another interviewee who has been trying to get onto the list 
stated, “I still have no idea what I am doing, you know I still need help asking how to do I get on 
the list and how do I do this and how do I do that.  And you know it is not new to me but it is 
challenging”.  One interviewee even shared that “Sure um I was placed on the waiting list and I 
waited 7 years, I never got a single phone call, nothing”.  Interviewees expressed communication 
as being an area of concern and an area they hope will improve in the future.  
Center Wait Times 
 Interviewees discussed variations in wait times across centers which caused some 
interviewees to list at centers further from their home due to the wait time being less.  “So the 
waittimes in Chicago are insane they are five to seven years I think. Um and then he said, and 
what I heard from different centers in Wisconsin I think on average is about two to three years 
but obviously it is just a different population, being from Chicago or New York or anything like 
that.  And similarly in Iowa the wait times were about 1 to 3 years.”  One interviewee stated that 
“Wisconsin’s wait time is shorter and their waittime is 3 to 5 years”.  Due to wait time 
differences and other differences across transplant centers, some transplant recipients waitlisted 
at multiple centers rather than just one in hopes of bettering their chances of receiving a 
transplant.   
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Multi-listing 
 Some transplant recipients were able to list in multiple transplant centers.  One 
interviewee shared “I was on Madison’s Waiting List and Freider’s Waiting List and over here in  
Illinois I was on Northwestern’s waiting List. I said I am going to list on all the transplant lists.  I 
will go to Tampa General, I went to Gainesville, and I went to Miami, listed on all three”.  
Another interviewee had to be waitlisted on two separate occasions and shared that their “1st 
transplant I was on Michigan and Minnesota because my main doctors were at the Mayo     
Clinic in Minnesota and that is where I actually ended up having my transplant.  2nd transplant 
but I was waiting longer than that I was listed in two states, I was listed in Michigan and Ohio.  
And I actually got the call in Ohio three times however I was the backup each time so I never 
got, never got the opportunity to get the kidney then.”  Other interviewees also shared that they 
had to navigate the transplant process more than once due to kidney failure.   
Previous Transplant 
 As discussed from the literature, a kidney transplant may not last long enough for the 
recipient therefore these patients will find themselves back on dialysis and working to get back 
onto the waitlist.  One interviewee shared about how long their transplant lasted “I received my 
kidney back in 2014 and it lasted me 4 ½ years” whereas another interviewee shared “December 
will be 6 years, 2013 I got mine. I had 2 kidney transplants”.  Participants shared how long their 
personal wait times were as well.  “Yeah so the first one was 7 years ago in 2012                                                     
and I was on dialysis for 14 months and I was on the waiting list for shorter than that because I 
had gotten listed after I started dialysis. Second time I knew prior to that that I was in kidney 
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failure because I actually got listed, I got listed before I had dialysis this time around. So I was 
listed in February of 2016, I had a family friend had gotten tested and he was a match so we went 
ahead once we found out he was a match in I want to say July, we scheduled it for September”.  
Personal Wait Times   
 The variations in waittimes just amongst the ten interviewees was eye opening.  One 
person shared “I was on the waiting list for about 3 ½ years and they actually added that time I  
 was on dialysis they added that to the waiting points”.  Another interviewee shared she had 
many medical issues throughout the process and she stated “I was on the list for 14 years” and 
she shared that she was indeed on dialysis that entire time.  Another patient shared that she was 
aware of her kidney disease early on and stated “I was placed on the waiting list and I waited 7 
years.  I was actually diagnosed 15 years before I received the transplant”.  Others had shorter 
wait times and shared “I was on dialysis for a little over a year. Just listed at the one center” and  
“My whole process from when I was diagnosed, I never even went on dialysis, but from the time 
I was diagnosed to the time I received my transplant was less than a year”.  One interview had a 
unique story as “the first one well I started, well mine is a little bit different because I was not in 
America when I was having kidney issues. So when I came to America I was waiting for dialysis 
and already I think after a couple of years I go on the list and then I waited for about 4 to 5 years 
before I got called for the transplant.  With the second transplant he waited “4 years because in 
2007 I got the transplant”.  Some patients shared their experience receiving a kidney through the 
shared exchange program which was developed to encourage more live donation and in turn 
hopefully less wait time.   
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Paired Exchange 
 The paired exchanged program is designed to help patients in need of a transplant that 
have someone who is willing to donate their kidney to them but may not necessarily be 
compatible for them.  This program “gives the candidate another option.  In kidney paired 
donation, living donor kidneys are swapped so each recipient receives a compatible transplant” 
(UNOS, 2019, para 1).  One interviewee explains their experience with this program.  “Okay so 
there are four families and the first family donates to the second family, um the second family 
has a family member that can donate to the third family member that is waiting and the third 
family member donates their kidney to me so that they can get bumped up the list faster to 
receive a kidney”.  One patient explained how they felt lucky for this program, “ Um I do not 
think (the experience was easy) because I was lucky actually because I waited only 3 ½ years 
and I actually received my kidney from a complete stranger through a group study”.  Having 
support during this difficult process was identified as important by many interviewees.   
 Some respondents expressed how difficult it was when they would get a call that a kidney 
was available and they would get all the way to the hospital to find out that it wasn’t a match for 
them.  “I was offered a kidney three times, one was a cadaver um it wasn’t a complete match, um 
I went all the way up to Madison they took my blood, I spent the whole night there and the next 
morning they were like, I am sorry it is not a 100% match, so I was crushed you know, 
heartbroken”.  Another interviewee experienced similar difficulties in the paired exchange 
program, “the second time, a few months later, they called me up and was like um we have a 
kidney for you and at the time I had a common cold and I told them I was sick and they were like 
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oh well then we cant give you this kidney if you are sick because we need you to be 100% 
healthy so I was kind of bummed out about that and then the third call was the group study call”.     
Social Support    
 Many interviewees identified their family as an important part of their support system.  
“My family has been always around.  Like in Minnesota when we moved it was just me and my 
sister I, my parents used to come back and forth from Dubai to here.  You know because my dad 
had a business in Dubai so I used to live with my cousins in Minnesota, I have a few cousins”.  
One interviewed stated that “my mom was by my side the first time I went through all of this, 
she was my rock and it was difficult for her, you know it was very emotional”.  “Family support 
has always been there for me so I have never any issues about that”.   
 Many interviewees also discussed having their friends as part of their support team.  “I 
also had a friend, a friend of 30 years and mother or my godson who offered to donate and she 
flew all the way from Virginia to have her testing done.  but that didn’t work out.  But that was 
very heartwarming to have her do that”.  Some even stated that they found friends to be more 
supportive than their own family.  “A lot of friends and friends of friends helped us more than 
our own family”. “Um honestly a lot of the people we were friends with came through, We have 
a lot of friends”. 
 Online support groups were also mentioned as providing a networking of transplant 
recipients who provide information from their own experiences that has been helpful.  “ the 
people in the support groups on Facebook, they been through it, they really helped too, they 
answered questions sometimes better than the doctors (laughter).  Yeah I think that was my best 
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resource.” One interviewee even expressed how she felt supported from and online support 
group and her husband, who donated to her, was also able to find support from a separate online 
support group. “Like you know my husband he donated and he had his own separate group and 
he was able to ask them a bunch of questions and you know that I couldn’t answer or that the 
doctor couldn’t answer really or like truthfully I would say”.   
 The last subcategory of support is that of support from the healthcare team.  Nurses were 
mentioned often as an important component to the support network.  “I had a nurse who drove up 
all the way from Miami it was on a Saturday or whenever she could to come give me the IVIG 
medication”.  “I really um I really liked my pretransplant nurse coordinator um she just like 
every time she called me and told me about the possibility of the kidney maybe there being a 
kidney for me, it was like one of my family members was calling me.  She was just as excited as 
my mom was”.  “Also the transplant RN, Brittany, I remember her name because she went above 
and beyond and she did not need to.  Post transplant I was not feeling well and I could not keep 
any food down.  She saw me in the office and gave me some of her own soup that she was 
planning on having for lunch.  She waited with me to make sure I was able to keep the soup 
down before having me leave the office.” 
Discrimination 
 When asked if the recipient felt discriminated against in any aspect of the waitlist 
process, some interviewees stated they felt little or no discrimination, “there was no overt 
discrimination that I can think of”.  Some shared discrimination based on insurance or income 
level.  “The doctors are funny about who they tell, if you got good insurance, then they will let 
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you know and if you have VA or if you are a veteran or if you are a business person, someone 
with a lot of money, they are going to let you know, you can’t avoid a transplant and they start 
doing the tests”.  “Now they are saying you got to have at least 3,500 in the bank and you got to 
show it.  You gotta show it.  And that is crazy and you know the thing about it is they tell you 
that you gonna have to be able to afford these drugs, well you know some people are, some 
people don’t but you know it is just crazy.  For them to make you say you need to have this 
money in the back”.  Some interviewees expressed discrimination due to their young age, “I will 
remember this, you do not have to tell me every time, all the time, you know so that I felt like 
because I was young they were like oh gotta do this, you gotta do that, and I was like okay I will.  
You don’t have to worry I will take my meds on time you don’t have to remind me and I was 
doing good”.  “Yeah, Yeah and I just feel like because I am young, they don’t want to tell me 
some things and I get upset so I start snapping on them and they get all upset  but I wouldn’t be 
snapping on them if they would just tell me what is going on”.      
 Much like the discussion of discrimination based on insurance and income level, one 
interviewee discussed her frustration with multi-factorial discrimination.  “Those kidneys are 
going to waste and there are people who need um but you cant get um because your transplant 
center is already discriminating against you because maybe you are an African American, you 
have Medicare, you can’t afford your 20% and plus you need to have your 3-5,000 dollars in the 
bank.  Then you gotta go fundraise”. 
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Suggests to Improve the Waitlist Process 
   When asked about ways to improve the waitlist process and to ways to make it easier for 
recipients, interviewees identified better education, better communication, better response 
system, shorter wait times, improve quality of life, help improve patient outlook, and better 
system not based on access to insurance.  One interviewee stated that they felt that financial 
areas need to be improved, “if I had the right insurance, we would not have had to raise any of 
the money.”   
Better Education and Communication 
An interviewee expressed how she felt she could have been better educated on the ability 
to waitlist at different and multiple locations.  “I guess on the East Coast the times might be long 
and maybe if you do have finances or family in another state, I think they should talk more to 
that and maybe you could go somewhere else and get listed faster  besides just going to another 
hospital in your region, you could go outside of your region”.  Many interviewees shared the 
same concern regarding communication issues within the centers.  “Communication most 
definitely and a more fair and equal system.  Also more education like I try my best to educate in 
my group and in the community but many people do not know what is out there.”  One 
interviewee explained that “They just need to be better with the communication because I 
probably would have been on the waitlist a lot sooner if the communication was there to where 
the tests didn’t expire”.  Another shared a similar feeling stating“ I did not even know that some 
of my tests had expired until my kidney transplant date was set so basically like 4 days before 
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my transplant I am running around and trying to get my tests done rather than just waiting for my 
transplant”.   
Shorter Wait Times 
 Many interviewees stated that they wished wait times were shorter.  “Yeah wishing the 
waiting time is less instead of years because there is a lot of people who need organs, you know, 
there are people dying every day waiting”.  One interviewee stated that “finding a way to shorten 
waittimes would obviously be ideal.  This would help in so many ways.”   
Quality of Life/Maintaining a Positive Outlook 
 While trying to get onto the wait list and even once on the wait list, awaiting a kidney, 
patients are typically enduring dialysis treatments to stay alive.  Some expressed how “ being on 
the machine 3 days out the week for 3 ½ hours it is tough, its draining, it is exhausting and you 
know people just want to live their life as normal as they can but we cant because we are on a 
machine”.  One interviewee even expressed how quality of life post-transplant was still not what 
they expected.  “It gives you back some quality of life.  It is a different way, definitely not the 
same life, there are side effects which I feel they do not discuss that either I think of transplant.  
You might think it is a cure all but it is definitely a new life, you will not go exactly back to your 
old life but I think they not prepare me for that, just knowing that your life is still changing, you 
will not be completely back to where you were, but just know it is going to be a new life.”  “I can 
tell a difference, my heart was so weak before the transplant, I mean like even now, I still get 
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short of breath but it is so much better than when I was in dialysis and before it was hard to even 
walk a little bit.” 
 One interviewee in particular focused a great deal on people keeping a positive outlook as 
a way to cope and make it through the hardships.  “So I mean it is emotional and it is tiring but I 
take it day by day and I have to be positive through life.”  “I mean, I do not take life for granted 
so I have to live life positive and just gotta believe that there is going to be good out there 
eventually, hopefully”.  Another stated “there are a lot of people that are reading and they are so 
depressed about dialysis and stuff like that.  If they are going to be that way you know it is going 
to be hard for them so it is better to just be positive”.  One interviewee expressed frustration with 
other people’s outlooks in his dialysis center, “Yeah and then when I go to dialysis I see the 
grumpy old people and they are like “I need this, I need that” and I am just like why can’t you 
just be thankful that you are still here”.  One interviewee provided advice about this, “ from age 
16,  I was on dialysis and I been through all that so I mean people need to be positive, stop being 
depressed about it if you not getting a transplant you know, hopefully some day your day will 
come”  
Obstacles 
 When asked about obstacles, interviewees expressed “just the travel. You know people 
that live in rural areas like that could be an issue but for me, it was not since for both transplants 
I had them near my home, even Toledo was only about an hour away so had I got a call and had 
to be there in under 2 hours, I could have done it.”  Another recipient stated that “ when I got 
ready to get onto the transplant list, they said you know you gotta lose weight and all of that sort 
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of thing and I said ok no problem”.  Another discussed how insurance was an obstacle for them, 
“well we were notified that I was placed as inactive on the list because with my insurance, there 
was concern that I could not afford the medications if I did get a transplant.  Well first of all, I 
had Medicare insurance and I thought I also had Medicaid but there was some kind of issue 
where the Medicaid was terminated. I called and spoke with many people at Medicaid but there 
was no quick fix for the problem so we had to fundraise and we were told we needed $5000 in 
the account to get back to active status”.  Based on their experience, interviewees were also 
asked to provide advice they would give to new patients going through the transplant experience. 
Advice  
One bit of advice given was to “do it as soon as possible, because you never know if they 
get you on or not and then you are sitting there wasting your time doing treatment and that is just 
like am I on the list for a kidney because that would be great and if not what can we do”.  
Another interviewee discussed multi-listing, “I would just recommend that people try one or 
more transplant centers because when I went to the second one, they were more thorough than 
the first place that I went to so I think that helped hearing the information again from a different 
transplant center.”  One interviewee shared that they “ would try to get on (the list) even if you 
have reservations with it, whether it be financial or support, because I know at the dialysis center 
there were a couple of people who choose not to get on the transplant list and from the ones that I 
do talk to they said it was because of their age, or maybe they did not have enough support or 
you need all this financial money to get on the list, um I think you should get on just in case and 
not be so reserved about it but I think that comes with education too”.  
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 Another interviewee had advice for new patients regarding how to advocate for 
themselves throughout the evaluation process.  “Oh yeah copies of everything.  And multiple 
lists. Yeah I am always telling people to get on many lists, I tell them about the new centers in 
Largo, there is one in Orlando, you got Shands, you got Tampa General and I think they just 
opened a new one in Ft. Myers.” As far as the evaluation testing, an interviewee advised to “do 
your yearly tests, your heart stress tests, etc.  The communication breaks down.  Are you doing 
your physicals, for a woman you have to do your breast tests, your pap smears, they don’t care if 
you have had a hysterectomy or not, they still want you to do it every year”.  Per the interviews, 
new patients should “follow all the rules, do everything they tell you.  I mean it is a process, be 
patient.  There is a lot that they need but there is a reason for everything that the doctors and the 
medical staff need so I would just say be patient and do whatever you need to do to get onto that 
waitlist”.  Lastly the advice given was to encourage new patients to do their research, “follow all 
the rules, do everything they tell you.  I mean it is a process, be patient.  There is a lot that they 
need but there is a reason for everything that the doctors and the medical staff need so I would 
just say be patient and do whatever you need to do to get onto that waitlist”.   
Post-Transplant Education 
 Lastly, interviewees discussed how they felt more information could have been provided 
about what to expect post-transplant.  Some recipients stated they expected to feel great post-
transplant but some expressed the difficulties of not being educated on some of the side effects of 
the medication.  One interviewee stated that they wish they had known because “now I have 
diarrhea from one of the meds, I have lower back pain which is another side effect of one of the 
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meds, and I am so tired, even more tired than I was before”.  Some people even expressed that 
they felt worse post-transplant.  “So yeah transplant did not improve my life, it worsened it.”  
“Absolutely.  In fact, my health is worse than before transplant”.  Lastly an interviewee provided 
advice about the difficulties post-transplant, “Transplant is not an easy thing you know because 
you have to take so many pills and stuff like that”.    
 The information provided from the interviews provides insight into each individual’s 
experience which is an important piece of understanding the patient’s wait list experience.  More 
qualitative research in this field can add valuable information to the literature.  
Results of Hypothesis Testing 
H1a-Respondents will report that they perceive their race/ethnicity as important in the 
process of getting waitlisted.  
The majority of the survey respondents indicated that they strongly disagreed that their 
race or ethnicity had a negative effect on their waitlist experience.  Out of the total number of 
respondents, 62% stated they strongly disagreed that their race had a negative effect on their 
waitlist process and 61.3% stated the same for their ethnicity.  Only one respondent reported that 
they strongly agreed that their race had a negative effect on their wait list experience.   
H1b- Respondents will report that they perceive their age as important in the process of 
getting waitlisted.  
More than half of the survey respondents indicated that they strongly disagreed that their 
age had a negative effect on their waitlist experience.  Out of the total number of respondents, 
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56.2% stated they strongly disagreed that their age had a negative effect on their waitlist process.  
Only two strongly agreed that their age had a negative effect on their wait list experience. 
H1c- Respondents will report that they perceive their sex as important in the process of 
getting waitlisted.  
Many of the survey respondents indicated that they strongly disagreed that their sex had a 
negative effect on their waitlist experience.  Out of the total number of respondents, 63.5% stated 
they strongly disagreed that their sex had a negative effect on their waitlist process.  There were 
no respondents that agreed or strongly agreed that sex had a negative effect.    
H1d- Respondents will report that they perceive their education level as important in 
the process of getting waitlisted.  
Some survey respondents indicated that they strongly disagreed that if they had a better 
education, the waitlist process would have been easier for them.  Out of the total number of 
respondents, 51.8% stated they strongly disagreed that if they had a better education, the waitlist 
process would have been easier.  Only one respondent strongly agreed that if they had a better 
education, the wait list process would have been easier for them.     
H2a- Respondents will report that they perceive their income/employment as important in 
the process of getting waitlisted.  
Almost half of the survey respondents indicated that they strongly disagreed that if they 
had a better paying job, the waitlist process would have been easier for them.  Out of the total 
number of respondents, 48.2% stated they strongly disagreed that if they had a better paying job, 
the waitlist process would have been easier.  Only six respondents (4.4%) strongly agreed that 
having a better paying job would have helped.   
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H2b- Respondents will report that they perceive their health insurance type as 
important in the process of getting waitlisted.  
More than half of the survey respondents indicated that they strongly disagreed that if 
they had better insurance, the waitlist process would have been easier for them.  Out of the total 
number of respondents, 51.8% stated they strongly disagreed that if they had a better health 
insurance, the waitlist process would have been easier.  Only three respondents (2.2%) strongly 
agreed that having better insurance would have helped.   
H2c- Respondents will report that they perceive their support system as important in the 
process of getting waitlisted.  
Less than half of the survey respondents indicated that they strongly disagreed that if they 
had better social support, the waitlist process would have been easier for them.  Out of the total 
number of respondents, 45.3% stated they strongly disagreed that if they had a better support 
system, the waitlist process would have been easier.  Only five respondents (3.6%) strongly 
agreed that having a better support system would have helped. Based on these results, the 
hypothesis was rejected.    
H3a-Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents in the older age groups  
In terms of the respondent’s age, there were no statistically significant differences in total 
mean scores on the Discrimination in Medical Settings Scale or on the individual question means 
due to respondent’s age.   
H3b- Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents in non-white racial groups  
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In terms of the respondent’s race, there were no statistically significant differences in 
total mean scores on the Discrimination in Medical Settings Scale or on the individual question 
means due to respondent’s race.   
H3c- Higher mean scores on the Discrimination in Medical Settings will be found  
in female respondents   
In terms of the respondent’s sex, there were no statistically significant differences in total 
mean scores on the Discrimination in Medical Settings Scale or on the individual question means 
due to respondent’s sex.   
H3d- Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents with lower educational achievement  
In terms of the respondent’s education level, there was no significant difference when 
looking at the total mean scores on the scale.  However, as previously discussed there were three 
questions that showed statistically significant differences in mean scores (Q1, 3, and 7) on this 
scale due to respondent’s education level.   
H3e- Higher mean scores on the Discrimination in Medical Settings will be found  
in respondents in the lower income groups. 
In terms of the respondent’s income level, there were no statistically significant 
differences in total mean scores on the Discrimination in Medical Settings Scale or on the 
individual question means due to respondent’s income level.   
H3f-Higher mean scores on the Discrimination in Medical Settings will be found in  
respondents with non-private insurance.  
In terms of the respondent’s insurance type, there was no statistically significant 
difference in the total mean score on the Discrimination in Medical Settings Scale.  However, as 
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previously discussed there were three questions that showed statistically significant differences 
in mean scores (Q1, 3, and 4) on this scale due to respondent’s insurance type.   
H3g- Higher mean scores on the Discrimination in Medical Settings will be found in  
respondents in rural transplant centers 
 In terms of transplant center location, there was no statistical significance in the total 
mean score on the Discrimination in Medical Settings Scale and this was also true when 
analyzing each individual question on the scale.  
H4a-Higher mean scores on the Medical Mistrust Scale will be found in respondents in the  
older age groups 
 In terms of the respondent’s age, there was no statistical significance when analyzing 
total mean scores on the Medical Mistrust Scale.  However, there was one question on the scale 
that had a statistically significant difference in mean score on the Medical Mistrust Scale due to 
respondent’s age (Q 2).   
H4b- Higher mean scores on the Medical Mistrust Scale will be found respondents in non- 
white racial groups  
In terms of the respondent’s race, there was no statistical significance when analyzing 
total mean scores on the Medical Mistrust Scale.  However, as previously discussed there were 
six questions on the scale that had statistically significant differences in mean scores on the 
Medical Mistrust Scale due to respondent’s race (Q 5, 6, 12, 13, 16 and 17).   
H4c- Higher mean scores on the Medical Mistrust Scale will be found in female  
respondents  
In terms of the respondent’s sex, there were no statistically significant differences in total 
mean scores or on the individual question means on the Medical Mistrust Scale between the 
different sex groups.  
H4d- Higher mean scores on the Medical Mistrust Scale will be found in respondents with  
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lower educational achievement  
In terms of the respondent’s educational level, there was no statistical significance when 
analyzing total mean scores on the Medical Mistrust Scale.  However, as previously discussed 
there were two questions on the scale that had statistically significant differences in mean scores 
on the Medical Mistrust Scale due to respondent’s educational level (Q1 and 7).   
H4e- Higher mean scores on the Medical Mistrust Scale will be found in respondents in the  
lower income groups.  
In terms of the respondent’s income level, there was no statistical significance when 
analyzing total mean scores on the Medical Mistrust Scale.  However, as previously discussed 
there were two questions on the scale that had statistically significant differences in mean scores 
on the Medical Mistrust Scale due to respondent’s income (Q3 and 16).   
H4f-Higher mean scores on the Medical Mistrust Scale will be found in respondents with  
non-private insurance.   
In terms of the respondent’s insurance type, there were no statistically significant 
differences in total mean scores or on the individual question means on the Medical Mistrust 
Scale between the respondent’s insurance.  
H4g-Higher mean scores on the Medical Mistrust Scale will be found in respondents in  
rural transplant centers.  
In terms of the transplant center location, there were no statistically significant 
differences in total mean scores or on the individual question means on the Medical Mistrust 
Scale between the different center locations.  
H4h-Higher mean scores on the Medical Mistrust Scale will be found in respondents in  
private transplant centers.  
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In terms of the type of transplant center, there was no statistical significance when 
analyzing total mean scores on the Medical Mistrust Scale.  However, there was one question on 
the scale that did have statistically significant differences in mean scores (Q15).   
H5a-Longer reported wait times will be found in respondents in the older age groups  
In terms of the respondent’s age, there was no statistical significance in reported pre or 
post wait times.   
H5b- Longer reported wait times will be found in respondents in non-white racial groups  
In terms of the respondent’s race, there was no statistical significance in reported pre or 
post wait times.   
H5c- Longer reported wait times will be found in female respondents   
In terms of the respondent’s sex, there was no statistical significance in reported pre or 
post wait times.   
H5d- Longer reported wait times will be found in respondents with lower educational  
achievement  
In terms of the respondent’s educational level, there was no statistical significance in 
reported pre or post wait times.   
H5e- Longer reported wait times will be found in respondents in the lower income groups.  
In terms of the respondent’s income level, there was no statistical significance in reported 
pre or post wait times.   
H5f- Longer reported wait times will be found in respondents with higher scores on the  
MMS scale. 
 There were no statistically significant differences in scores on the Medical Mistrust Scale 
and wait times except on question 13.  For this question there was a statistically significant 
difference between the score on the Medical Mistrust Scale and the pre-wait time group 
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CHAPTER FIVE: DISCUSSION 
 
            This study looked into the inequalities in the transplant wait list process through the 
experiences of the transplant patients.  This final chapter discusses the implications of the results 
of this study. The key findings from the data is discussed below and is related to information 
already found in the literature. The data collected could add to future research and provides a 
unique perspective from each transplant recipient’s wait list experience.   Additionally, 
limitations of this study will be discussed.   
Key Findings 
Theoretical Findings-Anderson Model 
As previously stated, The Anderson Model was used to organize the examination of 
factors that impact the likelihood of a patient getting onto a transplant waitlist.  This model 
coincides with fundamental cause theory regarding resources operating at the individual and 
organizational levels that result in variance in health care utilization, or in this case, access to the 
transplant waitlist. The Anderson Model suggests that predisposing characteristics, enabling 
resources and patient’s needs play a role in the patient’s ability to access healthcare resources or 
in this case, access the transplant waitlist.   
The predisposing characteristics (or causes) included the demographics (age, sex, race), 
social structure (ethnicity, education, employment) and health beliefs (patient education).  The 
model also includes enabling resources (social support, insurance type, income level, 
location).  Additionally, this model takes into account the patient’s need (patient perception 
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including discrimination and medical mistrust) for medical services which Anderson (1995) 
divides amongst perceived health need versus evaluated needs for health services.  The patient’s 
predisposing characteristics as well as their enabling resources can play an integral part in 
identifying the patient’s access to getting onto the transplant list.     
            This study surveyed a sample 137 kidney transplant patients from transplant support 
groups (in person and online groups) in the United States to explore factors within the transplant 
wait list process.  The table below displays the average wait time (pre meaning wait time from 
diagnosis to getting onto the list and post meaning wait time from getting waitlisted to getting a 
transplant) as well as the mean scores on both the Discrimination in Medical Settings and the 
Medical Mistrust Scale across the respondents’ predisposing characteristics and enabling 
resources.      
Table 114. Summary of All Variables Across Wait Times and DMS/MMS Scores. 
  Average Wait Time Average Scores 
Variables Respondents 
n=137 
Pre (months) Post (months) DMS Mean 
Score 
MMS Mean 
Score 
Race      
Asian 6 15.83 30.50 1.1917 2.8917 
Black 14 34.21 37.31 1.7043 2.9814 
Hispanic 5 15.00 26.60 1.6000 3.0725 
Mixed 6 10.83 14.83 1.5000 2.7833 
White 105 17.38 26.18 1.4080 2.7703 
Sig.  .565 .732 .392 .016 
Sex      
Male 31 16.27 19.20 1.5863 2.8357 
Female 106 19.34 29.10 1.3948 2.7986 
Sig.  .687 .165 .137 .513 
Age      
21-35 24 10.25 28.92 1.5772 2.8720 
35-44 27 16.26 23.52 1.4659 2.7656 
45-54 30 20.79 28.86 1.3913 2.8662 
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55-64 39 22.43 24.22 1.3979 2.7776 
65 or older 17 22.41 32.00 1.3481 2.7400 
Sig.  .737 .916 .747 .304 
Income      
less than $15,000 14 13.40 47.73 1.3782 2.8027 
$15,000-$24,999 13 26.00 28.75 1.5708 2.8183 
$25,000-$34,999 12 18.08 32.08 1.1317 2.8192 
$35,000-$44,999 12 14.00 17.00 1.8140 2.6270 
$45,000-$54,999 9 56.86 14.50 1.3083 2.6214 
$55,000-$64,999 6 26.71 20.86 1.8071 2.9193 
$65,000-$74,999 14 18.67 14.17 1.3917 2.8633 
$75,000-$84,999 12 28.50 26.50 1.2850 2.7650 
$85,000-$94,999 6 13.40 23.29 1.3637 2.7800 
> $95,000 35 26.00 38.92 1.3464 2.9186 
Sig.  .130 .408 .140 .151 
Education       
High school 28 26.41  33.32 1.0848 2.7381 
Some college 34 20.29 26.52 1.4367 2.8456 
College 41 13.43 18.76 1.6157 2.8231 
Grad/professional  33 17.61 33.52 1.5115 2.8144 
Sig.  .548 .222 .005 .474 
Insurance       
Medicaid 26 22.04 37.56 1.3084 2.7972 
Medicare  23 38.33 33.84 1.5132 2.8070 
Other  6 10.71 13.67 1.6114 2.7583 
Private  40 9.68 25.05 1.2898 2.8498 
Private+  42 16.61 20.50 1.5922 2.7766 
 Sig.    .146  
Center Location       
Rural 9 15.89 21.38 1.3822 2.8167 
Urban 96 19.22 29.96 1.4436 2.8259 
Suburban 25 21.28 15.39 1.4292 2.7400 
Other 5 6.00 34.80 1.3120 2.7640 
Sig.   .856 .290 .964 .562 
Center Type      
University 83 13.79 26.44 1.4770 2.7947 
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Private hospital 36 24.11 26.73 1.3671 2.8249 
Other 8 25.88 28.63 1.1062 2.8325 
Unsure 9 36.44 31.11 1.6833 2.8300 
Sig.  .202 .983 .219 .932 
 
Predisposing Characteristics 
Age 
 There are many studies in the literature that address the issues surrounding the patient’s 
age and treatment when it comes to kidney transplantation.  In a study by Salter, et al. (2014) 
they found that older adults reported that medical professionals had discussions with them about 
the option of transplant much less than the younger population.  Even when looking at the time 
from first meeting a nephrologist and beginning dialysis, older adults were more likely to have 
never had a discussion with a medical professional at that point (Salter, et al., 2014).  When these 
discussions did take place, older participants felt their discussions were less encouraging than 
younger patients (Salter, et al., 2014).   
The results from our study in terms of pre wait times (time from diagnosis to waitlisting) 
showed that respondents from age 55-64 took an average of 22.43 months to get onto the waitlist 
and the respondents aged 65 and older took on average 22.41 months.  On the other hand, 
respondents ages 21-35 took an average of only 10.25 months and those between the ages of 35-
44 reported an average of 16.26 months to get onto the waitlist.   
“Many transplant teams are still reluctant to include elderly patients on the waitlist for 
kidney transplant as objective selection criteria for transplantation in this population are poorly 
defined” (Hernandez, et al., 2018, p.257).  According to Hernandez, et al. (2018), due to donor 
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shortage, patients over the age of 65 are placed on the waitlist less frequently than younger 
patients.  They also state that once listed, they are still less likely to receive a transplant.  The 
respondents in this study aged 21-35 reported waiting on average 28.92 months to get onto the 
list and respondents between the ages of 35-44 reported waiting an average of 23.52 months.  
The respondents in the older age group of 65 years and older reported waiting an average of 32 
months and those between the ages of 55 and 64 waiting on average 24.22 months.  Of note, this 
study only included kidney transplant patients and therefore cannot account for those who have 
never made it to the transplant wait list.      
Sex 
As stated previously, the sample for this study consisted of 137 respondents, 77.4% (106 
respondents) of which identified themselves as female and 22.6% (31 respondents) identified as 
male.  In terms of their sex, participants were provided with the statement: I feel that my sex had 
a negative effect on my waitlist experience.  More than half of the respondents (56.2%) stated 
effect on their waitlist experience.       
The literature noted that during the pre-transplant stage, “women were more likely to be 
reported as unsuitable due to age, medically unfit and declined” (Kucirka, et al., 2012, p. 351).  
Women were also less likely than men to have discussions about the option of kidney transplant 
with medical professionals (Salter, et al., 2014).  Even though research shows that women have 
higher incidences of chronic kidney disease, they are still less likely to being dialysis or receive a 
transplant than men (Antlanger, et al., 2019).  In the pre wait time of our study, women reported 
238 
 
waiting an average of 19 months to be waitlisted as compared to the 16 months reported by the 
males.   
With post wait time, Schaubel, et al. (2000) explained that men in the US are more likely 
than women to receive a transplant.  In our study, women reported waiting an average of 29 
months for a transplant whereas the male respondents reported an average of 19 months.  
Schaubel, et al. (2000) found that women are transplanted less often and they stated that “women 
are either actively or unintentionally discriminated against, perhaps due to the overestimation of 
medical risks” (p. 2353).  Again, this study is not able to capture information from anyone who 
did not either get a transplant or those who never made it on the list at all. 
Race 
In terms of race, participants were provided with the statement: I feel that my race had a 
negative effect on my waitlist experience and 86 respondents (62.8%) stated that they strongly 
disagree that their race had a negative effect on their waitlist experience.  Whereas one person 
reported that they strongly agreed with this statement (.7%) and five reported they agreed 
(3.6%).  These results were similar when the respondents were asked the same question 
regarding their ethnicity.   
The literature identifies many areas throughout the transplant process in which minorities 
patients are treated differently than white patients.  Even though transplantation increases quality 
of life and has shown to be the best treatment for kidney disease, many studies show that black 
and Hispanic patients have had decreased access to both living and deceased donor transplant 
(Rhee, et al., 2014).  Preemptive transplantation is considered even more optimal for patients 
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with ESRD (OPTN Minority Affairs Committee, 2015).  Similar racial disparities were present 
for preemptive referral as well.   
In the initial steps of wait listing, minority patients tend to have a lower rate of referral to 
a transplant center despite their desire for transplant (Higgins & Fishman, 2006).  “The lower 
rate of referral for kidney transplant among blacks is also thought to be due in part to lack of 
education and information about the risks and benefits” (Harding, et al., 2017, p. 167).  The 
black respondents in this study reported the longest average wait time in both categories with an 
average of 34.21 months (pre). and 37.31 months (post).  White respondents reported an average 
wait time of 17.38 months (pre) and 26.18 months (post).  The findings in this study were 
consistent with the literature where Williams and Delmonico (2016) noted that blacks and other 
minority groups are disadvantaged in kidney transplantation.  Goldfarb-Rumyantzev, et al. 
(2012) also identified that racial disparities are evident when comparing blacks and whites in 
access to kidney transplantation.    
Education 
 
Participants were then provided with the statement: I feel that if I had a better education, 
the waitlist process would have been easier and 71 respondents (51.8%) stated that they strongly 
disagree that their educational level needed to be better to make the waitlist experience easier.  
Whereas, similar to race and ethnicity, one person reported that they strongly agreed (.7%) with 
this statement and five reported they agreed (3.6%).   
The respondents with a high school education reported waiting the longest during the pre 
waitlist stage.  They weighted an average of 26.42 months.  Respondents who reported only 
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some college education were the next longest reporting an average of 20.29 months.  This is 
consistent with the study by Greer, et al. (2011) which showed that physicians were less likely to 
have discussions in kidney disease office visits with patient some college education.  Patzer,et al. 
(2012) identified that patient education may be another factor that may account for some of the 
disparities evident in the wait list process.    
On the contrary when looking at the post wait list stage, the high school education group 
reported similar wait times as the graduate or professional degree group.  The high school 
education group reported an average of 33.32 months whereas the graduate/professional group 
reported an average of 33.52 months.  This finding differed from what was found by Schaeffner, 
Mehta and Winkelmayer (2008) as they found that college graduates were three times more 
likely to be waitlisted or transplanted.  Goldfarb-Rumyantzev, et al. (2012) found that disparities 
may be lessened if the patient has a higher education level.  Their study pointed out that racial 
disparities due exist within kidney transplantation but found that this may be alleviated for 
patients with higher eduation (Goldfarb-Rumyantzey, et al., 2012).     
Enabling Resources 
Insurance Type 
 
In terms of health insurance, participants were provided with the statement: I feel that if I 
had a better health insurance, the waitlist process would have been easier. Out of the 137 
respondents, 71 respondents (51.8 %) stated that they strongly disagree that with a better 
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insurance the waitlist experience would have been easier.  Whereas three people reported that 
they strongly agreed with this statement (2.2%) and six reported they agreed (4.4%).   
 In a recent study by King, et al. (2019) which evaluated the newer Kidney Allocation 
System, they noted that patients who received transplants preemptively (which has been shown 
to be the ideal for patient’s to accrue wait time while on dialysis) were more likely to have 
private insurance.  Also to note, they found that patients who had Medicaid insurance were even 
less likely to receive a transplant preemptively (King, et al., 2019).  Harhay, et al. (2018) 
uncovered that during the Medicaid expansion under the Affordable Care Act there was an 
increase in preemptive listing for patients due to now having access to insurance coverage.  Of 
this group, they found that the Medicaid expansion provided insurance coverage to the minority 
groups who had been shown to already have longer wait times and difficulty accessing the 
transplant list (Harhay, et al., 2018).  This is particularly important when discussing the kidney 
transplant wait list as the months while a patient is on dialysis can be counted towards their wait 
times and having insurance coverage provides the patient with this access.  
Income Level 
 
In terms of income, participants were provided with the statement: I feel that if I had a 
better paying job making more money, the waitlist process would have been easier.  Out of the 
137 respondents, 67 respondents (48.9%) stated that they strongly disagree that with a better 
paying job the waitlist experience would have been easier.  Whereas six people reported that they 
strongly agreed with this statement (4.4%) and seven reported they agreed (5.1%).   
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In our study, the highest income level (greater than $95,000/year) reported wait times of 
26 months to get onto the list and an average of 38.92 months once on the list to get a transplant.  
In the lowest income bracket from our study (<$15,000/year) the average reported wait time to 
get onto the list was only 13.4 months and once on the list, they reported an average wait time of 
47.73 months to transplantation.  Looking into disparities by income level or socioeconomic 
status is particularly difficult due to the fact that many barriers arise for patients in the low 
income bracket and it may make it difficult to determine if income is the only contributing factor 
(Zhang, Gerdtham, Rydell, & Jarl, 2018).   
The discussion of a patient’s income level can be particularly important when talking 
about post-transplant care necessary for transplant survival.  Simmerling (2007) discussed and 
provided an estimate of the high cost of post-transplant immunosuppressant medications which 
are important for the life of the transplant.  This article goes further to explain that these high 
cost medications may deter a medically suitable transplant recipient from ever getting onto the 
list.  This may be due to the patient’s choice or the decision of the transplant team (Simmerling, 
2007).  Not only does a patient’s income level affect wait listing but it also becomes a factor 
after a patient receives a transplant.  If a patient has received a transplant and for whatever reason 
is unable to pay for the medications, the organ could fail and then the patient would find 
themselves back on dialysis (Simmerling, 2007).   
While the cost of the medications is important, Hod and Goldfar-Rumyantzev (2014) 
state that the inability to afford care may not be the only factor in explaining the association 
between income and the outcomes of transplantation.  They discussed a study in the UK which 
has universal healthcare therefore the immunosuppressive medications were covered and they 
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found that low income was still a significant factor in survival of the transplant (Hod, & Goldfar-
Rumyantzev, 2014).           
Transplant Center Location 
Survey respondents were then asked which type of area the center was located.  A large 
portion of the respondents (70.1%) stated that they received their transplant in a transplant center 
located in an urban area.  Twenty-five respondents (18.2%) stated their center was located in a 
suburban area and nine respondents (6.6%) stated their center was in a rural location.   
Axelrod, et al. (2008) identified that patients in rural areas experienced lower rate of 
waitlisting and lower rates of transplantation.  In our study respondents living in rural areas did 
report less average wait times both pre waitlist (15.89 months) and post listing (21.38 months 
waiting to get a transplant).  Whereas patients in urban areas reported an average of 19.22 
months to get onto the list and 29.96 months to get a transplant.  However, overall there were no 
statistically significant differences in pre and post wait times between the transplant center types.  
Axelrod, et al. (2008) had similar results where significantly longer wait times were not found in 
kidney transplantation.  Tonelli, et al. (2009) also yielded similar results where “remote or rural 
residence was not associated with increased time to kidney transplantation among people treated 
for ESRD in the United States” (p. 1681).      
Transplant Center Type 
 
Regarding the type of transplant center setting that patients received their transplant, 83 
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respondents (60.6%) identified their center as a University or University Affiliated Center.  
Thirty-six respondents (26.3%) identified their center as a Private Hospital Transplant Center.  
Hall, et al. (2012) found racial disparities in all transplant centers in the US when referring to 
living donor kidney transplant.   
Ramos, et al. (1995) identified that university-based centers as well as larger centers were 
more willing to accept higher risk patients.  For our study in terms of the transplant center 
location type, there were no statistically significant differences in pre or post-wait times.  The 
differences in transplant center criteria and structure can impact which patient’s ability to get 
waitlisted, leaving some patient’s never hearing about transplant as an option. 
Theoretical Findings-Fundamental Cause Theory    
As previously stated, Fundamental Cause Theory seeks to identify why, even with 
advances in medicine and improvements in population health, some patients still tend to benefit 
more than others based on their demographics and socioeconomic status.  The first feature of this 
theory was addressed in the literature review and states that these causes, such as low SES and 
lack of education, can be utilized when discussing different diseases.  The second feature of this 
theory is that socioeconomic status can affect the outcome of the disease with multiple risk 
factors.  The sample for this study was unique in that 25.5% of the sample reported an income of 
greater than $95,000 and the group in this higher income bracket did not report the shortest wait 
times.   
As previously discussed, looking into disparities solely by income level or socioeconomic 
status is particularly difficult due to the fact that many barriers arise for patients in the low 
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income bracket and it may make it difficult to determine if income is the only contributing factor 
(Zhang, Gerdtham, Rydell, & Jarl, 2018).  For instance, insurance type is a factor that may be 
impacted by income level along with the coverage provided by the insurance plan.  The 
interviews from transplant recipients provided insight into personal experiences in which patients 
identified how socioeconomic status and insurance type played a role in their experiences.  One 
patient felt that doctors were more likely to get patients educated and started on the pre transplant 
testing if “you got good insurance, then then will let you know, or if you are a veteran or if you 
are a business person, someone with  a lot of money” (personal communication, 2019).  One 
patient also discussed how they had to raise money to get onto the transplant list as their 
insurance was not good enough.  Another patient explained how “we were notified that I was 
placed as inactive on the list because with my insurance, there was concern that I could not 
afford the medications if I did get a transplant” (personal communication, 2019).  A lot can be 
learned from patient experiences and these patients were able to discuss the factors that could 
come along with income levels that may also play a part in access to the transplant list.       
This leads into the third feature of this theory which involves access to resources that can 
be utilized to either avoid risk or to lessen the consequences of the disease (Phelan, Link, & 
Theranifar, 2010). The key resources include knowledge, money, power, prestige, and beneficial 
social connections (Phelan, Link, & Theranifar, 2010).  While discussing these resources, the 
discussion of minority status is necessary as well.  One of the limitations to the study that was 
identified was that the sample was not diverse with 77% of the sample identifying as female and 
77% of the sample identifying as White.  With that said, female patients reported longer wait 
times than the male patients.  Black patients also reported, on average, longer wait times than all 
other races.   
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Theoretical Findings-Critical Race Theory 
 To recap, Ford, Collins, and Airhihenbuwa (2010) discuss the four features of CRT they 
have identified, which include: race consciousness, contemporary orientation, centering the 
margins rather than in the mainstream and praxis.  Race consciousness is important as it provides 
an understanding as to a person’s awareness and understanding of racism in their own life and 
how it affects them (Ford, Collins, & Airhihenbuwa, 2010).  The Discrimination in Medical 
Settings Scale and Medical Mistrust Scales were used to gain an idea of whether the transplant 
recipients in the sample had felt discriminated against in the transplant process and also to 
address the third feature of this theory of the “outsiders within” concerns.  As previously 
discussed, Cuevas and O'Brien (2017) identified that the patient's racial identity was an 
important component of the patient's experience in terms of receiving equitable health care.  The 
sample for this study was primarily white and the scores on both scales did not show significance 
but the patients in the minority groups did report longer wait times.  
 Discussing race at the system level or contemporary orientation is the second feature of 
CRT.  Wait times at transplant centers and differences in transplant criteria are just some 
examples of system level issues.  While interviewing transplant recipients, some explained how 
they wish they had better insurance or better means of proving they could afford the post 
transplant medications as they felt that they were at a disadvantage.  Some mentioned the need 
for them to fundraise to provide money to prove they could afford the medications. Some also 
expressed their wish to have the ability to financially afford transportation to many centers as 
multilisting provided more opportunity for those who were able to.  Also similar to findings by 
Cuevas, O'Brien, and Saha (2017) who explained that "although African Americans perceive 
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discrimination in health care settings, experience higher levels of medical mistrust compared 
with European Americans, and experience poorer communication with health care providers" (p. 
987).  One of the most common and consistent issues identified in the interviews was that 
communication within the transplant center were lacking.  Many identified wanting more 
transplant education and information needed.  
 The final feature of CRT is praxis which has to do with using the information to guide the 
research by focusing on the information provided by those within the marginalized communities 
(Ford, Collins, & Airhihenbuwa, 2010).  One goal of this study was to gain insight and 
information from patient experiences in particular those in marginalized groups.  Future research 
could be the key into being better able to control access to the transplant list especially to those 
in marginalized communities in need.  
Medical Mistrust 
Medical mistrust has been shown to lead to many issues within the healthcare system 
including the underutilization of services which can be particularly troublesome for someone 
with kidney disease.  Harmoda, et al. (2017) found that “perceived medical racism, medical 
mistrust, and medical discrimination persist in the African American transplant patient 
population” (para 4).    
Medical Mistrust can impact a patient’s willingness to get the care and services they need 
and this is especially important when discussing End Stage Renal Disease. Harding et al. (2017) 
identified mistrust of clinicians and mistrust from the healthcare team as a reason for the racial 
disparities evident in kidney transplant wait listing.  As previously stated, LaVeist (n.d.) explains 
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that trust is evident in many areas such as doctor/patient relationships, trust in the pharmaceutical 
companies, trust in competence of the health care team, and trust in the education received and 
appropriate decision making in regard to the diagnosis.  
The mean scores on the Medical Mistrust Scale were run by each category and those 
categories that showed significance are shown below in the table.  The patient’s scores did not 
show any significant differences based on the patient’s sex.   
 
 
 
 
Table 115. Significance of MMS Mean Scores Across Demographics. 
Medical Mistrust Statement Significant by: 
1.You better be cautious when dealing with healthcare organizations Education level 
2. Patients have sometimes been deceived or mislead by healthcare organizations Age 
3. I trust that healthcare organizations will tell me if a mistake is made about my treatment Income Level 
4. Healthcare organizations often want to know more about your business than they need to know.  
5. When healthcare organizations make mistakes they usually cover it up Race 
6. Healthcare organizations have sometimes done harmful experiments on patients without their 
knowledge 
Race 
7. The patient’s medical needs come before other considerations at healthcare organizations Education level 
8. Healthcare organizations are more concerned about making money than taking care of people  
9. Healthcare organizations put the patient’s health first  
10. Healthcare organizations don’t always keep your information totally private  
11. Patients should always follow the advice given to them at healthcare organizations  
12. I typically get a second opinion when I am told something about my health Race 
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13. I trust that healthcare organizations check their staff’s credentials to make sure they are hiring 
the best people 
Race 
Pre-wait time 
14. They know what they are doing at healthcare organizations  
15. Sometimes I wonder if healthcare organizations really know what they are doing  
16. Mistakes are common in healthcare organization Race, Income Level 
17. I trust that healthcare organizations keep up with the latest medical information Race 
Discrimination in Medical Settings Scale 
“Evidence indicates that cultural factors including medical mistrust, perceived racism and 
discrimination, religious beliefs, and family influence, play a key role in decision making about 
medical interventions and that these issues are critical to understanding disparities in kidney 
transplantation” (Muaskovsky, et al., 2012, p. 423).  Shaubel et al. (2000) discussed that women 
are discriminated against in the transplant world and this may be due to overestimation of the 
medical risks in transplant for women.  They noted that physician bias may only be one factor as 
to why women are less likely than men to receive a transplant (Shaubel, et al., 2000).   
Shavers, et al. (2012) found that “74% of African Americans, 69% of other non-Whites, 
and 30% of Whites report personally experiencing general race-based discrimination” (p. 953).  
Harmoda, et al. (2017) found that of the patients who reported being treated unfairly while 
receiving medical care, 78% reported race/ethnicity as the main reason for the discrimination.   
In our study there was no statistical significance in mean scores on the Discrimination in 
Medical Setting Scale when discussing race, age, sex, or income.  This is inconsistent with the 
literature.  The patient’s education level and Insurance type showed significance on only the 
questions shown in the table below.  
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Table 116. Significance of DMS Mean Scores Across Demographics. 
Discrimination in Medical Settings Statement Significant by: 
1. I had a doctor or nurse act as though they were afraid of me Education Level, Insurance Type 
2. I had a doctor or nurse act as though they thought I was not smart   
3. I had a doctor or nurse act as if he or she was better than me  Education Level, Insurance Type 
4. I felt I was treated with less courtesy than other people   
5. I felt I received poorer services than other people  
6. I felt as though I was treated with less respect than other people  
7. I felt like a doctor or nurse was not listening to what I was saying Education Level 
 
Limitations to the Study 
 When discussing the results of the study, the limitations must also be identified.  While 
the survey was distributed to online support groups across the United States, the intention was to 
have a diverse sample size.  However, it turned out that the respondent group was not as diverse 
as originally planned which could account for some of the results that were obtained.  For 
example, the sample was 77% female.  This could be that the sample was taken from online 
support groups.  Studies have shown that females are more likely to join and participate in 
support groups than men (Mo, Malik, & Coulson, 2008).   
Also, to note was that 77% of the sample was white.  This could have had an effect on the 
results as discrimination in medical settings was “most common for Blacks…. minorities were 
more likely to report worse treatment compared to Whites” (Benjamins, & Whitman, 2014, p. 
403).   Prior research provides evidence that whites are less likely to report discrimination 
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compared to other racial groups (Shavers, et al., 2012).  Other “evidence suggests that perceived 
racial discrimination further varies with SES” (Stepanikova, & Oates, 2017, p. 953).   
Stepanikova and Oates (2017) found that subjects with a lack of health insurance, lower 
income, lower education levels and financial barriers to healthcare showed increased perceptions 
of racial discrimination.  Out of our sample, 49% reported an income over $65,000/year, with 
26% of the total sample reporting an income level greater than $95,000.  In terms of insurance, 
55% of the total sample reported having either private insurance or private and Medicare 
insurance.     
 Another limitation is that the survey requires the respondents to self-report about their 
experiences.  Self-reported data collection can have a limitation in that the respondent’s answers 
on the survey are taken at face value as there is no way to verify the answers provided (Sacred 
Heart University, n.d.).  Sacred Heart University (n.d.) identifies the potential sources of bias as: 
selective memory, telescoping, attribution and the possibility of exaggeration when discussing 
self-reported data.  Selective memory and telescoping refer to what Althubaiti (2016) referred to 
as recall bias.   
Selective memory was identified as “remembering or not remembering experiences or 
events that occurred at some point in the past” (Sacred Heart University, n.d., para 15).  Similar 
is the concept of telescoping where respondents recall events that they think happened at one 
time but actually happened at a different time.  This survey asked respondents to answer each 
question as truthfully and accurately as they could recall.  Also the survey did not include a way 
to differentiate if the respondents received a living or deceased donor which would have added 
more information to the study as this can affect wait time and there are many studies that look 
into disparities amongst living vs. deceased donor kidney access.        
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Future Research 
 
The purpose of this study was to bring more information and awareness on this topic and 
to add to the literature that exists to help continue to work on improvements.  The persistent 
challenges of bridging healthcare disparities for African Americans in need of a kidney remains 
an issue today at the national level (Harding, et al., 2017).  It is evident that there are issues with 
patients gaining access to the kidney transplant list even when transplant has been shown to be 
the best option for the patient.  There are many studies that identify areas in need of 
improvement, but this is no easy task.  There are many authors that discuss possible solutions or 
possible answers to alleviate some of the areas of inequalities.   
Williams and Delmonico (2016) note that the solutions to the disparities is quite complex 
and they offer three areas in need of improvement.  The three areas they discuss start from when 
the patient is first diagnosed as some are already facing barriers to care and some never even 
receive a referral or are never made aware in the first place.  Secondly is to focus on the issue 
with equal distribution of the kidneys as there are not enough for all the patients that need them.  
Lastly they identify that the outcomes after the transplant need to be addressed to ensure the 
patients also have equal access here as well (Williams & Delmonio, 2016).       
 Hod and Goldfarb-Rumyantzey (2014) focused on making improvements at the post 
transplant level in terms of access to insurance as this is a time when the patient will need to be 
able to have access to the necessary medications to keep the transplant alive.  This is also an area 
where disparities exist as some patients may be discriminated against due to not having enough 
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income or good enough insurance to cover the necessary medications.  They focused on 
improving the Medicare coverage for these medications to every transplant recipient by 
lengthening the amount of time the patient is able to keep their Medicare benefits post transplant.  
As is currently stands, the Medicare immunosuppressive benefits cover a patient for 3 years post 
transplant and Hod and Goldfarb-Rumyantzey suggest extended this as lifetime coverage.   
 In the area of transplant center improvements, there have been websites and online tools 
created such as the one from the Scientific Registry of Transplant Recipients (n.d.) which lists 
the transplant centers and provides detailed information about each center.  The information 
includes the distance of the center from the patient (once a city inputed), number of deceased 
donor transplants in a year, number of living transplant donors in a year, survival rating on the 
waitlist, and survival outcomes (Scientific Registry of Transplant Recipients, n.d.).  This can 
help educate patients but again if the distance is too much, not all patients can actually get to the 
center.  In terms of geographical disparities in access to kidney transplants in the US, Ata, Skaro 
and Tayur (2016) suggest an operational solution including using affordable jet services 
(OrganJet) to transport patients on the waitlist to their kidney so that these patients may place 
themselves on multiple lists to try to shorten their time on the list and improve their quality of 
life.    
An executive order recently signed by the president is focusing on five new payment 
models to motivate doctors to provide information to patient’s earlier and focus on limiting some 
of the lack of consistency within organizations.  This order also focuses on raising awareness and 
patient education and discusses the benefits of home dialysis for increasing quality of life 
(Berstein & Kindy, 2019).  These issues were also discussed by Patzer (2012) who explained that 
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dialysis centers have no incentive or financial motivation to refer patients for transplant or to 
spend time educating them on it.    
Awareness is also the key to improvement.  Purnell, et al. (2017) provide information on 
the barriers towards transplant as patient’s attitudes and beliefs, health care provider knowledge 
as well as their attitudes and beliefs and population awareness and attitudes.  Williams and 
Delmonico (2015) discuss how the newer system where patients can begin to accrue wait time 
while on dialysis is an excellent start but patients and health care providers need to know about 
these options so that they are able to benefit from them.  They go further to state that public 
health initiatives need to take place to better educate patients especially in the communities of 
color (Williams & Delmonico, 2015).   
 Research such as this study and taking time to speak with transplant recipients as well as 
those on the waitlist can give an insider’s view as to their experiences to be better able to identify 
areas of strength and areas in need.  It is also important to continue to do research on the patients 
who have been diagnosed but have not begun dialysis or have not wait listed as we need to 
ensure that these patients are all aware of their options regardless of race, sex, age, or 
socioeconomic status.  
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Introduction  
Hello this is Melanie and I want to thank you and tell you how much I appreciate you taking the time out for the 
interview. 
You are welcome 
How are you doing 
Well I am okay but I am back on dialysis 
I heard you say you are back on dialysis 
Yeah unfortunately, and today was pretty hectic considering the fact that they put us on late. 
Oh I am sorry to hear about this.   
And then they stuck me wrong and the needle was sitting on the wall and the machine kept beeping 
Oh you are kidding 
Yes so I got out of there pretty late 
How many hours do you have to be on it for? 
3 hours and 15 minutes 
Oh goodness 
How many times a week are you going 
3 days 
That takes a lot out of you so I am sure you are exhausted today 
Oh yeah plus I work a part time job too. 
Wow that takes a lot of strength to be out doing all of that 
Yeah (laughter) 
I work at a doggie daycare so I work with dogs all day 
Oh well that is rewarding though , I think 
No it is not boring at all 
No I said rewarding, it must be rewarding to be able to hang out with them  
Yes it beats dealing with people  
(Laughter) Yeah they cant talk back to you right (laughter) 
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Yeah 
That’s excellent, Well I wont hold up too much of your time as I am sure you would like to get some dinner and get 
some rest at this point, you know 
Yeah 
Um I just have like 8 open ended questions to kind of go along with the survey  just to kind of get people’s view of, 
you know with  surveys you can never really get a full idea of what people want to say if you are only able to answer 
multiple choice questions so um I just want to kind of get your ideas on waitlist stuff, I have like 8 questions that 
you can answer as long or as short as you want or some of your answers might be like no (laughter).  Um just to 
kind of get your feel if you had a few minutes 
Ok sure 
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
Well I am actually dealing with that right now um 
OK you are back on  
Well I hope so, I have not really gotten any update if I am on the list or not but that is something I am working on 
and before I went to um I did Northwestern and their waittime is 5 to 10 years.   
Oh my goodness 
And so I went up to Wisconsin because Wisconsin’s wait time is shorter and their waittime is 3 to 5 years so I was 
on Madison’s Waiting List and Freider’s Waiting List and overhere in Illonois I was on Northwestern’s waiting list.   
And that is all most recent, or was this previously 
This was previously, now I am waiting to see which list I am on. 
Oh my goodness, and how long ago were you on the waitlist before 
Um I received my kidney back in 2014 and it lasted me 4 ½ years  
Um hm 
Um so I was on the waiting list for about 3 ½ years and they actually added that time I was on dialysis they added 
that to the waiting points 
Ok so how long have you been on dialysis this time 
Um I want to say about 2 months now 
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Ok 
Yeah 
Do you feel like it is any easier getting on the waitlist this time versus last time or kind of even though you know 
how to do it, it is still quite a challenge 
It is still challenging because again I do not know what is going on, they are not really up to date with telling me 
information about me being on the list 
OK 
It is like when I ask, nobody knows 
That is terrible, you don’t have like a point of contact right I am assuming then right? 
Yeah no I talk to my nephrologist and he just lets me know  
Please describe some of the obstacles you experienced when trying to get waitlisted 
Um I just, probably knowing what is going on, you know letting me know what is going on because I would like to 
know you know and they do not tell me anything and I am sitting her like okay I am so young, I am not like 80 
something years old where I have lived my life and people take care of me and that is not the case 
Umhm 
I am 28 years old, 
Goodness you are very young 
Yes my kidneys failed when I was 20 
Wow 
Yeah so you can imagine I had a lot of growing up to do 
Absolutely and that waitlist process is a hard one to navigate especially when you are young 
Yeah I had no idea, I still have no idea what I am doing, you know I still need help asking how to do I get on the list 
and how do I do this and how do I do that.  And you know it is not new to me but it is challenging 
Absolutely and I am sure part of that is that your health is important and it is scary too 
Yeah absolutely yeah, I have been in and out of the hospital a lot where the hospital knows me as soon as I walk in  
Awe (laughter) 
Please describe any areas of the waitlist process that you found to be easy to navigate 
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Um I do not think so because I was lucky actually because I waited only 3 ½ years and I actually received my 
kidney from a complete stranger through a group study 
Interesting 
Yeah they, actually I was the last person to receive a kidney out of the 4 families that were donating 
And this was a live donation for you? 
It was yes 
That is amazing 
Yeah I think, I think that a lot more hospitals should do more group studies 
And what does the group study entail  
Um , okay so there are four families and the first family donates to the second family, um the second family has a 
family member that can donate to the third family member that is waiting and the third family member donates their 
kidney to me so that they can get bumped up the list faster to receive a kidney 
Wow 
Yes 
And how did you get chosen for that study 
Oh I do not know, they just called me and asked if I would like to be in a group study and I was like sure 
You were like, sign me up (laughter) 
Please discuss any people in particular that were helpful during the transplant waitlist process 
Um when I first started on the list, yes I did, now not so much, now it is just me dealing with it 
Ok 
So I mean it is nothing new to me but it would be nice to have someone there you know 
Absolutely 
Yeah I am dealing with it on my own 
And that is a lot being 28, on dialysis and to be working 
Yeah watching my fluids and what I eat, you know I have no kids but I have a dog I take care of and he is the world 
to me and that is basically my child (laughter). And even dealing with renal failure like I do not even know if I want 
children at this point.  Dealing with all of this 
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I understand.   
Do you feel there are any people in particular that were helpful during this process either this time or last 
time? 
Um my mom was by my side the first time I went through all of this, she was my rock and it was difficult for her, 
you know it was very emotional  
Um hm 
Um but now I am older and I have been through it I guess and it is like she is on her own and doing her own thing 
and I am doing my own thing and um I have my best friend who would like to donate her kidney to me 
Oh wow 
I just want to see if we are a match, you know we have to be 100% compliance with the kidney, and tissue and all 
the antibodies and all that 
Yeah and that is a big process too  
Yeah so I have my best friend 
That is tough 
Yeah 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
No, well no not really but I felt like because I was so young they just were like “oh you just got to make sure you 
take your meds” and they just kept constantly repeating themselves, “take your meds”, take your meds”  
Ok 
And I am like, I understand, again I am not like 80 something years old where I forget easily you know 
Um 
I will remember this, you do not have to tell me everytime, all the time, you know so that I felt like because I was 
young they were like like oh gotta do this, you gotta do that, and I was like okay I will.  You don’t have to worry I 
will take my meds on time you don’t have to remind me and I was doing good, I was taking my pills on time when I 
received my kidney.  Um I did doctors appointments and went to those y0ou kknow 
Ok  
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So you know yeah I took care of this kidney the best I could it was just giving me a rollercoaster ride and it wasn’t 
agreeing with me 
Oh 
Yeah, so  
Describe anything about yourself or your personal situation that, if you had the ability to change it, would 
have made the transplant list process easier 
Yep anything that will get a kidney sure um well I was offered a kidney three times 
Wow 
Yeah one was a cadaver um it wasn’t a complete match, um I went all the way up to Madison they took my blood, I 
spent the whole night there and the next morning they were like, I am sorry it is not a 100% match, so I was crushed 
you know, heartbroken 
I cant imagine 
And then the second time, a few months later, they called me up and was like um we have a kidney for you and at 
the time I had a common cold and I told them I was sick and they were like oh well then we cant give you this 
kidney if you are sick because we need you to be 100% healthy so I was kind of bummed out about that and then the 
third call was the group study call.  They were like hey we are going to put you in a group study and you will get the 
call when we have a family that is going to donate a kidney to you 
Um hm 
And that is when they called me and they were like, well fingers crossed you will get this kidney but if like the first, 
second or third family doesn’t want to donate, then you will not have a kidney.  Because if the first family member 
decided to not donate to the second family in need, then I wouldn’t receive one. 
I understand, that must have been stressful for you 
Yeah it is like a chain reaction 
So how long were you on the waitlist before you got into the group study, was that the 3 ½ years 
Yes it was, they put that waiting time towards um when I was doing dialysis, they put that waiting time towards my 
kidney 
And how long did it take you to get onto the list the first time 
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Um (uffff) it was so long, I want to say probably a month 
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
Do it as soon as possible (laughter) Um because you never know if they get you on or not and then you are sitting 
there wasting your time doing treatment and htat is just like am I on the list for a kidney because that would be great 
and if not what can we do, like 
Have you ever been taken off the list 
Um I was taken off when I received my kidney 
Ok so that was the only time 
Yes other than that , I was on the list until I received it but I have heard people have been taken off the list because 
of their situation whether it is taking drugs or they are not compliant, or you know it is just different circumstances 
but I have been good (laughter) 
Ok, that is important 
Yeah 
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
Um yeah wishing the waiting time is less instead of years because there is a lot of people who need organs, you 
know, there are people dying every day waiting and being on the machine 3 days out the week for 3 ½ hours it is 
tough, its draining, it is exhausting and you know people just want to live their life as normal as they can but we cant 
because we are on a machine 
Absolutely 
So so I mean it is emotional and it is tiring but I take it day by day and I have to be positive through life because I 
actually flat lined I died three times, like they had to bring me back.  Like the first time I was rushed to the 
emergency room because of my kidneys, they failed, and they had no idea and I was being rushed to the ER and I 
was in the ambulance I flat lined and they had to resuscitate me to bring me back.   
Oh my goodness’ 
So I mean, I do not take life for granted so I have to live life positive and just gotta believe that there is going to be 
good out there eventually, hopefully 
Absolutely, well you have a good outlook on it despite all of the struggles you have had with it, you know  
265 
 
Yeah and then when I go to dialysis I see the grumpy old people and they are like “I need this” “I need that” and I 
am just like why cant you just be thankful that you are still here, you do not have to be so rude. But I do not say that 
to them I just think it (Laughter) 
Yes you just keep it in your thought bubble 
Yeah I just think I hope I am not that grumpy when I get old. (laugter) And I hope to be off dialysis by then as well.  
I hope to receive a kidney that cause they told me that this kidney was supposed to last me my whole life but that 
didn’t work out 
Oh no 
So I mean four years is pretty long for a kidney but not as long as what they had told me  
Right and not getting the correct information seems to be a theme that you are having you know 
Yeah, Yeah and I just feel like because I am young, they don’t want to tell me some things and I get upset so I start 
snapping on them and they get all upset  but I wouldn’t be snapping on them if they wouldl just tell me what is 
going on 
Um hm how long did it take when you found out you had kidney disease for them to mention transplant, or did you 
already know that transplant was an option early on or did they take a while to mention it to you 
Um no they told me um they told me that I could receive a kidney or a transplant um but I had no idea that my 
kidneys had failed at all like it took me getting rushed to the hospital to realize trhat they were completely dead 
Oh my 
Yeah so  
That is so scary 
It is, I wasn’t breathing right, I was hyperventilating and I was just weak and wanted to sleep all day. Ugh, pale, it 
was bad 
Um hm.  I totally appreciate you sharing your story with me, I know it is hard when I am sure you just want to go to 
sleep probably (laughter).  Cause I know how draining dialysis can be as my husband had been on dialysis for quite 
some time so I can understand the struggle with that because it is so draining 
Yeah and a lot of people do not understand that, and I try to explain but they are just like all you do is sit in a chair 
for three hours.  But they do not understand that the blood is filtering throughout my whole body. 
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Yes it takes a big strain on your body 
Right like today was bad, they got me in late, they stuck me wrong they infiltrated my graft and the way the needle 
was sitting, the machine kept beeping and every time the machine would beep, it stops so the more it stops, the 
longer I am there 
Right 
And I am just like sometimes I get anxiety and I am just like I need to get off of this machine so I have to look into 
being prescribed something while being on the machine because there are days when I can sleep through it and there 
are days when I am just like get me off  
Oh I can imagine 
Yeah and the needles are not friendly either 
No they do not look friendly that is for sure (laughter) 
Yeah no not at at all 
Well I really hope things get better for you, I hope you get on that list and I hope you get the information about 
getting on the list soon.  
Thank you me too 
And I hope all goes well for you and I hope you will be feeling better and will be running around in no time, you 
know 
Yeah so do I  
Continue taking it one day at a time like you do you know and the support groups, I know you are on the online ones 
but any other ones you find, finding the support I am sure will help too you know  
Oh yeah I like reading people’s stories or people that have questions I like putting my input in and so  
You have a good story to share and to help other people 
Yeah thank you  
Your welcome 
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Introduction  
Hello 
Hi is this Lenora 
Yes this is she 
Hello Lenora, this is Melanie I am the one who was emailing you a couple of times regarding the interview  
It is okay, I know we were just going back and forth 
I know and I tried to call your house number and it was not working 
Oh sorry about that, just letting you know that I am currently at TJ Maxx but you can still ask me the questions 
I know you have received a kidney and I was wondering how it is going 
It is great, today is actually my year anniversary 
Today is your anniversary, congratulations, that is a lot to be celebrated as I know how hard it can be 
Yeah, yeah, it is a long process and I can see how some people give up 
Yes, How are you feeling now 
Um well I have had my ups and downs with medication but I thank God they got it right now finally 
Oh 
It has been like three months, and I have been having to see the doctor like every 1 to 2 weeks but now we can 
spread it out now 
Good that makes all the difference when you are feeling better 
Yes, it really does 
A lot of my questions relate to the transplant waitlist as this is the focus of my paper, I find it amazing how there is 
not a lot of information about how difficult the process is, so my questions pertain to your waitlist experience if that 
is okay? 
Yes of course, go ahead, shoot away 
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
As far as the waitlist process, I was very proactive in the process and so was my nephrologist.  My local 
nephrologist had been working with me because this was like my ___ flare up of lupus nephritis, I have had it since I 
was 12.  I guess after I had my daughter, she (nephrologist) began talking about it because I had a structural valve 
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after after having her and then I had another flare and my ________went down to like the 30s.  so she started talking 
to me then about being prepared when don’t know how long your natural kidneys are going to last so keep that in 
the back of your mind.  So you know I thought maybe around that time I still had a lot of time but um I guess it was 
like 3 summers ago I had another lupus flare up and I had no idea, I had no symptoms like I normally had with my 
lupus like the pain in my hands and my feet and like having  a lot of froth in my urine. I just didn’t recognize any 
symptoms.  The only thing I noticed was my blood pressure kept going up so I went to the ER and that it when I 
found out it was the lupus again but this time it totally wiped out the rest of my kidney function.   
Oh wow 
So I was at like a 10 and I spoke with my nephrologist so she came and she told me, I was kinda shocked because 
you know I thought I had more time but at that time I had to start dialysis and she just kept mentioning make sure 
we got to get you on the list because you are young and pretty healthy, it’s just your kidneys aren’t working.  So 
since then you know I worked on getting my testing done, as far as you know getting the echo, bloodwork, making 
sure I was compliant with dialysis and I scheduled my own consult for transplant.  I had no idea where you know 
she gave me an idea of where to go but basically I am a nurse by trade so I was very proactive and was like let me 
hurry and try to get this done.  She gave me the list of what kinds of tests I needed to you know get the consult 
going.  She knows me, I am not going to wait so I just started doing everything on my own, pulling my own records 
that was needed, you know from my lupus doctor, my heart doctor you know to let them know that my lupus is 
okay.  I had everything so when I went to the consult, I had all my paperwork, all my tests done. 
Wow that is excellent, that means you had a great nephrologist to even mention it so early to you and to give you all 
the information 
Yes, yeah, she is really good that way.  I think for most people, they don’t really even talk about it until you are 
close to that stage and you know I think earlier would be a benefit.  You know because once that thing happens, 
people need to know what kind of tests they need to get on a transplant list and what kind of support they need or 
whatever.  So that way when they go to the consult, they are not wasting their time getting the testing done  
Absolutely because that is key, how long did you wait on the waitlist for? 
Um I was part of the paired exchange so my husband donated on my behalf and we did the swap so I was on there 
maybe a year, maybe a year and ten months, a year and nine months. 
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That is a wonderful husband you have 
Yeah, yeah he is.  It is a stiff conversation that I am willing to ask someone to donate and you know we put it out 
there but you know there are a lot of people who were _______________ and I did not want to push them to get 
tested, I just kind of let people, you know get tested for me, I mean on their free will, I did not want people to feel 
pushed into it, you know? 
Absolutely 
But my husband is always dependable but I was actually more worried about him donating um versus some of my 
other family members but it just worked out that he donated. 
Oh that is wonderful 
 
Please describe some of the obstacles you experienced when trying to get waitlisted 
Um no I think at the transplant center um they really rushed through the information like um when I got there for my 
consult I feel like they rushed, I had a new, I guess, new NP that was doing the training so it was just like she was 
rushing through it, she never, she just started working for transplant so I just did not think it was that informative to 
be honest.  I mean she explained how the waitlist worked but you really have to kind of be proactive and do your 
own research because I just feel like they are so busy I feel like sometimes they rush through it and I would just 
recommend too that people try one or more transplant centers because when I went to the second one, they were 
more thorough than the first place that I went to so I think that helped hearing the information again from a different 
transplant center. 
And it is good that you knew you could go to more than one, you know? 
Yeah that is true too, people do not know that they can. 
Right, absolutely 
Please describe any areas of the waitlist process that you found to be easy to navigate 
Not really as I said I just tried to be proactive.   
Please discuss any people in particular that were helpful during the transplant waitlist process 
Um honestly a lot of the people we were friends with came through, I thought maybe my family would be more 
involved, it was kind of, the family support was not what I thought it would be.  Because there were some people 
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who were against my husband donating and all the drama of that you, some people on my side they were just 
apprehensive about the whole thing. We have a lot of friends, we did one of those, I forget one of those website 
things. 
Like a GoFundMe? 
No not a GoFundMe, its like so people can help by signing up for services for you.   
Oh ok 
Cause like we needed people to drive us, because neither one of us could drive.  I needed a babysitter because this 
was happening in the summertime.  Um and I had a dog so somebody had to walk the dog so it was just so we used 
like, I forget what it is called, Care something.  They could sign up to bring you meals, like helping do services for 
you and like that helped a lot 
Absolutely 
A lot of friends and friends of friends helped us more than our own family 
Oh, sorry to hear that, it is good to know who your friends are during your times of need. 
Yeah you know that’s true, that is true, this process opened my eyes to a lot.  The people I thought would come 
through were the ones who disappeared.  And the people I least expected were so sweet to us, so loving to us and it 
was just amazing 
That is wonderful, I am glad you found some good people, it is good you found others to help provide some support 
because without that, it would make it that much more difficult.  ] 
Yeah, it was stressing us a little bit until somebody brought that website to my attention and I was like, you know 
what,  I am just going to put it on Facebook and if people want to sign up to help us that is the easiest way you know 
people don’t know what they can do, or how they can help and that was the easiest way to do it.   
That sounds awesome.  That would be helpful for other people in this situation to know about too you know 
Yeah I put it a couple of times on the support groups on Facebook.  That is another thing, the people in the support 
groups on Facebook, they been through it, they really helped too, they answered questions sometimes better than the 
doctors (laughter).  Because they know that 
I noticed that a lot of people respond on those support groups if someone posts a question 
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Yeah I think that was my best resource if I could say you know besides me researching and talking to my own 
doctor, like, that was like second to none.  Like you know my husband donated and he had his own separate group 
and he was able to ask them a bunch of questions and you know that I couldn’t answer or that the doctor couldn’t 
answer really or like truthfully I would say.  (laughter)   
People who have been through it can tell you the nitty gritty (laughter) 
Exactly, exactly 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
Um yes and no, I would say that a lot of times they dismiss your concerns and that just urks me, like if you have a 
concern, they just dismiss it or they compare you to the whole group.  And you know if you have kidney disease, 
you have been in the health system for a long time and you understand your body and medicines might work and 
which don’t.  you know even down to how you take your pills, like just simply, sometimes they are not susceptible 
to hearing your concerns like they have a protocol and they just don’t want to stray from that, I mean even the time 
you take your pills or you know what I mean, or times you get your labs done.  Just to make it easier for you as an 
individual.   
Absolutely 
So that would be my only thing and I think sometimes too since I am a nurse, sometimes they I do not know, 
sometimes they get irritated if you have a lot of questions.  So I think because you just know a little bit more, so you 
might be asking more about the mismatch and how does that work and what is the percentage of outcomes with this 
and that or with this type of medication vs. other medication and I think this just gets passed over 
Describe anything about yourself or your personal situation that, if you had the ability to change it, would 
have made the transplant list process easier 
With the waitlist I would say more research I guess because I realize now there are different regions um that have 
different wait times and maybe I could have went to a different state where I have family, you know.  I think they 
just don’t really talk about that very much like if you live in a certain region.  Cause I guess on the East Coast the 
times might be long and maybe if you do have finances or family in another state, I think they should talk more to 
that and maybe you could go somewhere else and get listed faster  besides just going to another hospital in your 
region, you could go outside of your region, you know what I mean? 
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Is there any advice you would give to other patients trying to get onto the transplant waitlist 
I would try to get on even if you have reservations with it, whether it be financial or support, because I know at the 
dialysis center there were a couple of people who choose not to get on the transplant list and from the ones that I do 
talk to they said it was because of their age, or maybe they did not have enough support or you need all this financial 
money to get on the list, um I think you should get on just in case and not be so reserved about it but I think that 
comes with education too 
Absolutely 
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
Yeah, yeah I feel really bad about the people who cannot get on the list because I have heard a lot of people who say 
they financially they cannot do it or they do not feel they have the support to do it 
Well and hopefully putting something a little more standard in place so people know what resources are available to 
them you know  
Yeah 
You know because they find dialysis is too hard 
I can tell a difference, my heart was so weak before the transplant, I mean like even now, I still get short of breath 
but it is so much better than when I was in dialysis and before it was hard to even walk a little bit. 
Right, it gives you back some quality of life 
It is a different way, definitely not the same life, there are side effects which I feel they do not discuss that either I 
think of transplant.  You might think it is a cure all but it is definitely a new life, you will not go exactly back to 
your old life but I think they not prepare me for that, just knowing that your life is still changing, you will not be 
completely back to where you were, but just know it is going to be a new life.  
Absolutlely 
Yeah, I think this was kind of heart breaking for me in the beginning, I was like oh, this was not what I expected.   
Yeah 
I wanted to be back to my old self.     
I just want to thank you for allowing me to interview you and hear your story, I learn a ton from every person that I 
speak to and yours was no different, I learned a ton from you and I really appreciate that 
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Introduction 
Do you mind if I record our interview since I am driving and this way I can transcribe this accurately.  I will delete it 
once I transcribe it.   
Yes absolutely 
SO I just have questions mainly regarding, my research project for the PhD program that I am in is a lot to do with 
the waitlist and how difficult it is for people, how long some people have to wait on it versus others and just kind of 
learning what, there are a lot of statistics out there but I wanted to hear from the people themselves what it was like 
for you and what your experience was like cause I feel like you get a better understanding of the problem that way, 
you know? 
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
YEAH so for me, things moved entirely fast 
Oh wonderful 
It is not typically what you hear I imagine 
NO  
Um my whole process from when I was diagnosed, I never even went on dialysis, but from the time I was diagnosed 
to the time I received my transplant was less than a year 
Oh my goodness, that is excellent 
Isn’t that insane? 
And you never had to go on dialysis? 
I didn’t, no, so I was diagnosed I guess, it was three years ago, so I guess it was in the beginning of 2016. 
Ok 
Like very early January, um and we tried a bunch of things to try to improve my GFR but that was not working so 
by like March, and they were saying we need to start, actually it was probably even in January when they were 
saying it was pretty bad, we are hoping to correct it but you should probably start looking into getting on the 
transplant lists.  You know that process takes a while so I think by the time I actually got onto the transplant list, it 
was maybe April May timeframe.  I got on 3 different lists and I know not everyone can do that and but I got onto 
the one that would be closest to me so that would be Chicago.  Um I think I did UIC which is the University of 
Illinois Chicago.  Um and actually, the UNOS President, at least at the time, was one of the surgeons there and so I 
met with her which was kind of cool 
Oh that is awesome 
Yeah and you know my doctor, had um recommended, just based on where we are in the mid-west, he said  well 
why don’t you try to get on the Wisconsin list, it is not that far.  Um a couple of hours away and also get on the Iowa 
list, University of Iowa and the University of Wisconsin.  And they are both drivable and the decision to try those 
was based on how the system works with the geography borders and he is like, so often the waittimes are you know, 
so the waittimes in Chicago are insane they are five to seven years I think, at least that is what I heard but I 
obviously didn’t experience it.  Um and then he said, and what I heard from different centers in Wisconsin I think on 
average is about two to three years but obviously it is just a different population, being from Chicago or New York 
or anything like that.  And similarly in Iowa the waittimes were about 1 to 3 years.  Um so I got on those lists and I 
even turned down one in either June or July from Iowa as it was a bit of a high risk one.   
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Ok 
Intervenous drug use so, based on my age and other health factors, and the fact that I would need a transplant but 
wasn’t on dialysis um they scored me pretty highly and they sort of said, well the advice at Iowa, or really all the 
centers was that because of all these benefits of your otherwise healthy body, you should really be waiting for the 
cream of the crop in terms of the quality of kidney you got 
Ok 
And I mean I am still early in the process so it seemed fine to wait, I am sure I would think differently about whether 
I would have accepted a high risk one if I was a couple years into the wait 
Um huh 
Um and another thing kind of pushed me up in terms of priority on the list um I would get a kidney quicker than 
expected no matter where I was because I had a really high antibody level so my PRA score was really high. Um I 
think it can happen often in women, I hadn’t had any blood transfusions but I guess if you had children, there is a 
chance that your blood and their blood kind of mixes and because it increases your antibodies.  Um and it sounds 
like mine was 99 and because of that I got a lot of extra points or however it works, a lot of extra priority on the 
transplant list and that was a new thing.  I think by the time I actually got the transplant, even now, I don’t think 
there is much data out there on people with very high antibodies and how well kidneys do and how long the grafts 
last. Because from what I understood, before they did not prioritize these people and then people like me, were very 
low on the list because there was always the thought that well we can give her a kidney but because she’s got so 
many antibodies, or like because they think the chance of rejection is higher so why waste a kidney on someone like 
that 
That is a sad thought.  
Yes it is a very sad thought but things changed when it was about my time to get my transplant.  I think within a 
year or two of that, they started refocusing I think they had redefined the regional borders and um they kind of 
thought that people like me should not be deprioritized but rather be pushed to the top of the list. Um because you 
have the ability to really miss close matches you know.  So you know whereas I am not saying anybody but whereas 
how you match is obviously important but um because of the antibodies, it was already known that nobody in my 
family or my husband’s family could donate to me so that would always, I had a couple of people who would donate 
but I would never have thought that their kidney would have to be some sort of swap system 
Yeah like a paired exchange 
Yeah, and so um because of the antibodies they were like well these people should be at the top of the list because 
any kidney that comes in that is a match for that person, they should get it over someone who might be 4th or 5th on 
the list but don’t have that antibody issue.  Because the likelihood of me finding a match is just slimmer than for 
other people 
More difficult I can see 
Yeah um so the other factor that made mine go quite quickly, my doctor, my nephrologist had actually talked about 
this a little bit, the reason the waitimes are shorter in Iowa or Wisconsin a lot of rural areas.   
What kind of side effects are you dealing with? 
Its kind of well you know I mean obviously you are susceptible to a little bit more and um your immune system is 
not what it used to be. I get a lot of hand tremors, tons of hand tremors I mean to the point where my fine motor 
skills are absent, they are terrible, I cant open packaging.  I have little kids so just think about how much packaging 
there is to deal with in my life (laughter) 
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Yes I can understand 
Yeah so it is kind of annoying um I get a lot of foot cramps, these weird foot cramps that I heard can be very 
common as well.  
Yeah foot cramps especially when my husband was on dialysis that was the toughest, cramping was insane 
Yeah you are right about that, it is.  What else is there? There is another main one (side effect) but I cannot 
remember what it was (laughter) 
Too much to remember  
Yeah I do get tingling you know in different spots of my body 
Oh my that is difficult  
It just comes and goes, yeah but it is not life impacting at all, it is just weird things, totally weird things.   
Yeah I can understand and I am sure you thought once you got the transplant you would be good 
Yeah exactly right 
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Introduction 
Hey how are you 
Good and I am glad we are finally able to connect and I apologize for keep missing you 
You are fine and I was trying to get the time zone situation correct when I called you 
Oh I get it, I have a cousin who lives in Florida and he is forever calling me at midnight and I am like stop doing that 
That is exactly what I was trying to avoid.   
Well and the last time he did that, I was like hey you are a cross country truck driver, you should know better 
(laughter) 
Right there is no excuse at that point (laughter) 
Absolutely.   
So how are you doing, are you doing okay 
I am well thank you and good for you for pushing forward with the program and finishing you thesis and doing all 
that good stuff as it is not easy 
It is not easy and will hopefully be done soon (laughter).  
So I have a list of about eight questions to ask as I am trying to learn about each person and their personal 
experiences as I am getting great information from each person.  So if you have some time I could get started.   
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
Sure um I was placed on the waiting list and I waited 7 years, I never got a single phone call, nothing and then at 
that point my GFR was down to 7 and my husband stepped up and said I want to donate my kidney.   
No way 
So I said oh alright so I was fortunate enough to never go on dialysis and always thought well some day I would get 
to the top of the list.   
Never on dialysis? 
Nope um um.  Yep that was a relief. 
Absolutely because 7 years is a long time to wait.   
Yes yeah, well I did a lot of things in between to try to slow the progression of my disease. I was actually diagnosed 
15 years before I received the transplant 
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Wow 
And so when they told me I had chronic kidney disease, I did a lot of alternative sorts of things.  I checked with my 
team, I went to the doctor, I did all my labs, I did all the things I was supposed to do.  But I kept saying, okay I 
would like to try to do this and they just shrugged and said, oh well there is no research on that.  I said fine but there 
was nothing contraindicated and so I ended up doing acupuncture and tapping EFT and I consulted a couple of 
nutritionists to discuss things because nephrologists had specificially told me that diet does not make any difference 
(laughter) so I reached out to dieticians to see who could help me.  And just a lot of things like that, prayer, 
medication, hands on healing, all those sorts of things, whatever it was unfortunately I did not do a single subject 
design on myself so I cant tell you what worked.   
Right, right (laughter) it is very difficult to know what worked right? 
I know because I just did it all at once, I did not do it in a clean, scientific way, I just wanted to be better, I did not 
necessarily want to change the world of research.   
Right and to avoid dialysis for that long is wonderful 
Yes, uh huh 
And your husband was a perfect match? 
He is a type O so he is a universal donor 
Oh wonderful 
Yep so he matched, he would have matched anybody because you know now they do not look for a blood type 
match that much anymore.   
Right, right it is more about all the other testing and all of that 
Yeah 
Please describe some of the obstacles you experienced when trying to get waitlisted 
Nope uh I remember my nephrologist looking at me and saying you are very compliant patient and I came home and 
told my family and I remember laughing as I did not think I was doing anything right.  I began to realize how 
important that word compliance was.  What he was saying was, you make all your appointments, take what we 
prescribe and do all sorts of things and you are showing you are responsible enough to get a kidney and I just 
remember thinking he thinks I am going to do what he says (laughter).   
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As long as you are listed as compliant that is all that matters right? 
Yep (laughter) Hey here I am not knowing the deep meaning of that word in the transplant community 
Please describe any areas of the waitlist process that you found to be easy to navigate 
I know you said there were no barriers for you but how did you know you needed to get on to the list, was it mainly 
driven by your nephrologist? 
That is the good thing my nephrologist did he said you need to go and talk to the transplant team.  And so I had my 
first eval when I was not at 20% yet but they ran all of the tests and so as soon as my GFR because we were doing 
labs, was at 20%, they said okay so here we go 
So they did it really early for you so that is wonderful 
They did and I have to praise the nephrologist for that because he screwed up some stuff but he was absolutely right 
on about that one.   
 
Please discuss any people in particular that were helpful during the transplant waitlist process 
Besides the nephrologist and obviously your husband as you had previously mentioned? 
I also had a friend, a friend of 30 years and mother or my godson who offered to donate and she flew all the way 
from Virginia to have her testing done.   
No way 
Yep but that didn’t work out.  But that was very heartwarming to have her do that 
Absolutely. Just the thought and the gift all in of itself is wonderful.   
Yes absolutely, I have a good friend 
And how is your kidney now, how long have you had it 
My transplant was April 14th 2016 and it has been working fine since um my last creatinine was .88 and GFR of 60 
and above on my lab reports.  I am sure I could go figure it out with the National Kidney Foundation and their 
calculator (laughter) 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
Well this is very subtle  
OK 
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Well I started the process when I was about 58 and as I got closer and closer to 65, I kept making sure my team 
knew I was still working 
OK  
And I worked up until the day before my transplant and I had a sense, and they may be totally in my head, but I had 
a sense that since I was still contributing to society, I was working and paying taxes and I was a girl scout leader, 
and this may have given me a slight edge over somebody who didn’t do those things or who couldn’t work.  Well 
that could be all in my head  
Right right, I think about those things too 
I know but there was no overt discrimination that I can think of 
Ok 
 
Describe anything about yourself or your personal situation that, if you had the ability to change it, would 
have made the transplant list process easier 
Um no because I didn’t really mind waiting, I didn’t feel badly.  The only symptom I had was that towards the end I 
was feeling more tired. 
Ok 
But I have talked to people and I have read things and I know there are some really you know really life affecting 
symptoms that you can get, metal taste in your mouth, swollen legs and all of those sorts of things and you cant 
function and a friend of mine talked to me about being on dialysis and saying that he couldn’t think and I, I didn’t 
have any of those 
Oh that is wonderful.  Do you have any side effects now from the medications or anything? 
Absolutely.  In fact my health is worse than before transplant.   
No way 
Oh yeah because now I have diarrhea from one of the meds, I have lower back pain which is another side effect of 
one of the meds, and I am so tired, even more tired than I was before and what I have done is I have exchanged 
length of life for quality of life.   
Wow  
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So yeah transplant did not improve my life, it worsened it.   
Oh I am so sorry to hear that and I feel that many people just think that when you get a transplant, you are going to 
be healed and feel amazing.   
Hey I gotta tell you I thought I did my homework, I talked to two people, one was a friend, one was somebody that 
the National Kidney Foundation paired me up with as a mentor, like a peer mentor 
Um hum 
And they both told me, you just wait, the minute you wake up from your transplant you are going to feel 100% 
better, it is such a wonderful feeling, all of a sudden you feel healthy again well what I didn’t realize was that both 
of them had been on dialysis.   
I was actually going to say it could have been because they had been on dialysis.   
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Introduction 
Hello Janice this is Melanie, how are you 
Oh pretty good hello Miss Melanie, how are you doing? 
Good, good how are you doing? 
I am doing pretty good, yeah pretty good 
How have you been feeling 
Pretty good, I just came back from an amputee bowling group 
Interesting 
Yeah it is run by one of my friends who is a kidney patient  and she got a transplant and all of that you know kind of 
goes together because the diabetes, high blood pressure, amputation, it is kind of like one big group of people  
Absolutely, that is wonderful that you all get together for a bowling league 
Yeah it was for the students who make prostetic legs and stuff who were graduating so the teacher took them out 
with the amputees and everybody just started celebrating 
Oh that is amazing 
Yeah what they do, is like they take like my friend Cheryl, she is an amputee, and what she does is she goes and lets 
them practice on her you know making a prosthetic leg because what that does is gets them used to training on how 
to do it  
Right 
So they need amputees to practice on so they can become good at it 
Wow that is amazing and she also had kidney disease too? 
Yeah yes she did, she had a kidney transplant, yes yes she does 
Oh man and you as well? 
Yes yes both of us kidney transplants.  She had a lot of similar problems as I did and I kind of you know helped her 
through it and she helps me a lot with the support group 
Wow that is wonderful 
Yes 
You and her attend a face to face support group? 
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Awesome, I did not know that, I know you were the point of contact for that group but that is wonderful 
Yes I started the All Kidney Support Group as a means to bring more awareness because every year since 2009 I 
started doing World Kidney day and educated people on kidney disease when diabetes and blood pressure issues are 
two of the number one causes and you know I would get speakers and doctors to come in and yhou know talk to 
people and different things you know and from there then I moved on and created the support group and then I 
decided to become a 5013C and you know a non-profit and we just keep growing and growing  
Wow you are an amazing advocate 
Yes yes I just thank God for all of this and the contacts I make because you know it is amazing how you just meet 
people.  You know in the dialysis center the other day we were doing a live feed and a lady came to the door and it 
was like, she was just standing there and nobody was in the lobby but me and she was just standing there and I was 
like doesn’t she know she can just ring the buzzer so I just kind of like looked at her and then I said let me just open 
the door for her.   
Oh that is sweet 
Yes and I just opened the door and she asked if I worked there and I said no and she said I know you, I know you do 
the group.  And I was like, you do?  She said yes and she said she had made some blankets for kidney patients.  She 
said that her dad was a kidney patient and he would always get cold so she made these blankets to give out to the 
kidney people.  And she said I got about 10 blanket and I was like Oh my God, Oh my God.   
That is so wonderful 
Yeah and she said and you can have all of them.  And I said I will make sure the center gets one and I told her I run 
a support group and I let her know that not only this center but every center that I go to will get one of these 
blankets.  Somebody at that center gets a blanket 
Awww you are amazing 
It is not me (laughter) there was nobody around, just me.  It was like divine timing 
Right it was meant to be.   
It was meant to be and so you know I gave some of the people, you know and then when I gave a lady the blanket a 
lady came in in a wheelchair and she was from a nursing home and I said you are going to be the first person I gave 
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one to. And I gave her a blanket and the way she looked at me, her eyes was, it was just like, you know how when 
you give a baby a candy or something like that 
Yeah 
She said, I could feel with her eyes, they were just so thankful.   
Oh that is so rewarding 
Yeah and she was like you are giving me this?   This is such a beautiful, you are giving me this? You giving me 
this? And I am like yes you deserve it.   
That is amazing 
Yes that was just, that was just something, and those eyes, oh 
How rewarding this was, you can change a life just from a blanket 
I know because she gets so cold, and she said that most of the people from the nursing home don’t have no blanket.  
Oh you are kidding, that is so sad.   
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
December will be 6 years 
Wow that is great 
Yeah 2013 I got mine 
How long were you on the list for? 
I was on the list for 14 years 
Oh my goodness 
14 years 
Were you on dialysis that whole time? 
That whole time.  I did in center, I did peritoneal dialysis, I went back to in center, and I was like oh my God, in 
center was like oh I couldn’t take it.  And then my sister saw something on the news about this machine called the 
next stage machine and she gave me the article from the newspaper and I called every name on that list who to get 
an idea.  I told them I need to know about the machine, I need to know about what it is, what it is called, how can I 
get it, what is goig on with it and they were like you know well we don’t know, we don’t know what the focus it.  
You know I did not give up until I got that machine 
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 You know you do not seem like somebody who would  
So they finally got me in and they said that in Florida the closest place was Orlando so I told my doctor about it and 
I told my doctor about it and I am like look I am fittin to move to Orlando because I want to do this dialysis 
treatment and I called Orlando and Orlando was like there are so many weeks of training.  I was like okay that is 
fine I will do it because I got to drive there everyday and so then I found out that it is in North Clearwater they have 
it.  Ok me and my friend went to Clearwater because if they have it, then that is where I got to go.   
You made sure you went there and got it 
Nope what happened was my doctor did not want to leave me.  Like my nephrologist because I would have to sign 
off from him being my nephrologist.  And he said Janice something is going down the um the line here. He said 
there is a maching that will be given out by Davita.  He said if you give me a year they were thinking about doing 
the Next Stage, he said if you give me a year, you will be one of the patients on the new machine and I told him well 
you need to be the first one to try it.  (laughter)This was a test trial for them, I had already talked to a nurse and got 
her all excited about it.  So she would be the nurse and I already had everything in place, you know by talking about 
it.  And I was in business school at the time, working on my MBA and I said look I said you would be the first 
doctor with this ne hemo and look at all the patients you could have.  I said you would be the first doctor and he 
decided to do it (laughter 
Oh that is wonderful how long ago was that, how long ago were you on the home dialysis 
I was on there for about 6 years so I was on 3 years on peritoneal, 3 or 4 no 6 years on home hemo, And then the rest 
of the 4 year years was on in center 
Oh wow 
Yes so that is about 14 years.   
That is a long time to be waiting 
Yes a long time 
Please describe some of the obstacles you experienced when trying to get waitlisted 
Yes so I knew with all of the things that I went through I said you know I gotta be able to give back to the 
community and then with my transplant in 2003 when I got ready to get onto the transplant list, they said you know 
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you gotta lose weight and all of that sort of thing and I said ok no problem, I said I am going to list on all the 
transplant lists.  I will go to Tampa General, I went to Gainesville, and I went to Miami 
You listed on all three 
Yes yep 
Where did you reside, where is your home located 
I am in St. Petersburg, FL  
And which list did you finally get your transplant from? 
Miami 
Wow 
Yep at Jackson Memorial Hospital.  I had to drive back and forth to Miami to you know get on the list, you know 
you have to do all the appointments 
Yes all the appointments 
Yep you have to be at all the appointments and I tell people you have to be at your yearly check, I tell people you 
know they would lose my check, the doctors would lose my check I sadi to them get a copy of everything, every test 
you take, get a copy, keep a copy so whatever transplant center you go to, when they say the doctor did not send in 
your echo or your ekg, I got it.   
Laughter, you got it 
Yep and when you go in with your notebook when you go for your transplant, you make sure you know because 
there is lack of communication. You know in Miami Jackson, they speak mostly um Spanish, Cuban and  I you 
know they would lose stuff, they couldn’t find stuff,  
Oh man 
Uhh it was really something. 
Allo fthat on top of trying to get healthy and getting what you need 
Yes and in 2013 they said I had calcium in my milk ducts in my left breast so I said well me and my doctor talked 
and I said well I want to stay on the transplant list I said so go and remove my left breast.   
Wowo 
So I talked them into removing it but in the process of removing it, the doctor left a capillary open in my chest 
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No way 
Yeah and I started bleeding so I bled and bled and bled and bled and so it was a little small capillary and he kept 
saying they gave me heparin and the doctor didn’t want to see me.  So I kept getting bigger and bigger and I am like 
why is my arm getting big and everything and I remember laying in the hospital bed like I feel something dripping 
down the side of my body and the nurse was like no Ms Sterling, we have nothing, but it was the blood it was the 
capillary it was small and between my skin and my tissue so I could still feel it 
Oh so you could feel it inside like it was dripping 
Yes like it was dripping because I had got over 25 to 30 transfusions and plasma 
Please discuss any people in particular that were helpful during the transplant waitlist process 
And then my nephrologist, that was my third year on the transplant list and my nephrologist say you took your 
breast off to help you but I am telling you, it is keeping you from staying on the transplant list.  Because I kept 
getting blood, kept getting blood, now he kept me alive but I kept getting blood and it will go up and then drop and 
up and drop 
Oh my goodness 
I was in the hospital for over a week or so and they started looking at me in the bed and they started I started looking 
at the machine and my blood just kept dripping and dripping and dripping.  The little JP drain would just fill up with 
blood, fill up with blood and so I was just sent back to the ICU room and the doctor said look and my nephrologist 
said we should call the administration of the hospital because something is wrong and they are not owning up to it.  
So I called and told the doctor that if you do not come see me, I am going to file charges.  I called the hospital and I 
had to say that and then the doctor came in and said what is going on Ms. Sterling, I need to be giving you all this 
heparin, I have a very busy schedule.  Whats going on? I said look I am not afraid of you, I said look get over here.  
The lord has told me you need to fix this problem so get over here and pray, you only a man so come and lets pray 
so you know what to do 
And I said give me your hand so we can pray and I prayed with him and I tell you you talk about a humble man, he 
said Ms. Sterling I am fittin to clear my schedule right now and we are going to go in and see what is going on 
Oh man 
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So when he went in, I went into surgery, that is when they had them small little cell phones. Well I stuck a cell 
phone under my thigh so it was right with me because I was so scared they wasn’t going to do right I wanted to be 
able to call my family right away 
Oh my goodness 
 So when I was in surgery, because I had so much blood and fluid in me, they couldn’t hardly get the IV in.  and 
they kept sticking me and trying to get me stuck and all of this so in the process of when they finished the surgery, 
the phone rung and when I woke up. (laughter) 
And so the doctor looked at me and said Ms. Starling, where is that phone.  I said oh don’t worry it is just my sister, 
she is calling me.  (laughter) 
You had to tell them the phone is under my leg 
(Laughter) yep I know right, and so they were like we are almost done here.  He had brought in like 5 other people 
to make sure he got the surgery correct.   
Oh my goodness 
And it was that he had left a little capillary there and it was now fixed but the damage had been done because I had 
all of the antibodies and I had already had all the transfusions.  Yep so that is why I had to wait so long, going to 
Miami, going to Shands, going to Tampa General.   
Ugh 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
Tampa General said I was overweight I was too fat.  So I wrote them a letter telling them that I am not too fat, I said 
you are discriminating against my fat (laughter).  Iwas so upset and they said they would bring me in and look at me 
and they did.  They said you know you are right, you are not normal fat, you do not have a lot of fat around your 
belly you right but you still have to lose the weight (laughter) 
 How much did they say you had to lose 
Well I was like 230, 240 so they wanted me to get down to 190, 195 
Oh my goodness 
So I went ahead and had the lap band surgery 
Oh ok 
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So I went ahead and had that done and then I lost you know the weight and I was able to get the transplant, it made 
the transplant go even better.   
I am glad the transplant is going well for you 
It is, it has its ups and downs you know 
Yes 
And I continued to educate myself by going to conferences and I learned about IVIG to help lower antibodies and I 
spoke with the doctor about it at Jackson Memorial and at that time, it had not yet been approved by the FDA but 
once it was, I had a nurse who drove up all the way from Miami it was on a Saturday or whenever she could to come 
give me the IVIG medicaition 
Wow how amazing 
Yeah so I did that for almost 2 years and once they kept giving me the medicine, this was back in 2013, this was 
when my antibodies was low enough and I could get a kidney transplant 
Wow 
Now I have had one they tried to change my medicine so I went into rejection so I had to do diaphoresis  
Oh my goodness 
And so last year, they did the same thing and so now there is the BK virus but for me I have the BK but is in my 
bloodstream and not in my kidney and so with the BK they say it is something you have to look out for, because the 
rejection level cause I am taking the antirejection medications. This is why I had to have the kidney biopsy.  I had 
like 4 to 5, almost 4 or 5 kidney biopsies where they tested my kidney to see if the BK is in the kidney but the BK is 
not in the kidney 
So now in between figuring out what is the dosage of anti rejection I have to take since I do not have the BK virus 
all the way up to the thousands.  They don’t want me to get up to 5000 or something.  So I still do labs once a week 
and they still check me for the BK virus to see what is going on with my labs 
That is a lot of work to get labs every single week too 
Oh no not each week, I meant once a month, yeah every week girl I would be like “whoo” 
Laughter 
Yeah and I am anemic, anemic, that is another problem I have  
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Oh 
I have my hemoglobin has always been off which was another sign of my kidney disease.  That is one of the other 
things I have had to deal with but you know I am still here and I am still happy 
And you are still advocating which is amazing 
Yes I am advocating that is right you know other people they don’t have it easy.  Just like I went to a conference last 
week and we have a meeting once a month and you know I met a woman who stated they had built a dialysis center 
um close to my group and I am thinking about inviting her into the group to a meeting here you know which could 
be great for some of these people 
Oh that is wonderful 
So um yeah she said that she knows a person that is homeless on dialysis.  I couldn’t believe being homeless and on 
dialysis.   
Wow and unfortunately if you get sick, you may not be able to avoid that sometimes 
Right, you right. She said she has many people on dialysis that are homeless 
This may be a population that not many people think about 
Right, right, she said she is trying to help them because most have diabetes and dialysis people that are diabetic and 
they are not able to control it, plus being homeless and just does help you know 
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
I know you already said to make copies of everything which I think is great advice 
Oh yeah copies of everything.  And multiple lists 
Multiple listing is something not many people know about and that is why you educating everyone is a great  
Yeah I am always telling people to get on many lists, I tell them about the new centers in Largo, there is one in 
Orlando, you got Shands, you got Tampa General and I think they just opened a new one in Ft. Myers.   
Oh wow 
Then there is Miami but the thing about Miami is the language there.  You got to be patient enough to deal with the 
language barrier and the paperwork  and the people, that is with any transplant center is the paperwork and the 
moving around of the paperwork. Not finding it, they say they got it, oh the fax was down, the fax was broke that 
day.  That is one thing that people don’t know.  One man thought since he went to talk to Tampa General, that bam 
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he was on the list.  It was like, well are you doing your yearly tests, your heart stress tests, etc.  The communication 
breaks down.  Are you doing your physicials, for a woman you have to do your breast tests, your pap smears, they 
don’t care if you have had a hysterectomy or not, they still want you to do it every year 
These are all things that if you don’t get the right education from your nephrologist or your center, you are left in the 
dark 
Right and then another thing that people don’t know is that if you are at a 3.5 creatinine, or predialysis, CKD, you 
should automatically start going onto the transplant list.   
You are right and that is where some people get missed.  They can absolutely start the process early 
Right you could start that process, I have had people, who ask this and I don’t want to say this but the doctors are 
funny about this.  The doctors are funny about who they tell, if you got good insurance, then they will let you know 
and if you have VA or if you are a veteran or if you are a business person, someone with a lot of money, they are 
going to let you know, you cant avoid a transplant and they start doing the tests.  So as soon as you get close, you 
get on the list, you can get a transplant and avoid dialysis.  But there are people that they say oh well, you have to be 
on Medicaid or Medicare for at least a year or year and a half before you can do anything.  Well who is in charge 
and who is the one decided which people get on the list, not get on the list, you know insurance company, the 
doctors you know and it is not fair.   
  Now they are saying you got to have at least 3,500 in the bank and you got to show it.  You gotta show it.  And that 
is crazy and you know the thing about it is they tell you that you gonna have to be able to afford these drugs, well 
you know some people are, some people don’t but you know it is just crazy.  For them to make you say you need to 
have this money in the back 
Right, before you can get on the list 
Before you can do something that can change your life. Now I tell you, that is stress enough to make you to get a 
heart attack.  You know, they just telling you to go on dialysis and you know there is no hope because you don’t 
have that kind of money.  And then you have to get up and go to work, so I can understand why some people just 
don’t want to be bothered.   
And they don’t try to get onto the list your right 
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Yep they don’t try to get on. That is something else I learned from the workshop, there is something called Lord I 
cant remember the name but some kind of kidney where like if you are like 60 years old instead of getting a kidney 
from someone that is 30 or 25, they give you a kidney from someone that is like 40.  So they are disregarding those 
kidneys or they are just tossing kidneys from like people incarcerated because they are probably thinking that they 
don’t want a kidney from someone who is incarcerated becaasu they might this or that, you know 
Yeah 
Those kidneys are going to waste and there are people who need um but you cant get um because your transplant 
center is already discriminating against you because maybe you are an African American, you have Medicare, you 
cant afford your 20% and plus you need to have your 3-5,000 dollars in the bank.  Then you gotta go fundraise 
People are afraid to donate because they are afraid they are going to kill me off, put me on ice (laughter) 
That is why it is good that you are educating people  
You are right 
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
Communication most definitely and a more fair and equal system.  Also more education like I try my best to educate 
in my group and in the community but many people do not know what is out there.  
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Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
Yes First I was put on dialysis and my doctor told me about the waitlist process and all the tests I would need to do 
in order to be put on the waitlist.   
Ok how long were you on dialysis before they mentioned the waitlist 
I was on dialysis for a little over a year 
How long did it take for you to get all your stuff in to get onto the waitlist 
Oh my goodness, it took a good couple of months, close to three months cuz where I live I had to travel an hour 
away to get the tests done 
Oh that is hard 
Yeah 
Did you list at more than one center? 
Just listed at the one center 
How long did it take for you? 
I was on dialysis for a little over 3 years, when I found a donor, from the time I found the donor to the time of the 
transplant it was about 5 months.   
Ok so total like 3 ½ years? 
Yeah 
So did you find your own donor or was it a deceased donor 
She is a living donor and she is 6 years younger than me.  Um I found my donor through the news because I posted 
on craigslist.   
Oh wow 
So that is how I found my donor through craigslist and a lot of people found me on the news and they contacted me 
and the transplant began 
That is wonderful to find people that are willing to give you their kidney  
Yes definitely’ 
I know you said that getting onto the list took you a long time Please describe some of the obstacles you 
experienced when trying to get waitlisted 
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The lack of communication with the transplant center, always getting mixed up about which test I got, which test I 
need to get, which test I don’t need to take and with the lack of communication and getting everything mixed up, the 
test I took expired so I had to go back and retake some of the tests 
Oh man 
Please describe any areas of the waitlist process that you founds to be easy to navigate 
Communication made it all difficult because with the transplant center, you cannot just pop up there with out an 
appointment so of course I was never going to drive an hour away to not be seen because I didn’t have an 
appointment you know.  So it was definitely hard with the lack of communication and then you know I didn’t know 
that anyone could apply at any transplant center.  
Which one did you end up receiving your transplant at, which state are you in 
I am in Florida and I got my transplant in Miami at Jackson Memorial 
Please discuss any people in particular that were helpful during the transplant waitlist process 
Family and friends, and there was this one lady who was like the nursing coordinator or something, I cannot 
remember her title but she was basically my transplant coordinator or whatever,  and she was very good.  When she 
came on board and started dealing with me, I did not have any more problems from that point on.  She was awesome 
both before the transplant and even after the transplant.   
That is good to have that follow up and one person you know you can talk to 
Yes 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
Well when my daughter went through the testing and then they found out we were on the news trying to get a 
kidney.  They denied us the psychological evaluation they denied it so they denied the transplant stating that she 
answered the questions too fast and they believed I was paying her to donate.  
Oh my so how did you get through that 
My mom made a phone call and went off on them, and I do not know what she said but it helped 
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
Definitely do your research and do not limit to just one hopefully you have a good support team but definitely do 
your research, there are a lot of things out there that they will not tell you.   
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Ok  
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
They just need to be better with the communication because I probably would have been on the waitlist a lot sooner 
if the communication was there to where the tests didn’t expire  
Ok understandable 
Because I did not even know that some of my tests had expired until my kidney transplant date was set so basically 
like 4 days before my transplant I am running around and trying to get my tests done rather than just waiting for my 
transplant.   
Oh man, were you ever removed from the list at all 
No 
Oh that is good 
Well my doctor told me because I was young, I was about 24 or 25 because I was very young and I was on dialysis 
for a long amount of time already, that we would need to hurry up and try to get a new kidney because when you are 
on dialysis for a certain amount of time, it can start causing heart problems.  So we knew one way or another we had 
to get this transplant.   
How long have you had it for 
7 ½ years  
Wonderful 
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Hello sir 
Hello 
So basically what I am trying to do is kind of get everyone’s story about their waitlist process so first I just want to 
ask 
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
Oh ok I had 2 kidney transplants  
Ok  
So the first one well I started, well mine is a little bit different because I was not in America when I was having 
kidney issues 
Ok  
So like when I came to America uh like in like 2000, sorry 1991, and uh I was waiting for dialysis and already I 
think after a couple of years I go on the list and then I waited for about 4 to 5 years before I got called for the 
transplant 
Oh ok, so you started dialysis in the other country? 
Yes  
Which country did you come from  
Well I come from West Africa 
Ok 
But I lived in Dubai 
Ok wow 
Yes 
So you started dialysis over there first? 
Well over there they were telling me that transplant was not an option for me because I have some other issues but 
then when I came over here, things just turned around and they were like yeah you can get a transplant. Whatever 
you know 
Well that must have been good to hear 
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Oh yeah you know and then so like after I went through the workup and everything, I went to the doctors and I got 
everything tested and then I got on the list.  That took, sorry that one was a long time so I don’t really remember 
but… 
Yeah 
But it was just maybe around 6 months, maybe less or more 
Ok 
And how long did that kidney last for 
It lasted for, I would say, it lasted for about 7 years 
Ok 
And then you went back on dialysis and started over 
Yeah then I got on the dialysis and then I moved ok well at that time I had moved to Minnesota.  Like from the 
middle east I came to Minnesota and that is where I was living.  And then I had moved to over to Florida and then I 
think in 2004 I started having problems with that kidney.  I think actually about 2003 I started having issues, 2004 I 
got back on dialysis and with that short time, I got put back on  
And you waited how long for the second one? 
That is what I am trying to remember, because I got in 2004 (counting) yeah 4 years because in 2007 I got the 
transplant 
Oh an so far so good? 
Yes so far so good 
Oh that wonderful, because that is longer than your first one 
Oh yes, oh yes 
And how are you feeling 
Oh yeah feeling good 
So I know your first transplant was in Minnesota and your second one was here in Florida 
Yes, yes 
Ok did you list on multiple centers? 
No just one in each state 
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Please describe some of the obstacles you experienced when trying to get waitlisted 
I do not really recall anything 
Not anything ok, ok 
Please discuss any people in particular that were helpful during the transplant waitlist process 
Oh my nephrologist and everyone to me to do this, this, this, have to get this thing done.  Ok, done next this.  My 
family has been always around.  Like in Minnesota when we moved it was just me and my sister I, my parents used 
to come back and forth from Dubai to here.  You know because my dad had a business in Dubai so 
Ok  
I used to live with my cousins in Minnesota, I have a few cousins. Family support has always been there for me so I 
have never any issues about that 
Well that is wonderful because I know it is hard to make a move from another country especially for medical care 
Yeah 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
No, no not at all 
Well that is wonderful 
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
Differently? I mean ok, just to come off of the subject where was the survey located 
On the online support group 
Oh yes okay, I do not know if you have been reading it much but there are a lot of people that are reading and they 
are so depressed about dialysis and stuff like that.  If they are going to be that way you know it is going to be hard 
for them so it is better to just be positive you know 
Yep from age 16 I was on dialysis and I been through all that so I mean people need to be positive, stop being 
depressed about it if you not getting a transplant you know, hopefully some day your day will come 
Absolutely 
Transplant is not and easy thing you know because you have to take so many pills and stuff like that  
Yeah 
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It is just a state of your mind, you know, that is how I look at it you know ok I have many other medical conditions, 
you know, but things could be worse you know 
That is a good outlook on life 
Yeah so, yeah that is about it 
I appreciate your story as yours is very unique 
Well see over there at that time, it was not an option for me because transplant was still new where over here they I 
think it had already started.   
Oh yes 
Thank you  
Ok no more questions 
No sir I just hope all goes well for you and you continue to feel good. 
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I have about 8 questions to ask you as I am doing my research on people’s waitlist experiences and instead of just 
getting numbers, I like to hear people’s personal stories just so we can get a better idea of what people had to go 
through 
Ok cool no problem 
First of all how are you feeling 
I am doing good thank you, very well 
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
Um yeah definitely so the first time I was uh, well lets see, I had two transplants so do you want me to give you the 
times for both of them? 
Sure if you remember them as I don’t know how long ago they were 
Yeah so the first one was 7 years ago in 2012 and I was on dialysis for 14 months and I was on the waiting list for 
shorter than that because I had gotten listed after I started dialysis 
Ok  
Because I had no clue I was in kidney failure and by the time I was in kidney failure I had to start dialysis.  By the 
time I found out I was in kidney failure I had to start dialysis and we had no idea what the process was at that point 
so I was on dialysis for 14 months and my mom was my donor and that time I had a living donor um so I want to say 
my waitlist time from the time I found out I was um probably only a year from the time I found out, I am sorry from 
the time I was listed to the time I received my transplant 
Ok 
Um so we tested a few other people in between before my mom, um my brothers had to be tested for the disease that 
I had so to rule that out.  They don’t have the disease I have so they were able but um they were not matches.  So my 
brother was tested, my dad was tested, and then a friend was tested and none of them were compatible and mom was 
tested and she was compatible however she had an iron deficiency so before we could go through with it, she had to 
go through a few months of iron infusion and have constant good numbers with her iron before she could donate.  
So then my transplant was in May of 2012 
How long did that kidney last for you 
Uh well it lasted until July of 2016 
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Ok so you got 4 years out of it, and then did you have to go back on dialysis after that? 
I did I had to go back on dialysis in July of 2016 
Wow 
Um I knew prior to that that I was in kidney failure because um I actually got listed, I got listed before I had dialysis 
this time around.’ 
Ok 
So I was listed in February of 2016  
Is that because you knew or did someone tell you to get listed 
 Um yeah my doctor knew I was going to be in failure, well I was in failure but I did not need to immediately start 
um dialysis because I was doing okay but they knew it was coming.  I was a terrible patient to be honest and the 
reason I needed another transplant was because I was not compliant 
Ok with the mediciations? 
With the medications, with follow ups, with taking caer of it, with everything.  I drank, i was just stupid then and 
this time, well by the time I had my transplant I was 22 
Ok 
So between the ages of 22 and 26 or 27 you know I am not looking to be a patient, I am looking to have fun and I 
quickly learned quickly meaning that 4 years, that that was not clearly not going to work for me.  And that was not 
going to work for me, so I obviously get another chance and they said like you know you cant do this and you cant 
do that.  Yeah I got the warnings from everybody in the transplant center.  And actually while I was waitlisted, I was 
put on hold um due to non-compliance as well, cause they were not just going to say hey you can have another 
kidney, they wanted to make sure that I was completely well, in the mental capacity to have another transplant, so 
the second transplant was in September 2017 so I was on dialysis for like 13 months.   
Wow 
Um but I was waiting longer than that I was listed in two states, I was listed in Michigan and Ohio.  And I actually 
got the call in Ohio three times however I was the backup each time so I never got, never got the opportunity to get 
the kidney then. Again I did not get a deceased donor this time, I had a family friend had gotten tested um and he 
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was a match so we went ahead once we found out he was a match in I want to say July, we scheduled it for 
September and everythgin has been good so far 
That is wonderful, it is still pretty new so hopefully it goes for a very long time 
For sure, I am doing it all right this time.   
When you waitlisted the first time were you on multiple lists then too or just one 
Um I was on Michigan and Minnesota because my main doctors were at the Mayo Clinic in Minnesota and that is 
where I actually ended up having my transplant.   
Ok  
Please describe some of the obstacles you experienced when trying to get waitlisted 
Um I wouldn’t say so no, not anything that had to do with the waitlist itself but with me and my medical issues that 
caused obstacles but the actual waitlist process no 
Please discuss any people in particular that were helpful during the transplant waitlist process 
The nurses were actually very helpful.  In the Toledo one and the Michigan one I went to both, um I have gone 
through the training for this four times now so um both introductory classes, adb the nutrition classes and the 
medication classes and all that were run by nurses for the most part and everybody really in the process was super 
helpful.  I really um I really liked my pretransplant nurse coordinator um she just like everytime she called me and 
told me about the possibility of the kidney maybe there being a kidney for me, it was like one of my family members 
was calling me.  She was just as excited as my mom was.   
Oh  
Yes so I really had some awesome people on my medical team that were just like super helpful and always there to 
answer questions and whatnot.   
Oh that is excellent and it helps to make things less stressful.    
Yes definitely so I would say the nurse coordinator for sure.   
Ok 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
No only for being a bad patient but it was warranted right (laughter) 
Ok fair enough 
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Describe anything about yourself or your personal situation that, if you had the ability to change it, would 
have made the transplant list process easier 
Um lets see if I can think of anything.  Yeah no nothing off the top of my head.  Just the travel. You know people 
that live in rural areas like that could be an issue but for me, it was not since for both transplants I had them near my 
home, even Toledo was only about an hour away so had I got a call and had to be there in under 2 hours, I could 
have done it.   
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
Um yeah follow all the rules, do everything they tell you.  I mean it is a process, be patient.  There is a lot that they 
need but there is a reason for everything that the doctors and the medical staff need so I would just say be patient 
and do whatever you need to do to get onto that waitlist.   
Ok great advice 
Yep yeah 
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
No no I personally did not run into any issues at all so no.   
Ok well I appreciate everything and I appreciate you taking the time to tell me your story.   
Absolutely thank you 
Thank you so much  
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
The waitlist process was something I had never even thought about but the steps did take longer than I anticipated.  
However after hearing other people’s experiences, I realize that my wait time was not nearly as bad as others. 
How long did it take you to get on the list 
Um, well once my wife and I figured out how to even get onto a list, it took about a year or so 
Oh wow, and how long until you received a transplant? 
I waited about 2 ½ years and was on dialysis the entire time. 
Please describe some of the obstacles you experienced when trying to get waitlisted 
Some obstacles we faced were definitely financial and insurance issues 
Oh really, how so? 
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Well we were notified that I was placed as inactive on the list because with my insurance, there was concern that I 
could not afford the medications if I did get a transplant.   
Oh my, so what did you do 
Well first of all, I had Medicare insurance and I thought I also had Medicaid but there was some kind of issue where 
the Medicaid was terminated. I called and spoke with many people at Medicaid but there was no quick fix for the 
problem so we had to fundraise and we were told we needed $5000 in the account to get back to active status 
Wow so how did you fix this? 
Well thanks to social media, we were able to raise the money in a reasonable timeframe and I was so lucky for this.   
That is amazing 
Yes but I wondered if other people have had the same experience as me and would they be able to get the money 
quick enough.  
Please describe any areas of the waitlist process that you found to be easy to navigate 
Once I actually received some type of guidance and information, I was able to navigate they process but I literally 
had no idea when we started.  
Please discuss any people in particular that were helpful during the transplant waitlist process 
My wife would have to be the one I would say was my main support.  I had a heart attack as well and required 
surgery.  This was a lot for all of us.  
I cannot even imagine 
Also the transplant RN, Brittany, I remember her name because she went above and beyond and she did not need to.  
Post transplant I was not feeling well and I could not keep any food down.  She saw me in the office and gave me 
some of her own soup that she was planning on having for lunch.  She waited with me to make sure I was able to 
keep the soup down before having me leave the office. I will be forever grateful for that and I will not forget it.   
That is such a beautiful memory 
Yes we definitely need more people like that in the world.  If only all the transplant team could be that nice.  
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
I never felt discriminated against in the process.  I am actually not even sure I paid attention to this as I was so 
overwhelmed with trying to figure out the process.   
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Ok I understand this must have been very overwhelming for you 
You have no idea 
Describe anything about yourself or your personal situation that, if you had the ability to change it, would 
have made the transplant list process easier 
Well like I said before, if I had the right insurance, we would not have had to raise any of the money.   
Totally understand 
I also wish I had better education about the whole process from the beginning.  There could hav been more 
information provided so I did not feel so lost.  
That must have been so difficult for you.  
It was but thank God I have my transplant now 
Congratulations for that   
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
I would say to educate yourself, do your research and look at all centers.   
What do you mean? 
I did not know anything about multilisting but I do wish I had because some centers have different wait times and 
different criteria for transplant.   
I agree that education is key to success 
Got that right (laughter) 
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
One of the main ways to improve the process is finding a way to shorten waittimes would obviously be ideal.  This 
would help in so many ways. 
Totally agree, I wish there were enough for everyone so they did not have to pick who gets a transplant 
Yes it would be nice if there were more available 
Also education and information could be improved. The communication could be improved as well.   
There have been many people who have said the same thing 
Well I really appreciate your time and I hope you have been feeling well. 
Yes actually, I have been feeling great thank you for asking.  I hope to read your paper when this is all completed.  
Absolutely and have a great day 
312 
 
APPENDIX J: INTERVIEW NINE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
313 
 
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
The waitlist process was something I had never even thought about but the steps did take longer than I anticipated.  
However after hearing other people’s experiences, I realize that my wait time was not nearly as bad as others. 
How long did it take you to get on the list 
Once my wife and I figured out how to even get onto a list, it took about a year or so 
Oh wow, and how long until you received a transplant? 
I waited about 2 ½ years and was on dialysis the entire time. 
Please describe some of the obstacles you experienced when trying to get waitlisted 
Some obstacles we faced were definitely financial and insurance issues 
Oh really, how so? 
Well we were notified that I was placed as inactive on the list because with my insurance, there was concern that I 
could not afford the medications if I did get a transplant.   
Oh my, so what did you do 
Well first of all, I had Medicare insurance and I thought I also had Medicaid but there was some kind of issue where 
the Medicaid was terminated. I called and spoke with many people at Medicaid but there was no quick fix for the 
problem so we had to fundraise and we were told we needed $5000 in the account to get back to active status 
Wow so how did you fix this? 
Well thanks to social media, we were able to raise the money in a reasonable timeframe and I was so lucky for this.   
That is amazing 
Yes but I wondered if other people have had the same experience as me and would they be able to get the money 
quick enough.  
Please describe any areas of the waitlist process that you found to be easy to navigate 
Once I actually received some type of guidance and information, I was able to navigate they process but I literally 
had no idea when we started.  
Please discuss any people in particular that were helpful during the transplant waitlist process 
My wife would have to be the one I would say was my main support.  I had a heart attack as well and required 
surgery.  This was a lot for all of us.  
I cannot even imagine 
Also the transplant RN, Brittany, I remember her name because she went above and beyond and she did not need to.  
Post transplant I was not feeling well and I could not keep any food down.  She saw me in the office and gave me 
some of her own soup that she was planning on having for lunch.  She waited with me to make sure I was able to 
keep the soup down before having me leave the office. I will be forever grateful for that and I will not forget it.   
That is such a beautiful memory 
Yes we definitely need more people like that in the world.  If only all the transplant team could be that nice.  
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
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I never felt discriminated against in the process.  I am actually not even sure I paid attention to this as I was so 
overwhelmed with trying to figure out the process.   
Ok I understand this must have been very overwhelming for you 
You have no idea 
Describe anything about yourself or your personal situation that, if you had the ability to change it, would 
have made the transplant list process easier 
Well like I said before, if I had the right insurance, we would not have had to raise any of the money.   
Totally understand 
I also wish I had better education about the whole process from the beginning.  There could hav been more 
information provided so I did not feel so lost.  
That must have been so difficult for you.  
It was but thank God I have my transplant now 
Congratulations for that   
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
I would say to educate yourself, do your research and look at all centers.   
What do you mean? 
I did not know anything about multilisting but I do wish I had because some centers have different wait times and 
different criteria for transplant.   
I agree that education is key to success 
Got that right (laughter) 
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
One of the main ways to improve the process is finding a way to shorten waittimes would obviously be ideal.  This 
would help in so many ways. 
Totally agree, I wish there were enough for everyone so they did not have to pick who gets a transplant 
Yes it would be nice if there were more available 
Also education and information could be improved. The communication could be improved as well.   
There have been many people who have said the same thing. 
Well I really appreciate your time and I hope you have been feeling well. 
Yes actually, I have been feeling great thank you for asking.  I hope to read your paper when this is all completed.  
Absolutely and have a great day 
You do the same. 
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Good afternoon and I want to first thank you for taking time out of your day to speak with me 
You are welcome, I really don’t mind sharing my story as I know how hard this process can be 
Totally agree.  How have you been doing? 
Well, to tell you the truth, I have been feeling great.  I am able to work which is nice but it sure does make me tired. 
I can understand that, do you take some time for yourself to get some rest? 
I try but you know, you gotta keep up the household so there is sometimes not much time for napping.   
Please discuss the steps of the transplant waitlist process and approximately how long each step took for you 
Please describe some of the obstacles you experienced when trying to get waitlisted 
Please describe any areas of the waitlist process that you found to be easy to navigate 
Please discuss any people in particular that were helpful during the transplant waitlist process 
Please discuss any times where you felt discriminated against for any reason during the waitlist process 
Describe anything about yourself or your personal situation that, if you had the ability to change it, would 
have made the transplant list process easier 
Is there any advice you would give to other patients trying to get onto the transplant waitlist 
Please discuss any areas that you feel could have been improved in order to make waitlisting easier for you? 
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